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Abstract
Eye specific CDP-diacylglycerol synthase is a key regulator in the phototransduction 
pathway of the fruit fly Drosophila melanogaster. The enzyme is responsible for 
maintaining regeneration of phosphatidylinositol 4, 5 bisphosphate (PIP2) which is 
required for normal vision. The Drosophila eye-cds mutants display light dependent 
retinal degeneration. Mammalian homologues of Drosophila mutants such as eyeless 
and eyes absent have been associated with mammalian disease. Based on these studies 
and the discovery of CDS expression in human retina, this gene would appear to be a 
good candidate for causing a retinal phenotype in mammals.
The aim of the work presented here has been to isolate and characterise the murine 
homologues of eye-cds. To this end both cDNA and genomic clones have been isolated 
using a combination of traditional molecular biology techniques and a bioinformatic 
approach. Using the identified clones, the structures of Cdsl and Cds2 have been 
confirmed. The clones were subsequently used to characterise the genes. In this thesis I 
have identified the expression pattern of both genes, showing that Cds2 is ubiquitously 
expressed in both the embryonic and adult mouse whereas Cdsl expression is more 
specific to the adult eye and brain. In addition, Cdsl has been shown to be expressed 
only in the rod photoreceptor cells within the retina. Cdsl and Cds2 clones were also 
used to map the genes to chromosome 5E1 and 2G1 respectively. The remit of this 
thesis was further expanded to include the potential function of the murine genes. To 
this end, transgenic constructs of both genes were made for the rescue of the mutant 
Drosophila phenotype and a construct was prepared as a first step in the generation of a 
Cds2 null mouse.
In summary, the study reported in this thesis has succeeded in isolating and 
characterising the murine Cdsl and Cds2 genes. The expression pattern of the two 
genes has been determined both in a large panel of tissues and within specific cell types. 
The chromosomal location of both genes has been determined and constructs made for 
use in developing transgenic mice and flies for the study of gene function.
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CHAPTER ONE
INTRODUCTION
The use of Drosophila melanogaster as a model system has proved to be an invaluable 
tool in trying to understand the complexities of human disease. Mammalian 
homologues of several Drosophila genes involved in the development of the visual 
system have been shown to be involved in human eye disease. The work presented in 
this thesis is a result of extending this model to the phototransduction pathway. The 
enzyme CDP-diacylglycerol synthase (cds), is required for the regeneration of 
phosphatidylinositol, 4, 5-bisphosphate (PIP2). The hydrolysis of PIP2 is required in 
the Drosophila phototransduction cascade to mobilise internal calcium stores which 
operate the ion-gated membrane channels (see section 1.2). eye-cds is a tissue-specific 
form of the enzyme in Drosophila. When eye-cds is mutated in flies it results in light- 
induced retinal degeneration. The work presented here is the analysis of two murine 
homologues of eye-cds, Cdsl and Cds2.
This chapter is divided into three sections, the first is a description of the structure and 
development of the Drosophila and mammalian eye. The second section will discuss 
phototransduction and the third section is an overview of some of the techniques 
employed in this study
1.1 Ocular Structure and Development
1.1.1 Drosophila ocular structure
The fly ocular structure is very complex and highly organised. The adult compound eye 
(figure 1.1) is composed of eight hundred individual units, the ommatidia. Each 
ommatidium is positioned to capture light from distinct, but overlapping, visual fields. 
Each ommatidium is composed of twenty cells, which include, eight photoreceptor cells 
with twelve accessory bristle, lens secreting and pigment cells. This arrangement of 
cells means that each compound eye contains approximately sixteen thousand cells.
The cells of the eye are all derived from a single monolayer of epithelium and the
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Figure 1.1 Compound eye of Drosophila melanogaster
Shown is a scanning electronmicrograph of the compound eye 
of Drosophila melanogaster. The honeycomb pattern is formed 
from the 800 hexagonal ommatidia that are conical in shape 
resulting in the curvature seen in the adult eye. The bristles and 
the regular lenses which overlay the ommatidia can also be seen 
(Brennan and Moses, 2000).
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columnar appearance is retained in the adult cells. The cells still contain their apical 
and basal connections but each ommatidium widens basally to apically to form a conical 
shaped unit that gives the curvature to the surface of the adult eye (Wolf and Ready, 
1993).
The photopigments of each photoreceptor are embedded into the microvillar membrane 
stacks, called rhabdomeres, that extend from each photoreceptor cell into a central space 
in the ommatidium (figure 1.2). There are a total of eight rhabdomeres (R1-R8) 
arranged in a specific orientation within the ommatidium. The rhabdomeres of the outer 
photoreceptors, R1-R6, can be individually identified by the position they occupy in the 
irregular trapezoid shape that they form. R1-R6 span the full height of the ommatidium 
and contain a blue-sensitive opsin molecule (see section 1.1.3). These outer receptors 
provide ‘high-sensitivity’ light-capturing properties to the retina and have been likened 
to the vertebrate rod cells (Bowmaker et al., 1991; Zuker, 1996) (see section 1.1.3).
The smaller, more central photoreceptors containing R7 and R8 have UV and blue- 
green sensitive opsin molecules respectively. These photoreceptors are similar to the 
vertebrate cone cells and confer a ‘high-acuity’ photoreceptive capacity (Zuker, 1996).
The axons from each of the eight photoreceptors of the ommatidium pass through the 
basement membrane and extend directly into the brain via the optic stalk for signal 
transduction. The projections from the ommatidia to the optic lobe of the brain are 
complex. Since each ommatidium is cone shaped, the rhabdomeres within each 
ommatidium are not parallel. Individual axons from each rhabdomere in the 
ommatidium have to separate and join with parallel axons from neighbouring 
ommatidia before projecting into the brain. This arrangement allows a high degree of 
sensitivity while maintaining visual acuity. The precise array of components must be 
maintained for the complex visual system of the fly to operate (Meinertzhagen and O' 
Neil, 1991; reviewed by Brennan and Moses, 2000).
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Figure 1.2 Schematic representation of an adult ommatidium
A schematic representation of the adult Drosophila ommatidium, showing 
the arrangement of the rhabdomeres (R1-R8) and the various pigment cells 
taken at different cross-sections, indicated, in the ommatidium (adapted from 
Freeman et al., 1997; Brennan and Moses,2000).
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1.1.2 Drosophila ocular development
Drosophila melanogaster belongs to the Endopterygota group of insects. This group 
progresses through three larval stages called instars before pupating to form the adult 
fly. The eye of the adult fly develops from an epithelial pouch, called an imaginal disc, 
consisting of approximately twenty cells derived from the optic primordium in the 
embryonic blastoderm. The disc grows through larval life having increased in cell 
number by one hundred fold by the third larval instar. Differentiation of the cells in the 
disc is initiated in the final larval instar and is completed during larval metamorphosis. 
At this stage the disc evaginates and fuses with other imaginal tissues (Haynie and 
Bryant, 1986). To form the adult eye structure, a small number of discrete units are 
formed and are used as a template to form identical repeats units which join to give the 
final eye structure. The template units in the eye are the ommatidia. The development 
of the imaginal disc towards the adult eye structure starts in the third larval instar at the 
posterior edge, and expands anteriorly following a morphogenetic furrow. This furrow, 
which is an indentation in the eye disc that marks the anterior boundary of neural 
patterning, sweeps anteriorly across the disc (figure 1.3). Ommatidial photoreceptor 
clusters are specified one column at a time, beginning at the posterior margin of the eye 
imaginal disc during initiation of differentiation. They emerge from the furrow at the 
rate of one column every two hours (Ready et al., 1976). The morphogenetic furrow is 
caused by the co-ordinated apical-basal contractions of cells and moves in a wave-like 
motion over the disc in a period of approximately two days. Anterior to the furrow, the 
cells divide randomly, but at the furrow they synchronise and arrest in the G1 phase of 
mitosis. In, and posterior to the furrow, a subset of cells are determined as the initial 
five photoreceptors. The remaining cells undergo another round of co-ordinated mitosis 
several hours later, this new pool of cells provide the components required to complete 
the ommatidium. The remaining components include the final three photoreceptor cells, 
the four cone cells and, after pupation, the bristle and pigment cells (reviewed by 
Brennan and Moses, 2000).
As briefly mentioned above, the photoreceptor cell specific rhabdomeres differentiate 
sequentially. The founding photoreceptor cell in each ommatidium contains 
rhabdomere 8 (R8). R8 is required for the pair-wise recruitment of the other seven
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Figure 1.3 Drosophila ocular morphogenetic furrow
(A) shows a late third-instar eye disc stained to reveal filamentous cytoplasmic actin. Anterior is to the 
right where cells are randomly dividing. The posterior shows a more organised cell pattern. The intense 
condensation of apical cell profiles, that indicate the morphogenetic furrow, is highlighted by arrows. (B) a 
late third-instar eye disc stained to show neural differentiation, this staining notes the maturity of the cells 
and the formation of the ommatidia behind the path of the morphogenetic furrow (Brennan and Moses, 
2000).
cells. The assembly of the photoreceptors of the ommatidium is dependent on cell-cell 
interactions. R2 and R5 are the first pair of cells to be recruited by R8, followed by R3 
and R4, then by R1 and R6. The final cell to be recruited is R7 followed by the cone 
and pigment cells (figure 1.4). The steps in retinal determination are tightly controlled, 
in terms of rate of expansion and differentiation, with synchronised cell cycles and 
recruitment of cell types to the ommatidium cluster, as this is essential to build the 
compound eye with such high complexity.
1.1.3 Mammalian eye structure
All mammals have simple eyes with a single optical system that forms a single image. 
The roughly spherical human eye is a good representative of a mammalian eye. The 
adult eye is a fluid filled chamber, about 24mm in diameter, contained within three 
coats, or layers, the sclera, the choroid and the retina.
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Figure 1.5 Schematic representation of a human eye
A schematic representation of a cross-section of a human eye. The main structures of 
the eye are indicated. The sclera, choroid and retinal are represented by the beige, 
brown and yellow layers respectively.
The outermost coat, the sclera is a tough fibrous layer that protects the ocular tissues 
and provides structural support for the intraocular contents as well as forming
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Figure 1.4 Differentiation of Drosophila rhabdomeres
A schematic representation of ommatidial assembly. Shown are the first steps of ommatidial assembly of 
photoreceptor cells starting with the photoreceptor containing rhabdomere 8 (R8), then the pair wise recruitment of 
the other cells which have been numbered. Cone cells are labelled C and primary pigment cells labelled P (adapted 
from Kumar and Moses, 1997).
attachments to the extraocular muscles. The sclera is opaque and constitutes the ‘white’ 
of the eye except at the front where it becomes transparent and forms the cornea. The 
cornea is responsible for most of the refraction of light entering the eye, thus the 
transparency of the cornea is of upmost importance. The transparency arises due to the 
regularity and smoothness of the covering epithelium, its avascularity and the regular 
arrangement of the extracellular and cellular components of the central comeal layer 
called the stroma. The state of hydration, metabolism and nutrition of the stromal 
elements controls the effectiveness of the cornea. The surface of the cornea, which 
provides a tough physical barrier to infection and damage, is kept moist and dust-free by 
secretions from the tear glands.
The choroid, the middle layer, is deeply pigmented with melanin. The pigmentation 
reduces the reflection of stray light within the eye. At the front of the eye the choroid 
coat forms the iris which is also pigmented. It is the iris that is responsible for ‘eye- 
colour’. There is an opening at the front of the choroid, the pupil, the size of which is 
variable and is under the control of the autonomic nervous system. The pupil can vary 
in size from l-8 mm. The functions of the pupil include the regulation of the amount of 
light entering the eye (it increases 16-fold on dilation from 2  to 8 mm), and increases the 
depth of focus for near vision and minimises optical abberations.
The lens is located just behind the iris, a third of the way between the front and back of 
the eye. It is held in position by suspensory ligaments, called zonules, which extend 
from an encircling ring of muscle. The lens is a highly organised system of specialised 
surface ectoderm-derived cells, which are highly ordered and tightly packed with 
structural proteins called crystallins. The lens constitutes an important component of 
the optical system of the eye. The lens can alter the refractive index of light entering the 
eye and focus it onto the retina. The lens has less refractive power than the cornea but 
due to the cilary muscles of the eye the lens can change shape and alter its refractive 
power. The lens and the iris divide the eye into two main chambers: the front chamber 
is filled with a water-like material, the aqueous humour, and the rear chamber is filled 
with a jelly-like material, the vitreous humour. These fluids transport oxygen and 
nutrients as well as removing waste products and helping to maintain the shape of the 
eye.
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The retina is the innermost coat of the eye and consists of two primary layers, the inner 
neurosensory layer and the outer retinal pigment epithelium (RPE). The retina has two 
roles, firstly, to form a retinal image by detection of light and, secondly, to inform the 
brain about the features of the image that can be used to construct a mental picture of
•y
the external objects that are imaged on the retina. The retina is approximately 1250mm 
and varies in thickness from 100pm at the periphery to 230pm at the optic nerve head. 
The neural retina is highly complex, it contains the photoreceptor cells, the rods and 
cones, as well as a variety of nerve cells. In all vertebrates there is an optical disk where 
the nerve fibres exit the eye via the optic nerve. This disk contains none of the normal 
retinal layers and is referred to as the ‘blind spot’. The peripheral retina is 100-140pm 
thick and is rich in rod type photoreceptor cells. The foveal pit is an area of the retina 
near the optic nerve where cone photoreceptors are concentrated at maximum density 
with exclusion of the rods, and arranged at their most efficient packing density, which is 
in a hexagonal mosaic. The whole foveal area is referred to as the macula of the human 
eye. The macula has a yellow hue due to the reflection from yellow screening pigments, 
the xanthophyll carotenoids, zeaxanthin and lutein present in the cone cell axons. The 
macula is thought to act as a short wavelength filter, in addition to that provided by the 
lens. As the fovea is the most essential part of the retina for human vision, protective 
mechanisms for avoiding bright light and especially ultraviolet irradiation damage are 
essential (Forrester et al., 1996)
The retina is traditionally shown to contain ten main layers, but these can be subdivided 
further (figure 1.6). The layer furthest from the incident light, the vascular choroid, 
supplies the outer retina with nutrients. Bruch’s membrane, a thin layer which delimits 
the retina proper, supports the basal surfaces of the cells of the retinal pigment 
epithelium (RPE). The RPE separates the retina from the choroid circulation and 
consists of a single continuous layer of roughly cuboidal cells that contain the pigment 
melanin. While it is not directly involved in any of the neural events in vision, the RPE 
is critical for the normal functioning of the photoreceptors. The RPE has multiple 
functions such as, maintaining the interphotoreceptor matrix, transporting water and 
metabolites, maintenance of the blood-retinal barrier, immunoregulation and free radical 
scavaging, but the most important role of the RPE is the maintenance of the physiology
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Figure 1.6 Cross-section of the adult human retina
The section of the retina shown is taken from near the fovea 
illustrating the 10 main layers of the human retina. Over­
laid is a schematic representation of the locations of the 
major classes of neurones found in the retina (adapted from 
Oyster, 1999).
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of the photoreceptors. The RPE cells act as phagocytes to remove ‘spent’ photoreceptor 
tips in the diurnal process of photoreceptor renewal where the outer segments are shed. 
The RPE also participates in the recycling of 11 -cw-retinal required for 
phototransduction.
There are two types of visual photoreceptors in the mammalian retina, the rod and cone 
cells, identified in accordance with the morphological appearance of their light sensitive 
tips. The human retina contains around 120 million rods and 6  million cones. Each cell 
type has the same basic structure: an outer segment linked via a connecting cilium to the 
inner segment containing the nucleus and finally the synaptic body, which allows the 
transmission of impulses (figure 1.7). The photoreceptor cells span four of the 
traditional retinal layers: their outer and inner segments lie in the photoreceptor layer; 
their nuclei form the outer nuclear layer, and their axons and terminal endings make up 
the outer plexiform layer (figure 1 .6 ).
A photoreceptor cell is characterised by the photopigment that it contains. All the rods 
contain the same visual pigment, giving one type of rod photoreceptor. There are three 
types of cone photoreceptors, each ‘tuned’ to absorb light maximally from a portion of 
the spectrum of visible light due to the differing visual pigment; long-wavelength light 
(558nm) (red), middle-wavelength light (531nm) (green) and short-wavelength light 
(419nm) (blue) (Oprian et al., 1991; Merbs and Nathans, 1992).
The visual pigments are embedded in the membranes of the lamellae (flattened discs) of 
the outer segments of the photoreceptor cells. The discs are produced at the base of the 
outer segments and over the course of approximately ten days travel to the tips, which 
are enclosed by the apical microvilli of the RPE where spent tips are phagocytosed. The 
visual pigment molecules are the most abundant proteins within the outer segments, 
accounting for approximately 80% of membrane proteins present (Nathans, 1987). The 
density of the visual pigments in the discs of the outer segments is such that it is easy 
for even a single photon of light to stimulate a visual pigment molecule. The absorption 
of photons by these light sensitive pigments triggers a conformational change that 
stimulates the phototransduction cascade, which leads to a neural output from the 
photoreceptor cell which is modified and sent to the brain. The phototransduction 
cascade will be described later in section 1 .2 .
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Figure 1.7 Structural comparison of rods and cones
A schematic diagram of a transverse section though a rod and 
cone photoreceptor cell. The morphological similarities and 
differences between the cells are shown (adapted from Ali and 
Klyne, 1985).
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Each visual pigment consists of a transmembrane protein, opsin, coupled to a 
chromophore, retinal, a derivative of vitamin A. The opsins belong to the large family 
of seven transmembrane domain G-protein coupled receptors. These are integral 
membrane proteins that have an oc-helical conformation (Baldwin, 1993; Schertler et al., 
1993; Alkorta and Du, 1994). The opsin molecules are characterised by seven 
hydrophobic transmembrane domains (helices I-VII) that are linked by extramembrane 
hydrophilic loops (Mollon, 1991; Khorana, 1992; Trumpp-Kallmeyer et al., 1992). The 
amino-terminus (N-terminus) and the carboxy-terminus (C-terminus) of the protein lie 
within the extracellular and cytoplasmic regions of the cell membrane respectively 
(figure 1.8). The chromophore molecule is located in the seventh helix of the opsin 
molecule and is connected by a covalent Schiff-base linkage to a lysine residue 
(Bownds, 1967; Wang et al., 1980; Findlay et al., 1981; Thomas and Stryer, 1982). The 
chromophore is usually the 11 -cis isomer of vitamin A aldehyde, 11-czs-retinal (figure 
1.9). Retinal is a long-chain molecule that can exist in two forms: a straight chain form 
called all-/ra«s-retinal (figure 1.9) or a bent form, 11-c/s-retinal. It is only the bent 
conformation, that can bind to the opsin molecule. The retinal is the portion of the 
photopigment first affected by light absorption and is considered to be the active part of 
the opsin-retinal complex.
In addition to the photoreceptors, the retina contains bipolar and ganglion cell neurones 
that relay impulses generated by light. The activity of these neurones is modulated by 
other cell types such as horizontal cells, amacrine cells and possibly by non-neuronal 
elements. Synaptic junctions that form between bipolar, amacrine and ganglion cells 
give rise to the inner plexiform layer of the retina. The ganglion cell layer of the retina, 
as the name suggests, contains the ganglion cell bodies and the axons of the ganglion 
cells that travel to the optic disk from the nerve fibre layer of the retina. The ganglion 
cell axons are the sole information channels from the eye to the brain. Ganglion cells 
remain active constantly, even in the dark they generate trains of action potentials and 
conduct them back to the brain along the optic nerve. Vision is based on the 
interpretation and modulation of these nerve impulses by the brain (reviewed by 
Forrester et a l, 1996; Oyster, 1999).
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Figure 1.8 Schematic representation of rhodopsin in the plasma membrane
Schematic illustration of the rhodopsin molecule situated in the plasma membrane of a photoreceptor outer segment disc. The 
illustration shows the site of retinal binding in the seventh transmembrane domain, indicated by a red arrow (adapted from 
Hargrave, 1996; rhodopsin molecule courtesy of S. Wilkie and D. Hunt).
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Figure 1.9 Molecular structure of the two retinal isoforms
Shown are the molecular structures of the bent 11 -cw-retinal which covalently binds to 
the opsin molecule, and the straight all-£ra«s-retinal (adapted from Montell, 1999).
1.1.4 Mammalian ocular development
The human eye is representative of most mammalian eyes, and for the purpose of this 
section will be used to describe the ocular developmental process in mammals. The 
mammalian eye is a projection from the brain, and is formed by evagination of the 
anterior neural tube. The walls of the optic evagination are continuous with the 
forebrain and consist of neural epithelium. As development progresses the evagination 
gets displaced laterally and becomes bulbous at the periphery while the walls towards 
the forebrain become narrowed to form the optic stalk. The optic stalk will eventually 
become the optic nerve. The bulbous portions are the optic vesicles; these face the 
lateral aspect of the embryonic head but will rotate with further development to ensure 
that the present rostral aspect will become the future medial aspect. Invagination of the 
optic vesicle occurs on the future medial aspect to complete the formation of the optic 
cup. The outer layer of neuroepithelium which lines the cup will form the pigmented
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epithelium of the retina, cilary body and anterior iris epithelium. The inner lining layer 
will form the neural retina, non-pigmented epithelium of the cilary body and the 
posterior iris epithelium. The primary vitreous and hyaloid vessel system is formed 
from invasion of vascular mesenchyme from the optic primordium. Growth of the optic 
cup brings ventromedial edges towards each other for fusion. The cup is completed by 
trapping hyaloid vessels in the stalk; these will become the future central vessels of the 
retina.
Through invagination, the neural retinal layers and the retinal pigmented epithelium 
(RPE) are formed and are continuous. The developmental margins are still apparent; 
and it is from these margins that the cilary body and the iris will arise forming a 
pupillary margin. Figure 1.10 illustrates the development of the eye (reviewed by 
Forrester et al., 1996). The primitive neural retina has two layers; the outer nuclear 
zone and the inner acellular zone. The layers rest on their respective basal laminae, the 
inner zone is the inner limiting membrane and the outer is incorporated into Bruch’s 
membrane. Mitotic activity is greatest in the outer nuclear zone. The new cells then 
migrate to the inner zone to form the inner neuroblastic layer. The outer nuclear zone is 
now called the outer neuroblastic layer. Cells in the inner neuroblastic layer will later 
form ganglion cells, Muller cells and amacrine cells. The nerve fibre layer can be 
identified on the inner aspect of the neuroblastic layer due to the growth of ganglion cell 
axons converging at the optic stalk. The inner plexiform layer is formed from cellular 
processes intermingling. The new inner nuclear layer contains amacrine and Muller cell 
bodies. Shortly afterwards the bipolar and horizontal cells differentiate and migrate 
from the outer neuroblastic layer. The remaining components of the outer neuroblastic 
layer contain the cell bodies of the photoreceptors. The zone where the fibres from this 
layer intermingle with those of the inner nuclear layer constitute the new outer 
plexiform layer. The external-limiting boundary of the retina is identifiable in the 
earliest stages as rows of tight and gap junctions between adjacent neuroblasts.
Microglia invade the retina at four months gestation at around the same time as the 
synapses form in the cone pedicles. This is about one month before the same process 
occurs in the rod spherules. At four and a half months, the processes between the rod 
and cones can be identified and terminal expansion of the Muller cells beneath the inner 
limiting membrane mature around this time. At five months the photoreceptor outer
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Figure 1.10 Schematic representation of the development of the 
mammalian eye
The retina is derived from the neural tube(l). The retina is formed during 
development of the embryo from optic vesicles out pouching from two 
sides of the developing neural tube (2). The primordial optic vesicles fold 
back in upon themselves to form the optic cup with the inside of the cup 
becoming the retina and the outside remaining a single monolayer of 
epithelium known as the retinal pigment epithelium (RPE) (3). Initially 
both walls of the optic cup are one cell thick, but the cells of the inner 
wall divide to form a neuroepithelial layer many cells thick which form 
the retina (taken from Forrester et al., 1996).
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segments start to form and horizontal cells become distinguishable (reviewed by 
Forrester et al., 1996).
The RPE is first seen at 28 days when melanin can be identified. The cells form a 
mitotically-active ciliated epithelium. As melanogenesis progresses, the cilia disappear. 
The cells are uniformly sized and hexagonal in shape. Mitotic activity starts as early as 
28 days after fertilisation but stops before birth. Growth then occurs by the enlargement 
of existing cells (reviewed by Forrester et al., 1996).
1.2 Phototransduction
The photoreceptors in both mammals and Drosophila are very specialised structures and 
although they are physically different, they both possess a large membranous surface 
area to facilitate ion transfer. Both the mammalian and Drosophila phototransduction 
cascades are initiated by a photon of light causing a conformational change in a 
rhodopsin molecule, which then activates a G-protein cascade. It is after this point that 
the two systems differ and follow two distinct pathways (Figure 1.11). In brief, in 
mammals a G-protein cascade causes hydrolysis of cGMP by phosphodiesterase that 
results in the closure of membrane channels. This is in contrast to Drosophila where 
the G-protein cascade results in the hydrolysis of phosphatidylinostitol-4, 5, 
bisphosphate (PIP2) generating inositol triphosphate (IP3) and diacylglycerol (DAG).
IP3 starts a chain of events that leads to Ca release which opens membrane channels. 
Although the end cycles differ and the resultant effect on the channels is converse, both
OA- • •  • • •systems use Ca to cause deactivation and adaption. This section will descnbe m more 
detail both the Drosophila and mammalian cascades and the evidence that elements 
used in the Drosophila cascade are found in the mammalian retina.
1.2.1 Drosophila phototransduction
The Drosophila phototransduction pathway has been studied intensively but is still not 
fully understood. The G-protein cascade in this pathway is the fastest known, taking 
only a few tenths of a millisecond to occur. As discussed in section 1.1 the light 
sensitive molecule, rhodopsin, has two components, a seven a-helical transmembrane 
protein called an opsin, and a vitamin A derived chromophore which is covalently 
bound to the seventh helix of the opsin (figure 1.12). When a photon of light hits the 
rhodopsin molecule, a conformational change occurs in the chromophore. This event
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Figure 1.11 Comparison of phototransduction in Drosophila and 
mammals
Shown is a very simple schematic representation of the similarities 
and differences between the Drosophila and human phototransduction 
cascades.
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Figure 1.12 Structure of an opsin molecule
A secondary structure diagram of bovine Rho. Amino acid residues are depicted in single-letter code. The 
amino-terminal tail and extracellular domain is toward the top, and the carboxy-terminal tail and cytoplasmic domain is 
toward the bottom. Transmembrane a-helical segments (HI to H7) and the cationic amphipathic helix H8 are shown in 
colored cylinders. An essential disulfide bond links Cys-110 and Cys-187. Cys-322 and Cys-323 are palmitoylated. Inset: 
structure of the 11 -c/s-retinylidene (RET) chromophore. Carbon atoms are numbered 1 through 20 (adapted from Menon 
et al., 2001)
results in the isomerisation of the 1 1 - 1 2  double bond in the 1 l-czs-retinal molecule 
which converts it into the alWraws-retinal form (figure 1.9) (Vogt and Kirchfeld, 1984; 
Tanimura et al., 1986). The al\-trans conformation is active and is referred to as 
metarhodopsin. The active metarhodopsin molecule activates a heterotrimeric G- 
protein, Gapy. The inhibitory Py subunits are removed and the GTPa molecule becomes 
active. It is at this point that the Drosophila and mammalian cycles cease to follow 
similar pathways. The active GTPa molecule couples to and activates a phospholipase 
C molecule (PLCp ). The PLCp molecule is the effector molecule of the Drosophila 
pathway (Lee et al., 1990; Scott et al., 1995) (figure 1.13).
PIP2 is a membrane lipid, which is hydrolysed by the PLCp effector molecule into two 
intracellular messengers, inositol triphosphate (IP3) and diacylglycerol (DAG). IP3 
mobilises Ca2+ from internal stores. DAG activates protein kinase C (PKC). This 
reaction leads to the opening of selective cation channels and the generation of 
depolarising receptor potentials (reviewed in Baylor, 1996; Zuker, 1996). It is thought 
that there may be up to fifty different gene products involved in this cascade (Smith et 
al., 1991; Zuker, 1992; Ranganathan et al., 1995).
Eye-specific isoforms of many of the elements involved in phototransduction have been 
identified. Table 1.1 lists known genes from the Drosophila phototransduction pathway 
with their functions. Examples include eye-specific PKC, which is required for 
deactivation of calcium feedback regulation (Ranganathan et al., 1991; Smith et al.,
1991), and eye-specific CDP-diacylglycerol synthase (eye-cds) which catalyses the 
conversion of phosphatidic acid (PA) into CDP-DAG. CDP-DAG is the acceptor 
molecule for inositol head groups. Drosophila cds mutants undergo light-dependent 
retinal degeneration. The general points of the PLC signalling cascade are, (i) PIP2 is 
synthesised on demand, (ii) PIP2 pools for signalling are distinct from the general pool, 
(iii) PIP2 availability is the rate-limiting step in regulating the output of the signalling 
pathway (Wu et al., 1995). Figure 1.14 schematically illustrates the PIP2 regeneration 
cycle.
These initial steps in phototransduction are well established, however recent findings 
suggest that events that occur downstream are more complex than first thought 
(Tsunoda et al., 1997; Montell, 1998). The control mechanism of Drosophila
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Figure 1.13 Drosophila phototransduction cascade
Phototransduction in Drosophila photoreceptors. Absorption of a photon 
causes a conformational change in the rhodopsin molecule (R) and 
activates its catalytic properties. Active metarhodopsin (M*) catalyses 
G-protein activation. Active G-protein catalyses the activation of norpA- 
encoded PLC which hydrolyses PIP2 into IP3 and DAG. Extracellular 
Na+ and Ca2+ enter the cell through the light-activated conductance and 
cause the depolarisation of the photoreceptor cells. Light-activated 
conductance is composed of at least two types of channels. The trp gene 
is required for a class of channel with high calcium permeability. DAG is 
thought to modulate a photoreceptor cell-specific PKC (encoded by inaC) 
that regulates deactivation and desensitisation of the light response. 
Metarhodopsin is inactivated via phosphorylation by rhodopsin kinase 
(RoK) and arrestin binding (encoded by the arrl and arr2 genes (Mppp- 
Arr)). Inactive metarhodopsin is photoconverted back to rhodopsin and 
then dephosphorylated by the rdgC-encoded phosphatase (adapted from 
Zuker, 1996).
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Locus Protein Product Function Retinal degeneration
arrestinl Arrestin Rhodopsin inactivation Not examined
arrestin2 Arrestin Rhodopsin inactivation Yes (light dependent)
cds CDP-DAG synthase Production of PIP2 intermediate Yes (light dependent)
Gqa a-subunit of G-protein Activation Not examined
Gqp P-subunit of G-protein Activation/deactivation Not examined
inaC Protein kinase C Deactivation/adaption Not examined
inaD PDZ containing protein Activation/deactivation Yes (light dependent)
ninaA Cyclophilin homologue Rhodopsin transport Yes (light independent)
ninaC Protein kinase Deactivation/adaption Yes (light dependent)
ninaE Rhodopsin Light receptors Yes (light independent)
norpA Phospholipase C Activation Yes (light dependent)
rdgA DAG-kinase Production of PIP2 intermediate Yes (light independent)
rdgB PI transfer protein Recovery from light stimulus Yes (light dependent)
rdgC Protein phosphatase Rhodopsin phosphatase Yes (light dependent)
trp Cation channel Light-responsive channel Yes (light dependent)
trpl Cation channel Light-responsive channel Not examined
Table 1.1 Genes from the Drosophila phototransduction cascade
Listed are the genes from the Drosophila phototransduction cascade with their protein product named,
their predicted function and whether a mutation in that gene causes retinal degeneration to occur (taken from Montell, 1999).
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Figure 1.14 Drosophila PIP2 regeneration cascade
Upon activation phospholipase C hydrolyses phosphatidylinositol-4,5-bisphosphate (PIP2) to yield inostiol 
triphosphate (IP3) and diacylglycerol (DAG). To regenerate PIP2, DAG is phosphorylated by DAG kinase to 
phosphatidic acid (PA). PA is converted to CDP-diacylglycerol (CDP-DAG) by the enzyme CDP-diacylglycerol 
synthase (CDS). CDP-DAG is the activated donor of the phosphatidyl group to inositol. Phosphatidylinoitol (PI) is 
phosphorylated by PI kinase to give phosphatidylinoitol monophosphate (PIP) which is phosphorylated by PIP 
kinase to yield PIP2. The genes encoding the enzymes of the pathway are shown in red. Broken arrows indicate a 
number of steps to reach the product (adapted from Wu et al., 1995)
phototransduction is still not fully understood, but recent findings suggest that the 
control is very complex and tightly regulated (Tsunoda et al., 1997; Montell, 1998).
Ca ions are required for the opening and closing of channels in the photoreceptor cells 
that govern phototransduction. The light dependent influx of these ions is highly 
transient and spatially localised to small regions within the rhabdomeres (Ranganathan 
et al., 1994). Since the Ca2+ influx appears to be limited to small domains, and other
04 -signalling proteins require Ca as part of their negative feedback loop, a problem would 
arise if the upstream signalling proteins were spatially separated from the ion channels. 
Recent findings suggest that most proteins that function in Drosophila 
phototransduction are assembled into a supramolecule called a signalplex. The 
signalplex involves at least seven signalling proteins binding to a scaffold protein called 
INAD (reviewed in Montell, 1999).
INAD has five protein interaction domains referred to as PDZ domains, PDZ 1-5. PDZ 
is named after a domain common to PDS-95 (postsynaptic density protein), Drosophila 
disc large (dig) and the tight junction protein ZO-1 (Shieh and Niemeyer, 1995; Huber 
et al., 1996b; Saras and Heldin, 1996). The proteins bound to the scaffold include 
rhodopsin (Rhl) (Xu et al., 1998a), PLC (Huber et al., 1996a; Chevesich et al., 1997), 
PKC (Huber et al., 1996b; Adamski et al., 1998; Xu et al., 1998b), neither inactivation 
nor afterpotential C (NINAC) (Wes et al., 1999), calmodulin (Xu et al., 1998a), and 
both light sensitive channels transient receptor potential (TRP) (Huber et al., 1996a; 
Shieh and Zhu, 1996), and transient receptor potential-like (TRPL) (Xu et al., 1998b). 
Figure 1.15 schematically illustrates the structure of the signalplex in the plasma 
membrane.
Mutations in INAD disrupt the rhabdomere specific localisation of TRP, PLC and PKC 
while spatial distribution of the remaining binding proteins are not influenced by the 
presence or absence of INAD (Chevesich et al., 1997; Shieh et al., 1997; Tsunoda,
1997; van Huizen et al., 1998). It seems that most if not all of the interacting proteins 
are complexed into a signal unit since Rhl and PLC co-immunoprecipitate with TRP 
from wild type but not from inaD mutant photoreceptor cells (Chevesich et al., 1997). 
INAD appears to self assemble in vitro to form oligomers with a subunit composition of 
eight or greater (Xu et al., 1998a). The multimerisation is thought to occur under the
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Figure 1.15 Schematic representation of the signalplex complex
Model of the signalplex. Shown is an INAD homomultimer consisting of several INAD monomers that interact 
through homo- and heterophilic interactions between PDZ3 and PDZ4. Each INAD monomer contains five PDZ 
domains indicated by numbered ovals. INAD binds to a minimum of seven target proteins: rhodopsin (Rh), PLC, 
PKC, NINAC, TRP, TRPL and calmodulin (CaM). With the exception of CaM, which binds to the linker region 
between PDZ1 and PDZ2, the remaining INAD targets bind to one or more PDZ domains (numbered 1-5). Because 
NINAC is an actin-binding protein, the actin-based cytoskeleton may be indirectly coupled to the signalplex 
(adapted from Montell, 1999)
control of PDZ3 and PDZ4. Homomultimerisation and target binding occurs 
simultaneously (Xu et al., 1998a). If this homomultimerisation happens in vivo a single 
signalplex could indirectly link many TRP and TRP/TRPL ion channels with a single 
activated rhodopsin. Amplification of the cascade may be mediated by activation of 
many ion channels through protein/protein interactions with the signalplex (reviewed in 
Montell, 1999).
The function of the signalplex within the phototransduction cascade is still not fully 
determined but may:
(i) promote termination of the photoresponse (Shieh and Zhu, 1996; Tsunoda, 1997).
(ii) facilitate rapid activation of phototransduction (Tsunoda, 1997).
(iii) amplify the phototransduction cascade (Scott and Zuker, 1998b).
Ca has been implicated in the light response for many years (Ranganathan et al., 1991; 
Hardie, 1991; Hardie and Minke, 1994). Ca2+ levels have been shown to alter the 
kinetics of activation and deactivation of the photoresponse (Hardie, 1995) and are 
required for the maturation of light activated currents as well as maintaining a
•jt
responsive state (Hardie et al., 1993; Hardie and Minke, 1992). The influx of Ca and 
the generation of DAG from the breakdown of PIP2 activates eye-specific PKC. Eye-
94*PKC is required for the return to resting levels of Ca in the cells (Ranganathan et al., 
1994). Active PKC then phosphorylates specific targets to mediate the termination of 
the light response by catalysing the inactivation of the active intermediates (reviewed in 
Montell, 1999).
Two channels are associated with calcium permeability in the photoreceptors, transient- 
receptor-potential (TRP) and transient-receptor-potential-like (TRPL). The TRP 
channel is responsible for most of the calcium permeability (Hardie and Minke, 1992). 
The trp mutant is defective in maintaining a light response (reviewed in Montell, 1999), 
and has lost the calcium entry pathways (Peretz et al., 1994; Hardie and Minke, 1992). 
TRP encodes a six transmembrane domain protein (Montell and Rubin, 1989; Wong et 
al., 1989). TRPL was isolated by Phillips et al. (1992) in a screen for retinal 
calmodulin-binding proteins. TRPL is >50% identical to TRP at the N-terminus. Both 
TRP and TRPL are highly expressed in the rhabdomeres and display weak homology to 
voltage-gated ion channels (reviewed in Montell 1999).
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An indication that TRPL as well as TRP contributes to light dependent calcium influx is 
that trpl mutant photoreceptor cells exhibit changes in the relative permeabilities to 
various cations (Reuss et al., 1997). trp and trpl double mutants are completely 
unresponsive to light (Niemeyer et al., 1996; Scott et al., 1997; Reuss et al., 1997).
Ca influx via TRP channels mediates amplification of rapid response termination and 
light adaptation through multiple feed back targets (Scott and Zuker, 1997; Hardie and 
Mmke, 1995). The Ca influx has also been implicated in regulating PIP2 metabolism 
by inhibiting PLC and facilitating PIP2 regeneration (Hardie et al., 2001). TRP has one 
calmodulin (CaM) binding site whereas TRPL has two. In TRPL these CaM binding 
sites seem to be involved in Ca2+ inactivation of the channel (Scott et al., 1997). The 
TRP channel relies on an ion block which is voltage dependent. The block intensifies 
as the cell depolarises from -70mV to OmV (Hardie and Mojet, 1995; reviewed by 
Hardie and Raghu, 2001).
When the proteins were expressed in 293T cells, TRP acts as a regulatory channel 
whereas TRPL is constitutively active. This constant activity in the TRPL channel is 
most probably due to the lack of an interacting regulatory protein. When the proteins 
were co-expressed in vitro they formed a store-operated channel combining both 
proteins. TRPL bound more readily to TRP than to itself suggesting this is what may 
occur in vivo (Xu et al., 1997).
Wild type flies are thought to most likely form TRP homomultimers and TRP/TRPL 
heteromultimers (Xu et al., 1997) but others argue that they do not present as separate 
channels (Reuss et al., 1997; Scott and Zuker, 1998a). The TRP and TRPL channels are 
responsible for controlling the influx of calcium into the photoreceptor cells but the 
structure of the channel in vivo has not been determined (reviewed in Montell, 1999).
1.2.2 Mammalian phototransduction
The initial stages of mammalian phototransduction are very similar to those of 
Drosophila phototransduction described in section 1.2.1. As described in section 1.1, 
the photosensitive pigments are situated in the lamellae of the outer segments of the
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photoreceptor cells. When a photon of light hits the rhodopsin molecule, a 
conformational change occurs in the chromophore changing the 1 1 -cw-retinal to the all- 
trans form. The opsin molecule attached to the chromophore goes through a series of 
intermediates, one of which is the active form, metarhodopsin II. The conversion to 
metarhodopsin causes an increase in affinity for transducin, the photoreceptor specific 
G-protein coupled to rhodopsin.
Transducin is a heterotrimeric molecule consisting of three subunits (Ta, Tp, Ty) in rods 
and two (Ta, Ta, Tp,) in cones. In the inactive state, transducin is bound to a molecule 
of guanosine diphosphate (GDP). When metarhodopsin II binds to transducin, a 
molecule of guanosine triphosphate (GTP) is substituted for GDP on the transducin oc- 
subunit. This results in the dissociation of the metarhodopsin II-transducin-GTP 
complex to give, metarhodopsin, Ta-GTP and Tpy. Metarhodopsin II can catalyse up to 
500 such exchanges before it is inactivated. Inactivation occurs in two stages, firstly, 
the protein is inactivated by phosphorylation of a cluster of serine residues near the C- 
terminus (Ohguro et al., 1993). This phosphorylation event is mediated by rhodopsin 
kinase and protein kinase C (PKC) under the control of a Ca2+ binding protein called 
recoverin (Udovichenko et al., 1997; Sanada et al., 1996). This reduces the ability of the 
active rhodopsin molecule to interact with transducin but does not completely quench it 
(Krupnik et al., 1997). Complete inactivation, and restoration of rhodopsin to its 
original light-responsive state, occurs upon capping of the phosphorylated molecule by 
retinal arrestin (Granzin 1998; Freedman et al., 1996; Hausdorff et al., 1990). The 
deactivated opsin spontaneously re-binds to 1 1 -cw-retinal to form light responsive 
rhodopsin (Reviewed by Pepe, 1999).
The released active Ta-GTP molecule modulates the activity of the effector molecule, 
cGMP phosphodiesterase (PDE). The cGMP-PDE molecule is tetrameric and consists 
of an alpha, beta and two inhibitory gamma subunits. The active Ta-GTP subunit 
modulates the removal of the two inhibitory gamma subunits from PDE. When free 
from the inhibitory subunits, the catalytic a  and p PDE subunits can hydrolyse cGMP 
into GMP and H+, a critical step in phototransduction.
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Conversion of GTP to GDP deactivates the Ta-GTP.PDEap complex and releases PDEap 
which reassociates with the PDE y-subunits. The Ta subunit, once again bound to GDP, 
reassociates with the Tpy subunits to complete the cycle initiated by the absorption of a 
photon by rhodopsin. Figure 1.16 schematically illustrates the human 
phototransduction cascade in rod photoreceptors. Hydrolysis of cGMP results in the 
reduced levels of the molecule within the photoreceptor cell which, in turn, causes the 
ion-gated membrane channels to close and the receptors to hyperpolarise (reviewed by 
Lem, 1998; Muller, 1995).
^  i
Ca concentrations also change during phototransduction and are involved in the 
recovery of the dark state of photoreceptors. One mechanism is through the regulation 
of retinal guanylate cyclase (ret-GCl). Ret-GCl is a retinal-specific membrane 
associated guanylate cyclase found in the outer segments of photoreceptor cells 
(Dizhoor et al., 1994). This reduced level of cGMP also results in the closure of cation 
channels. This means that there is an outflux of Ca2+ ions and Ca2+ can no longer enter 
the cell, thus resulting in a decrease of intracellular Ca2+. The falling levels of Ca2+ 
activates ret-GCl via the Ca2+ binding proteins guanylate cyclase activating proteins 
(GCAPs) (Palczewski et al., 1994; Gorczyca et al., 1995; Dizhoor et al., 1995) to 
produce cGMP (Koutalos and Yau, 1996). The cGMP-gated cation channel is thought 
to be responsive to the concentration of Ca2+ and is modulated by calmodulin (Hsu and 
Molday, 1993).
The biochemical and physiological properties of the components of phototransduction 
in cones is essentially the same as described above for rods. Although functionally 
analogous, rods and cones use different protein isoforms (products of a distinct set of 
genes) in most of these steps (reviewed in Yau, 1994). For example, different numbers 
of isoforms of transducin subunits are present in rods and cones, this may explain some 
of the physiological differences between the two receptor types (Peng et al., 1992).
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Figure 1.16 Human phototransduction cascade
Shown is a schematic diagram of the human phototransduction cascade adapted from Baehr et al., 1996. After a photon of light is 
absorbed by a rhodopsin molecule it undergoes a conformational change which induces activation of transducin. The a-subunit 
dissociates from transducin which leads to the removal of the inhibitory y -subunits of phosphodiesterase which results in the 
hydrolysis of cGMP and the closure of membrane ion channels (adapted from Polans et al., 1996).
1.2.3 Comparison of Drosophila and mammalian phototransduction
The first two cascades in the phototransduction pathway of Drosophila and mammals 
are the same, a photon of light induces a conformational change in the rhodopsin 
molecule which then stimulates a G-protein coupled cascade, after this point they differ. 
This section will describe the similarities and differences between phototransduction in 
Drosophila and mammals.
The major difference between the two pathways are that in darkness mammals have a 
‘dark current’ that leaves the inner segments of the photoreceptors as K+ ions and enters 
the outer segments as Na and Ca ions. This movement of ions causes a 
hyperpolarisation event (Copenhagen, 1991; Detwiter, 1992; Lagnado, 1992). This is in 
contrast to Drosophila where light depolarises the photoreceptors by stimulating Na+ 
influx across the plasma membrane (Rayner et al., 1990).
The mechanism of both the mammalian and Drosophila primary photoevents are 
fundamentally similar with the conversion of rhodopsin into metarhodopsin by a 
conformational change in 11-czs-retinal. This conformational change event in both 
system activates a G-protein cascade (Rayner, 1990). Mammalian transducin is 
responsible for metarhodopsin II coupling to cGMP-PDE (Hurley, 1987). In 
Drosophila, light stimulates the Gaq subunit of the heterotrimeric protein (Pottinger et 
al., 1991; Nobes et al., 1992; Ryba et al., 1993). The Gaq subunit binding to rhodopsin
^  i
occurs in the same ratio as transducin binding in mammals. The Ca binding protein 
recoverin plays a key role in controlling the binding of transducin and hence 
phototransduction. This is mirrored by Gpy inhibitory subunits that control Drosophila 
phototransduction (Lagnado et al., 1992).
It is from this point that the cascades in Drosophila and mammals diverge. In mammals 
TaGTP stimulates PDEa and p catalytic subunits by binding inhibitory PDEy subunits. 
PDEy remains bound to Ta even after GTP has been hydrolysed. Reassociation of 
Tpy with Ta releases PDEy. Light stimulated hydrolysis of cGMP by PDE results in 
the closure of the plasma membrane cation channels (Fesenko et al., 1985; Yau et al., 
1985). This is compared to Drosophila where the molecules inositol triphosphate (IP3)
1
and Ca are the photoexcitation transmitters (Bloomquist et al., 1988). Multiple
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channels with different ionic selectivities exist in the photoreceptor plasma membranes 
(Nagy, 1991). The Drosophila trp channel is responsible for light activated calcium
9+conductance (Hardie et al., 1992). Ca and calmodulin then control a second channel, 
trpl, which is light sensitive and uses Ca2+ release to open the channels (Phillips et al.,
1992).
Both mammals and Drosophila inactivate metarhodopsin by using rhodopsin kinases 
(Inglese et al., 1993; Palczewski et al., 1991) and arrestins (Hargrave et al., 1992). 
Drosophila have an additional measure to convert metarhodopsin back to rhodopsin 
quickly and efficiently. Drosophila metarhodopsin is unusually thermostable and can 
be directly re-isomerised back from all-trans to the 11 -cis conformation of rhodopsin by 
absorption of longer wavelength light. The conversion occurs using the ambient light 
diffusing through the Drosophila eye tissue (Hardie, 1986).
9-1-The changes in concentration of free Ca induced by light cause deactivation and 
adaption in both mammals and Drosophila. However they differ in that light lowers the 
concentration of Ca2+ in mammalian photoreceptors but increases it in Drosophila 
photoreceptors (Rayner, 1990; Yau, 1991; Selinger et al., 1993).
So in summary, both the Drosophila and mammalian phototransduction cascades are 
initiated by a photon of light which causes a conformational change in a rhodopsin 
molecule, which in turn activates a G-protein cascade. The G-protein cascade 
stimulates different pathways in Drosophila and mammals. In mammals the activation 
of cGMP by phosphodiesterase results in the closure of membrane channels. This is in 
contrast to Drosophila where hydrolysis of PIP2 generates IP3 molecules and, along
9+with Ca release, causes membrane channels to open (figure 1.11). Although the end 
cycles of both systems differ, components of the Drosophila final PIP2 hydrolysis and 
regeneration cascades have been identified in the mammalian retina. Described in 
section 1.2.4.
1.2.4 Evidence for the presence of the Drosophila PIP2 pathway in mammals
As described in section 1.2.3, phototransduction in mammals and Drosophila are very
similar in the initial stages, the cascades only differ in their final stages. In mammals,
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the final stage of phototransduction is the activation of phosphodiesterase subunits 
whereas in Drosophila, the final stage involves the hydrolysis of phosphatidylinositol 4, 
5-bisphosphate (PIP2) by phospholipase Cp (PLCp). Although mammals use a different 
final pathway to Drosophila, homologues of the components of the Drosophila PIP2 
regeneration pathway have been identified in the mammalian retina (table 1.2). It has 
been through the examination of naturally occurring Drosophila mutants that the fly 
visual cascade has been determined and this in turn has given some insight into 
mammalian ocular disease.
This section will describe the elements from the Drosophila pathway that have been 
found in the mammalian retina. These genes are good candidates for mammalian retinal 
diseases, since they are expressed in the mammalian retina and many have been mapped 
to chromosomal regions that are known to contain retinal disease loci.
Drosophila M utant Gene Product Human Homologue
norpA
(no receptor potential A)
PLC PLC4
rdgA DAGK1
(retinal degeneration A) DAGKi
DAGK DAGK3
DAGK4
rdgB PITP PITPN1
(retinal degeneration B) NIR2
NIR3
rdgC PPEF1
(retinal degeneration C) PP PPEF2
PP7
cds Eye-CDS CDS1
(CDP-diacylglycerol synthase) CDS2
Table 1.2 Human homologues of Drosophila genes from phototransduction cascade
Listed are the genes from the Drosophila phototransduction cascade that are known to have human 
homologues which have been identified in the mammalian retina. The mammalian homologues are 
listed in the right hand colunm.
1.2.4.1 rdgA
Retinal degeneration A (rdgA) encodes the enzyme diacylglycerol (DAG) kinase used 
in the breakdown of DAG to phosphatidic acid (PA). This conversion is the initiation 
point of the regeneration cycle of PIP2 used in phototransduction. The enzyme DAG 
kinase is found in the photoreceptor cells. Mutations in this gene lead to retinal 
degeneration in the fly (Masai et al., 1993). Four mammalian homologues of rdgA have 
been identified from human retinal and brain libraries (Pilz et al., 1995; Ding et al.,
1998). They are called DAGKI, DAGKi (DAGK2, which is the most homologous to 
Drosophila rdgA), DAGK3 and DAGK4, and the human chromosomal locations of 
each have been determined. The genes map to human chromosome 12ql3.3 (Hart et al., 
1994), 7q32.3-33 (Ding et al., 1998), 3q27-28 (Fitzgibbon et al., 1995) and 4pl6.3 
(Endele et al., 1996) respectively. The chromosomal localisation of DGKi contains a 
locus for an inherited form of retinitis pigmentosa (RP), a disease involving the 
progressive degeneration of the retina. No mutations in the DGKi gene have, thus far, 
been associated with human RP (Bowne et al., 2000). DAGK3 gene maps to a region 
that contains a locus for optic atropy (OPA1). Mutation screening in a cohort of 
German OPA1 patients did not reveal any mutations in the DAGO gene (Stohr et al.,
1999). Houssa et al. (1997) found high levels of DAGK4 expression in rat brain, 
specifically in the cerebellum and hippocampus. The human gene DAGK4 which was 
mapped to chromosome 4pl6.3 by Endele et al. (1996), report that the gene which is 
expressed in the mammalian retina and is 90% identical to the rat homologue. To date 
this gene has not been associated with any mammalian ocular disease. DAGKI, which 
was cloned by Schaap et al. (1990), and mapped to chromosome 12ql3.3 by Hart et al. 
(1994), has also not been associated with any mammalian ocular disease.
1.2.4.2 rdgB
The various phosphatidylinositol transfer protein (PITP), retinal degeneration B (rdgB), 
and amino-terminal domain interacting receptor (Nir) PITPs can be divided into two 
structural families. The small, soluble PITP isoforms contain only a 
phosphatidylinositol transfer domain and have been implicated in phosphoinositide 
signaling and vesicle trafficking. In contrast, the rdgB proteins, which include Nir2 and 
Nir3, contain an amino-terminal PITP-like domain, an acidic, Ca2+ -binding domain, six 
putative transmembrane domains, and a conserved carboxyl-terminal domain.
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However, the full biological function of mammalian rdgB-like proteins are still unclear 
(Fullwood et al., 1999).
Flies with mutations in the rdgB gene undergo light dependent retinal degeneration as 
this protein plays a role in the recovery after phototransduction (Hotta and Benzer, 
1970). The first human homologue of the rdgB gene to be described was PITPN1 which 
was cloned in 1994 (Dickeson et al.) and subsequently mapped to human chromosome 
17ql3.3 (Fitzgibbon et al., 1994). The human Nir family of PITPs were then isolated 
and mapped, human RDGB-alpha (now called Nir2) maps to chromosome 1 lql3, and 
human Nir3 (second homologue to be identified) which maps to chromosome 12, 
constitute a family of phosphatidylinositol transfer proteins. All three homologues are 
abundantly expressed in the brain and retina (Guo et al., 1997; Aikawa et al., 1997; 
Fullwood et al., 1999; Lev et al., 1999). Expression studies using in situ hybridisation 
on mouse embryonic sections showed that Nir2 was expressed in the neural retina and 
the central nervous system. The pattern of expression in the mouse follows the pattern 
of expression observed in Drosophila (Rubboli et al., 1997). The mouse Nir2 gene was 
used successfully to rescue the Drosophila rdgB mutant phenotype, a result that 
suggests there are similarities between the later steps of invertebrate and vertebrate 
phototransduction not previously appreciated (Chang et al., 1997). In summary, 
PITPN1 maps to 17pl3, Nirl to 1 lql3 and Nir3 to chromosome 12. The regions on 
17pl3 and llq l3  contain loci for several retinal dystrophies including cone-rod 
dystrophy 5 (CORD5), central areolar choroidal dystrophy (CACD), exudative 
vitreoretinopathy (EVR1) and neovascular inflammatory vitreoretinopathy (VRNI) 
making Nirl and 2 excellent candidate genes for these disorders (Guo et al., 1997).
1.2.4.3 rdgC
The retinal degeneration C (rdgC) gene encodes a serine/threonine phosphatase. rdgC 
is involved in the final stages of returning the metarhodopsin to the resting rhodopsin 
conformation. Drosophila rdgC mutants undergo light dependent retinal degeneration 
(Steele and O'Tousa, 1990; Steele et al., 1992). The Drosophila rdgC gene is expressed 
in the visual system and mushroom bodies of the central brain (Montini et al., 1997).
To date, three human homologues of rdgC have been identified (PPEF1, PPEF2 and 
PP7 ) and all are expressed in the mammalian retina (Sherman et al., 1997; Montini et 
al., 1997; Huang and Honkanen, 1998). Protein protease with EF-hand motifs (PPEF),
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and protein phosphatase 7 (PP7) are from a family of protein phosphatases. PPEF1 has 
been mapped to human chromosome Xp22.2-22.1 and is 61% similar at the amino acid 
level to Drosophila rdgC. The PPEF1 gene has been shown to be expressed in the rod 
photoreceptors, somatosensory neurones and inner ear cells of the developing mouse. 
The chromosomal location to which the gene has been mapped has a locus for X-linked 
juvenile retinoschisis (RS), a progressive vitreoretinal degenerative disorder. However, 
no mutations in PPEF1, have been detected in RS patients (Montini et al., 1997; van de 
Vosse et al., 1997).
The gene, PPEF2 has been mapped to human chromosome 4 (Sherman et al., 1997) and 
splice variants of the gene have been identified. The rat homologue of PPEF2, was 
shown to be expressed in the inner segments of the rod photoreceptors and in the pineal 
gland. Due to the location within the photoreceptors, this gene is probably not directly 
involved in phototransduction since the phototransduction cascade occurs in the outer 
segments of the photoreceptors. Of the two mammalian PPEFs, PPEF2 is reported to 
be most like rdgC (Sherman et al., 1997).
The gene encoding protein phosphatase 7 (PP7) was identified from a human retinal 
cDNA library. PP7 shares the catalytic core domain of the protein phosphatase family 
but has unique N- and C-terminal regions. The unique C-terminal region of PP7 has 
multiple calcium binding sites and shares 42% identity with the Drosophila gene rdgC. 
PP7 is not ubiquitously expressed like other PPases but is found only in the retina 
(Huang and Honkanen, 1998).
1.2.4.4 norpA
The no receptor potential A (norpA) gene encodes PLCp. The PLCp protein catalyses 
the hydrolysis of PIP2 to EP3 and DAG. Drosophila norpA mutants develop light 
dependent retinal degeneration (Bloomquist et al., 1988). The homologous mammalian 
PLCp4 has been identified in the retina and the brain and mapped to human chromosome 
20pl2 (Alvarez et al, 1995). Immunohistochemical staining using bovine retina 
identified PLC34 in the photoreceptors, bipolar cells, horizontal cells and ganglion cells. 
Studies using mice lacking PLCp4 showed that the mice had impaired visual processing 
abilities (Pak, 1995; Jiang et al., 1996; Miyata et al., 2001). To date, however, 
mutations in the PLCp4 protein have not been associated with any human disease.
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1.2.4.5 eye-cds
The eye-cds gene encodes the regulatory enzyme CDP-diacylglycerol synthase (cds) 
which catalyses the formation of CDP-diacylglycerol (CDP-DAG) from phosphatidic 
acid (PA) and is thought to be the rate limiting step for phosphoinositide synthesis (Wu 
et al., 1995). PA is a key regulator of the amount of PIP2 available for signalling 
(Monaco and Gershengorm, 1992; Heacock et al., 1996; Weeks et al., 1997). CDP- 
DAG is an essential precursor in the biosynthesis of phospholipids such as cardiolipin, 
phosphatidylglycerol and phosphatidylinositols (Bishop and Bell, 1988; Kent et al., 
1991), which are required for cellular localisation, regulation and signalling (Raetz and 
Dowhan, 1990; Cronan and Rock, 1996; Dowhan, 1997). CDP-DAG controls inositide 
triphosphate (IP3) levels (Lavie and Agranoff, 1996), and therefore affects levels of 
3’phosphoinositides, which are the intermediates used by multidomain proteins to 
recruit their host proteins to specific regions in cells, (Lavie et al., 1996; Cullen et al., 
2001), and hence have influence over membrane traffiking (Shepherd et al., 1996).
cds genes have been identified in many species but the first to be described was from E. 
coli (Langley and Kennedy, 1978). The identification of the E.coli gene was followed 
by the cloning of the Drosophila melanogaster (Wu et al., 1995), yeast (S. cerevisiae) 
(Shen et al., 1996) and the human CDS genes (Heacock et al., 1996; Weeks et al., 1997; 
Halford et al., 1998; Volta et al., 1999). Comparisons of cds sequences derived from 
the various species show that the genes share a 2 0 % or greater sequence identity at the 
amino acid level. The lowest level of identity is between human and bacteria that show 
20% identity (Ranganathan et al., 1991) and the highest is human CDS2 and Drosophila 
cds with 64.5% identity (Halford et al., 1998; Volta et al., 1999). The most interesting 
tissue-specific isoform of cds, in relation to this project, is Drosophila eye-cds (Heacock 
et al., 1996). As detailed above, this isoform is a key regulator of phototransduction. 
The eye-cds enzyme is required for the continuous supply of PIP2 , which is required to 
be regenerated for fly vision (Wu et al., 1995). The eye-cds mutant flies are viable but 
cannot sustain a light activated current as PIP2 is depleted. Light exposure results in 
retinal degeneration in the mutant flies (Wu et al., 1995). Wu et al. (1995) showed that 
the cds protein is found in all eight rhabdomeres in Drosophila.
The Drosophila cds gene transcript is 2.5kb (Wu et al., 1995) and the corresponding 
protein is 447 amino acids in length with an estimated molecular mass of 28kDa and is
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localised to the photoreceptor neurones in both the compound eye and the ocelli. Two 
human homologues of the Drosophila cds gene, CDS1 and CDS2, have been identified 
(Halford et al., 1998; Volta et al., 1999). Human CDS1 has been mapped to 
chromosome 4q21 (Halford et al., 1998; Volta et al., 1999). The predicted CDS1 
protein is 444 amino acids in length with eight predicted membrane-spanning domains 
(predicted in Volta et al., 1999, using the PHD computer analysis program). Human 
CDS1 has been reported to show two transcripts on a Northern blot of bands of 3.9kb 
and 5.6kb (Lykidis et al., 1995). The transcripts have been reported to be expressed at 
different levels in different tissues. Expression of CDS1 has been reported in the inner 
segments of the photoreceptors (Volta et al., 1999). Human CDS2 has been mapped to 
chromosome 20pl3 (Halford et al., 1998). The predicted protein is 445 amino acids in 
length, and Volta et al. (1999) have predicted that there are nine transmembrane 
domains. Volta et al. (1999) mapped the mouse homologue of CDS2 to chromosome 2, 
to a region that is syntenic with human chromosome 20. Kent et al. (1995) showed dual 
localisation of rat Cds in the microsomal and mitochondrial fractions from liver 
extracts. Saito et al. (1998) used fluorescence studies on rat tissues to show that the Cds 
protein is found in close association with the membranes of the endoplasmic reticulum, 
with mRNA expression observed in the cerebellar Purkinje cells, pineal body and inner 
segments of photoreceptor cells. To date, there have been no reports of mutations in 
either human CDS genes causing retinal diseases.
The CDS genes remain good candidates for retinal disease primarily due to their retinal 
expression patterns but also their mapped positions on human chromosomes. CDS2 is a 
particularly good candidate in this respect with several ocular disease loci positioned 
around the same chromosomal location including, Hallervorden-Spatz syndrome and 
Comeal hereditary endothelial dystrophy 2 (CHED2).
Hallervorden-Spatz syndrome (Taylor, et al., 1996), is a progressive disorder that 
affects muscle tone and voluntary movement and causes, mental deterioration, 
emaciation (due to feeding difficulties) and visual impairment. Death usually occurs 
before the age of 30 years. At post mortum iron deposits were found in the brain tissue 
(Elejalde et al., 1979). Casteels et al, (1994) described patients who developed visual 
impairments and bilateral optic atrophy before developing any of the other classical 
symptoms listed above. This study suggested that the patients should be studied
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ophthalmologically to exclude the coincidental occurrence of optic atrophy with typical 
Hallervorden-Spatz syndrome. Since the map location remains close to that of the 
CDS2 gene and the expression pattern of the CDS2 gene implies multiple tissue 
expression, this gene is a good candidate for this disease. CHED2 was mapped to 
chromosome 20pl3 (Hand et al., 1999). CHED2 is the autosomal recessive form of the 
disease (CHED1 being the dominant form). Patients suffer from corneal clouding but a 
corneal transplant restores their vision. This disease is interesting again due to the map 
position and results reported in this thesis (see section 3.6.3) enhance this interest as the 
results show there is expression of murine Cds2 in the mouse cornea.
1.3 Retinopathies
The retinal dystrophies are a hetergeneous group of diseases in which the retina 
degenerates, leading to either partial or complete blindness. They are the major cause of 
incurable blindness in the western world. The inherited forms of retinal degeneration, 
including retinitis pigmentosa (RP) and various macular degenerations, affect 
approximately 1 in 3000 people but many more suffer from age-related macular 
degeneration in later life. The heterogeneous nature of these disorders was evident even 
before the advent of molecular genetics with wide variations in severity, mode of 
inheritance and phenotype. RP can have an autosomal dominant, autosomal recessive, 
X-linked or digenic mode of inheritance. With the advent of molecular genetic 
techniques the genes underlying these disorders started to be identified. However it was 
not until 1990 that Dryja and collegues linked mutations in rhodopsin (RHO) in a panel 
of patients with autosomal dominant form of RP (Dryja et al., 1990). Since then, many 
other mutations in the RHO gene showing both autosomal dominant and autosomal 
recessive inheritance of RP and the dominant form of congenital stationary night 
blindness (CSNB) have been reported. Although mutations in RHO are the most 
common cause of adRP with an estimated prevalence varying between 25-50% 
(Ingleheam 1998, Sochocki et al., 2001) many other genes for RP, CSNB and other 
retinal disorders have been identified through positional cloning and candidate gene 
approaches (reviewed in Gregory-Evans and Bhattacharya 1998, Inglehem 1998, 
Molday 1998, Rattner et al., 1999, Clark et al., 2000 and Farrar et al., 2002). Figure 
1.17 shows an ideogram of the progress made in the identification of new loci and genes 
involved in inherited retinal diseases in the past 22 years (taken from RetNet:
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http://www.sph.uth.tmc.edu/RetNet/). To date 134 loci accounting for different retinal 
disorders have been reported and 89 genes have so far been cloned. Many of the genes 
identified code for photoreceptor specific proteins, which is not surprising considering 
the complexity and the number of genes involved in the various steps of the 
phototransduction cascade (see section 1.2.2), and the extreme metabolic activity of the 
photoreceptor cells which makes them vulnerable to even minor changes in the genes 
expressed in or near them. In fact, the underlying assumption of the candidate gene 
approach used to clone the majority o f these genes is that a mutation in a photoreceptor- 
specific gene known to be indispensable for photoreceptor function is likely to confer a 
phenotype of retinal degeneration or dysfunction. Table 1.3 list some of the genes 
identified as causing a retinal phenotype and lists the function, where known, of these 
genes.
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Figure 1.17 This graph shows the number of genes causing retinopathies 
which have been mapped but not cloned (blue) and mapped and cloned (red) 
from January 1980 to January 2003. The number of genes identified has 
increased rapid from the early 1990s. Graph taken from 
http: //www. sph. uth. tmc. edu/RetN et/.
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RP Rhodopsin Visual Transduction Yes
RP a-subunit of rod cyclic GMP-PDE Visual Transduction No
RP [3-subunit of rod cyclic GMP-PDE Visual Transduction Yes
RP a-subunit of rod cyclic GMP- Visual Transduction No
RP
gated channel 
Arrestin Visual Transduction Yes
RP PRKCG Visual Transduction No
Oguchi Disease RHOK Visual Transduction No
CSNB CACNA1F Visual Transduction No
CSNB GNAT1 (transducin) Visual Transduction No
CSNB NYX Yet to be established No
RP RDS-peripherin Photoreceptor Structure Yes
RP ROM-1 Photoreceptor Structure Yes
Usher Syndrome Harmonin Photoreceptor Structure No
Usher Syndrome Myosin Vila Photoreceptor Structure Yes
Usher Syndrome Usherin Extracellular matrix No
Usher Syndrome Cadherin-like protein Extracellular matrix No
RP/LCA CRB1 Retinal development Yes
RP RP2 Protein folding No
RP RPGR Protein transport Yes
RP CRBP Retinoid cycle No
RP/LCA RPE65 Retinoid cycle Yes
RP ABCA4 Retinoid cycle yes
RP RGR Retinoid cycle No
RP LRAT Retinoid cycle No
RP MERTK Disc shedding Yes
RP/LCA CRX Transcription Factor Yes
RP NRL Transcription Factor Yes
RP/LCA TULP1 Transcription Factor Yes
RP NR2E3 Transcription Factor Yes
RP PRPC8 Pre-mRNA slicing No
RP PRP3 Pre-mRNA slicing No
RP PRPF31 RNA processing No
RP-deafness MTTS2 tRNA No
syndrome
RP TTPA Transport Yes*
LCA AIPL1 Protein No
LCA RPGRIP
folding/trafficking 
Photoreceptor cilia No
LCA RetGC-1 cGMP synthesis Yes
LOA LHON Metabolism No
STGD3 ELOVL4 Metabolism No
DHRD EFEMP1 Structural No
LHON OPA1 Structural No
LHON OPA3 To be established No
BB BBS2 To be established No
BB BBS4 To be established No
BB BBS6 To be established No
Retinoschisis RSI To be established Yes
RP/NFRCD RLBP1 Vitamin A cycle No
Stargardts ABCA4 Transport Yes
Cone-rod RetGCl To be established No
dystrophy 
Cone dystrophy GCAP1 Calcium binding No
Fundus RDH5 Vitamin A cycle Yes
albipunctatus
(SNB)
BMD VMD2 Protein folding No
Table 1.3 A list of the different types of retinal degeneration, the corresponding mutated 
gene, the gene function, if known, and existence of an animal model. The animal models are 
not all rodents and are a mixture of laboratory generated, diet induced and naturally 
occurring (adapted from Farrar et al., 2002). RP-Retinitis Pigmentosa, CSNB-Congenital 
Stationary Night-blindness, LCA-Leber’s Congenital Amaurosis, LHON-Leber hereditary 
optic neuropathy, STGD-Stargardt Disease, DHRD-Doyne Honeycomb Retinal Dystrophy, 
BB- Bardet Beidl Syndrome, NFRCD-New Foundland Rod-Cone Dystrophy, BMD-Best’s 
Macular Dystrophy.
1.3.1 Retinitis Pigmentosa
Retinitis pigmentosa is the most common retinal generation that is clearly hereditary 
and is estimated to affect 1 in 5000 people worldwide (Weleber and Gregory-Evans 
2001). RP is the result of the loss of both rod and cone photoreceptors throughout the 
retina. If the rods and cones are lost within the first two years of life or are already dead 
or non functional at birth the diagnosis of the patient is that of congenital retinal 
blindness, also known as Leber congenital amaurosis, especially if recessively inherited 
(Francois, 1968).
1.3.1.1 Mode of inheritance
RP is genetically heterogeneous. Only a few genes for retinal degenerations had been 
discovered by the 1990s, but this number dramatically increased to 75 genes identified 
and 45 additional genes assigned to chromosome locations but not identified, by 
January 2002. It has been estimated that the actual number of genes could be two or 
three times that currently identified (Wright and van Heyningen, 2001).
Most forms of RP are monogenic and come under the classical inheritance patterns of 
autosomal dominant, autosomal recessive, X-linked or mitochondrial (maternally 
inherited). However there have been some families which have exhibited more complex 
patterns of inheritance such as digenic diallelic inheritance, digenic triallelic inheritance, 
dominant RP with reduced penetrance, and uniparental disomies (Rivolta et al., 2002). 
These modes of inheritance are shown schematically in figure 1.18.
Digenic diallelic disease begins in the offspring of unaffected parents, each of whom 
carry one of the two mutations for a disease. Only offspring that inherit both mutant 
alleles (double heterozygotes) are affected. Therefore the first generation of affected 
individuals mimics a recessive disease. However like a dominant disease, the affected 
individuals can transmit both mutations and hence the disease to their offspring. The 
transmission ratio would only be 1 in 4, not 1 in 2 as seen in a dominant disease. This 
mode of inheritance had been seen in laboratory animals when specific mating is carried 
out, but the first reported human disease of this nature came from studies of the RDS 
and ROM1 genes in a handful of RP families. All the affected individuals were double 
heterozygotes for a null mutation in the ROM1 gene on chromosome 1 lq  and a
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Autosomal Dominant Autosomal Dominant 
(reduced penetrance)
+1 +1
Digenic
Diallelic
B/+
A/+
B/+
A/+  
B/+
+/+
■»/+
/+2 /+ 1 B/+ B/+ V+
Autosomal
Recessive
Digenic
Triallelic
V  ai/+ +/a2 ai/a2 ai/+ ai/a2 +/a2 +•/ ai/a2 ai/a2
b/+ +/+
a2/+ ai/+ a2/+
b/+ ■+/+ +/+
b/+
Figure 1.18 Schematic pedigrees demonstrating dominant, dominant with reduced 
penentrance, digeneic dialleleic, recessive, and digenic-trialleleic disease.
All of these inheritance patterns have been observed in families with RP. Affected 
individuals are represented by filled circles and squares. A diamond in an individuals 
symbol indicates that he or she is an unaffected carrier of a dominant RP allele. The 
genotypes appear under each family member’s symbol. A, ai, a2 , B and b all designate 
mutant alleles, with A, ai, and a2 alleles found at one locus and the B, and b alleles found 
at a second not linked to the first. + designates a wild type allele. In the family with 
autosomal dominant disease with reduced penetrance +i and + 2  designates isoalleles, 
with the isoallele +2 preventing the expression of RP in a patient with the mutant A allele 
in trans (a situation presumed to be present in an unaffected carrier of an RP11 mutation). 
Note that the digenic diallelic disease mimics a recessive pedigree in the first affected 
generation and mimics a dominant disease with a reduced transmission ration in 
subsequent generations. Digenic triallelic disease differs from autosomal recessive 
disease by its lower recurrence risk (adapted from Rivolta et al., 2002).
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missense mutation in the RDS gene on chromosome 6 p (Kajiwara et al., 1994, Dryja et 
al., 1997). Relatives with only one of the mutations were unaffected. (Kedzierski et al., 
2001). Both ROM1 and RDS genes have been shown to be expressed in the rims of 
photoreceptor cell discs, where they form homodimers and interact to form tetrameric 
complexes that are essential for the structure of the rod and cone outer segment discs 
and without which the photoreceptors degenerate (Sanyal et al., 1980, Molday et al., 
1987, Travis et al., 1989, Bascom et al., 1992, Lefkowitz, 1992, Goldberg et al., 1995, 
Goldberg and Molday, 1996a, Goldberg and Molday, 1996b, Moritz and Molday, 1996, 
Kedzierski et al., 1999a, Kedzierski et al., 1999b).
Digenic triallelic inheritance is more often found in syndromic diseases such as Bardet- 
Biedl (section 1.3.5). In this mode of inheritance there are generally more than two loci 
for the disease. In the case of Bardet-Biedl syndrome six genes have been associated 
with the disease. Until recently it was thought that the disease was recessive and that 
only one of the loci would be involved (Beales et al., 1997, Katsanis et al., 2000, 
Mykytyn et al., 2001, Nishimura et al., 2001). However it has been discovered recently 
that affected individuals have mutations affecting both alleles at one locus and another 
mutation affecting one allele at a second locus (Katsanis et al., 2001).
Families with dominant RP with reduced penetrance all exhibit linkage between the 
responsible gene, RP11, and markers within chromosome 19ql3.4 (Al-Maghtheh et al., 
1994, Xu et al., 1995, McGee et al., 1997). These studies provided evidence that a 
single locus determines whether or not carriers of an RP11 mutation would develop RP 
and this penetrance locus was either closely linked to RP11 or it was RP11 itself 
(McGee et al., 1997). The evidence was generated from siblings who were both carriers 
but were affected and unaffected. The unaffected carriers all inherited the same wild- 
type RP11 allele from their noncarrier parent and the affected siblings all inherited the 
other noncarrier RP11 allele from the unaffected parent. So there are wild-type alleles 
(isoalleles) at the RP11 locus or a closely linked locus which by themselves produce no 
observed phenotype, but, when in trans with a dominant mutation in RP11, permit or 
inhibit the pathogenicity of that mutation. The RP11 gene has recently been shown to 
encode a ubiquitously expressed protein which forms part of the spliceosome, a factor 
called PRPF31 (Vithana et al., 2001). It is thought that the deficiency in the splicing
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function under the conditions of high splicing demand to replenish the photoreceptor 
discs may underlie the pathology of RP11 (Deery et al., 2002).
Uniparental disomies occur when, as a result of abnormal events during either meiosis, 
fertilization, or early stages of embryogenesis, an individual inherits both copies of a 
chromosomal pair from one parent (Engle, 1980). This can either be heterodisomy, if 
both chromosomes are the same as the donor parent, or homodisomy if one of the 
parental chromosomes has been duplicated. This mode of inheritance has been reported 
in RP patients with mutations in the MERTK gene (the human orthologue of the RCS 
rat retinal dystrophy gene) (Thopson et al., 2002), the RPE65 gene (Hamel et al., 1993, 
Nicoletti et al., 1995) and for a patient with rod monochromacy but where the gene 
remains as yet unidentified (Pentao et al., 1992, Gal et al., 2000, Thompson et al., 2000, 
Thompson et al., 2002).
1.3.1.2 Animal models of RP
Table 1.3 lists the animal models, which are available for retinitis pimentosa and Leber 
congenital amaurosis. Some of these models have been found to be naturally occurring 
while others have been generated in the laboratory as a tool to help in the investigation 
of the human disease.
Various rhodopsin {RHO) transgenic mice have been generated. Mutations in this gene 
account for approximately 15% of all inherited human retinal degenerations. Olsson et 
al. (1992) demonstrated that the overexpression of the normal opsin gene results in 
photoreceptor cell degeneration. Humphries et al. (1997) generated mice carrying a 
targeted disruption of the Rho gene. Rho-/- mice did not develop rod outer segments and 
lost their photoreceptors within three months. Heterozygotes retained most of their inner 
and outer segments but with a degree of structural disorganisation. A second targeted 
disruption of Rho was carried out by Lem et al. (1999). In these mice, the rod outer 
segments failed to develop and retinal degeneration quickly followed. Retinae with a 
single normal opsin allele developed normally except that there was only half the 
normal quantity of rhodopsin protein the outer segments. The photoreceptors of these 
mice also degenerated. These models allow for a better understanding of the functional
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and structural role of rhodopsin in the normal retina and the pathogenisis of retinal 
disease. Recently, Kijas et al. (2002) has identified a naturally occurring mutation in the 
Rho gene of English Mastiff dogs which gives a phenotype similar to that seen in 
human patients with a RHO mutation.
Mice with an inactivated Rpe65 gene, which is involved in the retinoid cycle, also lack 
the visual pigment rhodopsin. Redmond et al. (1998) showed that the outer segment 
discs of the rod photoreceptors are disorganised and that rod responses are abolished. A 
four-base-pair deletion in the RPE65 was found to occur naturally in a pedigree of 
Swedish Briard dogs. Initially this mutation was thought to cause an analogous disorder 
to that of human congenital stationary night blindness (Narfstrom et al.9 1989) but was 
later found to be progressive and was termed hereditary retinal dystrophy (Wrigstad et 
al., 1994).
Another gene that is thought to play a role in the retinoid cycle is ATP-binding cassette 
transporter, subfamily A member 4 (ABCA4). This gene can also be called ABCR 
(retinal specific) (Allikmets et al., 1997). The ABCR gene maps to chromosome 1 p22 
(Azarian and Travis, 1997, Nasonkin et al., 1998, Allikmets et al., 1998). The gene 
spans approximately 150kb and is comprised of at least 51 exons Gerber et al., 1998). 
Mutations in this gene have been found in autosomal recessive Stargardt’s disease 1 
patients (Allikmets et al., 1997, Nasonkin et al., 1998, Rozet et al., 1998), age-related 
macular dystrophy (ARMD) patients (Allikmets et al., 1997, De La Paz et al., 1998, 
Bernstein et al., 2002), Retinitis pigmentosa-19 patients (Martinez-Mir et al., 1998) and 
Cone-rod dystrophy patients (Maugeri et al., 2000). Table 1.4 lists the known disease 
causing mutations in the ABCA4/ABCR gene. A knockout mouse model was generated 
and characterised by Weng et al. (1999). The outcome of the investigation indicated that 
the retinal degeneration in this case was caused by ‘poisoning’ of the RPE by lipfuscin 
fluorophore deposits in the RPE as a result of delayed dark adaptation.
The rds and roml genes encode proteins required for photoreceptor structure. Mice with 
rds and roml genotypes similar to those found in the families with digenic diallelic 
inhertitance (described above) have been found to have corresponding phenotypes
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through the generation of rds and roml knockout mice (Clarke et al. 2000, Kedzierski et 
al. 2001).
Stargardt’s disease 1 V931M, A1028V, L2027F, V2012L, W855X, 
G1036K, A1038V, Y340D, IVS13-1G-A
Age-related macular dystrophy 2 D2177N, G1961E
Retinitis Pigmentosa 19 1847delA
Cone-rod dystrophy 3 Splice site mutations IVS30 G-T, +1, IVS40, G-A, 
+5.
Fundus Flavimaculatus L1970F, L1971R
Table 1.4 List of known mutations in the ABCR gene that result in a disease phenoype.
A naturally occurring RPGR mutation was first seen in Siberian husky dogs and the 
phenotype closely resembled X-linked RP in humans (Zeiss et al., 2000). Hong et al. 
(2001) then created an RPGR deficient mouse model to further examine the structure 
and function of this protein. In this model the cone cells exhibited ectopic localization 
of cone opsins in the cell bodies and synapses and the rod cells had a reduced level of 
rhodopsin. Subsequently both cell types degenerated. RPGR appears to have a role in 
protein transport and in the maintenance of photoreceptor viability.
The Royal College of Surgeons (RCS) rat is a classical model of recessively inherited 
retinal degeneration whereby the RPE fails to phagocytose the shed outer segments and 
the photoreceptor then die. D’Cruz et al.(2000) used positional cloning to identify the 
retinal dystrophy (rdy) locus in the rat. They found that a small deletion that disrupted 
the Mertk gene. With this conclusion, Vollrath et al.{2001) sought to determine whether
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gene transfer of human MERTK into a RCS rat retina would correct the defect. They 
successfully showed that the defect could be corrected and hence photoreceptor 
degeneration in the rat avoided.
CRX is a transcription factor that is expressed in the photoreceptors of the retina and 
also in the pinealocytes of the pineal gland. Furukawa et al. (1999) generated mice with 
a targeted disruption of the Crx gene. This resulted in mice that did not develop 
photoreceptor outer segments and lacked rod and cone cell activity and had disrupted 
circadian rhythms. Expression levels of several other photoreceptor- and pineal-specific 
genes were also reduced in these mice.
Mears et al. (2001) generated mice with a deletion of the NRL gene. The null mutant 
mice had complete loss of rod function and supernormal cone function mediated by S 
cones. The photoreceptors in the mutant retina had a cone-like morphology and had 
abnormal outer segment discs. Analysis of the retina confirmed the apparent functional 
change of rods into S cones. The authors suggest that NRL acts as a molecular switch 
during rod-cell development by directly modulating rod-specific genes while 
simultaneously inhibiting the S-cone pathway through the activation of NR2E3. Haider 
et al. (2001) proposed that NR2E3 may function by regulating genes involved in cone 
cell proliferation, and mutations in this gene may lead to retinal dysplasia and 
degeneration by disrupting normal photoreceptor cell topography as well as cell-cell 
interactions. A splicing error in the NR2E3 gene is thought to be responsible for an 
autosomal recessive retinal degeneration of the rd7 mouse that was identified at the 
Jackson Laboratory (Akhmedov et al., 2000, Haider et al., 2001).
The retinal degeneration mouse (rd) is a naturally occurring mutant exhibiting 
mutations in the gene coding the p-subunit of the rod cyclic guanosine monophosphate 
(cGMP) phosphodiesterase (Bowes et al., 1990). The rods degenerate rapidly and are 
essentially lost by one month of age (Carter-Dawson et al., 1978). The retinal 
degeneration slow (rds) exhibit mutations in the gene coding for rds/peripherin (Travis 
et al., 1989). The rod degeneration is much slower than in the rd mouse with 
degeneration occurring over months rather than days (Sanyal et al., 1986).
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1.3.2 Cone, cone-rod and macular dystrophy
Patients with macular dystrophy lose the rods and cones of the central retina (macula) 
while the peripheral photoreceptors are spared (Green and Enger, 1993). Cone-rod 
dystrophies show an initial loss of cones, followed by rods, and cone dystrophies are 
where photoreceptor loss is restricted to the cones.
1.3.2.1 Best’s macular dystrophy
In Best disease, a yellow mass like the shape of an egg yolk forms at the macula. To 
identify the gene that is mutant in Best macular dystrophy, Petrukhin et al. (1998) 
defined the minimum genetic region by recombination breakpoint analysis, and mapped 
to this region a novel retina-specific gene designated VMD2. Genetic mapping data lead 
to the identification of 5 independent disease-specific mutations, and expression studies, 
provided evidence that mutations within the VMD2 gene were a cause of the disorder. 
The 3* untranslated region (UTR) of the gene contained a region of antisense 
complementary to the 3’ UTR of the ferritin heavy-chain gene, suggesting the 
possibility of antisense interaction between VMD2 and FTH1 transcripts. The gene is 
thought to encode a protein which plays a role in protein folding. Thus far no animal 
model has been produced for this disorder.
1.3.2.2 Stargardt’s Macular Dystrophy
Most instances of Stargardt’s disease shows an autosomal recessive mode of inheritance 
and is characterized by macular dystrophy with flecks (Cibis et al., 1980) as described 
in section 1.3.1.1. Stargardt disease 3 (STGD3) is a progressive form of the disease and 
has an autosomal dominant mode of inheritance (Stone et al., 1994). The STGD3 
patients have normal vision until the age of 5 years. Central vision is affected between 5 
and 23 years of age, this is followed by central atrophy and visual acuity decreasing to 
20/200 or worse in all patients over the age of 31 years. This disease is as the result of 
mutations in the gene encoding elongation of very long chain fatty acids-4 (ELOVL4) 
(Griesinger et al., 2000, Bernstein et al., 2001, Zhang et al., 2001). As yet there are no 
animal models for this disease.
1.3.2.3 Doyne Honeycomb Retinal Dystrophy (DHRD)
DHRD is characterized by small round white spots in the posterior pole of the eye 
including the macula and the optic disc that appear in early adult life. These progress to
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form a honeycomb-like pattern (Doyne. 1899). These spots form as the result of 
swelling of the inner part of Bruch’s membrane (Collins, 1913). These physical changes 
occur long before impairment of vision. The majority of cases are a result of a mutation 
in the gene encoding EGF-containing fibulin-like extracellular matrix protein-1 
(EFEMP1) (Stone et al., 1999, Matsumoto and Traboulsi, 2001, Tarttelin et al., 2001).
1.3.2.4 Cone and Cone-Rod Dystrophy
Cone dystrophies often present with photophobia, reduced visual acuity and abnormal 
colour vision. COD1 occurs due to mutations in the RPGR gene (Seymour et al., 1998, 
Demirci et al., 2002, Yang et al., 2002). COD1 is also sometimes referred to as 
incomplete achromotopsia, this however should be viewed as a symptom and not a 
diagnosis due to the effects the disease has on colour vision. COD3 is as the result of 
mutations in the guanylate cyclase activator-1 A (GUCA1 A) gene (Payne et al., 1998, 
Wilkie et al., 2001).The initial symptoms of this disease are reduced visual acuity 
associated with loss of colour vision are often apparent between the 20 and 40 years of 
age. Changes in the RPE at the macula are offten apparent prior to the visual loss. This 
is followed by central atrophy of the retina.
Cone-Rod dystrophy is characterised by early loss of visual acuity and colour 
discrimination associated with the loss of cone cells followed by nyctalopia and 
progressive peripheral field loss as the rods subsequently degenerate (Yagasaki and 
Jacobson, 1989, Moor, 1992). There are several known cone-rod dystrophy loci, 
CORD1, 2, 6, 7, 8 and 9, although some of the causative genes remain unknown. Table
1.5 lists the known loci and where known the causative gene.
1 18q21.1 -q21.3 Warburg et al., 1997
2 CRX 19ql 3 Freund et al., 1997
6 GUCY2D 17p 12 Kelsell et al., 1998
7 6q Kelsell et al., 1998
8 Iql2-q24 Khaliq et al., 2000
9 8pl 1 Danciger et al., 2001
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Table 1.5 List known genes and loci for Cone-Rod Dystrophy.
CORD2 is inherited in an autosomal dominant pattern and is caused by mutations in the 
CRX gene on chromosome 19q 13. Mutations in the CRX gene cause adCRD either by 
haploinsufficiency or by a dominant negative effect (Furukawa et al., 1997, 
Papaioannou et al 1997, Freud et al., 1997). See above for details of the Crx knockout 
mouse phenotype.
Three diferent muations in codon 8383 of the GUCY2D gene which encodes retina 
guanylate cyclase 1 (retGCl) on chromosome 17pl2-pl3 have been linked to autosomal 
dominant cone-rod dystrophy at the the CORD6 locus (Kelsell et al 1998, Perrault et 
al., 1998). The three different mutations confer differing severities of the disease 
(Wilkie et al 2000). As yet no animal models for CORD6 have been generated.
1.3.3 Congenital Stationary night blindness
1.3.3.1 Description of CSNB
Patients with congenital stationary night blindness usually have a full complement of 
rod and cone cells, but the rod photoreceptors are insensitive to dim light or require an 
abnormally extended time to adapt to dim light. In other patients there is a defect in the 
bipolar cell layer which prevents the correct transduction of the signals from the 
photoreceptors (Dryja, 2000).
1.3.3.2 Genes and animal models associated with CSNB
The X-linked NYX gene is responsible for congenital stationary night blindness type 1 
(Pusch et al., 2000). The X-linked form is distinguished from the autosomal form by the 
association in the former case with myopia. In general, X-linked congenital stationary 
night blindness is a nonprogressive retinal disorder resulting from a presumptive defect 
of neurotransmission between the photoreceptors and the bipolar cells. Both ‘complete’ 
and ‘incomplete’ forms of the disease can be present. The complete form lacks rod 
function by ERG and dark adaptometry and is accompanied by refractive error ranging 
from mild to severe myopia. The incomplete typ^ shows some rod function on scotopic 
testing and is accompanied by refraction ranging from moderate hyperopia to moderate 
myopia (Musarella et al., 1989).
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Congenital stationary night blindness type 2 is caused but mutations in the X-linked 
CACNA1F (calcium channel, voltage dependent, alpha-lF subunit) gene involved in 
cation exchange in photoreceptors. The various mutations in this gene, all give the 
‘incomplete’ type of the disease (Boycott et al., 2001). The third form of CSNB is 
caused by mutations in the alpha subunit of the rod transducin gene, GNAT. This causes 
an autosomal dominant form of the disease (Dryja et al., 1996).
1.3.4 Retinoschisis
1.3.4.1 Description of Retinoschisis
Retinoschisis is intraretinal splitting due to degeneration. The abnormality may not be 
clinically apparent until middle life. Affected males show cystic degeneration leading to 
split in the retina, detachment of the retina, and finally complete retinal atrophy with 
sclerosis of the choroid. Cystic maculopathy is sometimes the only finding in these 
patients. The basic lesion is cystic degeneration in the deep nerve layer. Visual handicap 
is usually mild up to age 40 to 50 years; thereafter, impairment of vision is slowly 
progressive. The lesions of the disease are thought to be related to defects in Muller 
cells (Sauer et al., 1997).
1.3.4.2 Genes and animal models associated with Retinoschisis
The disease-causing Rsl gene was identified on the X-chromosome (Sauer et al., 1997). 
To gain insight into the function of the retinoschisin protein and its role in the cellular 
pathology of RS, Weber et al. (2002) generated knockout mice deficient in Rsl. They 
showed that the pathologic changes in hemizygous mutant male mice were evenly 
distributed across the retina, apparently contrasting with the macular-dominated features 
in human. Similar functional anomalies in human and hemizygous mutant male mice, 
however, suggested that both conditions are a disease of the entire retina affecting the 
organization of the retinal cell layers as well as structural properties of the retinal 
synapse.
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1.3.5 Retinal degeneration syndromes
1.3.5.1 Usher’s Syndrome
Gorlin et al. (1979) summarized the classification of Davenport and Omenn (1977) as 
follows: type I has profound congenital deafness with onset of RP by age 10; type II has 
moderate to severe congenital deafness with onset of RP in late teens; type III has RP 
first noted at puberty with progressive hearing loss; type IV is a possible X-linked form.
El-Amraoui et al. (1996) reported that the myosin VIIA gene is expressed in the 
cochlear sensory hair cells during mouse embryonic development and that myosin VIIA 
expression is restricted to sensory hair cells in the developing human optic vesicle 
(Pearsall et al., 2002). They noted that this expression pattern correlated to the 
vestibular and cochlear dysfunctions resulting in balance problems and hearing 
impairment observed in Usher type 1 patients. As yet a knockout model has not been 
made of the MyoVIIa gene.
The USH2A gene encodes a protein, designated usherin by Weston et al. (2000), which 
is responsible for the less severe form of Usher syndrome. The protein is thought to 
have a role in the extracellular matrix.
1.3.5.2 Bardet Biedl syndrome
Bardet Biedl syndrome is characterized by mental retardation, pigmentary retinopathy, 
polydactyly, obesity, and hypogenitalism (Bardet, 1920, Biedl, 1922) and a high 
frequency of renal abnormalities (Alton and McDonald, 1973).
Bardet-Biedl syndrome is a genetically heterogeneous disorder with linkage to 6 loci: 
BBS1 on llq l3 ; BBS2 on 16q21; BBS3 on 3pl3; BBS4 on 15q22.3; BBS5 on 2q31; 
and BBS6 on 20pl2. Mutations have been found in genes at several BBS loci: BBS1, 
BBS2, BBS4, and BBS6 (MKKS). Although BBS had been originally thought to be a 
recessive disorder, Katsanis et al. (2001) demonstrated that clinical manifestation of 
some forms of Bardet-Biedl syndrome requires recessive mutations in 1 of the 6 loci 
plus an additional mutation in a second locus. While Katsanis et al. (2001) called this 
'triallelic inheritance,' Burghes et al. (2001) suggested the term 'recessive inheritance
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with a modifier of penetrance.' Mykytyn et al. (2002) found no evidence of involvement 
of the common BBS1 mutation in triallelic inheritance. There are as of yet no animal 
models of Bardet Bield syndrome.
1.4 The Human Genome Mapping Project
The ultimate goal of the Human Genome Project is to sequence the entire human 
genome and to outline the position of all genes by the year 2005. The Human Genome 
Project is the result of an international 15-year collaboration involving over 20 
laboratories and hundreds of people around the world. The concept was bom through 
scientific meetings held during the years 1984 to 1986 (Palca 1986). However the US 
National Research Council proposed a broader programme to create genetic, physical 
and sequence maps of the human genome in parallel with other species and deposit all 
of this information into publicly accessible databases. The US Department of Energy 
launched the initiative and was supported by the US National Institute of Health and 
many other Institutes around the world including the UK Medical Research Council. 
After the construction of the genetic and physical maps of the human and mouse 
genomes (Donis-Keller et al 1987, Hudson et a l 1995, Nusbaum et a l 1999), and the 
partial sequencing of the S. cerevisiae (yeast) and C. elegans (worm) genomes (Oliver et 
al 1992, Wilson et al 1994), a new, more rapid strategy for genome sequencing was 
developed. This strategy was initiated by Craig Venter who, once a NIH employee, did 
not agree with the slow strategy being employed to sequence the genome using a series 
of ‘genomic signposts’ to assemble the sequence generated. Instead he opted for a more 
rapid method o f ‘shotgun’ sequencing manageable sized fragments of the genome 
performed on random genomic fragments, the data was then entered into a second phase 
whereby the gaps in the sequence were closed and any ambiguous sequence was 
resolved by direct analysis. These random fragments were conceived as a short cut to 
the finish line by Venter, but as an obstacle by the HGP consortium due to the 
possibility of producing large numbers of errors. Venter however took the idea to the 
private sector and to a company called Celera Genomics who took up the idea and 
ploughed the much-needed funds into the project. The sequences produced from Celera 
were not however made publicly accessible. The competition between the two groups 
meant that the Human Genome Project moved into full production in early 1999. Under
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the new strategy, a draft sequence of more than 90% of the genome was anticipated by 
the year 2001, (Collins et al 1998). The goal was achieved with the completion of the 
draft sequence of the human genome (International Human Genome Sequencing 
Consortium 2001, Hattori et al 2000, Dunham et a l 1999). The new goal is to have a 
full, finished sequence by the year 2003, 2 years ahead of previous predictions.
The information obtained so far predicts that the Human Genome contains between 
30,000 and 40,000 genes which is significantly less than previous estimates of 100,000 
(Antequera and Bird 1994, Liang et al 2000), and only approximately twice as many as 
C. elegans (19000) ox Drosophila (13600).
The sequence information generated by HGP and on a smaller scale by independent 
scientists is deposited and maintained by GenBank. GenBank is housed at the NIH and 
provides annotated DNA sequences. The volume of sequences collected here has 
rapidly escalated, especially in the last three years, and as of August 2002 there were 
approximately 18,197,000 sequences. GenBank is part of an international collaboration 
including the DNA DataBank of Japan (DDBJ) and the European Molecular Biology 
Laboratory (EMBL) with exchange of DNA data occurring daily between the groups. 
Submission of sequence data to GenBank comes under three forms, ESTs, STSs and 
HTGs.
Expressed sequence tags (ESTs) are short sequences of around 300-500bp in length that 
have been generated from cDNAs. When produced by the International Collaboration 
they are deposited into GenBank in large batches, however independent scientists can 
register single sequences. ESTs represent a ‘snapshot’ of genes expressed in a given 
tissue at a given developmental stage, some even provide a chromosomal location when 
the mapping data is known. Most of the accumulated sequences are stored in the dbEST 
division of GenBank database (Boguski et a l 1993). The IMAGE consortium who 
deposit an array of cDNA sequences, cDNA libraries and expression and mapping data 
from clones into GenBank make the clones they have generated available for academic 
researchers making ESTs a very useful tool to get a ‘handle’ on a gene of interest 
(Lennon et a/1996). Caution has to be observed however since artefacts including 
genomic contamination, sequencing errors, pseudogenes, multiple transcripts of the 
same gene due to different tissue expression patterns and improper splicing have been
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associated with deposited ESTs, so ‘bench’ verification of obtained clone sequence is 
still required (Wolfsberg and Landsman, 1997). Whatever the negative aspects of ESTs 
they have produced a resource whereby homologous genes within and between species 
can be identified quickly and obtained in clone form for further analysis.
Sequenced Tagged Sites (STSs) are also short (200-5Obp) and are known to be unique 
to the genome, ie they can be specifically detected by PCR in the presence of all other 
genomic sequences. These tags can be used to define a specific position on a physical 
map. High Throughput Genomics (HTGs) allow the rapidly growing genomic data to be 
available to the scientific community even in the ‘unfinished’ forms. Unfinished HTG 
contigs contain sequence greater than 2kb generated from a single cosmid, BAC, YAC 
or PAC clone but the sequence may be unordered or contain sequence gaps. HTGs 
progress through three phases and it is only when in phase 3 that the sequence has been 
ordered and the gaps closed that the information is moved in its final form to another 
division of GenBank.
The publication of the draft sequence means that the project is now entering the final 
stage of assembling consensus maps of the human genome and entering the transition 
period from the era of physical mapping to that of functional genomics.
1.4.1 Bioinformatic tools for sequence data analysis
Part of the facilitation of the Human Genome Project was the ‘development of 
computational tools such as algorithms, software and databases for the collection, 
interpretation and dissemination of the vast quantities of complex mapping and 
sequence data generated by the Human Genome Project’ (Pearson and Soli, 1991).
Since then several hundred programs using different algorithms have been designed to 
predict individual coding features within any genomic sequence, but none of these tools 
cover all aspects or is 100% accurate. Table 1.6 lists some of these most commonly 
used tools. However the most effective results to date have been produced by the new 
generation exon predictor programs such as GENSCAN, but many of the programs still
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NCBI http://www.ncbi.nlm.nih.gov
HGMP http://www.hgmp.mrc.ac.uk
BLAST http://www.ncbi.nlm.nih.gov/BLAST
FASTA http://www.ncbi.nlm.nih.gov/BLAST/fasta
GRAIL http://avalon.epm.ornl.gov/Grail-
bin/EmptyGrailForm
NIX http://www.hgmp.mrc.ac.uk/NIX
RUMMAGE http://genlOO.imb-j ena.de/rummage
Genotator http://www.hgmp.mrc.ac.uk/Registered/option/geneo
tator.html
EMBOSS http://www.hgmp.mrc.ac.uk/software/EMBOSS
dbEST http://www.ncbi.nlm.nih.gov/dbEST
Ensembl http://www.ensembl.org
GenBank http://www.ncbi.nlm.nih.gov/GenBank
GenWise http://www.sanger.ac.uk
GeneScan http://bioweb.pasteur.fr/seqanal/interfaces/genes
can.html
UniGene http://www.ncbi.nlm.nih.gov/UniGene
SNP http://www.snp.cshl.org
SWISS-PROT http://expasy.ch/sprot/
FEX,HEXON,Fgene http://genomic.sanger.ac.uk/gf/gf.html
GeneMark http://genemark.biology.gatech.edu/GeneMark
Genefinder, MZEF http://sciclio.cshl.org/genefinder
GetMaps http://telethon.bio.unipd.it/GATMaps/
Mouse genomic http://informatics.jax.org/
informatics
Table 1.6 Listed are the URLs of some of the most commonly used gene prediction 
programs and packages.
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have difficulty in accurately predicting splice sites (Thanaraj, 2000). To minimise the 
errors generated by using these programs, it is advisable to analyse genes using a 
combination of two or more gene prediction packages. Packages include many 
individual programs to analyse different aspects of sequence characteristics. In the 
following paragraphs four of the common gene prediction packages, NIX, RUMMAGE, 
Genotator and EMBOSS, will have their advantages and disadvantages described.
NIX is comprised of a collection of programs and is available on the UK HGMP 
website (see table 1.6 for URL). The programs include, GRAIL, TSSNW, GENSCAN, 
Fgene, FEX, HEXON, MZEF, GeneMark, Genefinder, HMMGene, Polyah, BLAST, 
Repeatmasker and tRNAscan (Table 1.7 shows comparison between packages and gives 
brief details of the programs). NIX main disadvantage is that all the parameters of the 
programs are preset and cannot be altered by the user. Up to 500kb of sequence can be 
analysed at any one time but for better resolution of the generated data, smaller 
fragments up to 20kb are more advisable. The analysis occurs on a unix server and the 
output data displayed on a web browser where it is stored for one month. Regions of 
interest can be enhanced using the web browser. Analysis of the input sequence occurs 
on both strands and the output data separated accordingly. The output data are grouped 
by program of the same function and are colour co-ordinated appropriately. For 
example the information is grouped as follows, CpG islands and promotor predictions, 
exons and gene predictions, BLAST searches against protein, EST, Unigene, mRNAs 
and other sequence datasets. Also identified are E. coli sequences, tRNA and vector 
sequences. The strength of the predictions is represented by the intensity of the coloured 
blocks, the raw data can be accessed by ‘clicking’ on these blocks (Reviewed Jones et al 
2002).
RUMMAGE contains twenty-six programs including prediction of repeat motifs, exons 
and homology searches against a number of databases (see table 1.7). In contrast to the 
NIX parameters, RUMMAGE parameters can be altered but only by request to the 
program administrator. This package can analyse up to lOOOkb, but shorter sequences 
give clearer results. Again the data are generated on unix and are visualised via a web 
browser. The output is similar to NIX but only the features present within the sequence 
are shown for any one stretch. Again both strands are analysed and regions of similar 
function are grouped together by colour. The selection of the blocks produces complex
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Feature
NIX RUMMAGE Genotator EMBOSS
Promoter prediction NNPP CpG plot
GENESCAN GENESCAN
Fgene ProScan promoter newcpgseek
TSSW Compile-Alu
GRAIL CpG
Exon prediction No
GRAIL GRAIL GRAIL
GENSCAN GENSCAN
MZEF MZEF
Xpound
Xpound
GeneMark Exonsampler
FEX Compile-exon
HEXON
Gene Prediction No
GENSCAN GENSCAN
Genefinder
Genefinder
GeneMark Genesampler Genie
GRAIL
Fgene
Poly A site prediction No
GENSCAN GENSCAN
Polyah
Fgene
GRAIL
ORF prediction No No Yes Yes
EST searches Water
BLAST BLAST BLAST
MRNA searches No Water
BLAST BLAST
BLAST-protein db
Embl Embl
Genpept Genpept
Swissprot
PROSITE PROSITE
OWL
STS identification BLAST No stssearch
BLAST
Repeats Repeatmasker
Repeatmasker
BLAST einverted
Etandem
maskfeat
E .coli/vector No vectorstrip
sequences BLAST BLAST
TRNA scan TRNAscan-SE No Yes No
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Table 1.7 Listed are some of the programs used in the packages described in the text to 
predict genes. The function has been indicated and those programs common to two or 
more packages are highlighted in bold (adapted from Jones et al., 2002).
tables of sequence data and hence this program’s main disadvantage is that it is less 
user-friendly than NIX.
The Genotator package runs fewer programs than the previous two, but it includes the 
novel promoter program NNPP, the gene prediction program, Genie and a BLASTX 
search of GenBank (table 1.7). This package differs from the previous two by allowing 
all parameters to be altered by the user. The package can easily handle sequences of 
25kb and is run in unix with the output displayed in X-windows. On the whole the data 
are viewed in a similar way to NIX and RUMMAGE. The raw EST data are shown in 
separate windows when the colour block is selected. Generally the output data are easier 
to extract in Genotator than they are in RUMMAGE.
Finally, the EMBOSS package contains a suite of over 100 applications (some are 
included in table 1.7), but exon and gene prediction programs are not available, however 
open reading frame detection programs are available. This program can be run in both 
unix and in windows HTML and the output data are given in the form of tables rather 
than graphically as in the previous packages. This makes comparison between analysis 
packages more difficult if pooling results.
On the whole these packages contain several common programs but some are unique, so 
running two or more can be beneficial. Caution must be taken when comparing 
packages, since some have the option of altering parameters and hence the results may 
be compromised. Probably the most commonly used package is NIX as it contains most 
of the required programs and it has the added bonus of being user-friendly.
The packages described above go a long way in predicting characteristics of the input 
sequence. However to predict a functional role of a gene, the information on expression 
patterns from the EST database can be examined. This is useful when trying to identify 
potential disease-causing genes in a specific tissue. Programs such as GetMaps can 
speed up this process as GetMaps interprets all the expression information that is stored
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in UniGene (a subdivision of GenBank). However resultant clones identified in this way 
should still be verified by Northern blot or in situ hybridisation using the tissue of 
interest.
Another useful site for exploring expression patterns in other species is the Mouse 
Genomic Informatics site (MGI). Using this site, the nineteen species listed, including 
cattle, dogs, cats, rats and mice, can be screened to see if the expression pattern of a 
gene of interest has been reported. This site also gives information on naturally 
occurring and generated animal models of genetic disease which may help outline the 
function of a particular gene (Lichanska and Simpson, 2002).
As more sequence information is generated and processed, database emphasis has been 
changing. There has become a need for the generation of techniques, databases and 
algorithms to deduce the function of genes and how they interact with each other. These 
databases and software programmes, such as SAGE, are starting to emerge with the 
introduction of tissue- and micro-array techniques. However a discussion of these 
databases is outwith the remit of this thesis.
In summary, from the advent of the Human Genome Mapping Project a vast quantity of 
sequencing data has been deposited into Genbank. This information however is useless 
without the facilities to analyse it. So under the current demand a plethora of resources 
have been developed (core resources listed in table 1.6). The software packages are at 
an advanced stage where the sequence data banks can be used to identify interesting 
genes based on homology (BLAST), possible gene features can be predicted (NIX), and 
the expression pattern derived (ESTs, MGI). This however is virtual, and although the 
development of ‘data-mining’ tools has cut down the laborious bench practice of library 
screening for initial gene identification, caution must be applied when interpreting 
computational results and the need for bench verification is still very much here.
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1.5 Transgenic Techniques
1.5.1 Drosophila melanogaster as a genetic tool
Drosophila has been used as a model to understand genetic mechanisms for many years. 
Around the late 1960's Drosophila research was beginning to dwindle and interest was 
only associated with old-fashioned classical genetic, as most of the exciting new 
discoveries were being found using Eschericia coli. This was until P-elements were 
discovered in the Drosophila genome in the mid-1970s. Within the last twenty years 
these elements not only have become ubiquitous tools for Drosophila geneticists, but 
have also been used as a link between Drosophila and mammalian genetics.
1.5.1.1 Drosophila transposable P-elements
The first P-element found its way into the Drosophila melanogaster genome from 
another Drosophila species, D. willistroni, somewhere in Latin America. The sequences 
of the P-element derived from both species differ by only one base pair in nearly three 
thousand base pairs of sequence, which includes intronic sequence. D. melanogaster 
and D. willistroni diverged 60 million years ago, so this insertion most likely happened 
due to horizontal transmission from the species D. willistroni in recent years, mostly 
likely through the introduction of D. melanogaster from its native Western Africa to its 
now global colonies. Once in the genome, the P-elements made use of their new host’s 
DNA repair mechanism to increase their copy number while transposing to new 
genomic positions. Within a few decades they spread worldwide to encompass nearly 
the entire species. Only the stocks maintained in laboratories from early Drosophila 
geneticists remained uninfected (reviewed by Engels, 1997).
P-elements are transposable DNA elements (one of a family of approximately thirty 
elements referred to as transposons), which are highly mobile in the germline of 
Drosophila melanogaster. The prototype of a P-element is a 2.9kb element from which 
other members have arisen from different internal deletion events. The elements are 
characterised by a perfect 31 base-pair inverted terminal repeat. This is the site of 
action for the transposase, the enzyme that cuts the chromosomal DNA where the P- 
element inserts. Transposase makes staggered cuts in the DNA and in a replicative 
process, a copy of the transposon inserts at the target site. The gaps are then filled using 
the host’s DNA repair mechanism being sealed with DNA polymerase I and DNA
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ligase, resulting in a duplication of the target site and formation of a new direct repeat 
sequence. Three long open-reading frames have been identified in the prototype DNA 
sequences. One of these open-reading frames encodes the transposase protein. The 
messenger RNA for this protein is produced by the removal of the introns from its 
primary transcript. The germline specificity of transposition is due to the fact that 
splicing out of one of these introns occurs in germ cells but not somatic cells (Laski et 
al., 1986). Some naturally occurring short P-elements are defective. They cannot 
encode functional transposase but are transposable when they are found in the nucleus 
of a cell which contains a non-defective P-element. The act of transposition has been 
referred to as illegitimate recombination because no homology between sequences is 
required and it is not site specific. The P-elements have been affectionately termed the 
Swiss army knife of Drosophila genetics as they are used as tools in many techniques. 
P-elements are now used in mutagenesis, transposon tagging, germline transformation 
and to provide the framework for the Drosophila genome project (reviewed by Engels, 
1997).
1.5.1.2 Fly mutant rescue
In the early 1980s, Spradling and Rubin (1982) exploited the newly discovered P- 
elements (described in section 1.5.1.1). They used a naturally-occurring, short (1.2kb), 
internally deleted member of the P-element family. This defective P-element cannot 
encode any of the putative protein products of the 2.9kb prototype element (O’Hare and 
Rubin, 1983). The first experiments of this kind used the wild type rosy (ry) gene as the 
selectable marker for identification of insertion of target DNA (inserted into a prepared 
polylinker site) into the genome (figure 1.19). The ry gene encodes the enzyme 
xanthine dehydrogenase and conveys the wild type red eye colour, whereas the null 
mutant ry flies have brown eye colour making the gene easily identifiable. The 
construct was then co-injected with a plasmid containing a non-defective 2.9kb P- 
element into the posterior pole of a developing ry embryo.
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A. Structure of P-element derivative
Polylinker
Insert DNA as required
31 bp inverted repeat (IR)
7.2kb ry fragment 
Lacks own transposase gene
B. Structure of helper P-element
pUC8 vector
IR
<
0 1
T
i
.23bp of IR deleted therefore 
cannot be transposed
pUC8 vector
Open reading frame 2 encodes transposase
Figure 1.19 P-element derivatives as a vector system
The figure shows (A) a short derivative of a P-element which lack it's own transposase gene. This derivative has been utilised by 
inserting a selectable marker gene (ry) which confers eye colour and a polylinker site to insert gene specific DNA. In order for this 
construct to be inserted into the genome, it is co-injected into the posterior pole of an embryo (see figure 1.18) with (B) a helper P- 
element. The helper P-element encodes the transposase gene required for the insertion of (A) into the embryo’s genome, but lacks 
an entire repeat sequence at one end preventing its own transposition (adapted from Old and Primrose, 1994).
The injections into the posterior pole were performed at the blastoderm stage as the 
multinucleated embryo has not yet become partitioned into individual cells. The 
developing germ cells are at the posterior pole and are the first to be partitioned. 
Injection in this region increases the chance of the construct DNA being randomly 
inserted into one or more germ cells (figure 1.20). Ry progeny were recovered from 20- 
50% of injected embryos. This finding showed that foreign DNA could be delivered 
into the fly genome via vectors containing the components used by P-elements 
(reviewed in Primrose and Old, 1994). This technique was further developed to include 
the insertion of DNA from species other than Drosophila and the ‘tagging’ of the target 
DNA with reporter genes such as green fluorescent protein (GFP) which allows the 
detection of transgene expression using fluorescence microscopy.
Mammalian homologues of Drosophila genes have since been shown to be capable of 
insertion into the fly genome and can rescue mutant fly phenotypes and hence confirm 
that the genes confer a similar function in both species. An example of this is the rescue 
of the Drosophila rdgB (phenotypes detailed in section 1.2.4.2) mutant phenotype using 
the mouse homologue (Chang et al., 1997).
In this project, the CDP-diacylglycerol synthase genes Cdsl and Cds2 are tagged with 
GFP and cloned into P-element containing vector before being injected into fly embryos 
in the attempt to rescue the Drosophila eye-cds mutant phenotype (see section 3.7).
1.5.2 Gene targeting in the mouse
The previous section discussed the random insertion of foreign DNA into a genome, 
generally referred to as transgenics. In this section the more site-specific form of gene 
manipulation, gene targeting, will be discussed. This section will discuss the molecular 
basis of gene targeting events used in the preparation of a knockout mouse. Gene 
targeting relies on homologous recombination of DNA to introduce a change in an 
organism's DNA at a specific location within the genome.
The ability to insert foreign DNA into a host’s genome was first discovered through 
tissue culture experiments in the mid-1970’s. Jaenisch et al. (1976) demonstrated that a
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Figure 1.20 Injection of transgenic DNA into embryo
Shown is a schematic representation of an early Drosophila 
embryo. Transgenic DNA is injected into the posterior pole just 
prior to pole cell formation and is incorporated into the germline 
(adapted from Old and Primrose, 1994).
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murine retrovirus, Moloney murine leukaemia virus (MMLV), could infect mouse 
embryos and insert a proviral copy of DNA into the genome which was then transmitted 
as a Mendelian trait to the offspring. This however, did not imply that recombinant 
DNA, that is a DNA molecule formed by joining segments of DNA from different 
sources, could be integrated into the genome since the virus contained all the biological 
activity required to function and may seek out specific sights for integration. These 
experiments suggested that novel DNA could be tolerated by the developing mouse, 
even though it was under very specialised conditions (Mann et al, 1983; Jahner et al, 
1985; Van der Putten et a l, 1985). In early gene transfer experiments, selectable 
markers, which would result in the transformants being easily recognised, were 
transferred into cells (Maitland et a l , 1977; Wigler et al.t 1977). The frequency of 
success of insertions into cells was low when the genes were transfected into the cell. 
The success rate increased to 20% when the genes were injected directly into the cell 
nucleus (Graessman et a l, 1979; Capechi, 1980).
However, probably the most important discovery in the history of germline 
transformation was from mammalian embryologists, who developed techniques to 
remove embryos, culture them briefly in vitro and then return them to foster mothers 
where the remainder of normal embryogenesis could occur. This opened the way for 
the production of chimaeric animals (reviewed by Palmiter and Brinster, 1986). It was 
through the study of the development of teratocarcinoma, which are tumours in the 
germ cells of the testis and ovaries many of which are benign, that led the way forward 
in transgenic studies. Malignant tumours in the germ cells are called embryonic 
carcinomas (EC). Mouse strain 129 has a high incidence of spontaneous embryonic 
carcinoma formation. EC cells are multipotent and can proliferate and differentiate into 
tissue and cell types representative of all the embryonic germ layers. The malignant 
cells are capable of transplantation due to the presence of the embryonic stem (ES) cell 
material in the tumours. It has been shown by transplantation of EC cells into 
blastocysts, which are then placed in a pseudopregnant mouse, a normal mouse is 
obtained and is composed of both cells from the host blastocyst and from the malignant 
carcinoma. This technique was exploited further to select mutant cells, while in culture, 
and transplant the mutants into the blastocyst. This resulted in a mouse carrying the 
mutant cells. If the mutant cells populate the germline it is possible to create a stock of 
mice with a lesion in every cell (Lehman, 1980; Brinster, 1993). This technique
91
progressed away from EC cells and instead healthy embryonic stem (ES) cells were 
used for manipulation of transgenic mice.
Transgenic technology takes advantage of four unique characteristics of the ES cell 
systems:
(i) they are derived from a single mouse embryo.
(ii) they can be maintained in culture.
(iii) they consist of pluripotent cells.
(iv) they are germline compatible (Nagy, 1997).
ES cells are derived from the inner cell mass of very early blastocysts. These cells 
express all the housekeeping genes as well as the essential transcription factor genes 
which are required to maintain the cells (Tada et al., 1993). These cells occur after the 
first differentiation in the cleaving mammalian embryo. The inner and outer cell masses 
separate, with the inner cell mass forming the first polarised extra embryonic 
epithelium. The inner cell mass is totipotent (Tarkowski, 1967). The 129Sv mouse 
strain was continued to be used to harvest the ES cells, due to the knowledge gathered 
from the EC cells. The preimplanted blastocyst is the optimum starting stage for 
manipulation (Wells et a l, 1991). Genomic DNA is then introduced into the ES cells, 
usually by electroporation, and then the cells are implanted into the pseudopregnant 
mouse.
Gene targeting has many functional roles in genetics. By the manipulation of specific 
genes, their functional role can be examined. In this project a gene knockout construct 
(the principles of which are described later in this section) has been prepared to target 
the murine Cds2 gene in order to prevent the production of wildtype Cds2 protein. This 
technique relies on the genetic principle of homologous recombination. Homologous 
recombination relies on two regions of sequence identity to align and exchange genetic 
information during a crossover event (figure 1.21). In gene targeting studies, the 
principle of homologous recombination is used to manipulate an organism's DNA at a 
specific location. In knockout studies, a construct is prepared whereby two regions of 
gene specific, genomic DNA are separated by the insertion of a neomycin gene. The 
role of the neomycin gene is two fold, firstly it disrupts the gene of interest and gives 
rise to the production of a truncated protein and secondly, the gene confers resistance to
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Cells resistant to both neomycin and gangcyclovir
t Target gene insert
/ \
neo | tk
\ /
vector
neo tk
Random gene insertion
A* = replacement allele 
A = original allele
= gene of interest region of homology
Figure 1.21 Homologous recombination
Shown is a schematic representation of homologous recombination 
which is used in making transgenic models. A construct is designed 
using an expression vector which contains the genes neor and 
thymidine kinase (t) which are employed as selectable markers for 
detecting targeted ES cells.
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the antibiotic neomycin. The resistance to neomycin is one of two selectable markers 
used in this technique. The second selectable marker to be positioned in the targeting 
construct is thymidine kinase (tk) gene. The tk gene is sensitive to the antibiotic 
gancyclovir. The tk gene is positioned downstream of the 3’ region of specific gene 
sequence. If homologous recombination occurs effectively, the neomycin gene will be 
carried into the targeted embryonic stem (ES) cells but the tk gene will not (figure 1.21). 
Therefore correctly targeted cells will grow on medium containing both neomycin and 
gancyclovir and are easily identified. The linearised, cloned constructed DNA fragment 
with selectable markers are transferred into ES cells for homologous recombination 
(Thomas et al., 1986; Viville, 1997; Bishop, 1999).
Transgenic mice enable the analysis of gene function and provide models for gene 
therapy studies. Examples of successful gene targeting knockout mouse models, which 
give rise to retinal phenotypes, include the yPDE knockout (Tsang et a l , 1996), 
rhodopsin knockout models (Humphries et al., 1997, Lem et al., 1999), the retinol 
binding protein (RBP) knockout (Quadro et al., 1999), the Tulpl knockout (Hagstrom et 
al., 1999), the arrestin knockout (Chen et al., 1999), GCAP knockout (Mendez et al., 
2001), the retGC knockout (Yang et al., 1999) and the deletion of the rod transducin a- 
subunit (Calvert et al., 2000)
Many mutations found in the rod opsin gene have been associated with RP, a 
progressive disease resulting in the loss of photoreceptor cells. In the rhodopsin /_ mice 
the gene has been disrupted in the first exon (Humphries et al., 1997; Lem et al., 1999). 
Later studies used transgenic lines expressing a rhodopsin triple mutant (V20G, P23H, 
P27L (GHL)) (Fredrick et al., 2001). The triple mutant mouse heterozygote shows slow 
progression of disease similar to human autosomal dominant RP (Frederick et al 2001) 
but the phenotype is further enhanced by crossing the mice with the rhodopsin null 
mutation. Both transgenic studies conclude that the absence of the rhodopsin gene 
results in the progressive loss of photoreceptor cells and thinning of all retinal layers. 
Complete loss of photoreceptor cells is seen by day 90 in the null mutant rhodopsin 
mice and by day 30 in the triple mutant/rhodopsin mice (Humphries et al., 1997; Toda 
et al., 1999; Hobson et al., 2000; Frederick et al., 2001).
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Retinol binding protein (RBP) is the specific transport protein for retinol (vitamin A) in 
the circulation, its only known function being to deliver retinol to tissues. In tissues, 
retinol is converted to retinoic acid which regulates many hundreds of genes. In the 
eye, retinol is converted to 11-czs-retinal, the visual chromophore. The RBP knockout 
mouse has several phenotypes including reduced blood retinol levels and impaired 
retinal function in the first few months of life. The retinal function of the mice 
improved however when they were fed a vitamin A sufficient diet to the point that, at 5 
months, they were practically indistinguishable from wild type mice. However, when 
deprived of vitamin A, vision remained abnormal and blood retinol became 
undetectable. RBP null mutants cannot mobilise internal stores of retinol so their 
vitamin A status is dependent on a regular dietary vitamin A intake. From the knockout 
of the RBP, it was concluded that RBP was required for normal vision in young animals 
and for retinal mobilisation in times of dietary vitamin A deficiency (Quadro et al., 
1999).
Mutations in TULP1, a member of the Tubby family of genes, have been associated 
with autosomal recessive RP (Baneijee et al., 1998; Gu et al., 1998; Hagstrom et al., 
1999). Tulpl protein is found exclusively in the photoreceptor inner segments and 
photoreceptor degeneration involving both the rods and cones cells is seen in the tu lp fA 
knockout mice. A function of Tulpl is thought to be in maintenance and viability of rod 
and cone cell photoreceptors and the phenotype in the mice is consistent with the loss of 
polarised transport of nascent opsins to the outer segments (Hagstrom, 1999).
Calvert et al., (2000) deleted the gene for the rod transducin a-subunit in mice. As 
described in section 1.2, transducin is a heterotrimeric G-protein involved in coupling 
rhodopsin during phototransduction. The a-subunit is the active component of the 
molecule. Exons 3-6 were deleted an replaced by a neomycin cassette in the knockout 
construct. The results of this were that the hemizygous mice showed a small reduction 
in retinal transducin a-subunit content but retinal morphology and physiology of single 
rods are largely normal. In homozygous knockout mice, a mild retinal degeneration 
occurs with age. Rod-driven components were absent from electroretinograms but 
cone-driven components were retained. These results suggested that rod 
phototransduction is driven by a single type of transducin subunit.
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As described in section 1.2, mammalian phototransduction follows from the 
photoisomerisation of a visual pigment to a G-protein mediated activation of a 
phosphodiesterase (PDE) hydrolysing cGMP. This results in the closure of ion-gated 
channels which causes a decrease in intracellular Ca concentration, which acts through 
guanylyl cyclase activating proteins (GCAPs) to increase guanylyl cyclase activity.
This increase in cyclase activity represents an important mechanism for photoreceptor 
adaption and recovery. Two eye-specific guanylyl cyclases have been identified in 
humans, RetGCl and RetGC2 (Shyjan et al., 1992; Lowe et al., 1995) with homologues 
GC-E and GC-F in rats (Yang et al., 1995). When the GC-E (RetGCl) gene was 
disrupted, the rats displayed morphologically normal rods up to 1 year of age but the 
cone cells rapidly degenerated. The rods displayed a normal dark current despite the 
absence of GC-E with no compensatory increase in GC-F levels. The role of the GC-E 
gene has not yet been determined but it appears to be required for the maintenance of 
the normal retinal structure and function and seems critical for survival of cone cells 
(Yang et al., 1999).
Mendez et al. (2001) disrupted the expression of the GCAP genes to assess their 
function in the retina. The mutant mice appeared to have no Ca regulation and had 
longer and slower rod responses to flashed light than wild type mice. Null mutant mice 
for both GCAPs had a GCAP2 transgene inserted and expressed in rods cells which 
restored maximum light induced guanylyl cyclase (GC) activity but did not restore 
normal flash response kinetics. From evidence obtained from the transgenic mice 
GCAPs seem to strongly regulate GC activity in rods and thereby extend the rod 
operating range, but GCAP1 and GCAP2 may subserve different specific function in 
mouse rods.
As described above and in previous sections, cGMP-PDE is a key regulator of 
vertebrate phototransduction. Tsang et al. (1996) disrupted the murine PDEy gene, thus 
preventing the production of the two inhibitory y subunits, which would normally bind 
to the active a  and p subunits. This disruption resulted in a rapid retinal degeneration 
which resembled human retinitis pigmentosa (RP), a common inherited degenerative 
retinal disease which progresses to blindness. Homozygous mutant mice displayed
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reduced levels of PDE activity instead of the predicted increase due to the lack of 
inhibition. In the mutant mice the a  and P subunits formed but did not possess 
hydrolytic activity. Evidence from the mice therefore seems to suggest that the y-PDE 
subunits are necessary for the survival of photoreceptors and PDE activity.
Arrestins are molecules used in the visual cascade to switch off activation of the G- 
protein cascade and terminate the signalling pathway that triggers cellular response by 
binding to G-protein coupled receptors. Chen et al. (1997) produced knockout models 
where one or both copies of the arrestin gene were disrupted. When one copy was 
removed, photoresponses were unaffected suggesting that the binding of arrestin is not a 
rate limiting step for the recovery of the rod photoresponse in humans while it is in 
Drosophila. When both copies of the gene were disrupted the flash response in the 
mice displayed a rapid partial recovery followed by a long final phase. This suggested 
that an arrestin-dependent mechanism initiates the quench of rhodopsin’s catalytic 
activity and that arrestin completes the quench. The evidence from the behaviour of the 
mutant mice suggests that arrestin is required for normal signal transduction but does 
not participate directly in light adaptation.
Mouse knockout models are useful tools in identifying the possible functional role of a 
gene or protein in an in vivo situation. However, although these models are useful tools 
in their own right, caution should be applied since mice are obviously not identical to 
humans and although the functional role in the mouse has been deduced, this does not 
mean the functional role in man will always be the same.
CHAPTER TWO
MATERIALS AND METHODS
2.1 Materials
2.1.1 Reagents
All reagents were purchased from Sigma, Promega, GibcoBRL (now trading as 
Invitrogen), Boehringer Mannheim (now trading as Roche Diagnostics) or Amersham 
Pharmacia Biotech unless otherwise stated; Oxoid supplied the broth stocks.
2.1.2 Vectors and Libraries
pBlueScript was supplied by Stratagene, and pGEM-T Easy by Promega. The targeting 
vector, pPNT was a kind gift from Victor Tybulewicz.
All gridded libraries were obtained from the Human Genome Mapping Project Resource 
Centre (HGMP-RC), Hinxton, UK (http://www.hgmp.mrc.ac.uk). The 129X mouse 
spleen genomic library in A.FIXII vector was purchased from Stratagene.
2.1.3 Bacterial strains and competent cells
DH5a competent cells were purchased from GibcoBRL. XL1 Blue cells were 
purchased from Stratagene and Promega supplied JM109 cells for cloning into pGEM 
T-easy.
2.1.4 Kits
Kits for the preparation of DNA, gel purification and PCR product purification were 
supplied by Qiagen. The oligolabelling kit and the cDNA synthesis kits were supplied 
by Amersham Pharmacia Biotech.
2.1.5 Oligonucleotide Primers
All primers used for polymerase chain reaction (PCR) and for sequencing were supplied 
by Sigma-Genosys Ltd.
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2,2 Buffers, Solutions and Media
2.2.1 Media
NZY:
L-Broth (LB):
2YT:
For plates:
For top agarose:
2.2.2 Solutions & Buffers
SM Buffer:
2 0 x SSC:
Denaturing Solution:
For 1 litre 
21gNZY mix 
2 NaOH pellets
lOg Tryptone 
5g Yeast extract 
lOgNaCl
16g Tryptone 
lOg Yeast extract 
5g NaCl
15g agar per litre 
6 g agarose per litre
lOOmMNaCl 
lOmM MgS04 .7H20  
50mM 1M Tris Cl (pH 7.5) 
0 .0 1 % gelatin (w/v)
3M NaCl
0.3M Sodium Citrate
0.5M NaOH 
1.5MNaCl
99
Neutralising Solution:
lOOx Denhardt’s:
5 Ox TAE:
Homogenization Buffer: 
Lysis Buffer:
lOx 3-[N-Morpholino] 
propanesulfonic acid (MOPS):
Transformation Buffer I:
Transformation buffer II:
1.5M NaCl 
1M Tris Base 
ImM EDTA (pH 7.2)
2% Ficoll (w/v)
2% Polyvinyl pyrrolidine (PVP) (w/v) 
2% Bovine Serum Albumin {w/v)
9M Tris Base
57. lg glacial acetic acid
0.5M EDTA (pH8.0)
1M NaCl 
0.5M EDTA
1M NaCl 
0.5M EDTA 
20% SDS (w/v)
0.2M MOPS 
50mM NaOAc 
lOmM EDTA 
pH to 7 with NaOH
lMKAc 
IMRbCl 
0 .1M CaCl2 
lMMnCl2 
35% Glycerol (v/v)
lOOmM MOPS 
0 .1M CaCl2 
IMRbCl
35% Glycerol (v/v)
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Pre/Hybridisation Buffer:
PI solution:
P2 solution:
P3 solution:
Nuclease solution (lOmls):
2.2.3 In situ Hybridisation Buffers
DIG 1 Buffer:
DIG 3 Buffer:
50mM Phosphate Buffer (pH 6 .8 ) 
4x SSC
75pg/ml Salmon Sperm DNA 
5x Denhardt’s Solution 
10% Dextran Sulphate (w/v)
0.3% SDS (w/v)
0.15% Sodium Pyrophosphate (w/v)
15mM Tris-Cl pH8  
lOmM EDTApH8  
lOOpg/ml RNase A
0.2M NaOH 
1% SDS (w/v)
3M KOAc pH 5.5
50mg DNase I 
50mg RNase A 
10ml 50% glycerol (v/v)
30mM sodium acetate (pH 6 .8 )
lOOmM Tris Base 
lOOmM Tris HC1 
150mMNaCl 
pH to 7.6 with NaOH
lOOmM Tris Base 
lOOmM NaCl 
50mM MgCl2 .6H20  
pH to 9.5 with HC1
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Nitro Blue Tetrazolium 
(NBT) (Sigma) (lOOpl):
7.5mg NBT
70% dimethyl formamide
Bromo-Chloro-Indolyl-Phosphate 
(BCIP) (Sigma) (lOOpl):
5mg BCIP
100% dimethyl formamide
Levamisole (Sigma): 2.3mg in IOjj.1 DIG 3 buffer
Pre Hybridisation Buffer: 10% 2Ox SSC
50% Formamide (v/v) 
in CIH2O
Hybridisation Buffer: 5M Tris pH 7.5
lOOx Denhardt’s 
20xSSC 
0.5% SDS (v/v)
50% Formamide (v/v)
10% Dextran Sulphate (v/v)
75pg/ml Sheared Salmon Sperm DNA 
in CIH2C)
2.2.4 Protein Buffers
Electrophoresis Buffer (pH 8.3): 0.1M glycine 
50mM Tris 
0.1% SDS (w/v)
Transfer Buffer: 25mM Tris 
190mM Glycine 
20% Methanol (v/v)
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Blocking Buffer:
Tris buffered saline (TBS):
Detection Buffer:
Substrate Buffer:
Quenching Buffer:
Coomassie Blue Stain:
De-stain 1:
De-stain 2:
Anti-crack solution:
50mM Tris
150mMNaCl
5% Skimmed Milk (w/v)
0.05% Tween-20 (v/v) pH 7.4
lOmM Tris 
0.9% NaCl (w/v)
0.05% Tween-20 pH 7.4
lOOmM Tris, pH 9.5 
lOOmM NaCl 
50mM MgCl2
0.04mM NBT 
0.04mM BCIP 
in detection buffer
lOmM Tris, pH7.5 
ImM EDTA, pH8.0 
150mMNaCl
2% Coomassie Brilliant Blue R250 (v/v) 
50% methanol (v/v)
1 0 % acetic acid (v/v)
50% methanol (v/v)
1 0 % acetic acid (v/v)
5% methanol (v/v)
7% acetic acid (v/v)
30% methanol (v/v)
3% glycerol (v/v)
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Homogenisation Buffer: 
Sample Buffer:
2.2.5 Gels
RNA gel:
Preparation of RNA samples 
for gel electrophoresis:
Gel Loading Dye:
5mM Tris 
2mM EDTA 
2mM EGTA 
2% SDS (w/v) in dH20
125mM Tris-HCl (pH 6 .8 )
4% SDS (w/v)
20% Glycerol (v/v)
1 0 % 2 -mercaptoethanol (v/v)
0.2% Bromophenol blue in dH2 0  (w/v)
30ml dH20  DEPC 
0 .6 g agarose 
8 ml 5x MOPS Buffer 
2 ml formaldehyde
lOpl formamide
3.5pi formaldehyde
2pi 5x MOPS Running Buffer
1 pi RNA sample
2 pl loading dye
5 pi lpg/ml Ethidium Bromide.
25% Ficoll (w/v)
0.25% Xylene cyanol (w/v) 
0.25% Bromophenol blue (w/v)
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RNA loading buffer:
ABI loading dye:
ABI gel:
SDS-PAGE Resolving gel:
SDE-PAGE Stacking gel:
750pl formamide 
240pl formaldehyde
lOOpl d e p c h 2o
lOOpl glycerol
80pl 1 0 % bromophenol blue
150pl lOx MOPS buffer.
25mM EDTA (pH8.0)
Blue Dextran (50mg/ml)
Deionised formamide
5:1 formamide to EDTA/blue dextran
0.04g Ammonium persulphate (APS) 
40ml Sequagel- 6  (National Diagnostics) 
10ml Sequagel complete
30% Acrylamide mix 
1.5M Tris (pH8 .8 )
10% SDS (w/v)
10% APS (w/v)
0.05% TEMED (v/v)
30% Acrylamide 
1M Tris (pH6 .8 )
10% SDS(w/v)
10% APS(w/v)
0.05% TEMED(v/v)
2.3 Methods
2.3.1 DNA
2.3.1.1 Preparation of plasmid DNA (Miniprep)
Plasmid DNA was prepared by the alkaline lysis method (Bimboim and Doly, 1979) 
using a Qiagen miniprep spin kit according to manufacturer's instructions. lOmls of 
selective media was inoculated with a single bacterial colony and incubated with 
shaking at 37°C overnight. 1.5ml of the culture was spun in an eppendorf tube in a 
microcentrifuge at 13,000g for 3 minutes. The supernatant was removed to leave the 
cell pellet. The cell pellet was resuspended in 200pl of PI solution and inverted several 
times to mix. 200jil of P2 solution was added and inverted to mix. 300jj1 of 
neutralising P3 solution was added immediately and the tube inverted to mix. The 
mixture was spun at 13,000g for 10 minutes, resulting in the separation of cellular 
debris and the DNA-containing aqueous solution. A pre-equilibrated Qiagen miniprep 
spin column was placed inside an eppendorf tube and the solution containing the DNA 
applied to the column. The column was spun at 13,000g for 1 minute. The eluted 
solution was discarded. The column resin was washed with 700pl of ethanol wash 
buffer and spun twice at 13,000g for 1 minute, with the eluted solution being discarded 
between spins. The column was then transferred to a clean eppendorf tube and the 
DNA was eluted with 50pl of dH2 0  applied to the centre of the resin. This was 
incubated at room temperature for 1 minute and then spun at 13,000g for 1 minute to 
collect the plasmid DNA.
2.3.1.2 Preparation of plasmid DNA (Maxiprep)
Up to 50pg of plasmid DNA were prepared using a Qiagen Maxi prep Qiafilter kit. 
250ml of selective media was inoculated with 250pl of a 1 0 ml overnight culture 
(described in 2.3.1.1) and grown with shaking at 37°C overnight. The cells were 
pelleted by centrifugation at 10,000g for 10 minutes at 4°C. The media was discarded 
and the cell pellet was resuspended in 10ml of solution PI. 10ml of solution P2 was 
added and the tube inverted to mix. The mixture was then incubated at room 
temperature for 5 minutes. 10ml of chilled P3 solution was added to the mixture and 
again inverted to mix. The mixture was applied to a Qiafilter column and incubated 
without the plunger for 1 0  minutes at room temperature before the mixture was applied 
to a pre-equilibrated Qiatip by pressure through the Qiafilter to remove any cellular
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debris. The column was washed with 60ml of wash buffer. The DNA was eluted from 
the column using 15ml of elution buffer. The DNA was precipitated from the eluate by 
the addition of 10.5ml of isopropanol. The solutions were mixed then immediately spun 
at 10,000g for 30 minutes at 4°C. The isopropanol was removed and the pellet was 
washed by adding 5ml of 70% ethanol. This was spun at 10,000# for 10 minutes at 4°C. 
The ethanol was removed and the pellet allowed to air dry briefly before being 
resuspended in 100pl of (IH2O.
2.3.1.3 PI Artificial Chromosome (PAC) Mini Prep
10ml of 2YT, supplemented with 25pg/ml kanamycin, was inoculated with a single 
PAC colony and grown overnight at 37°C. 1.3ml of this culture was then transferred to 
an eppendorf tube and spun in a microfuge for 3 minutes. The supernatant was 
removed and another 1.3mls of culture added and spun again. The supernatant was 
removed again and the pellet resuspended by vortexing in 300pl of PI solution. 300pl 
of P2 was added and the tube inverted several times to mix. It was then left to stand at 
room temperature for 5 minutes. 300pl of P3 solution was added and mixed. The tubes 
were then incubated on ice for 10 minutes. The samples were spun for 10 minutes and 
the supernatant transferred to a tube containing 800pl of isopropanol at room 
temperature. The tubes were incubated at -20°C for 20 minutes before being spun for 
20 minutes at 4°C. The excess isopropanol was removed and 500pl of 70% ethanol was 
overlaid. The tubes were spun for 10 minutes. Excess 70% ethanol was removed and 
the pellet resuspended in 50pl of dH^O.
2.3.1.4 PI Artificial Chromosome (PAC) Maxi Prep
250ml of 2YT with 25pg/ml kanamycin was inoculated with 2.5ml of an overnight 
culture (described 2.3.1.3) and grown at 37°C overnight in a shaking incubator. The 
culture was then decanted into six 50ml Falcon tubes (Greiner, UK) and spun at 
3000rpm for 10 minutes. The supernatant was removed and each cell pellet was 
resuspended in 10ml of PI solution. The cells were then lysed with 10ml of P2 solution 
and left to stand on ice for 5 minutes. 10ml P3 solution was added and stirred. The 
tubes were incubated on ice for 1 0  minutes before being spun down for 1 0  minutes.
The supernatant from the six tubes was decanted onto one Qiagen column pre- 
equilibrated with buffer QBT. Polymer wool was used as a pre-filter to prevent the 
column from becoming blocked. The column was then washed with 2 volumes of
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Qiagen wash buffer. The DNA was eluted using 15ml of elution buffer. 10ml of 
isopropanol at room temperature was added to precipitate the DNA. The DNA was 
pelleted by spinning at 10,000rpm at 4°C for 30 minutes. The DNA pellet was rinsed in 
70% ethanol and spun again. Excess 70% ethanol was removed and the pellet was left 
to air-dry briefly before being resuspended in 2 0 0 pl dH2 0 .
2.3.1.5 Phenol/Chloroform Extraction
The addition of phenol to an aqueous solution of nucleic acids helps remove any 
contaminating proteins. This purification process is enhanced by the addition of 
chloroform/isoamyl alcohol (CHCI3/IAA in a ratio of 24:1) which denatures proteins 
and enhances the separation of the organic and inorganic phases. The extraction was 
carried out by adding 1 volume of phenol, vortexing, then spinning at 13000rpm for 5 
minutes. The top aqueous layer was removed and transferred to a clean tube. 0.5 
volumes of phenol and 0.5 volumes of CHCI3/IAA are added, vortexed, and spun down 
as before and the aqueous layer removed and transferred to a clean tube. 1 volume 
CHCI3/IAA was added and vortexed. The tube was spun again as before, and the top 
layer removed and transferred to a clean tube. The DNA was precipitated by the 
addition of 1ml of 100% ethanol and incubated overnight at -20°C (or -80°C for 45 
minutes). The tube was spun at 13000rpm for 30 minutes at 4°C. Excess ethanol was 
removed and the pellet was then washed with 100pl of 70% ethanol. The excess 70% 
ethanol was then removed, the pellet was allowed to air dry briefly and was then 
resuspended in an appropriate volume of (IH2O, and stored at -20°C.
2.3.1.6 Genomic DNA Preparation
Genomic DNA was prepared from various mouse tissues. Initially the weight of the 
tissue to be used was determined. 5ml of homogenization buffer was added per gram of 
tissue. The tissue was homogenized using a small Ultra-turrax probe (Janke & Kunkel- 
IKA-Labortechnik) for 30 seconds. The resulting homogenate was poured through 
gauze into a 30ml centrifuge tube. The cells were pelleted by spinning the tube at 
10,000rpm at 4°C for 30 minutes. The cells were then resuspended in 1.5ml of ice cold 
3M sodium perchlorate (NaClCU). 3ml lysis buffer was added and the tube was left on a 
rotating wheel at room temperature for 45 minutes. An equal volume of CHCEiIAA 
(5:1) was then added to the sample and mixed for 10 minutes before being spun for 10 
minutes at 10,000rpm. The aqueous layer was then removed and transferred into a 
clean tube and the last step was repeated. The DNA was then precipitated by adding 0.1
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volume of 3M sodium acetate (pH 4.8) and 3 volumes of absolute ethanol. The DNA 
was spooled onto a glass rod, it was washed in 70% ethanol before being left to air dry. 
The DNA was resuspended in 1.5ml of TE (pH 8 ). SDS to a final concentration of 0.5% 
(37.5ja.l of a 20% stock) and proteinase K to a final concentration of 500jo,g/ml (15)ol of 
a 50mg/ml stock) were added and incubated for 60 minutes at 50°C. The sample was 
phenol/chloroform extracted (see 2.3.1.7), reprecipitated, spooled onto a glass rod, 
washed and dried as before, then resuspended in an appropriate volume of TE and 
stored at 4°C.
2.3.1.7 Preparation of DNA from Embryonic Stem cells.
All embryonic stem (ES) cell work was performed by Dr Kim Wells at the Gene
Targeting Unit, Charing Cross Hospital, London.
ES cells for DNA preparation were grown to confluency until they acidified the culture 
media every day for several days (see section 2.3.12.3). The cells were then washed in 
PBS and resuspended in 0.5ml of 50mM Tris pH8 ,200mM NaCl, lOOmM EDTA and 
100pg/ml proteinase K and incubated overnight at 37°C. An equal volume of 
isopropanol was added and the tube shaken gently until the DNA was visible. The 
DNA was spooled out onto a glass rod, rinsed in 70% ethanol for 15 minutes and 
redissolved in 100 j j,1 of TE.
2.3.1.8 Preparation of Phage DNA
Single phage plaques (see section 2.3.1.20.1) were extracted using a Pasteur pipette and 
put into 1ml of SM buffer then allowed to elute for 2 hours. 50jj1 of this phage stock 
was added to 500p,l of host cells (prepared as detailed in section 2.3.1.21.1) and 
incubated for 30 minutes at 37°C. The pre-adsorbed phage were then added to 37ml of 
NZY broth in a 250ml flask and incubated overnight at 37°C with gentle shaking. The 
mixture was then transferred to a centrifuge tube and lOOpl of chloroform and 370pl of 
nuclease solution added. This mixture was incubated at 37°C for 30 minutes. 2.1g 
NaCl was then added and dissolved gently. After spinning at 7000rpm for 20 minutes 
at 4°C the supernatant was transferred to clean tubes containing PEG. The PEG was 
dissolved and the tubes incubated on ice for 60 minutes. They were then spun at 
7000rpm for 20 minutes at 4°C. The supernatant was poured off and the phage pellet 
resuspended in 500)il SM, this was allowed to mix for 30 minutes. One chloroform 
extraction was carried out (see section 2.3.1.5). The aqueous phase was transferred into
109
clean eppendorf tubes and 20pl of 0.5M EDTA, lOpl 10% SDS and 10pl proteinase K 
(2.5mg/ml) were added. The tubes were incubated at 65°C for 30 minutes. One phenol 
and one chloroform extraction was carried out (see section 2.3.1.5). 170pl of 6M 
ammonium acetate was added to the aqueous phase and 700pl of isopropanol was added 
to precipitate the DNA. The phage DNA was then hooked onto a glass rod, washed in 
70% ethanol and allowed to air dry briefly before being resuspended in 500pl TE.
2.3.1.9 Restriction Endonuclease Digestions
Restriction endonuclease digests were carried out using the reaction buffer supplied by 
the enzyme manufacturer. 1-2 U of enzyme was used to digest lpg of DNA, however 
the volume of enzyme added did not exceed 1/10 of the total volume. The digests were 
incubated at the optimum temperature recommended by the manufacturer for 1-3 hours, 
except for genomic DNA digests which were incubated for 6-8 hours.
2.3.1.10 Agarose Gels and Visualisation
Agarose gel electrophoresis was used to separate DNA fragments, the size of the DNA 
fragments to be separated determined the percentage of the agarose (w/v) used. The 
appropriate amount of agarose was dissolved in lx TAE buffer by heating in a 
microwave oven. When the solution had cooled to below 60°C ethidium bromide was 
added to a final concentration of 0.5pg/ml. The solution was then poured into a gel 
former with an appropriate comb. The gel was allowed to set completely and was 
placed in a horizontal gel tank and covered in lx TAE buffer, the comb was then 
removed. The samples to be run had 1/10 volume of loading dye added and were 
loaded into the slots. A commercial lkb DNA ladder (Invitrogen, UK) was also loaded 
for size determination. The DNA was electrophoresed horizontally along a voltage 
gradient of 1-5 V/cm until the required separation had been achieved. During 
electrophoresis, the ethidium bromide in the gel becomes intercalated with the DNA, 
this enables the DNA to be visualised on a UV transilluminator (302nm). The gel was 
either photographed using a Polaroid MP-4+ camera (Kodak) with a Wratten gelatin 
filter attached or with Gene Genius Bio Imaging system (Syntoptic Ltd) using Syngene 
imaging software (Synoptic Ltd).
2.3.1.11 Southern blotting
Southern blotting allows the transfer of DNA fragments from an agarose gel onto a 
nitrocellulose or nylon filter (Southern, 1975). DNA fragments were separated using
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agarose gel electrophoresis (described in 2.3.1.10) and then transferred to a nylon 
membrane (Hybond-N) (Amersham Pharmacia Biotech, UK) using the technique 
described by Southern (1975). Briefly the DNA on the gel was denatured and 
neutralised before being blotted onto a nylon membrane by capillary action. The 
blotting step was performed overnight in 20xSSC. The position of the wells was 
marked onto the filter before removal from the gel. The filter was then washed in 
3xSSC, air dried and baked for 2 hours at 80°C to bind the DNA to the filter.
2.3.1.12 Cell preparations
2.3.1.12.1 Phage host cell preparation
Host cells were prepared by inoculating 10ml of NZY broth, to give a final 
concentration of, with 0.2% maltose (w/v) and lOmM MgSC>4 with a single colony of 
the host strain required and incubated overnight at 37°C. The cells were pelleted by 
centrifugation at 3000rpm for 5 minutes and resuspended in 0.5 volumes of lOmM 
MgS04.
2.3.1.12.2 Preparation of competent DH5a cells
10ml of LB was inoculated with a single DH5a colony and grown overnight at 37°C. 
50ml of LB was then inoculated with 0.5ml of the overnight culture. The culture was 
grown with shaking at 37°C for 60 minutes or until the O.Dssonm was 0.45 - 0.55. The 
culture was chilled on ice for 10 minutes and then spun down at 4000rpm at 4°C for 10 
minutes to pellet the cells. The cell pellet was resuspended in 20ml of Transformation 
Buffer (TfB) I and incubated on ice for a further 5 minutes and spun as before. The 
pellet was resuspended in 2ml TfB II and incubated on ice for 10 minutes. The 
competent cells were stored at -80°C in 200pl aliquots.
2.3.12.3 Embryonic Stem (ES) cell preparation
R1 ES cells (129J background, kind gift of Andreas Nagy, University of Toronto) were 
grown on mitomycin C treated STO SNL2 fibroblast feeder layers (ATCC CRL-2225). 
These feeder cells were transfected with a construct expressing LIF and are G418 
resistant. Feeders were grown in DMEM containing Glutamax-1,10% FCS, 20 pg/ml 
Gentamycin (all supplied by Gibco BRL now Invitrogen). Feeders were routinely 
passaged, and split 1:5 every 2 days over several weeks. A new vial was thawed to 
provide feeders at the point of picking the selected ES colonies to avoid problems with 
senescence over multiple passages. When cultures reached confluency the medium was
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replaced with medium containing 10 pg/ml mitomycin C (Sigma) and incubated for 2-3 
hours. The media was removed and the cells washed twice with PBS, once with 
PBS/EDTA (0.02% EDTA final) and trypsinised with 1ml of 0.1% trypsin in 
PBS/EDTA per 90mm dish for a maximum of 5 minutes. The action of trypsin was 
stopped by the addition of 1 0 ml of normal growth media, cells were pelleted, 
resuspended in a small volume, counted and plated on gelatin coated dishes at a density 
of 3 x 106/90mm dish (gelatin 0.1% final concentration in sterile water). Cells were 
prepared the day before thawing a vial of ES cells.
The ES cells were grown in DMEM/F12 media (including Glutamax-1) supplemented 
with 1% NEAA (non-essential amino acids), 0.1 mM ME, lOOOu/ml 
Penicillin/Streptamycin or 20 jig/ml Gentamycin and 15% GlobePharm FCS (batch 
tested for ES cell growth). During the initial rounds no additional LIF was provided but 
for the dose response experiment and the final targeting attempt, LIF (ESGRO™ 
Chemicon) was added to a final concentration of lOOOU/ml. Early passage ES cells 
(pi5) were thawed and plated on mitomycin C treated feeders. The cells were fed every 
day and passaged 1:3 2 days after plating and again two days later to give 9 plates. Two 
days later the cells were fed early in the day and were later passaged as follows:
ES cell cultures were washed with PBS then PBS/EDTA and trypsinised with 3ml of 
standard trypsin solution for 5 minutes in the incubator. The cells were pipetted up and 
down to ensure a single cell suspension, 7ml of growth media added and the cells were 
mixed again by pipetting. The cells were then left for 30 minutes in the incubator for the 
fibroblast feeder population to adhere back to the plate. The less adherent ES cells were 
collected carefully from the plate. The cells were pelleted and resuspended in 5 ml of 
ice cold PBS and an aliquot counted. Cells were diluted to a concentration of 1 x 10 /ml 
in PBS or as required.
2.3.1.13 Ligation of DNA fragments
Ligation reactions allow a specific fragment of DNA to be inserted into a vector so that 
the DNA can then be manipulated. The target DNA to be ligated was excised from the 
vector it was in by the appropriate restriction enzyme(s) or generated by the polymerase 
chain reaction (PCR) (section 2.3.1.17). The vector for subcloning was digested with 
the appropriate enzyme(s). If only one enzyme was used for digestion alkaline
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phosphatase (AP) was added to prevent re-ligation of the vector. AP catalyses the 
hydrolysis of the 5' phosphate group at the 5' phosphorylated termini of the vector.
Both vector and target DNA were then phenol/chloroform extracted (detailed in section 
2.3.1.5) , precipitated and resuspended in water at concentrations of 50ng/pl and 
lOng/pl respectively. To optimise the ligation reactions a number of different ratios of 
vector: insert were set up. In addition to the target DNA and the vector, 1/10 volume of 
lOx ligation buffer and 1 U T4 ligase were added in a final volume of 20pl.
Appropriate control reactions were also set up. Reactions were incubated overnight at 
14°C.
2.3.1.14 Transformations
Transformation reactions allow fragments of DNA contained in a vector to be stably 
inserted into a bacterial cell, the cells can then be propagated which allows the 
production of large quantities of the specific DNA fragment to be generated.
Competent cells were either DH5a (GibcoBRL), subcloning efficiency prepared cells 
(see section 2.3.1.12.2) or JM109 (Promega) depending on the vector used. 5 pi of the 
ligation reaction was mixed with 50pl of competent cells and incubated on ice for 30 
minutes. The reactions were heat shocked at either, 37°C for 20 seconds if DH5a cells 
were used or at 42°C for 45 seconds if JM109 cells were used, then returned to ice for 
two minutes. 950pl of SOC broth (Invitrogen, UK) at room temperature was added and 
allowed to incubate at 37°C for 60 minutes, shaking. 200pl of the mixture was then 
plated onto selective 2YT agar plates. With vectors where blue/white (white coloration 
indicating the presence of successfully cloned insert DNA) selection was possible lOOpl 
IPTG (24mg/ml) and 50pl of X-GAL (lOmg/ml) were spread onto each plate prior to 
plating the transformed cells. The plates were incubated at 37°C overnight. Colonies 
were minipreped as in 2.3.1.1.
2.3.1.15 Transfections of Human embryonic kidney (HEK)-293T Cells
Previously frozen stocks of HEK-293T cells were thawed from liquid nitrogen. After
two passages, cells were split onto 90mm petri dishes and grown to 40-50% confluency. 
5pg of expression construct per plate was added to 10ml of DMEM (Sigma-D5796). 
Lipofectamine transfection reagent (Invitrogen) (40pl per plate) was then added and the 
plates incubated at room temperature for 45 minutes. The media was removed and the 
cells were washed with 4ml of media per plate. Cells were incubated at 37°C for 24
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hours. The media was then changed on the cells by adding 5-10ml of media containing 
10% FCS, 1% antibiotics (penicillin/streptomycin) and 1% antimycotics was added and 
incubated for a further 24 hours at 37°C.
The media was removed and the cells were washed in lxPBS (Oxoid). The cells were 
scraped off in to PBS and spun at 2000rpm for 10 minutes. The supernatant was 
removed and the cell pellet was washed again in PBS, and spun as before. The cell 
pellet was stored at -80°C.
2.3.1.16 Polymerase Chain Reaction (PCR)
The polymerase chain reaction (PCR) allows the amplification of specific DNA 
sequences, using two oligonucleotide primers which hybridise to opposite strands and 
flank the target region of DNA. PCR reactions were performed in a final volume of 
50pl, using lx PCR buffer (16mM (NH^SC^, 67mM Tris-Cl (pH 8.3), 0.01% Tween- 
20), lOpmoles of each oligonucleotide and 50-100ng of genomic DNA or 0.1-lng 
cloned DNA as template. The constituents were mixed in a 0.5ml eppendorf tube and 
0.2U Taq polymerase (Bioline) was added. The DNA was denatured by incubation at 
96°C for 3 minutes, the reaction was then allowed to proceed in a DNA thermal cycler 
programmed for the required conditions. Standard reactions generally involved 35 
cycles of denaturation at 96°C for 30 seconds, annealing at x°C for 30 seconds and 
extension at 72°C for 1 minute. The appropriate annealing temperature (x°C) was 
estimated from the Tm of the oligonucleotide primer pair, which is calculated as:
Tm = (2°C x no. A + Ts) + (4°C x no. G + Cs)
and was 6 °C below the Tm. Followed by a final extension step at 72°C for 5 minutes.
2.3.1.17 Colony PCR
Colony PCR was used to screen many colonies generated in a transformation reaction 
(see section 2.3.1.14) for a specific DNA fragment using the selected colony as the 
template. Colonies picked from transformation plates were first restreaked onto a 
gridded selective agar plate then the loop used in the streaking process was used to 
inoculate a 50pl PCR reaction. PCR was performed as described in 2.3.1.16.
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2.3.1.18 Sequencing
Sequencing reactions were performed using the ABI PRISM® BigDye™ Terminator 
Cycle Sequencing Ready reaction kit (PE Applied Biosystems) with AmpliTaq® DNA 
polymerase, FS. AmpliTaq® is a varient of Taq DNA polymerase, with point mutation 
resulting in less discrimination against nucleotides, and the elimination of 5'—>3' 
nuclease activity. The BigDye™ terminator ready reaction mix contains AmpliTaq® 
and also BigDye™ terminators labelled with novel, high-sensitivity dyes. These 
contain a fluorescein donor dye linked to a dichlorohodamine acceptor dye. The donor 
dye has an excitation spectra corresponding to the argon ion laser of the ABI sequencer. 
However, the 4-dideoxynucleotide terminators are each labelled with a slightly differing 
acceptor dye, with corresponding different emission spectra, allowing differentiation 
between nucleotides. The terminators are labelled as follows:
Terminator Acceptor Dye
A-Dye dichloro [R6 G]
C-Dye dichloro [R110]
G-Dye dichloro [ROX]
T-Dye dichloro [TAMRA]
The BigDye™ ready reaction mix also contains deoxynucleoside triphosphates (dATP, 
dCTP, dITP, dUTP), MgCl2 and Tris-HCl buffer (pH9.0).
2.3.18.1 Cycle Sequencing
This protocol was used to prepare a successfully cloned fragment for sequencing. The 
following were added to a 0 .2 ml microcentrifuge tube:
Component Amount
ABI BigDye terminator ready 4pl
reaction mix
Primer 1.6pmols
DNA template 0.2-3 pg
dH20  to lOpl
The reaction was then mixed, and the following cycling conditions used (using a Perkin 
Elmer Cetus system 9600 thermal cycler): 25 cycles of 96°C for 10 seconds, 50°C for 5 
seconds and 60°C for 4 minutes, with a final holding step of 4°C.
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2.3.1.18.2 Direct sequencing
If a single band, with no obvious non-specific bands, was obtained by PCR the band 
was either excised from the agarose gel and eluted using a Wizard™ column or the PCR 
was used directly. In this case, the cycle sequencing reaction was set up as described in 
section 2.3.1.18.1, but typically using 4 pi of BigDye, 1.6pmol primer (0.5 pi) and 5.5pl 
of eluted PCR product as template.
2.3.1.18.3 Purification of extension products
Following the labelling reaction, the labelled template was purified prior to sequencing. 
Firstly, the labelling mix was transferred to a 0.5ml eppendorf tube and 30pl of dH2 0  
and 60pl of 96% ethanol were added. The reaction was vortexed briefly and then 
incubated at room temperature for 15 minutes. Following this incubation, the sample 
was spun at 13,000rpm for 20 minutes. The supernatant was removed by aspiration, 
leaving the pellet of labelled DNA. 200pl of 70% ethanol was then added to wash the 
pellet and centrifuged at 13,000rpm for 10 minutes. Finally all the ethanol was 
removed by aspiration. The tubes containing labelled product were then left to dry on 
the benchtop for 1-2 hours. When dry 3 pi of ABI loading dye was added to the sample 
and vortexed to mix. Immediately prior to loading the sample onto the sequencing gel, 
the sample was denatured by heating to 95°C for 3 minutes then quenched on ice.
2.3.1.18.4 Preparation of sequencing gels
Automated sequencing was conducted using a 373a DNA sequencer (ABI) using 6 % 
acrylamide gels. The glass gel plates were thoroughly cleaned with tap water then 
rinsed with deionised water prior to assembly with 1mm spacers. The gel mix consisted 
of 40ml of Sequagel 6 ™ sequencing gel solution with 6 ml of Sequagel™ complete 
buffer reagent. 0.04g of ammonium persulphate (APS) was then added and dissolved to 
induce gel polymerisation. The gel mixture was then injected between the glass plates 
using a 50ml syringe, with tapping of the plates to encourage gel movement if slow and 
to prevent the formation of air bubbles, finally a flat comb was placed at the gel front. 
The gel was left to polymerise for at least one hour before the plates were washed again 
first with tap then deionised water, and assembled into the sequencer for a pre-scan.
The rest of the components of the sequencer were assembled according to the 
manufacturer's instructions, and lx TBE buffer was added to both top and bottom tanks. 
Following a pre-run of 15-60 minutes, a 48 or 64 well comb was inserted into the gel 
and the wells were washed out to remove any traces of urea. 1.5 pi of denatured,
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labelled sequencing sample (prepared as in 2.3.1.18.3) was loaded per lane. The 373a 
DNA sequencer was run in accordance with the manufacturer's instructions, typically 
electrophoresing for 12 hours and yielding roughly 300-700bp read, depending on the 
sample purity and structure.
2.3.1.18.5 Analysis of sequencing data
Data from the sequencer was stored in raw form as an electropherogram, showing the 
dye emissions as peaks, and then in a translated form as the actual sequence read by the 
operating program. Electropherograms were based upon automatic tracking of the 
sample, but it was often necessary to track each lane by eye then re-extract the data to 
optimise the sequencing read. When clean unambiguous sequence was produced base- 
calling was usually accurate allowing analysis of the translated data. However, in some 
cases, particularly when faced with difficult templates, when reads extended beyond 
400 bases (when longer extension products are scarce) or after runs of identical bases, 
analysis of the electropherogram to confirm the translated sequence was necessary.
2.3.1.19 Library screening
2.3.1.19.1 Phage libraries
All cDNA libraries were plated and screened in the same way, with only the bacterial 
host strain being different. Serial dilutions of the library were prepared in SM buffer. 
These were then mixed with 500pl of the prepared host cells (described 2.3.1.12.1) and 
allowed to adsorb for 30 minutes at 37°C. 10ml aliquots of NZY top agarose were 
prepared and kept molten at 50°C. An aliquot of top agarose was mixed quickly with 
the cell/phage mixture and poured onto an NZY agar plate. The top agarose was 
allowed to harden before the plates were incubated overnight at 37°C. The number of 
plaques formed were counted and the titre of the library calculated.
A library screen usually consisted of 20 plates each with 20,000 -  25,000 plaque 
forming units (pfu). The plates were incubated overnight at 37°C and then placed at 
4°C for 30-60 minutes to ensure the top agarose did not lift off in later steps. Duplicate 
replica filters were made from each of the master plates by placing a Hybond-N filter 
onto the plate, the first filter was left on the plate for 3 minutes and the second for 5 
minutes, orientation marks were made with a 21 gauge needle. The DNA was released 
by the method of Benton and Davis (1977). The filter was carefully peeled from the
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plate and placed DNA side up into a tray containing 3MM filter paper soaked in 
denaturing solution. After 5 minutes the filter was placed on 3MM soaked in 
neutralising solution, after a further 5 minutes the filter was placed in another tray 
containing neutralising solution for 3 minutes. The filter was rinsed in 3xSSC and then 
allowed to air dry. The whole process was then repeated for the second duplicate filter. 
The same orientation marks were used. The filters were baked for 2 hours at 80°C to 
bind the DNA to the filters. The filters were prehybridised and hybridised as described 
in section 2.3.1.21.
2.3.1.19.2 Gridded libraries
Gridded libraries obtained from HGMP-RC were screened by pre-wetting the filters in 
3xSSC before being covered with hybridisation solution in a hybridisation bottle and 
hybridised as described in 2.3.1.21.
2.3.1.20 Preparation of radioactive probes
DNA probes were prepared by excising the appropriate band from a low melting point 
(LMP) agarose gel with a scalpel blade on an UV transilluminator. The LMP agarose 
gel slice was processed in one of two ways. The gel slice was either placed in a 
Wizard™ column (Promega) in an eppendorf tube and spun for 3 minutes at 5,000g or 
the band was weighed and 3ml water per gram of agarose added. The solution was 
heated to 65°C to melt the agarose, vortexed then stored at -20°C until needed.
The DNA extracted from the agarose gel was first denatured at 95°C for 7 minutes, then 
incubated at 37°C for 5 minutes. The DNA was randomly radiolabelled using the 
RadPrime DNA labelling system (Invitrogen). 25-100ng of DNA was added to 20pl of 
2.5x random primer solution, lpl of each of 500pM dATP, dGTP, dTTP, 5pi a-32P 
dCTP and make up to a final volume of 49pl with distilled sterile water. This mixture 
was centrifuged briefly then 1 pi Klenow was added and the reaction was incubated at 
37°C for 10 minutes. Finally 5pl of Stop buffer was added to terminate the labelling 
reaction. The reaction was then loaded onto a ProbeQuant™ G-50 Micro column 
(Amersham Pharmacia Biotech) and spun for 2 minutes at 3,000g to remove any 
unincorporated nucleotides. The labelled probe was denatured for 5 minutes at 95°C 
and then quenched on ice for 2  minutes before being added to hybridisation buffer.
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2.3.1.21 Hybridisation of Filters
Filters were pre-hybridised in hybridisation solution in petri dishes or hybridisation 
bottles with shaking or rotating for 2 hours or overnight. Both pre-hybridisation and 
hybridisation were carried out at 65°C unless otherwise stated. The probe (prepared as 
in 2.3.1.20) was added to fresh hybridisation solution. The pre-hybridisation solution 
was removed from the filters and the hybridisation solution containing the probe was 
added. Hybridisation was performed overnight with shaking or in a rotating oven.
Following hybridisation, the filters were washed at varying stringencies depending on 
the probe used. Generally filters were first washed in a solution of 6 xSSC, 0.1% (w/v) 
SDS for 30 minutes at 65°C, then subsequently in decreasing salt concentrations, but not 
less than O.lxSSC 0.1% (w/v) SDS, until monitoring with a hand-held Geiger counter 
(Mini Instruments Ltd, UK) indicated an appropriate level of radioactivity (usually 5-10 
cps).
Washed filters were mounted onto intensifying screens under clingfilm and exposed to 
X-ray film in autoradiographic cassettes, with a second screen, usually overnight at -  
80°C. The exposed film was developed in an automated developing machine using Fuji 
reagents.
2.3.2 RNA
All reagents in this section are prepared with 0.1% diethylpyrocarbonate (DEPC) 
solutions. 0.1% DEPC is added to distilled water and all autoclavable solutions, the 
solutions are then incubated overnight in a fumehood to allow the DEPC to deactivate 
any contaminating RNAases. The solutions are autoclaved to remove the DEPC. A 
glass and plasticware used in this section was washed with DEPC-treated water before 
and after use.
2.3.2.1 RNA extraction
RNA was extracted from tissue using TRIzol™ reagent (Invitrogen) according to the 
manufacturer’s instructions. 1ml of TRIzol was added per 50mg of tissue and then 
homogenized using a small Ultra-turrax probe (Janke & Kunkel-IKA-Labortechnik) for 
30 seconds. The homogenate was incubated at room temperature for 5 minutes. 0.2ml 
chloroform was then added per 1ml of TRIzol before being mixed and centrifuged at
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12,000g for 15 minutes at 4°C. The upper aqueous phase was transferred to a clean 
eppendorf. The RNA was precipitated from the aqueous layer by the addition of 0.5ml 
of isopropanol. The reaction was incubated at room temperature for 10 minutes before 
being spun at 12,000g for a further 10 minutes. The supernatant was removed and the 
RNA pellet was washed once with 75% ethanol. The pellet was allowed to air dry and 
was then dissolved in an appropriate volume of DEPC-treated water before stored at - 
80°C until required.
2.3.2.2 mRNA preparation
mRNA was prepared from total RNA using Oligotex Spin Columns (Qiagen). lmg of 
total RNA was combined with the appropriate volume of water, 2x binding buffer and 
oligotex according to the manufacturers instructions depending on the concentration of 
RNA used. This was incubated for 3 minutes at 65°C, then at room temperature for 10 
minutes. The column was centrifuged for 2 minutes and the supernatant removed. The 
pellet was resuspended in 400pl of wash buffer OW2 and pipetted on to a spin column. 
The column was spun at 13,000rpm for 30 seconds. 400pl of OW2 wash buffer was 
applied to the column and then the column was centrifuged for a further 30 seconds at 
13,000rpm. The RNA was eluted from the spin column by the addition of 50pl of 
elution buffer preheated to 70°C, the column was spun for 30 seconds at 13,000rpm and 
the eluted RNA stored at -80°C until required.
First strand cDNA synthesis allows the generation of cDNA from a purified mRNA 
population. First strand cDNA synthesis was performed using the You-Prime First- 
Strand Beads Ready To Go kit (Amersham Pharmacia Biotech, UK). For this procedure 
oligo-dT primers were used. Oligo-dT primers bind to the polyA tail of mRNA, and 
this allows the generation of cDNA from all the mRNA population in a sample. Gene 
specific primers complementary to the mRNA sequence or random primers could have 
also been used. The You-Prime First-Strand Beads Ready To Go kit provides beads 
containing all the reagents for the production of first strand cDNA, except primers. The 
beads contain buffer, dNTPs, murine reverse transcriptase, RNA guard and 
RNase/DNase-free BSA. 0.02pg-2pg of mRNA (see above) or 0.1pg-5pg of total RNA 
(as prepared in section 2.3.2.1) was used in the reaction. The RNA sample was made 
up to a volume of 29pl with DEPC treated water. The sample was then heated at 65°C 
for 10 minutes, then chilled on ice for 2 minutes. This solution was transferred to the
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reaction tube containing the beads. 1 pi of lOOnM of an oligo-dT primer was added.
The reaction was incubated at room temperature for 1 minute, and then mixed by 
vortexing. The reaction was then incubated at 37°C for 60 minutes. The product was 
stored at -20°C until required.
2.3.2.3 RT-PCR
First strand cDNA was synthesised as detailed in section 2.3.2.2. The cDNAs were 
used for PCR with gene specific primers as detailed in section 2.3.1.17.
2.3.2.4 Northern Blotting
Northern blotting allows the transfer of RNA from a gel onto a nylon membrane. 10- 
15pg of total RNA (1 volume) was combined with 2 volumes of RNA sample buffer 
and heated to 65°C for 15 minutes then quenched on ice before 1/10 volume of RNA 
loading buffer was added. The samples were electrophoresed in a DEPC-treated 
environment, this was to avoid the degradation of the RNA samples by RNases. The 
gel was blotted overnight on to a Hybond-N filter. After blotting the filter was soaked 
in 2xSSC for 5-10 minutes then air dried on 3MM paper before baking for 1 hour at 
80°C. It was then placed in a UV Stratalinker (Amersham Pharmacia Biotech) for 7 
seconds which crosslinks the RNA to the filter. The filter was washed in 
prehybridisation buffer for 2 hours at 42 °C. DNA probes were prepared as detailed in 
section 2.3.1.20. Freshly prepared probes were added to hybridisation buffer and 
applied to the filter overnight at 42 °C. The radioactive hybridisation buffer was 
removed from the filter. The filter was washed twice in lxSSC, 0.1% SDS for 30 
minutes at 42 °C then twice in 0.05xSSC, 0.1% SDS for 30 minutes at 42 °C before 
being exposed to X-ray film. All hybridisation and washing was performed in a 
rotisserie oven.
2.3.2.5 Riboprobe production
The production of riboprobes allows the detection of specific mRNA in tissues. The 
DNA to be transcribed is cloned into the polylinker of a vector containing promoters for 
SP6  9or T3) and T7 RNA polymerases adjacent to the polylinker. After linearisation of 
the template DNA at a suitable site, the RNA polymerases are used to produce "run-off1 
transcripts. DIG-UTP is used as a substrate and incorporated into the transcript. Every 
20-25th nucleotide of the newly synthesised RNA is a DIG-UTP. Since the nucleotide 
concentration does not become limiting in the standard transcription assay, a large
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amount of labelled RNA can be generated. Digoxigenin (DIG)-labelled probes were 
synthesised using lpg of purified linearised DNA, DIG-labelling mix, lOx 
Transcription buffer, RNase inhibitor, RNA polymerase in a final volume of 20pl. This 
was incubated at 37°C for 2 hours. After incubation 1U of RNase-free DNasel was 
added and incubated for a further 15 minutes at 37°C to degrade the DNA template.
70pl of DEPC (0.5% v/v) H2 0 ,10pl 3M NaOAc and 300pl absolute ethanol were added 
and stored at -20°C overnight to precipitate the RNA. The RNA was pelleted and then 
resuspended in lOOpl DEPC (0.5% v/v) H2O.
The digoxigenin (DIG) system is a synthetic molecule based on the steroid hapten 
digoxigenin. Digoxigenin is the so-called aglucon of the steroid digoxin, which occurs 
in certain digitalis plants. Aglucon means that the three sugar moieties at the C3 OH 
group which are part of the digoxin molecule are lacking. There are two features of the 
digoxigenin molecule which make it exceptionally valuable for establishing detection 
systems. First, if digoxigenin is coupled as a hapten to a suitable carrier molecule high 
affinity antibodies can be easily generated, e.g. in sheep. Since digoxin occurs 
exclusively in digitalis plants there are no endogenous background problems with these 
antibodies as in the case of other haptens, such as biotin. Second, digoxigenin can be 
coupled to nucleotides like dUTP or UTP and incorporated into nucleic acids using 
generally available polymerases like Klenow polymerase, Taq polymerase, or RNA 
polymerases. The probes thus generated can be used in standard blotting and 
hybridization procedures including in situ hybridization and detected with anti- 
digoxigenin conjugates. The most frequently used conjugates are fluorescent or alkaline 
phosphatase labelled antibodies. If phosphatase labelled antibodies are employed 
hybridized probes can be detected either by chemiluminescence or a colour reaction. 
DIG labelled probes that hybridised to a target sequence are detected with an alkaline 
phosphatase labelled anti-DIG antibody. If the blot is incubated with suitable reagents, 
such as NBT and BCIP, phosphatase activity is detected by a colour reaction.
In order to ensure the riboprobes were labelled a dot-blot was performed. This 
technique involves the immunodetection of the DIG-labelled riboprobes with anti- 
digoxigenin Fab fragments conjugated to alkaline phosphatase. The bound antibody 
conjugate is visualised by colour detection using substrates NBT and BCIP. lpl of
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riboprobe was dotted onto a Hybond-N+ charged membrane and UV cross-linked for 12 
seconds. The filter was washed for 30 minutes in DIG2 buffer. 1 pi of anti-DIG AP was 
diluted in 5ml of DIG2 buffer. The filter was washed in this solution for 45 minutes, 
subsequently washed twice in DIG1 buffer for 5 minutes, then for 5 minutes in DIG3 
buffer. Finally the filter was washed for one hour in a "light-tight" box in 
DIG3/BCIP/NBT (10mls/34pl/44pl).
2.3.3 In situ Hybridisation Studies
2.3.3.1 In situ Hybridisation
In situ hybridisation is used to detect the location of specific gene transcripts in tissue 
sections. 5 pm thick formalin fixed whole mouse eye sections were adhered to APS 
(aminopropryltriethoxysilane) (Sigma) treated slides. The sections were dewaxed in 
fresh xylene for 10-15 minutes then taken through a graded series of ethanol from 1 0 0 - 
30%, two minutes in each, before being washed in DEPC-treated PBS. The slides were 
then immersed in 0.2M HC1 for 15 minutes. They were then rinsed in DEPC-treated 
PBS before being washed in 0.3% (v/v) Triton X-100 for 15 minutes on a shaker at 
room temperature. The slides were washed again in PBS for 10 minutes before being 
incubated with lOOpg/ml proteinase kinase (Proteinase K). The sections were left 
covered in proteinase K solution for 10-30 minutes in a moist chamber at 37°C. The 
slides were rinsed again in PBS (DEPC) then post-fixed in 2% (w/v) paraformaldehyde 
solution for 5 minutes at room temperature. The slides were washed again in PBS for 
1 0  minutes and were then covered in pre-hybridisation solution and incubated for 1 - 2  
hours at 37°C. The riboprobe (see section 2.3.2.5) was adjusted to the required dilution 
(1:50-l :100) using hybridisation buffer. 25-50pl of probe was dotted onto a cover slip 
of an appropriate size. The excess pre-hybridisation solution was removed and the 
sections were mounted using the coverslip dotted with probe. The slides were heated to 
70°C for 2  minutes, the temperature was lowered to 55°C and the slides were hybridised 
overnight in the moist chamber. The moist chamber prevents the sections from drying 
out by maintaining a constant temperature in a humid environment.
The cover slips were removed by washing the slides twice in 2xSSC for 20 minutes 
each. The solution was changed to O.lxSSC at room temperature for 10 minutes, then 
O.lxSSC at 50°C for 30 minutes then O.lxSSC for 10 minutes at room temperature. The
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slides were rinsed in DIG1 buffer for 5 minutes at room temperature. Anti-DIG/AP in 
1:2000 DIG1 buffer (containing 10% normal swine serum) was applied for at least 2 
hours at room temperature in a moist chamber. The excess antibody was washed off in 
DIG1 buffer twice for 15 minutes each. The slides were then rinsed in DIG3 buffer for 
5 minutes. The slides were finally immersed in NBT/BCIP/levamisole for between 30 
minutes to 3 hours or until a colour change was observed, this was checked 
microscopically every 30 minutes. When the reaction was complete, the slides were 
washed in DEPC-treated dE^O then mounted.
2.3.3.2 Fluorescent in situ Hybridisation (FISH)
All FISH mapping in this project was performed by Ruby Baneijee at the MRC 
Cytogenetics Unit, Harwell, UK. The protocol used is briefly outlined below.
2.3.3.2.1 Metaphase spreads
Mouse metaphase chromosome spreads were made from spleen cultures. Intact spleens 
were dissected and collected into cold RPMI1640 medium, cells were grown in 
complete RPMI 1640 medium supplemented with glutamine, penicillin and 
streptomycin, foetal calf serum, concanavalin A and lipopolysaccharide. The cells were 
allowed to incubate in a 5% CO2 incubator for 48 hours and then harvested the 
following day. Before harvesting, cells were incubated for a further 30 minutes in 
colcemid solution (final concentration of 0.05pg/ml). Chromosome spreads were made 
using standard procedures, treatment in hypotonic (KC1) and subsequent fixation 
(methanokglacial acetic acid - 3:1) followed by air drying. Slides were examined using 
phase contrast microscopy and stored at 4°C with a desiccant. Prior to application of the 
probes, slides were treated with RNase and then dehydrated through an alcohol series 
(70%, 90%, 100%) and the chromosomes were denatured in 70% formamide in 2xSSC 
for 2 minutes at 72°C, then passed through the ethanol series at 4°C a second time and 
air dried.
2.3.3.2.2 Labelling and Hybridisation
Probes were labelled by nick-translation with Biotin- 16dUTP (Boehringer Mannheim) 
using the Bio Nick Kit (Invitrogen) at 16°C for 90 minutes. 400ng of the product were 
ethanol precipitated along with Cot-1 DNA and salmon sperm DNA and the pellet was 
resuspended in hybridisation mix containing 50% formamide and 10% dextran sulphate. 
It was then denatured at 75°C for 8  minutes followed by pre-annealing at 37°C for 30
124
minutes. 12pl of the hybridisation mix was applied to each denatured slide. Slides were 
incubated overnight in a humid chamber at 37°C.
2.3.3.2.3 Signal detection
Post hybridisation washes were performed in three changes of 50% formamide, 2xSSC 
and 4xSSC, 0.05% Tween 20 at 42°C followed by another wash in 4xSSC, 0.05% 
Tween 20 at room temperature. Slides were incubated in a Blocking Reagent (Roche) 
for 30 minutes. For signal detection, slides were incubated at 37°C with Avidin FITC 
(Vector Labs) for 25 minutes then washed with 4xSSC Tween 20 three times. 
Incubation at 37°C was repeated with Biotinylated Anti Avidin and Avidin FITC again 
with washes in 4xSSC Tween 20 in between. In this case PAC 439 has been detected 
with Avidin FITC and PAC 572 with Avidin Texas Red. Finally, the slides were 
embedded in Vectashield mounting medium (Vector Labs) containing lpg/ml DAPI.
2.3.3.2.4 Microscopy
FISH images were generated with an epifluorescence microscope equipped with a 
cooled CCD camera (Photometries, Sensys) and computer-controlled filter wheels with 
excitation and emission filters for visualization in DAPI, FITC and Texas Red.
2.3.4 Protein
2.3.4.1 Tissue Homogenisation
To generate protein samples from Drosophila heads, the flies were decapitated and a 
20% homogenate made in homogenisation buffer. Samples were homogenised and the 
supernatants collected. Homogenates were diluted 1:1 with sample buffer and 
denatured under reducing conditions by boiling at 100°C for 5 minutes in a dry block. 
Volumes of lOOpl were stored at -20°C until required.
2.3.4.2 Cell Membrane Preparation
The cell pellet (see section 2.3.1.15) was resuspended in cold homogenisation buffer 
(lml per dish). The cells were lysed on ice for 30 minutes and by 5 passes through a
0.5mm needle, spun down at 2000rpm for 5 minutes at 4°C. The supernatant was 
transferred to a new tube, 50pl 5M NaCl was added and the tube inverted to mix. This 
was spun at 13000rpm for 30 minutes at 4°C. The supernatant was removed and the 
membrane pellet was resuspended in 50pl of PBS/dish of cells. 1 volume of 4x Sample
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Buffer was added and proteins were denatured by heating to 100°C for 10 minutes 
before being loaded onto an SDS-PAGE gel or stored at -20°C until needed.
2.3.4.3 SDS-PAGE gels
Gels were cast using equipment purchased from BIO-RAD Laboratories, Inc. The cast 
dimensions were 8 cm x 5 cm, with a thickness of 0.75cm. The 12% resolving gel was 
overlaid with a 6 % stacking gel layer into which the samples were loaded.
Each well was loaded with up to 20pl of denatured sample. To determine the molecular 
weights of sample proteins, pre-stained molecular weight markers, Rainbow™ coloured 
protein markers (molecular weight range 10-250kDa) (Amersham Pharmacia, Biotech), 
were diluted 1:1 with sample buffer and were also loaded onto the gel. Proteins were 
separated by electrophoresis. Samples were subjected to SDS-PAGE for 1.5 hours at 
lOOv.
Protein bands separated in the gels were visualised with Coomassie blue stain. Excess 
stain was removed using de-stain 1 and de-stain 2. Gels were placed in anti-crack 
solution and dried in a Gel Air Dryer (BIO-RAD Laboratories).
2.3.4.4 Western Blotting
Western blotting is the transfer of proteins separated by SDS-PAGE (as described in 
2.3.4.2-3) onto nitrocellulose membranes. The gel was placed on a nitrocellulose 
membrane and the gel and membrane were sandwiched between a stack of Whatman 
3MM paper pre-soaked in transfer buffer. The entire sandwich was secured in a plastic 
frame and placed in the transfer apparatus (Trans-blotR SD Semi Dry Transfer cell, 
BIO-RAD Laboratories) according to the manufacturer’s instructions. Proteins were 
transferred from the gel onto the nitrocellulose membrane by electrophoresis at 2 0  volts 
for 1 hour in transfer buffer. The gel was stained, as described in 2.3.4.3, to determine 
the amount of protein left on the gel after blotting. The membrane was then blocked at 
room temperature for 30 minutes shaking then 30 minutes not shaking in blocking 
buffer. Primary antibody was added to the membrane, diluted in blocking solution and 
incubated overnight at 4°C with shaking.
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The membrane was washed 5 times in Tris buffered saline (TBS) and incubated for 1 
hour at room temperature with secondary antibody. Unbound secondary antibodies 
were removed by washing in TBS. Antibody binding was detected by nitro blue 
tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) (alkaline 
phosphatase) as chromogens. The membrane was washed in TBS, equilibrated in 
detection buffer and exposed to substrate solution. The colour reaction was stopped by 
washing the membrane in quenching buffer. Blots were air-dried and the molecular 
weights of the protein bands were determined by comparison with Rainbow™ 
molecular weight markers.
2.3.4.5 Immunostaining of transfected cells
293T cells were plated on coverslips a day prior to transfection (see section 2.3.1.15). 
5pg of the DNA construct of interest was mixed with 40pl of Lipofectamine 
Transfection reagent (Gibco, UK) and incubated for 45 minutes at room temperature. 
Cells were washed in DMEM and 1ml of the DNA/transfection reagent was added per 
coverslip and incubated at 37°C overnight. Cells were fed the following day with 
DMEM containing 10% foetal calf serum and 0.1% antibiotic/antimycotics. Cells were 
prepared for immunostaining by washing twice in PBS prior to being fixed in 4% (v/v) 
formaldehyde in PBS for 10 minutes at room temperature. Cells were washed in PBS 
and permeabilised in 0.2% (v/v) Triton X-100 in PBS for 10 minutes at room 
temperature. Cells were subsequently washed in PBS and blocked with 5% (v/v) foetal 
calf serum in PBS for 30 minutes at room temperature. Cells were washed in PBS and 
incubated with a 1:500 dilution of anti-myc antibody (Santa Cruz Biotechnology, Inc) in 
PBS. Cells were washed six times in PBS prior to being incubated with the secondary 
antibody. An anti-mouse FITC conjugated secondary antibody was used to visualise 
primary antibody binding. Anti-mouse FITC (Pierce, UK) was used at a 1:50 dilution 
and incubated at room temperature for 30 minutes. Cells were washed 6  times in PBS 
before being mounted on glass slides. Immunolabelling was visualised using a 
fluorescence microscope.
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CHAPTER THREE 
RESULTS
The work presented in this thesis describes the isolation and characterisation of the 
murine genes CDP-diacylglycerol synthase 1 (Cdsl) and 2 (Cds2). These genes are the 
murine homologues of the Drosophila eye-cds gene. The Drosophila eye-cds gene 
causes retinal degeneration when mutated (this is described in detail in section 1 .2 ).
The mammalian homologues of eye-cds were identified from mammalian retinal 
samples, thus the Cds genes are good candidate genes for mammalian retinal disease 
phenotypes. The data gathered forms two main sections. The first section includes the 
identification, characterisation and expression of the two murine Cds genes and the 
second section uses the data generated in the first section to define possible gene 
functions through transgenic studies.
3.1 Isolation o f  murine Cdsl
3.1.1 Identification of cDNA clone 801-h9
Two human homologues of the Drosophila eye-cds gene, CDS1 and CDS2 have 
previously been described (Heacock et al., 1996; Weeks et al., 1997; Halford et al., 
1998; Volta et al., 1999). The human CDS1 nucleotide sequence (GenBank accession 
number: XM_034414 (Weeks et al., 1997) was used to search the Expressed Sequence 
Tag (EST) database using the BLAST-N algorithm (http://www.ncbi.nlm.nih.gov 
/BLAST) to identify homologous murine cDNA clones. This resulted in the 
identification of one murine cDNA clone (GenBank accession number: w30593,
I.M.A.G.E number: 349880). The clone was obtained from the Human Genome 
Mapping Project Resource Centre (HGMP-RC) Hinxton, UK (http://www.hgmp.mrc.ac. 
uk) and was given the laboratory number 801-h9. The clone originated from a Soares 
mouse p3NMF19.5 library and had been cloned into the Notl and EcdRl restriction sites 
of a pT7T3D vector. DNA was prepared from the clone (see section 2.3.1.1-2) and was 
digested with the enzymes Notl and EcoRl to release the 1.3kb insert and the 3kb 
pT7T3 vector (figure 3.1) (see section 2.3.1.9). The ends of the clone were sequenced
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lkb 801
< 3kb
<«------- 1.3kb
Figure 3.1 Insert from Cdsl cDNA clone 801-h9
801-h9 was digested with the restriction enzymes ZTcoRI and AM . 
This generated two fragments, the insert of ~1.3kb and the 3kb 
vector.
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using vector primers M13F and M13R (see section 2.3.1.18). This confirmed that the 
clone was the expected Cdsl homologue and the entire insert was then sequenced on 
both strands using gene specific primers (see table 3.1 for primer sequences).
8 0 1 R 2 A A C C T G G C C A G T G A G G G 1 0 9 7
8 0 1 F 2 G G T A G A G G G C G A A G G A T A T C 1 9
8  0 1 R 3 G T C T A C C T A A A T C A T G G 1 1 1 4
8 0 1 F 3 C C T T G A A G G T G T A G C T G 8 1 7
8  0 1 R 4 C A T T A T C C C G C C A T G T C C A G 6 3 6
8 0 1 R 5 A T G T G A C T G A G T G A C G G T T A 1 3 2
8 0 1 F 5 A A T G C A C T G G A G G C A C C T T G 1 2 0 3
Table 3.1 Primers used to generate the 3' sequence of Cdsl using cDNA clone 801-h9.
The nucleotide sequence of 801-h9 and the derived amino acid sequence of the longest 
open reading frame are shown in figure 3.2 (the primer sequences listed in table 3.1 are 
highlighted in red). Aligning the derived amino acid sequence of 801-h9 and that of 
human CDS1 (figure 3.3), using the standard alignment algorithm in GeneWorks 2.5. IN 
(supplied by IntelliGenetics), it can be seen that the 5’ end of the murine Cdsl gene is 
not represented in 801-h9. The human CDS1 and mouse 801-h9 nucleotide sequences 
are 85% identical and the amino acid sequences are 96.7% identical.
GeneWorks was used to predict the restriction map of 801-h9 (figure 3.4) this was then 
verified by restriction digests. The map was prepared in order to identify restriction 
sites that could later be used to generate probes.
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A T A T C C T T C G C C C T C T A C C T G G C A G G T T T C T G C A T G T T T G T C C T G A G C C T G G T G A A G A A G C A C T A C A G A C T G C A G T T C T A T A T G T T C G C A  9 0
T A T A G G A A G C G G G A G A T G G A C C G T C C A A A G A C G T A C A A A C A G G A C T C G G A C C A C T T C T T C G T G A T G T C T G A C G T C A A G A T A T A C A A G C G T
I S F A L Y L A G F C M F V L S L V K K H Y R L Q F Y M F A
TGGACGCACGTCACTTTACTGATAACCGTCACTCAGTCACATCTTGTCATCCAAAATCTGTTTGAAGGCATGATATGGTTCCTTGTTCCC 180
ACCTGCGTGCAGTGAAATGACTATTGGCAGTGAGTCAGTGTAGAACAGTAGGTTTTAGACAAACTTCCGTACTATACCAAGGAACAAGGG
W T H V T L L I T V T Q S H L V I Q N L F E G M I W F L V P
ATATCAAGCGTCATCTGCAATGACATCACAGCTTATCTTTTTGGATTTTTTTTTGGAAGAACTCCTCTAATTAAGCTGTCTCCTAAGAAG 2 7 0
TATAGTTCGCAGTAGACGTTACTGTAGTGTCGAATAGAAAAACCTAAAAAAAAACCTTCTTGAGGAGATTAATTCGACAGAGGATTCTTC
I S S V I C N D I T A Y L F G F F F G R T P L I K L S P K K
ACTTGGGAAGGATTCATTGGTGGTTTCTTCTCCACAGTCATATTTGGATTCATTGCTGCCTATGTGTTGTCCAAGTACCAGTACTTTGTG 3 60
TGAACCCTTCCTAAGTAACCACCAAAGAAGAGGTGTCAGTATAAACCTAAGTAACGACGGATACACAACAGGTTCATGGTCATGAAACAC
T W E G F I G G F F S T V I F G F I A A Y V L S K Y Q Y F V
TGCCCGGTGGAATACCGAAGCGACGTCAACTCCTTCGTGACAGAGTGTGAGCCCTCAGAACTGTTCCAGCTTCAGAATTACTCCCTCCCT 4 5 0
ACGGGCCACCTTATGGCTTCGCTGCAGTTGAGGAAGCACTGTCTCACACTCGGGAGTCTTGACAAGGTCGAAGTCTTAATGAGGGAGGGA
C P V E Y R S D V N S F V T E C E P S E L F Q L Q N Y S L P
CCATTCCTACAGGCAGTGATGAGCCGGGAGACTGTGAGCTTGTACCCCTTCCAGATACACAGCATTGCCCTTTCAACGTTCGCGTCACTG 54 0
GGTAAGGATGTCCGTCACTACTCGGCCCTCTGACACTCGAACATGGGGAAGGTCTATGTGTCGTAACGGGAAAGTTGCAAGCGCAGTGAC 
P F L Q A V M S R E T V S L Y P F Q I H S  I A L S T F A S L  
ATTGGCCCATTTGGAGGCTTCTTTGCCAGTGGATTCAAAAGAGCTTTCAAAATCAAGGATTTTGCAAACACGATTCCTGGACATGGCGGG 63 0
TAACCGGGTAAACCTCCGAAGAAACGGTCACCTAAGTTTTCTCGAAAGTTTTAGTTCCTAAAACGTTTGTGCTAAGGACCTGTACCGCCC 
I G P F G G F F A S G F K R A F K I K D F A N T I P G H G G  
ATAATGGACAGGTTTGACTGTCAGTATTTGATGGCAACGTTCGTGCACGTGTACATCACCAGCTTCATCAGGGGTCCGAATCCCAGCAAA 72 0
TATTACCTGTCCAAACTGACAGTCATAAACTACCGTTGCAAGCACGTGCACATGTAGTGGTCGAAGTAGTCCCCAGGCTTAGGGTCGTTT 
I M D R F D C Q Y L M A T F V H V Y I T S F I R G P N P S K
GTGCTCCAGCAGCTGTTAGTGCTTCAACCAGAACAGCAGTTAAATATCTACAGAACCCTGAAGATTCATCTCACCGAGAAAGGGATCCTG 810
CACGAGGTCGTCGACAATCACGAAGTTGGTCTTGTCGTCAATTTATAGATGTCTTGGGACTTCTAAGTAGAGTGGCTCTTTCCCTAGGAC 
V L Q Q L L V L Q P E Q Q L N I Y R T L K I H L T E K G I L  
CAGCCCACCTTGAAGGTGTAGCTGCCCTTGAGGACGACGGGCTGCTGAGGAGGAGCTCACAGACCAGCTCTGACTGGAGCCGTGCACTGA 900
GTCGGGTGGAACTTCCACATCGACGGGAACTCCTGCTGCCCGACGAUTCCTCCTCGAGTGTCTGGTCGAGACTGACCTCGGCACGTGACT 
Q P T L K V  . L P L R T T G C  . G G A H R P A L T G A V H  
GCCAGCCTGGGGCTAAAACTCAGTAGATGCAGGCTTTGCAGATACAAAGGTTTCTTTTTCTGAATTTACAATTACTGTGAATATTTAACA 990
CGGTCGGACCCCGATTTTGAGTCATCTACGTCCGAAACGTCTATGTTTCCAAAGAAAAAGACTTAAATGTTAATGACACTTATAAATTGT 
A S L G L K L S R C R L C R Y K G F F F  I Y N Y C E Y L T
AACACGTGGTCTAAGGTGAGTGCAGCAGTCGCCCACCCGTGAAAGATCCTGTACTTTTCTAAAATGTATTTTCCAATGTTAAGTTCTCTG 108 0
TTGTGCACCAGATTCCACTCACGTCGTCAGCGGGTGGGCACTTTCTAGGACATGAAAAGATTTTACATAAAAGGTTACAATTCAAGAGAC 
N T W S K V S A A V A H P  . K I L Y F S K M Y F P M L S S L  
CCCTCACTGGCCAGGTTCCATGATTTAGGTAGACTTGCGTTTTAAAGAGTCAAACACTATCAACTGAGGCCCTCGTAGGGTGTTGACCTT 117 0
GGGAGTGACCGGTCCAAGGTACTAAATCCATCTGAACGCAAAATTTCTCAGTTTGTGATAGTTGACTCCGGGAGCATCCCACAACTGGAA 
P S L A R F H D L G R L A F  . R V K H Y Q L R P S  . G V D L  
TGCCCTGGTGCTGCCCTGGCGTAGCCATAGCTGAATGCACTGGAGGCACCTTGGGAATCGAGGTCTCGGGGTTTCCTCCTCTAATGATCT 12 60
ACGGGACCACGACGGGACCGCATCGGTATCGACTTACGTGACCTCCGTGGAACCCTTAGCTCCAGAGCCCCAAAGGAGGAGATTACTAGA 
C P G A A L A  . P . L N A L E A P W E S R S R G F L L  . S
CAAGCATTTCTGAAGGGCTGAGTTAGATTAAAAAAAAAAAAAAAAAAA 13 0 8
GTTCGTAAAGACTTCCCGACTCAATCTAATTTTTTTTTTTTTTTTTTT 
Q A F L K G  . V R L K K K K K K
Figure 3.2 Nucleotide and derived amino acid sequence of 801-h9
The 1308bp nucleic acid sequence generated from cDNA clone 801-h9. The stop codon is highlighted in blue at 
position 828bp. The oligonuclotide primers used to generate the sequence are listed in table 3.1 and highlighted above 
in red.
hCDSl
801
hCDSl
801
hCDSl
801
MLELRHRGSC PGPREAVSPP HREGEAAGGD HETESTSDKE TDIDDRYGDL 50
DSRTDSDIPE IPPSSDRTPE ILKKALSGLS SRWKNWWIRG ILTLTMISLF 100
FLIIYMGSFM LMLLVLGIQV KCFHEIITIG YRVYHSYDLP WFRTLSWYFL 150
hCDSl
801
LCVNYFFYGE TVADYFATFV QREEQLQFLI RYHRF ESFAL YLAGFCMFVL 
ESFAL YLAGFCMFVL
200
15
hCDSl
801
SLVKKHYRLQ FYMFAWTHVT LLITVTQSHL VIQNLFEGMI WFLVPISSVI 
SLVKKHYRLQ FYMFAWTHVT LLITVTQSHL VIQNLFEGMI WFLVPISSVI
250
65
hCDSl
801
CNDITAYLFG FFFGRTPLIK LSPKKTWEGF IGGFFSTV' 
CNDITAYLFG FFFGRTPLIK LSPKKTWEGF IGGFFSTV
GFIAAYVLSK
GFIAAYVLSK
300
115
hCDSl
801
YQYFVCPVEY RSDVNSFVTE CEPSELFQLQ 
YQYFVCPVEY RSDVNSFVTE CEPSELFQLQ YSLPPFLU,
_RQEM/SLY
SREtfSLY
350
165
hCDSl
801
IPFQIHSIALS TFASLIGPFG GFFASGFKRA FKIKDFANTI PGHGGIMDRF 
’FQIHSIALS TFASLIGPFG GFFASGFKRA FKIKDFANTI PGHGGIMDRF
400
215
hCDSl
801
JCQYLMATFV HVYITSFIRG PNPSKVLQQL LVLQPEQQLN IYKffOC 
JCQYLMATFV HVYITSFIRG PNPSKVLQQL LVLQPEQQLN I Y U L K
450
265
hCDSl
801
EKGILQPTLK V 
EKGILQPTLK V
461
276
Figure 3.3 Amino acid alignment of human CDS1 and 801-h9
This figure shows the amino acid sequence alignment of the mouse 
clone 801-h9 and the human CDS1 sequence. The regions of 
complete identity are shown boxed and shaded and regions of 
similarity are just shaded. 801-h9 aligns with the 3' end of the 
human sequence. This alignment shows that 801-h9 does not 
contain the 5’ end of the mouse gene.
132
5 ’-» 3 ’
Notl
Pstl BamHl Pstl
EcoRl
75bp 730bp 496bp
ATATCCTTCG CCCTCTACCT 
TTCTATATGT TCGCATGGAC 
TTTGAAGGCA TGATATGGTT 
TTTTTTTTTG GAAGAACTCC 
TCCACAGTCA TATTTGGATT 
CGAAGCGACG TCAACTCCTT 
CCATTCCTAC AGGCAGTGAT 
ACGTTCGCGT CACTGATTGG 
TTTGCAAACA CGATTCCTGG 
CACGTGTACA TCACCAGCTT 
GAACAGCAGT TAAATATCTA 
GTGTAGCTGC CCTTGAGGAC 
GCCAGCCTGG GGCTAAAACT 
TGTGAATATT TAACAAACAC 
AAAATGTATT TTCCAATGTT 
AGAGTCAAAC ACTATCAACT 
CTGAATGCAC TGGAGGCACC 
GGCTGAGTTA GATTAAAAAA
GGCAGGTTTC TGCATGTTTG 
GCACGTCACT TTACTGATAA 
CCTTGTTCCC ATATCAAGCG 
TCTAATTAAG CTGTCTCCTA 
CATTGCTGCC TATGTGTTGT 
CGTGACAGAG TGTGAGCCCT 
GAGCCGGGAG ACTGTGAGCT 
CCCATTTGGA GGCTTCTTTG 
ACATGGCGGG ATAATGGACA 
CATCAGGGGT CCGAATCCCA 
CAGAACCCTG AAGATTCATC 
GACGGGCTGC TGAGGAGGAG 
CAGTAGATGC AGGCTTTGCA 
GTGGTCTAAG GTGAGTGCAG 
AAGTTCTCTG CCCTCACTGG 
GAGGCCCTCG TAGGGTGTTG 
TTGGGAATCG AGGTCTCGGG 
AAAAAAAAAA AAA
TCCTGAGCCT GGTGAAGAAG 
CCGTCACTCA GTCACATCTT 
TCATCTGCAA TGACATCACA 
AGAAGACTTG GGAAGGATTC 
CCAAGTACCA GTACTTTGTG 
CAGAACTGTT CCAGCTTCAG 
TGTACCCCTT CCAGATACAC 
CCAGTGGATT CAAAAGAGCT 
GGTTTGACTG TCAGTATTTG 
GCAAAGTGCT CCAGCAGCTG 
TCACCGAGAA AGGGATCCTG 
CTCACAGACC AGCTCTGACT 
GATACAAAGG TTTCTTTTTC 
CAGTCGCCCA CCCGTGAAAG 
CCAGGTTCCA TGATTTAGGT 
ACCTTTGCCC TGGTGCTGCC 
GTTTCCTCCT CTAATGATCT
CACTACAGAC TGCAG 75
GTCATCCAAA ATCTG 150
GCTTATCTTT TTGGA 225
ATTGGTGGTT TCTTC 300
TGCCCGGTGG AATAC 375
AATTACTCCC TCCCT 4 5 0
AGCATTGCCC TTTCA 525
TTCAAAATCA AGGAT 600
ATGGCAACGT TCGTG 675
TTAGTGCTTC AACCA 750
CAGCCCACCT TGAAG 825
GGAGCCGTGC ACTGA 900
TGAATTTACA ATTAC 975
ATCCTGTACT TTTCT 1050
AGACTTGCGT TTTAA 1125
CTGGCGTAGC CATAG 1200
CAAGCATTTC TGAAG 1275
1308
Figure 3.4 Schematic restriction map diagram of 801-h9
A simple restriction map of clone 801-h9 is shown with vector sites shown in black text and the 
restriction sites contained within the clone shown in red. The nucleotide sequence generated from 801- 
h9 is shown beneath the map with the actual restriction sights highlighted in red. Pstl- CTGCAG, 
BamHl- GGATCC.
3.1.2 Identification of cDNA clone 2279-dl9
To identify a clone containing the 5' sequence of Cdsl, the nucleotide sequence o f801- 
h9 was used to re-search the EST database. This resulted in the identification of a 
further clone (GenBank accession number: AI596413,1.M.A.G.E number: 917346) 
which was obtained from HGPM-RC and given the laboratory number 2279-dl9. The 
clone originates from a Stratagene mouse adult testis library and is cloned into the 
EcoRl and Xhol sites of a pBluescriptSK- vector. DNA was prepared from the clone, as 
before. The DNA was digested with iscoRI and Xhol to release the insert. This 
produced three fragments of 3kb, 1.8kb and 950bp. The DNA was digested with Xhol 
only which linearised the clone and with EcoRl only which produced two fragments, 
4.8kb and 950bp. This suggests that a co-ligation may have occurred or that the clone 
contains an internal EcoRl restriction site. Clone 2279-dl9 was sequenced initially with 
vector primers M13F and M13R. The sequence from the 3’ end of 2279-dl9 was 
aligned with clone 801-h9 (figure 3.5). This shows that the 3’ end of 2279-dl9 is 100% 
identical to clone 801-h9, however the 5’ end of clone 2279-dl9 extends greatly in the 
5' direction from 801-h9. The remainder of the insert from clone 2279-dl9 was then 
sequenced with specific primers (table 3.2). The nucleotide sequence generated from 
clone 2279-dl9 and the derived amino acid sequence is shown in figure 3.6 with the 
internal EcoRl site highlighted in red, and the sequencing primers highlighted in blue. 
The sequence showed that the 5'-*- 3’ adapter sequence (GGCACGAGAAACCCT) was 
present after the EcoRl site, making the presence of a co-ligation the most likely 
explanation for the location of the EcoRl site. The sequence preceeding the sequence 
representing Cdsl in clone 2279-dl9, appears to be running in the opposite direction 
(3'-» 5'), and contains a poly (A) tail at the start of the clone. The nucleotide sequence 
generated from clone 2279-dl9 was aligned, as before, with the nucleotide sequences of 
human CDS1 (figure 3.7) this alignment showed that the 5’ end of2279-dl9 did not 
match the human sequence. The first 950bp of clone 2279-dl9 was used to screen the 
EST database to determine what the co-ligation sequence represented. The 5’ end of 
clone 2279-dl9 did not align strongly with anything in the database. The first 950bp of 
sequence from clone 2279-dl9 were removed and the longest open reading frame of the 
remaining 1.8kb of sequence was derived. The derived amino acid sequence from 
2279-dl9 was aligned with the human CDS1 amino acid sequence (figure 3.8). The 
alignment shows that the amino acid sequence derived from clone 2279-dl9 does not 
align with the 5’ end of the human sequence. This alignment shows
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2279 FFFFFFFGNGYLFSPIQCLVIFQKXSIIYITNFLFRDSLVEHMFRLLFVACASSSGFLIVSLTFCRSCLMXVSXHERMGKNEVFLDSFAS 90
2279 FRASGDPLYXGWPVSPLPXDDAAFRIPPRARCXWTQFSHPCTAASPPETXFLAXCLLRCPPVPXLXSEILTADLNSVSAELSVAKRGHLS 180
2279 AVQSLLALTRIHXFLSSGRQGILLIFDFPGXEGPSFGHLHRFHFLSSLEFQNVCGFSHFQGLVSVLFLASYFPCRLYIXXCPFYSGKWCC 270
2279 SSFSRLASLLKRHCGGTXASCFFLXSPLLLPEAVGGFLVPNSARAPPREGEAAGGDHETESTSDKETDIDDRYGDLDARGDSDVPEVPPS 360
2279
801
SDRTPEILKKALSGLSSRWKNWWIRGILTLTMISLFFLIIYMGSFMLMLLVLGIQVKCFHEIITIGYRVYHSYDLPWFRTLSWYFLLCVN 450
U>
L it
2279
801
YFFYGETVADYFATFVQREEQLQFLIRYHRIFflSFALYLAGFCMFVLSLVKKHYRLQFYMFAWTHVTLUTVTQSHLVIQNLFEGMIWFLV
ISFALYLAGFCMFVLSLVKKHYRLQFYMFAWTHVTLLITVTQSHLVIQNLFEGMIWFLV
540
59
2279
801
PISSVICNDITAYLFGFFFGRTPLIKLSPKKTWEGFIGGFFSTVIFGFIAAYVLSKYQYFVCPVEYRSDVNSFVTECEPSELFQLQNYSL
PISSVICNDITAYLFGFFFGRTPLIKLSPKKTWEGFIGGFFSTVIFGFIAAYVLSKYQYFVCPVEYRSDVNSFVTECEPSELFQLQNYSL
630
149
2279
801
PPFLQAVMSRETVSLYPFQIHSIALSTFASLIGPFGGFFASGFKRAFKIKDFANTIPGHGGIMDRFDCQYLMATFVHVYITSFIRGPNPS
PPFLQAVMSRETVSLYPFQIHSIALSTFASLIGPFGGFFASGFKRAFKIKDFANTIPGHGGIMDRFDCQYLMATFVHVYITSFIRGPNPS
720
239
2279
801
KVLQQLLVLQPEQQLNIYRTLKIHLTEKGILQPTLKV
KVLQQLLVLQPEQQLNIYRTLKIHLTEKGILQPTLKV
757
276
Figure 3.5 Amino acid alignment of 801-h9 and 2279-dl9
The derived amino acid sequence from 2279-dl9 was aligned with the derived amino acid sequence of 801-h9.
The amino acid sequence of 2279-dl9 was derived from the second reading frame as this gave the best alignment 
with 801 -h9. Regions of identity are boxed and shaded, the alignment shows that the sequences are 100% identical 
at the 3' end.
F F F F F F F G N G Y L F S P I Q C L V I F Q K .  S I I Y I
ACGAACTTT CT GTTT AGAGACAGTTT GGTT GAACACAT GTTCAGATT ATT GTTCGT GGCCT GT GCTT CTT CTTCCGGCTT CTT GATT GTT 1 8 0
T N F L F R D S L V E H M F R L L F V A C A S S S G F L I V
T CTTT AACATTTT GC AGAT CCT GCTT AATGT GAGTCTCCT AGCATGAGAGGATGGGG AAAAACGAAGT ATTT CTT GATT CT TT T  GCTT CT 2 7 0
S L T F C R S C L M . V S . H E R M G K N E V F L D S F A S
TTCCGAGCTT CT GGAGATCCT CTTT ACT AAGGCT GGCCGGT GAGTCCT CTTCCAT AAGACGACGCAGCCTTT CGAATCCCCCCACGAGCC 3 6 0
F R A S G D P L Y  . G W P V S P L P  . D D A A F R I P P R A
AGGT GCT GATGGACT CAATTTTCTCATCCCTGTACTGCAGCTTCGCCACCAGAGACTTAATTTCTTGCATAGTGTCTTCTCCGGTGCCCA 4 5 0
R C  . W T Q F S H P C T A A S P P E T  F L A .  C L L R C P
CCAGTTCCTT AATT AT GAT CT GAAATCCT GACAGCAGATCTGAATAGTGTGAGTGCTGAACTATCAGTTGCCAAGAGAGGTCACCTGAGT 5 4 0
P V P .  L . S E I L T A D L N S V S A E L S V A K R G H L S
GCT GT ACAGT CACTACTTGCTTTGACGCGT ATT CATT GATTT C TTT CTT CAGGT AGGCAAGGT ATT CT CTT AATTTTT GATTTTCCAGGA 6 3 0
A V Q S L L A L T R I H .  F L S S G R Q G I L L I F D F P G
T GAGAAGGGCCAT CTTTTGGT CATTT ACAT AGATTT CATTTT CT AAGTT CTTT AGAATTT CAAAATGTTTGTGGGTTTTCTCACTTTCAA 7 2 0
. E G P S F G H L H R F H F L S S L E F Q N V C G F S H F Q
GGT CTCGT AAGT GTTTT ATTT CT CGCTT CAT ATTTTCCGT GCCGT CT GT ACAT CT GAT GAT GTCCTTTCT AT AGCGGAAAATGGT GTTGC 8 1 0
G L V S V L F L A S Y F P C R L Y I  . C P F Y S G K W C C
TCATCGTTTTCTCGTCTTGCTTCTTTGCTGAAACGTCACTGTGGAGGGACCTGAGCATCCTGTTTTTTTCTCT G A A G T C .T C , TCTGCTA
CCT GAAGCT GT GGGAGGGTTT CTCGTGCCGAATTCGGCACGAGCGCCACCCCGCGAGGGAGAGGCGGCCGGCGGT GACCACGAAACCGAG 9 9 0
P E A V G G F L V P  71 5  A R A P P R E G E A A G G D H E T E
AGCACCAGCGACAAAGAAACAGATATTGATGACAGGTATGGAGATCTCGATGCCAGAGGCGATTCCGACGTGCCTGAGGTCCCACCGTCC 1 0 8 0
S T S D K E T D I D D R Y G D L D A R G D S D V P E V P P S
T CAGACAGGACCCCCGAGATT CTCAAGAAAGCCCTGTCCGGACTATCTTCAAGATGGAAGAACTGGTGGATTCGCGGGATCCTCACCCTC 1 1 7 0
S D R T P E I L K K A L S G L S S R W K N W W I R G I L T L
ACCAT GATCTCCCT CTT CTTCCT GATT AT CT AT AT GGGGT CCTT CAT GCT GAT GCTT CT GGTT CT GGGCATCCAAGTGAAGTGCTTCCAT 1 2 6 0
T M I S L F F L I I Y M G S F M L M L L V L G I Q V K C F H
GAGAT CAT CACCATCGGGT ACCGGGT CT ACCACT CCT ACGACCTCCCAT GGTTT AGGACACT AAGTT GGT ACTTCCTCCTGT GTGT GAAC 1 3 5 0
E I I T I G Y R V Y H S Y D L P W F R T L S W Y F L L C V N
T ACTT CTT CT ATGGAGAGACGGT GGCAGATT ACTTCGCCACGTTT GTT CAGAGGGAGGAGCAGCTGCAGTTCCTCATTCGCTACCACAGG 1 4 4 0
Y F F Y G E T V A D Y F A T F V Q R E E Q L Q F L I R Y H R
TTCAT AT CCTTCGCCCT CT ACCT GGCAGGTTTCT GCAT GTTT GTCCT GAGCCT GGT GAAGAAGCACT ACAGACTGCAGTTCTATATGTTC 1 5 3 0
F I S F A L Y L A G F C M F V L S L V K K H Y R L Q F Y M F
GCAT GGACGCACGTCACTTT ACT GAT AACCGT CACT CAGT CACAT CTT GT CAT CCAAAAT CT GTTT GAAGGCAT GAT ATGGTTCCTT GTT 1 6 2 0
A W T H V T L L I T V T Q S H L V I Q N L F E G M I W F L V
CCCAT AT CAAGCGT CAT CTGCAAT GACAT CACAGCTT AT CTTTTTGGATTTTTTTTTGGAAGAACTCCT CT AATT AAGCT GT CTCCT AAG 1 7 1 0
P I S S V I C N D I T A Y L F G F F F G R T P L I K L S P K
AAGACTT GGGAAGGATTCATT GGT GGTTT CTT CTCCACAGT CAT ATTT GGATT CATT GCT GCCT AT GT GTT GTCCAAGT ACCAGT ACTTT 1 8 0 0
K T W E G F I G G F F S T V I F G F I A A Y V L S K Y Q Y F
GT GT GCCCGGT GGAAT ACCGAAGCGACGT CAACT CCTTCGT GACAGAGTGTGAGCCCTCAGAACTGTTCCAGCTTCAGAATTACTCCCTC 1 8 9 0
V C P V E Y R S D V N S F V T E C E P S E L F Q L Q N Y S L
CCT CCATT CCT ACAGGCAGTGATGAGCCGGGAGACTGTGAGCTTGTACCCCTTCCAGATACACAGCATTGCCCTTTCAACGTTCGCGTCA 1 9 8 0
P P F L Q A V M S R E T V S L Y P F Q I H S I A L S T F A S
CTGATTGGCCCATTTGGAGGCTTCTTTGCCAGTGGATTCAAAAGAGCTTTCAAAATCAAGGATTTTGCAAACACGATTCCTGGACATGGC 2 0 7 0
L I G P F G G F F A S G F K R A F K I K D F A N T I P G H G
GGGAT AAT GGACAGGTTTGACTGTCAGTATTTGATGGCAACGT TCGTGCACGTGTACATCACCAGCTTCATCAGGGGTCCGAATCCCAGC 2 1 6 0
G I M D R F D C Q Y L M A T F V H V Y I T S F I R G P N P S
AAAGTGCT CCAGCAGCT GTT AGT GCTT CAACCAGAACAGCAGTTAAATATCTACAGAACCCTGAAGATTCATCTCACCGAGAAAGGGATC 2 2 5 0
K V L Q Q L L V L Q P E Q Q L N I Y R T L K I H L T E K G I
CTGCAGCCCACCTTGAAGGTGTAGCTGCCCTTGAGGACGACGGGCTGCTGAGGAGGAGCTCACAGACCAGCTCTGACTGGAGCCGTGCAC 2 3 4 0
L Q P T L K V .  L P L R T T G C  . G G A H R P A L T  G A V H
T GAGCCAGCCT GGGGCT AAAACT CAGT AGAT GCAGGCTTT GCAGAT ACAAAGGTTTCTTTTTCTGAATTTACAATTACTGTGAATATTTA 2 4 3 0
A S L G L K L S R C R L C R Y K G F F F  . I Y N Y C E Y L
ACAAACACGTGGTCTAAGGTGAGTGCAGCAGTCGCCCACCCGTGAAAGATCCTGTACTTTTCTAAAATGTATTTTCCAATGTTAAGTTCT 2 5 2 0
T N T W S K V S A A V A H P  K I L Y F S K M Y F P M L S S
CTGCCCT CACT GGCCAGGTTCCATGATTTAGGTAGACTTGCGTTTTAAAGAGTCAAACACTATCAACTGAGGCCCTCGTAGGGTGTTGAC 2 6 1 0
L P S L A R F H D L G R L A F  . R V K H Y Q L R P S  . G V D
CTTTGCCCTGGTGCTGCCCTGGCGT AGCCAT AGCT GAAT GCACT GGAGGCACCTTGGGAATCGAGGT CT CGGGGTTTCCTCCTCT AAT GA 2 7 0 0
L C P G A A L A .  P .  L N A L E A P W E S R S R G F L L  .
T CT CAAGCATTT CT GAAGGGCT GAGTT AGATT AAAAAAAAAAAAAAAAAAA 2 7 5 1
S Q A F L K G  . V R L K K K K K K
Figure 3.6 Clone 2279 nucleotide sequence
The sequence of the clone 2279-dl9 which contains most of the mouse 
Cdsl gene is shown. The co-ligation is highlighted in red with the 5 ’-*3’ 
adapter sequence highlighted in purple and sequencing primers (table 3.2) 
highlighted in blue.
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TTTTTTTTTTTTTTTTTT CTTTGGCAAT GGCTATTTATTTT CACCAATACAGT GTTTAGT AATATTTCAAAAAT AAAGCATAAT TTATAT 
AACGAACTTTCTGTTTAGAGACAGTTTGGTTGAACACATGTTCAGATTATTGTTCGTGGCCTGTGCTTCTTCTTCCGGCTTCTTGATTGT 
TT CTTTAACATTTTGCAGATCCT GCTTAATGTGAGTCTCCTAGCATGAGAGGATGGGGAAAAACGAAGTATTTCTT GATTCTTTT GCTTC 
TTTCCGAGCTTCTGGAGATCCTCTTTACTAAGGCTGGCCGGT GAGTCCTCTTCCATAAGACGACGCAGCCTTTCGAATCCCCCCACGAGC 
CAGGTGCTGATGGACTCAATTTTCTCATCCCTGTACTGCAGCTTCGCCACCAGAGACTTAATTTCTTGCATAGTGTCTTCTCCGGTGCCC 
ACCAGTTCCTTAATTATGATCTGAAATCCTGACAGCAGATCTGAATAGTGTGAGTGCTGAACTATCAGTTGCCAAGAGAGGTCACCTGAG 
TGCTGTACAGTCACTACTTGCTTTGACGCGTATT CATTGATTTCTTTCTT CAGGTAGGCAAGGTATTCTCTTAATTTTT GATTTTCCAGG 
ATGAGAAGGGCCATCTTTTGGTCATTTACATAGATTTCATTTTCT AAGTT CTTTAGAATTT CAAAATGTTTGTGGGTTTTCTCACTTTCA
-------   R n T G p ^ c n m f r i T f 3 T G f a f ^ G « f ? r 3 c G G G 4 3 T c < r a < r a G C G C ( f G 3 t n
AGGTCTCGTAAGTGTTTTATTTCTCGCTTCATAftFl C C pTG { C TtT4 c H  c I G4 T ♦ 1 TCC1TTCT41A AAT(IG i1G I
GAAGA|rafi^GpttTiApprXcCGCG(iAfpiRcRR[TlcrriGpiflGfrSlGTCGCiGCCACA(ICGCGAGGGAGAGGt(i<i<!^(;ciCGG I
TCTTC[Tg |I|T}- > p )CTGA|vp c TGTpG G A pp t n  T P T 1 I  P T GI: ^ 4  M 4 t T t GG4 AGGAG4 GGGAC<l 4 GGGGAGGGAGAGGGGGGGGGGGG |
A(!<5AAA(!(!(SA<lA<l(!A(!<rAG<!<SA<!A"AACAAA(^AGATATTGATGA(!A<I4TATGCAGATlT?|f7rri<f ^ AGA^CA(TATTT,Tl(nn|ATTl<l^ -l 
ACCACGAAACCGAGAGCACCAGCGACAAAGAAACAGATATTGATGACAG4|ATGGAGAT(jT(j4AT(|(|CAGAqGC4ATTCq(]AqG4qqC |
^ A ^ G [ r ^ C A C C ^ [ r C C T C A G A ^ f ^ ^ C C C ^ ^ A G A T T C T C A A ^ f A A G c } P ^ f ^ { ^ c f A T C T T C A A ^ | G G A A j j A C T G G T G G A T ^ ^ F l
^G^T^TCAC^T^^^^TGATCTc|cnf^ {'TCCTGAlftTCTATATGGGjfcCTTCATGCTGATGCTTCT^ C^TGGGC^  |
[AGTGAA^GCTTCCATGA^Pt^TCAcfFrl^Gl^A^c R ^TCTAjfA^fclfA^fA^fT^fCATGGTTTAGjf^CTAAGTTGGTACTT |
cjcTJ: cfrGTGTGlJ^ACTACTTf f T c T A r G G A G A G A c } | c j ^ A T T A ^  |[t } { t TGTTCA^^G^|a <^[a^<[a^ ^ A G T T C cT]
I C A T T  C G C T A C C A r ^ G A f T T T A T A T  C f r Y T E C C C T ^ T A t  t T G G f A G G T T T C T  G C A T  G T T T  G T  A C T  G A G !  I T G G T  G A  A G  A A A l d X T l T A T l C  cTTjcTT- 1 |CATTCGCTACCAp|^Gp[rTt:^TATcHrTt^ CCCTCTA4|:TGGCAGGTTTCTGCATGTTTGTc|4TGAG(|ctGGTGAAGAA(j(jA(jjAqA(j/>)(]T |
pnreTrilTA'f'Affn (Lil.E'XTGTrAdtrATETCAETTTAETEATAACTCTrAETEAGT^AEAdfTTETt’ATEEAAAAT^TGTTTCAAGECAT1]
| G C A G T T | : [ r A T A T G T T C G C A T G G A C p p A ( p T C A C T T T A C T G A T A A C 4 t T C A C T C A G T C A C A 4 4 T T G T C A T C C A A A A T C T G T T T G A A G G C A T  |
IGATATGGTTCCTTGTTCCfATATCAAGrpTTATCTGCAATGACATilfrtiCTTAdtTTTTTGGATTTTYTTfTGGqAGAACTCCAITlAAT I 
|G A T A T G G T T C C T T G T T C C p p T A T C A A G tp T t ) V T C T G C A A T G A C A T 4 j> c 4 t^ T T A 4 tT T T T T G G A T T T T T T T T T G G ^ 4 ^ A A C T C C l | c ~|A A T  |
rTO^ir^T^^TAAKAAaTTTCfiiA-A^aTT^ATTi^aTYmTf^A^-erriGraTTT ^iATT^ATTC^r^^^TATCTTrrT/Wrn
[ T A A G t : | T G T C T C C T A A p ^ A G A C T T G G G A A G G A T T C A T T G G T G G T T T C T T 4 f C C A C A G T < | A t 4 t T T G G A T T C A T T G C T G C C T A T G T G T T q 4 c  |
| c A A ^ A C C A G T A C T T T G T ^ | r G C C c t | T G G A A T A C C G A A G | ^ ^ f A C T C C T T C G T G A C A G A ^ | G T G A G C C C T C A G A A C T ^
[T d! AfiAtn’Ya(! Y<!|vpTl'pTrACTT|rTl A(j<jC agY f 7 Y g a g a R  C7Ta^1T2a c Y CiAdcYTGTACcE’iT'i’^ tACiAYdqACAGCATT Gd AJdT”"]
t r C A G A f i p ' T A C T C p p  p p  C C f  [r T f  (l TA f  fiGGC A G T f A f  GAGf  £ 4 T f  TGAGCTTGTACCC q  JT C C  AGAT4 |qAC A G C A T T G C q cjT |
Gff<^AA<:t|rnrc^nTrT|rApTT(:(:<!c:OT,rTGGAGGt:TT(;TTTG(:uc;rGGATT<:AAAAGAGc:qrr(!AAAAT(:AAGGATTTT(;<:AAA,ri4rn 
Tt r C A A C p | T T p | G C p f r c p c [ r p p T T G G C C C A T T T G G A G G C T T C T T T G c 4 | G T G G A T T C A A A A G A G C ' | t T C A A A A T C A A G G A T T T T G C A A A C M c  I
cCYT^^TGSA^ATGGftGGATAATGGA'^AGAITT^TnrGT^AGTAnTGATGGtlAAcllfnfra^^^rrATATrA^M/f^fnwmfSn 
(jA T T C C T G G A C A T G G ppG G A T A A T G G A C A G tF T T G A tfG T C A G T A T T T G A T G G C A A C ()tT(l i T(H A(1 4 T G T A C A T C A C (j4 G q iT c H T q 4 G  |
P ^ S t i n i V l f t A T C C C A G C A A A G T G C T f r A f i ^ A G T r G T T C p t t C T T C A A C C T C A A C A G C A G T T A A A T A T / l f A l / r a A A C C C T G A A G A q i C A T C T  I 
|GGG[qCCp)&ATCCCAGCAAAGTGCTt:pA GCA Gt :f G T T 4 p T G C T T C A A C C 4 4 A A C A G C A G T T A A A T A T ( | tA ( j4 c | 4A CCCT GAAGAT|4CATCT |
PA]T TJGAGAAAGEAIATCCTprXApCCACCTTGAAGGTAF A A r T t f T A T R A f A ^ l G G f A A f G A f T ^ A C A4^ 3 4 GGA / I T  f3l rqAGA/^A/radA]
|CA|:c|GAGAAAGGp^TCCTp|:Ap|:CCACCTTGAAGGT4rA4p T ) p 4 c n T pAG4AC4A(|4G(|4TG<|TG4G(|4GGA(|c4-|cA()AGAqc4qcjT]
|(^TGAC»V|^T|^TT[rKTl^ATTpYAnrS>AAAATApTrAAAAArir7firATr4nG/f4nTTTGq4GATA‘I dTYTC-l- f^TCTGA-j - 
|C TGACp)GpA|Gp C G[Tp Cftp TGApp - AG^ C CTGGGpp P AAAA4 M  f A4 I AG414CI 4 tTTG(l4GATA<lAAAG4TTT^1IT1 n1cTGAAr T
 ^ A T T A C T G ' f G A A T A T T Y A A C A A A ( ; A C r T A C T l T l r C T A T { r [ T A r ^ 7 f 4 A T A f ( r t f ^ a A A A T T G ( f r 7 l < r a A 4 7 J A T l G t n | ' I G T A q q T T T T C  I
TACyATTACTGTGAATATTTAACAAACACt---GfG4pCTA4H  -GfGA4TGC4G44GtcGCCCA4cq44G4AA(|Atcq4GTA-|cjTTTTC |
f f A A A p f T G T A T T T T C r G h T ( i T b p A T j n T l T | r i p C t T t f r r T p r f f G G T T T f T r 4 A T T T A - j A A 4 G A C T q ( r i A
P~AAAf4rGTATTTTCpA|MGT^Ap|rTCf clrtpCCTtfCT^pC^f GGTT4pAT4|TTTA4GT4GACT44qG
E P H AA| ^ ^ A i i [ i AAg [ T i j | i g GGAGg { i i 3 g ® c A A A i A T T T A c T T T
tT T tT A < ;< ;K A |IV A Y G rT T T A |n r fA IV G G ( !A C A A r ip G A A « T C fr fr r r4 n f4 A C rT C C T C C T C A T G tT lG fr ra G 4 ^ T |4 ^ 1 T T C T /1/1AG^ <^ I fTAGC|TG|lVATGpA C - [rG ^G p G G C A C tT lrp p G A A tcG fG 4 F G Tu 4 H GTt TC CTC C TC 1 A A t q A t CT(1A 4 G(l4 H l TT C T(y i AGGG I
ETrKGTTNGATTClAAAAAAAAAAAAAAAAtA
Figure 3.7 2279-dl9 and human CDS1 nucleotide alignment
As can be seen by the grey, boxed areas, the central sequence from clone 2279- 
d 19 aligns with the nucleotide sequence of human CDSL The 5' of clone 2279- 
d 19 does not contain sequence homologous to the CDS1 gene. The 3' ends of 
both sequences represent the 3'UTR and are not expected to be highly 
homologous._________________________________________________________
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hCDSl
2279-dl9
MLELRHRGSCPGPREAV5 PI
PPL
REGEAAGGDHETESTSDKETDIDDRYGDLD5 
REGEAAGGDHETESTSDKETDIDDRYGDLD<
1 DSD
DSD\
IPPSSDRTPEILKKALSGLSSRWKNWWIRG 
kPPSSDRTPEILKKALSGLSSRWKNWWIRG
90
71
hCDSl
2279-dl9
ILTLTMISLFFLIIYMGSFMLMLLVLGIQVKCFHEIITIGYRVYHSYDLPWFRTLSWYFLLCVNYFFYGETVADYFATFVQREEQLQFLI
ILTLTMISLFFLIIYMGSFMLMLLVLGIQVKCFHEIITIGYRVYHSYDLPWFRTLSWYFLLCVNYFFYGETVADYFATFVQREEQLQFLI
180
161
hCDSl
2279-dl9
RYHRFISFALYLAGFCMFVLSLVKKHYRLQFYMFAWTHVTLLITVTQSHLVIQNLFEGMIWFLVPISSVICNDITAYLFGFFFGRTPLIK
RYHRFISFALYLAGFCMFVLSLVKKHYRLQFYMFAWTHVTLLITVTQSHLVIQNLFEGMIWFLVPISSVICNDITAYLFGFFFGRTPLIK
270
251
hCDSl
2279-dl9
LSPKKTWEGFIGGFFSTV
LSPKKTWEGFIGGFFSTVfl
FGFIAAYVLSKYQYFVCPVEYRSDVNSFVTECEPSELFQLQ1YSLPPFLvAVLRC
FGFIAAYVLSKYQYFVCPVEYRSDVNSFVTECEPSELFQLQ'YSLPPFL AVMSF
EFVSLYPFQIHSIALS 
ElVSLYPFQIHSIALS
360
341
hCDSl
2279-dl9
TFASLIGPFGGFFASGFKRAFKIKDFANTIPGHGGIMDRFDCQYLMATFVHVYITSFIRGPNPSKVLQQLLVLQPEQQLNIY 
TFASLIGPFGGFFASGFKRAFKIKDFANTIPGHGGIMDRFDCQYLMATFVHVYITSFIRGPNPSKVLQQLLVLQPEQQLNIY:
TLK1HLI
TL.K1HL
450
431
hCDSl
2279-dl9
EKGILQPTLKV
EKGILQPTLKV
461
442
Figure 3.8 Human CDS1 and 2279-dl9 amino acid alignment
The figure shows the alignment between the amino acid sequence of human CDS1 and the amino acid sequence derived 
from clone 2279-dl9. The sequences are 96.6% identical over the aligned regions and 88.5% identical over the full length. 
Identical residues are boxed and shaded and similar residues are just shaded. The clone 2279-dl9 is lacking the first 
nineteen amino acids if the start sites are maintained by both the mouse and human, this results was verified (see figure 3.10) 
by the rat sequence since the rat sequence is 19 amino acids longer than the mouse sequence derived from clone 2279-dl9.
that 2279-dl9 does not contain the translation start site and hence does not represent the 
entire Cdsl gene.
801R5 AATGCACTGGAGGCACCTTG 2647
2279F1 GTGAGTCTCCTAGCATGAGA 210
22 7 9R1 ACGCGTCAAAGCAAGTAGTG 571
CDSlexonlR GTGCTCTCGGTTTCGTGGTC 996
MCDS1F4 CTTAATGTGAGTCTCCTAGC 205
MCDS1R4 AATTCGGCACGAGAAACCCT 935
CDSlintronlF GACCACGAAACCGAGAGCAC 977
CDSlintronlR TGGCATCGAGATCTCCATAC 1046
MCDS1R3 GAATCCACCAGTTCTTCCATC 1154
CDSlintron7F TTGGGAAGGATTCATTGGTG 1717
CDSlintron9F TTGCCCTTTCAACGTTCGCG 1959
MCDS1R1 CAAACATGCAGAAACCTGCCAG 1484
MCDS1R2 GTGCGTCCATGCGAACATAT 1543
Table 3.2 Primer names, sequences and the start position in the sequence generated 
from cDNA clone 2279-dl9.
3.1.3 Identification of the 5' end of mouse Cdsl
The Cdsl sequence generated from murine clone 2279-dl9 was used to re-screen the 
EST database for a cDNA clone containing the 5’ end of the mouse Cdsl gene. The 
search did not identify a mouse clone but did identify a rat cDNA Cds clone (GenBank 
accession number: NM 031242) with a full-length coding region, when compared to 
the human sequence, this provided evidence that the mouse gene was not complete. The 
amino acid sequences derived from clone 2279-dl9 and rat Cdsl were aligned (figure 
3.9) and are 99% identical. As a mouse clone containing the 5’ end of the Cdsl gene 
had not been identified, the 5’ end of the gene was amplified using polymerase chain 
reaction (PCR) (see section 2.3.1.16). Adult mouse eye and brain cDNA (see section 
2.3.2.3) was used as template.
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3.9 Amino acid alignment of rat Cdsl and clone 2279-dl9
The figure shows the alignment between the amino acid sequence of rat Cdsl and the amino acid sequence derived from 
clone 2279-dl9. The sequences are 98.8% identical over the aligning regions and 90% identical over the full-length. A 
primer was designed to the start site of rat and another was designed to the mouse nucleotide sequence. The primer pair 
was used to amplify the 5' end of the mouse gene from mouse cDNA.
RatCDSIF TGACATGCTGGAGCTGCGGC 1 (Rat)
CDSlintron2R T CAGGAAGAAGAGGGAGAT C 335
Table 3.3 Primer names, sequences and position on the sequence derived from cDNA 
clone 2279 (where relevant) that were used to amplify the 5! end of mouse Cdsl from 
eye and brain cDNA.
RatCDSIF TGACATGCTGGAGCTGCGGC 1 (Rat)
CDSlintron2R T CAGGAAGAAGAGGGAGAT C 335
CDSlintronlR TGGCATCGAGATCTCCATAC 186
Table 3.4 Primer names, sequences and position on the sequence derived from cDNA 
clone 2279 that were used to sequence the 5' end of mouse Cdsl that was amplified 
from eye and brain cDNA.
In order to amplify the 5’ end of the murine Cdsl gene, the rat nucleotide sequence was 
used to design an oligonucleotide primer that contained the start site of the rat gene 
(rCDSIF). This was used with a second mouse specific primer, (CDS 1 intron2R) (for 
sequences see table 3.3). The PCR reaction resulted in the amplification of a 250bp 
fragment. The 250bp PCR fragment was directly sequenced (see section 2.3.1.18) using 
the primers in table 3.4. The nucleotide and derived amino acid sequences that were 
generated from the PCR fragment are shown in figure 3.10. The sequence from the 
PCR fragment was aligned with the sequence generated from clone 2279-dl9 to 
generate the full-length amino acid sequence for mouse Cdsl (figure 3.11 summarises 
the generation of the coding region of mouse Cdsl). The full-length human, murine and 
rat Cdsl amino acid sequences were aligned and are shown in figure 3.12.
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ATGCTGGAGCTGCGGCACCGCGGGGGCTGCCCCGGCCCTGGGGGAGCGGGGGCGCCGCCC 60 
M L E L R H R G G C P G P G G A G A P P
CT CCGCGAGGGAGAGGCGGCCGGCGGT GACCACGAAACCGAGAGCACCAGCGACAAAGAA 120 
L R E G E A A G G D H E T E S T S D K E
ACAGAT ATT GAT GACAGGTAT GGAGAT CT CGAT GCCAGAGGCGATT CCGACGT GCCT GAG 180 
T D I D D R Y G D L D A R G D S D V P E
GTCCCACCGTCCTCAGACAGGACCCCCGAGATTCTCAAGAAAGCCCTGTCCGGACTATCT 240 
V P P S S D R T P E I L K K A L S G L S
TCAAGATGGA 250
S R W
Figure 3.10 Nucleotide sequence of 5’ Cdsl fragment 
The nucleotide and derived amino acid sequence generated 
from the fragment shown in figure 3.1.9. The start site is 
highlighted in red.
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Figure 3.11 Summary of Cdsl sequence generation
Shown is a schematic diagram of the generation of the mouse Cdsl sequence. The central line (red) represents the whole 
coding region and the 3’UTR of the gene. Shown are clones 801-h9 (dark blue), 2279-dl9 (purple) (dotted line represents 
the rest of the clone not representing Cdsl), and the PCR product (green) from which the coding sequence was generated. 
The three murine ESTs which were identified from the BLAST database (pale blue) using the 3'UTR sequence from rat are 
shown beneath the central line. The start location in the full-length sequence is marked at the 5' end of each clone in bp.
hCDSl MLELRHRG >CPGP 7E / S
ratCDSl MLELRHRG J CPGP j G \ jT
mCdsl MLELRHRG J CPGP j G \ j A
PP H 
PPP 
PP
REGEAAGGDHETESTSDKETDIDDRYGDLDlfl 
REGEAAGGDHETESTSDKETDIDDRYGDLD/ IK 
REGEAAGGDHETESTSDKETDIDDRYGDLD/ IK
DSD]
l)SD\
()SD\
PE]
PEN
PEN
PPSSDRTPEILKKALSGLSSRWKNWWIRG
PPSSDRTPEILKKALSGLSSRWKNWWIRG
PPSSDRTPEILKKALSGLSSRWKNWWIRG
90
90
90
hCDSl
ratCDSl
mCdsl
ILTLTMISLFFLIIYMGSFMLMLLVLGIQVKCFH
ILTLTMISLFFLIIYMGSFMLMLLVLGIQVKCFO
ILTLTMISLFFLIIYMGSFMLMLLVLGIQVKCFI)
IITIGYRVYHSYDLPWFRTLSWYFLLCVNYFFYGETVADYFATFVQR
IITIGYRVYHSYDLPWFRTLSWYFLLCVNYFFYGETVADYFATFVQK
IITIGYRVYHSYDLPWFRTLSWYFLLCVNYFFYGETVADYFATFVQR
E EQLQFLI 
E EQLQFLI 
E EQLQFLI
180
180
180
hCDSl
ratCDSl
mCdsl
RYHRFISFALYLAGFCMFVLSLVKKHYRLQFYMFAWTHVTLLITVTQSHLVIQNLFEGMIWFLVPISSVICNDITAYLFGFFFGRTPLIK 270
RYH RFIS FALYL AGFCM FVLS LVKKHYRLQFYMFAWTHVTLLITVTQSHLVIQNLFEGMIWFLVPISSVICNDITAYLFGFFFGRTPLIK 270
RYH RFIS FALYL AGFCM FVLS LVKKHYRLQFYMFAWTHVTLLITVTQSHLVIQNLFEGMIWFLVPISSVICNDITAYLFGFFFGRTPLIK 270
hCDSl
ratCDSl
mCdsl
LSPKKTWEGFIGGFFSTV 
LSPKKTWEGFIGGFFSTV 
LSPKKTWEGFIGGFFSTV
fFGFIAAYVLSKYQYFVCPVEYRSDVNSFVTECEPSEl 
FGFIAAYVLSKYQYFVCPVEYRSDVNSFVTECEPSEN 
FGFIAAYVLSKYQYFVCPVEYRSDVNSFVTECEPSEl
QLQ1
QLQt
QLQf
"SLPPFLh/ 
WSLPPFL( / 
''SLPPFLC /
RQE
SRE
SRE
SLYPFQIHSIALS 360
SLYPFQIHSIALS 360
SLYPFQIHSIALS 360
hCDSl
ratCDSl
mCdsl
TFASLIGPFGGFFASGFKRAFKIKDFANTIPGHGGIMDRFDCQYLMATFVHVYITSFIRGPNPSKVLQQLLVLQPEQQLNIYK
TFASLIGPFGGFFASGFKRAFKIKDFANTIPGHGGIMDRFDCQYLMATFVHVYITSFIRGPNPSKVLQQLLVLQPEQQLNIYR
TFASLIGPFGGFFASGFKRAFKIKDFANTIPGHGGIMDRFDCQYLMATFVHVYITSFIRGPNPSKVLQQLLVLQPEQQLNIYR
7 LKT 
1 LKI 
1 LKI
450
450
450
hCDSl
ratCDSl
mCdsl
EKGILQPTL 
EKGILQPT A 
EKGILQPTL
461
461
461
Figure 3.12 Amino acid alignment of sequences representing Cdsl, derived from rat, human and mouse.
The figure shows the alignment of the derived amino acid sequences from the rat, human and mouse Cdsl. The areas boxed 
and shaded are identical residues and similar residues are just shaded. The human and mouse sequences share 96% identity, 
the human and rat sequences share 95% identity and the mouse and rat sequences share 98% identity.
The mouse and human CDS1 genes are 96% identical and the mouse and rat genes are 
99% identical at the amino acid level.
3.1.4 Identification of murine Cdsl 3’ UTR
The first murine Cdsl cDNA clone, 801-h9, to be identified appeared to contain a poly 
A-tail although there was no obvious poly-adenylation signal present. Analysis of the 
human and rat sequences from the database, which were being used to find the 5’ end of 
mouse Cdsl, showed that the other two species had much longer 3’ untranslated regions 
(UTRs) than the sequence derived from 801-h9. To verify if the mouse sequence was 
genuinely shorter than that of the human or rat sequence, the sequence representing the 
3’UTR of the rat was used to search the mouse-EST database using BLAST-N. This 
search identified three overlapping clones (GenBank accession numbers: AI314024 
(I.M.A.G.E: 1920907), AI316951 (I.M.A.G.E: 1920907), AKO14670). Using the 
sequence data from the database more of the 3TJTR of the mouse Cdsl gene was 
generated. The composite nucleotide sequence with derived amino acid sequence of 
murine Cdsl is shown in figure 3.13. The generated sequence is of similar length to 
that of rat and human. The rat 3' UTR is 2345bp in length and is 6 8 % identical to the 
2303bp 3TJTR of the mouse gene at the nucleotide level.
3.1.5 Cdsl sequence homology between species
The mouse Cdsl gene was identified as a homologue of Drosophila eye-cds using the 
human CDS1 sequence. In order to establish the identity between the newly generated 
mouse Cdsl coding region and that of the Drosophila gene eye-cds (GenBank accession 
number: P 56079), which was used initially to identify the human CDS1 gene, an 
alignment of the amino acid sequences was performed (figure 3.14). The mouse Cdsl 
and Drosophila eye-cds are 56% identical at the amino acid level.
In order to predict if the Drosophila, mouse and human CDS1 proteins all have the 
same transmembrane structure, the amino acid sequences from each species were used 
to computer generate hydrophobicity plots using the computer programme TMPred 
(http://www.ch.embnet.org/soflware/TMPRED). The TMPred programme makes 
predictions of membrane-spanning regions based on statistical analysis of Tmbase, a 
database of naturally occurring transmembrane proteins.
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ATGCTGGAGCTGCGGCACCGCGGGGGCTGCCCCGGCCCTGGGGGAGCGGGGGCGCCGCCCCTCCGCGAGGGAGAGGCGGCCGGCGGTGAC
M L E L R H R G G C P G P G G A G A P P L R E G E A A G G D
90
CACGAAACCGAGAGCACCAGCGACAAAGAAACAGATATTGATGACAGGTATGGAGATCTCGATGCCAGAGGCGATTCCGACGTGCCTGAG 1 8 0
H E T E S T S D K E T D I D D R Y G D L D A R G D S D V P E
GTCCCACCGTCCTCAGACAGGACCCCCGAGATTCTCAAGAAAGCCCTGTCCGGACTATCTTCAAGATGGAAGAACTGGTGGATTCGCGGG 2 7 0
V P P S S D R T P E I L K K A L S G L S S R W K N W W I R G
ATCCTCACCCTCACCATGATCTCCCTCTTCTTCCTGATTATCTATATGGGGTCCTTCATGCTGATGCTTCTGGTTCTGGGCATCCAAGTG 3 6 0
I L T L T M I S L F F L I I Y M G S F M L M L L V L G I Q V
AAGTGCTTCCATGAGATCATCACCATCGGGTACCGGGTCTACCACTCCTACGACCTCCCATGGTTTAGGACACTAAGTTGGTACTTCCTC 4 5 0
K C F H E I I T I G Y R V Y H S Y D L P W F R T L S W Y F L
CTGTGTGTGAACTACTTCTTCTATGGAGAGACGGTGGCAGATTACTTCGCCACGTTTGTTCAGAGGGAGGAGCAGCTGCAGTTCCTCATT 5 4 0
L C V N Y F F Y G E T V A D Y F A T F V Q R E E Q L Q F L I
CGCTACCACAGGTTCATATCCTTCGCCCTCTACCTGGCAGGTTTCTGCATGTTTGTCCTGAGCCTGGTGAAGAAGCACTAC AGACTGCAG 6 3 0
R Y H R F I S F A L Y L A G F C M F V L S L V K K H Y R L Q
TTCTATATGTTCGCATGGACGCACGTCACTTTACTGATAACCGTCACTCAGTCAC ATCTTGTCATCCAAAATCTGTTTGAAGGCATGATA 7 2 0
F Y M F A W T H V T L L I T V T Q S H L V I Q N L F E G M I
TGGTTCCTTGTTCCCATATCAAGCGTCATCTGCAATGACATCACAGCTTATCTTTTTGGATTTTTTTTTGGAAGAACTCCTCTAATTAAG 8 1 0
W F L V P I S S V I C N D I T A Y L F G F F F G R T P L I K
CTGTCTCCTAAGAAGACTTGGGAAGGATTCATTGGTGGTTTCTTCTCCACAGTCATATTTGGATTCATTGCTGCCTATGTGTTGTCCAAG 9 0 0
L S P K K T W E G F I G G F F S T V I F G F I A A Y V L S K
TACCAGTACTTTGTGTGCCCGGTGGAATACCGAAGCGACGTCAACTCCTTCGTGACAGAGTGTGAGCCCTCAGAACTGTTCCAGCTTCAG 9 9 0
Y Q Y F V C P V E Y R S D V N S F V T E C E P S E L F Q L Q
AATTACTCCCTCCCTCCATTCCTACAGGCAGTGATGAGCCGGGAGACTGTGAGCTTGTACCCCTTCCAGATACACAGCATTGCCCTTTCA 1 0 8 0
N Y S L P P F L Q A V M S R E T V S L Y P F Q I H S I A L S
ACGTTCGCGTCACTGATTGGCCCATTTGGAGGCTTCTTTGCCAGTGGATTCAAAAGAGCTTTCAAAATCAAGGATTTTGCAAACACGATT 1 1 7 0
T F A S L I G P F G G F F A S G F K R A F R I K D F A N T I
CCTGGACATGGCGGGATAATGGACAGGTTTGACTGTCAGTATTTGATGGCAACGTTCGTGCACGTGTACATCACCAGCTTCATCAGGGGT 1 2 6 0
P G H G G I M D R F D C Q Y L M A T F V H V Y I T S F I R G
CCGAATCCCAGCAAAGTGCTCCAGCAGCTGTTAGTGCTTCAACCAGAACAGCAGTTAAATATCTACAGAACCCTGAAGATTCATCTCACC 1 3 5 0
P N P S K V L Q Q L L V L Q P E Q Q L N I Y R T L K I H L T
GAGAAAGGGATCCTGCAGCCCACCTTGAAGGTGTAGCTGCCCTTGAGGACGACGGGCTGCTGAGGAGGAGCTCACAGACCAGCTCTGACT 1 4 4 0
E K G I L Q P T L K V
GGAGCCGTGCACTGAGCCAGCCTGGGGCTAAAACTCAGTAGATGCAGGCTTTGCAGATACAAAGGTTTCTTTTTCTGAATTTACAATTAC 1 5 3 0
TGTGAATATTTAACAAACACGTGGTCTAAGGTGAGTGCAGC AGTCGCCC ACCCGTGAAAGATCCTGTACTTTTCTAAAATGTATTTTCCA 1 6 2 0
ATGTTAAGTTCTCTGCCCTCACTGGCCAGGTTCCATGATTTAGGTAGACTTGCGTTTTAAAGAGTCAAACACTATCAACTGAGGCCCTCG 1 7 1 0
TAGGGTGTTGACCTTTGCCCTGGTGCTGCCCTGGCGTAGCCATAGCTGAATGCACTGGAGGC ACCTTGGGAATCGAGGTCTCGGGGTTTC 1 8 0 0
CTCCTCTAATGATCTCAAGCATTTCTGAAGGGCTGAGTTAGATTAAAAAGAAAGAAAAAGAGCGATTGTCCACTTTTCTCTCTCTTCTTT 1 8 9 0
TTGTTTGTTTGTTCATGGTACTGGGCTAGAACCCAGGGTCCGGTCCACACCAGGC AGGTGCCCCACTCTTGGGCTCCGCCTTGGCTGGGC 1 9 8 0
CGCCTACTTTCAGAGTAGCAGTCATCTGCCAAGTGTTAACGCCCTGGTGTTAAGGAGTTTCAAAATCAGAAGCTAGAGGCTGGTGCTTAG 2 0 7 0
ACCACTGTTGATTTGTTGAAAAAGAAGTTATCAGAATCCATTTCTGATGC AAAAGAGACTCAGAGTGGGTCCTGC ATGGCGAGCCCAGCA 2 1 6 0
CGAGGCTCCTCCACC AGAAATACCTCACC AGGGATGGTAGGGATGAGTGGTGTGTGGTGGTGGCTGGGGAGCC ACCTGGAAAGGAGAGTT 2 2 5 0
TTCCCTAAAGACCCAGCTCCAGGCCAGCCCCCTGCTGGTAATTAACCTCTGTCACCTTGCACTTCCTGAACCCAAGAATAAAAGTACAGC 2 3 4 0
AGAAAC AGCAGCCATGAAGC AGGAAAGCCTACAAATGCCACACCTTGCCCCTGTGCAGGTGGGGCCGGACCCTGTGAGTGGACTAGGGGA 2 4 3 0
TCTCCTGTTGCTGTGTGTGCTCTGCAGCCATACTTAACCAAATGTCGCGGTCACCCGCAGAGACGACCTGGAGGGGGAGAAATGGAGATG 2 5 2 0
CTGCAGAGGATAATTTGGTAATGAAAAGAATAAATATTTTGTTTAAGGTTAGAAATCACCCATTATTTCCTTTCCACTGTGGATGCCCCT 2 6 1 0
AGGGTTTCTGGAGGAGGAAGCCCACAGGCATCAGTAGCAGTCCTGAGAACACCATTGTTGGCCCACAGGTGACTGGTGACCCTGCGTTGG 2 7 0 0
ATTCAGCCCACGCCCTCTGCATACAAGCCAGGGGAGCGCTGTCACCTTAGGAGATCCCCTCTCAGTGGCTGATGTCAGTGTCCCCTGCTT 2 7 9 0
TTGTGTGTCCCCCCGCCCCGCCCCAGATGTTGACCATAAATGAGTTGCAGGCACAAAAGAAATGGAGGGAAGCCTTGTGGTAGGAGCATG 2 8 8 0
TCCAGGAACAGGCTGTCTGCAGAGGTAAAGGATGGTTGAGGACATGGTGGCTTCTCCTTACCCACCATGCTCTCATGGCTTGCGAGGCAG 2 9 7 0
AATTATGGAAGCATTACTTAATACACGTATTAAAAATCAATATTCTAAACACAAAGGATGAAACTAGGACTATCTGGGGTTACAATAAAA 3 0 6 0
GCTCTTCTCAATTAGATCTTTTAGAGCTGGGTGTAC ATTATGCCATATAAAAACAAGCGAGTTCTTTAACAAC AAC ACTCTAGTAATGAA 3 1 5 0
CATTTTAGCCTACTTTTTATAGCGTGTACATTAAAGTGGACTATAGCAAACAACCACCGTGAGAGCGACTGTGACCAGCGTTCCATTTGC 3 2 4 0
ACTGGAACAGGCGTCATCCAGTGGAGTGAAGTGGTGGATGAGTGGCAACCAGGAAGGCCCTCCACAGCAGAGATCCATCGATGGAAAATC 3 3 3 0
GACCTTTGAACTGCTGTCTGACCTGGTAGCTTTTGGGATGGTGATGTCTGAGAACCAGGGCGCTCTCCCTAGTCTTCCTTGTGGATTCAC 3 4 2 0
ACAGACAGTTGCTGTCCGAGATTAAAGGCTGCCCCCACTTTTGTCCCTTTGCACTTTGAACAGAGGTCATGGCGACACCTGGTCTGATGA 3 5 1 0
GAAGAAAGGTCGAGACAGTGTGGATATACTGTACGGGGTGAGAGTTTATTATATGTGTCTATCAGCCCTCAGCGCTGTGGATATATATAC 3 6 0 0
TGTAGAGCTTATGATATGTGTCAATCAGTCCTCTGAATCTTTTTACTGAAACTGGGATAGAAAAATAAAGATCCAATGGTATTTTG 3 6 8 6
Figure 3.13 Full length mouse Cdsl sequence
Shown is the known full-length sequence of mouse Cdsl. To date no 5!UTR 
sequence has been identified. The start and stop codons are highlighted and 
underlined in red, the derived amino acid sequence is shown in blue and the 
3'UTR excluding polyA+ tail (poly A+ signal highligted and underlined in 
purple) is shown from position 1386bp. The 3'UTR was generated in full from 
mouse sequences homologous to the 3'UTR of rat and human.
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Figure 3.14 Drosophila cds and mouse Cdsl amino acid alignment
The amino acid alignment shows that the sequences are 56% identical at the amino acid level. The highly 
homologous regions highlighted in red correspond to peaks V and VI on the hydrophobicity plots shown in 
figure 3.26, which predict transmembrane regions. Regions of residue identity are boxed and shaded, while 
similar residues are shaded.
The prediction is made using a combination of several weight-matrices for scoring 
(Kyte and Doolittle, 1982; Hofinan and Stoffel, 1993). The plots that were generated to 
compare mouse and Drosophila are shown in figure 3.15 and the plots comparing 
mouse and human Cdsl shown in figure 3.16. The plots predict that the Drosophila, 
mouse and human have seven transmembrane domains.
3.1.6 Summary of section 3.1
In summary, the mouse Cdsl gene is 3686bp in length (excluding the 5' UTR), with a 
derived amino acid length of 461 amino acids and the protein has been predicted to 
form seven transmembrane domains. The gene sequence was generated by the 
identification of clone 801-h9 and 2279-dl9 and by sequencing a PCR fragment 
amplified from mouse cDNA using primers designed to the start codon of rat Cdsl.
The 3' UTR was generated bioinformatically using the BLAST-N algorithm 
(http://www.ncbi.nlm.nih.gov/). The amino acid sequence generated for mouse Cdsl is 
98% identical to rat, 96% identical to human and 56% identical to Drosophila. The 
experiments performed in this section were done in order to gather information about 
the mouse Cdsl gene. This was then used in section 3.3 to generate the genomic 
structure, in section 3.6 to examine the expression patterns of the gene and in section
3.7 in the preparation of a Drosophila rescue construct.
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Figure 3.15 Mouse and Drosophila cdsl hydrophobicity plots
The hydophobicity plots which were generated using TMPRED online software from the amino acid sequences 
of mouse Cdsl and Drosophila cds are shown. The package predicts seven transmembrane domains for both 
mouse Cdsl (A) and Drosophila cds (B). The transmembrane regions are numbered in red I-VII, and 
correspond to the amino acid region numbered along the base axis. Peaks V and VI correspond to regions of 
high sequence identity (see figure 3.16)
II III IV V
TMpred output for hi
VI VII I II III IV V VI VII
TMpred output for mouse Cdsl
0
4500 50 1 0 0 150 200 300 350
0
450 500150 250 300 350 4000 50 1 0 0
Figure 3.16 Mouse and human Cdsl hydrophobicity plots
The hydophobicity plots which were generated using TMPRED online software from the amino acid sequences 
of human CDS1 and mouse Cdsl are shown. The package predicts an almost identical pattern of seven 
transmembrane regions for both human (A) and mouse Cdsl (B). The transmembrane domains are numbered I- 
VII in red.
3.2 Isolation o f  Murine Cds2
3.2.1 Identification of cDNA clone 1500-bl9
To isolate murine Cds2, a similar approach was taken as described in section 3.1 for 
Cdsl. The nucleotide sequence of the previously identified human CDS2 (GenBank 
accession number: AF069532 (Halford et al., 1998)) was used to search the EST 
database to identify murine clones. This search identified one clone (GenBank 
accession number: AA170489,1.M.A.G.E number: 618162) which was obtained from 
HGMP-RC and given the laboratory number 1500-M9. This clone originated from a 
Soares mouse 3NbMS spleen library and was cloned into the Notl and £<%>RI sites of a 
pT7T3D vector. DNA was prepared from the clone (see section 2.3.1.1-2). The insert, 
which was 660bp in length, was released from the vector by restriction digestion using 
enzymes EcoKl and Notl (see section 2.3.1.9). 1500-M9 was initially sequenced with 
vector primers M13F and M13R (see section 2.3.1.18) in order to verify that it was 
correct and then fully sequenced with specific primers (table 3.5).
1500F1 GCCTTGGAAGATGAGTAGA 544
1500R1 ATCTAAGTCACAGCAGCTGG 623
1500F2 GGCCACCTTTGTCAATGTGT 388
1500R2 GTAC C CAGACAT CACAT 57
1500R3 CCACAGTGAAGCTGTTGGTG 109
Table 3.5 Primers used to sequence clone 1500-b 19
The derived amino acid sequence for clone 1500-b 19 was aligned with the known 
human CDS2 amino acid sequence (figure 3.17). The alignment in figure 3.20 shows 
that clone 1500-b 19 represents the 3’ end of murine Cds2 and that the 5’ end is not 
contained within 1500-b 19. The amino acid sequences of the two species differ in 
length by 12 amino acids at the 3' end. Clone 1500-b 19 is 99.4% identical to the 3’ end 
of human CDS2 at the amino acid level.
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hCDS2
1500
MTELRQRVAHEPVAPPEDKESESEAKVDGETASDSESRAESAPLPVSADDTPEVLNRALS
hCDSZ
1500
N L SSRWKNWWVRGILTLAMIAFFFIIIYLGPMVLMIIVMCVQIKC FHEIITIGYNVYHSY
hCDSZ
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DLPWFRTLSWYFLLCVNYFFYGETVTDYFFTLVQREEPLRILSKYHRFISFTLYLIGFCM
hCDS2
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FVLSLVKKHYRLQFYMFGWTHVTL LIVVTQSHLVIHN L FEGMIWFIVPISCVICNDIMAY
hCDS2
1500
MFGFFFGRTPLIKLSPKKTW EGFIGGFFATVVFGLLLSYVMSGYRCFVCPVEYNNDTNSF
GFIGGFFATVVFGLLLSYVMSGYRCFVCPVEYNNDTNSF
hCDS2
1500
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Figure 3.17 Amino acid alignment of 1500-M9 and human CDS2
Shown is the amino acid alignment of clone 1500-bl9 and human CDS2 
sequences. The human sequence differs from 1500-b 19 at the 3’ end, this 
sequence was verified ( see figure 3.24). Residues which are identical are 
boxed and shaded whereas residues which are similar are only shaded. This 
alignment shows that a clone containing the 5' mouse Cds2 gene is required.
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3.2.2 Identification of cDNA clone 1247-c2
To find a clone which contained the 5' end of mouse Cds2, the nucleotide sequence of 
clone 1500-b 19 was used to re-screen the EST database to identify overlapping clones. 
This resulted in the identification of a further clone (GenBank accession number: 
AI427541,1.M.A.G.E number: 521017) which originated from a Stratagene adult 
mouse diaphragm (# 937303) library constructed in the EcoRl and Notl restriction sites 
of a pBluescript SK- vector. The clone was obtained from HGMP-RC and given the 
laboratory number 1247-c2. DNA was prepared from clone 1247-c2, as before, and the 
1.5kb insert was released by restriction digestion with the enzymes EcoRl and Xhol. 
The clone was sequenced initially using vector specific primers M13F and M13R and 
then with sequence specific primers (table 3.6). The 1556bp nucleotide sequence 
generated from clone 1247-c2 with derived amino acid sequence is shown in figure 
3.18. In figure 3.18 the start and stop codons of Cds2 are highlighted and underlined in 
red, and the primer sequences (table 3.6) are highlighted in purple. The sequences 
derived from clone 1247-c2 and 1500-b 19 align with 100% identity at the 3' end.
1500R2 GTAC C CAGACAT CACAT 975
1247F1 GTAACGCAGTCACACCTTGT 744
1500R3 CCACAGTGAAGCTGTTGGTG 1030
1247R1 GCAGAATCCTGTCAGATAC 660
Table 3.6 Primer names which were used to generate the sequence of clone 1247-c2.
Gene Works was used to predict the restriction map of 1247-c2 (figure 3.19) which was 
then verified by restriction digests using the enzymes BamHl, HindiII, Pstl and £coRI 
in single, double and triple digests. The map was prepared in order to identify 
restriction sites which could later be used to generate probes.
153
CGGGCGAGGCACGGTGGGGCTGCGAGGTGCTCGGGCCCGCCGAGAGCCCGTGCTCACTGAGCCGACCCCCGCGGCCACCGTGCTGCTCAC 9 0  
TCGGGGTGACGTCGCGCCGGGGTCCCCAGCAJGACCGAACTACGGCAGAGGGTTGTCCGCGAGGACGCACCTCCGGAGGACAAGGAATCA 1 8 0
M T E L R Q R V V R E D A P P E D K E S
GAGTCCGAAGCAAAGCTAGATGGAGAGACAGCGTCTGACAGCGAGAGCCGAGCGGAAACAGCTCCCCTACCAACCTCCGTAGATGACACC 2 7 0  
E S E A K L D G E T A S D S E S R A E T A P L P T S V D D T
CCAGAGGT CCTT AACAGGGCCCTTT CCAACCT GTCCT CAAGGT GGAAGAACT GGT GGGT GAGAGGCATCCT GACTTT GGCCAT GATCGCG 3 6 0  
P E V L N R A L S N L S S R W K N W W V R G I L T L A M I A
TTTTT CTT CATTAT CATTT ACCT GGGACCAAT GGTTTT GAT GAT GATT GTT AT GT GT GT CCAGATT AAGT GTTT CCAT GAAATAAT CACT 4 5 0  
F F F I I I Y L G P M V L M M I V M C V Q I K C F H E I I T
ATT GGCT ACAAT GT AT ACCACT CCTACGACCT GCCCTGGTT CAGGACCCT CAGCT GGTACTTCCTGCTGTGTGTGAACTACTTCTTCTAT 5 4 0  
I G Y N V Y H S Y D L P W F R T L S W Y F L L C V N Y F F Y
GGGGAGACAGT GACGGACT ACTT CTT CACT CT GGT CCAGAGAGAGGAGCCTTT GCGGAT CCT CAGT AAATACCACCGGTT CAT CT CCTTT 6 3 0  
G E T V T D Y F F T L V Q R E E P L R I L S K Y H R F I S F
GCCCTGTAT CT GACAGGATT CT GCAT GTTT GT ACT GAGT CTAGTT AAGAAGC ATT AT CGGCT GCAGTT CT AC AT GTTT GGCT GGACCCAT 7 2 0  
A L Y L T G F C M F V L S L V K K H Y R L Q F Y M F G W T H
GT GACCTT GCTT ATT GTCGT AACGCAGT CACACCTT GTT ATCCATAACTT GTTT GAAGGAAT GAT AT GGTTT ATT GTT CCCAT CT CGT GC 8 1 0  
V T L L I V V T Q S H L V I H N L F E G M I W F I V P I S C
GT CAT CT GCAAT GACATTATGGCCTATAT GTTTGGCTTTTTCTTTGGTCGGACCCCACT CATTAAGCT CTCT CCAAAGAAGACCTGGGAA 9 0 0  
V I C N D I M A Y M F G F F F G R T P L I K L S P K K T W E
GGCTT CATT GGGGGCTT CTTT GCC ACT GT GGT GTTT GGCCTTTT GCT CT C CT AT GT GAT GT CT GGGT ACAGAT GCTT CGTGTGTCCCGTG 9 9 0  
G F I G G F F A T V V F G L L L S Y V M S G Y R C F V C P V
GAATACAACAATGACACCAACAGCTTCACTGTGGACTGTGAGCCGTCTGACCTATTCCGCCTGCAGGAGTACAACATCCCTGGGGTGATC1080
E Y N N D T N S F T V D C E P S D L F R L Q E Y N I P G V I
CAGTCGGCCATT GGCT GGAAAACGGT GAGGAT GT ACCCTTT CCAGATCCACAGCAT CGCCCT CTCCACCTTCGCCTCGCT CATCGGCCCT 1 1 7 0  
Q S A I G W K T V R M Y P F Q I H S I A L S T F A S L I G P
TTCGGAGGGTTCTTCGCCAGTGGATTCAAACGGGCCTTTAAAATCAAAGATTTTGCCAATACCATTCCCGGTCATGGAGGCATCATGGAT 1 2 6 0  
F G G F F A S G F K R A F K I K D F A N T I P G H G G I M D
CGCTTTGACTGCCAGTACCTGATGGCCACCTTTGTCAATGTGTACATCGCCAGCTTTATCAGGGGTCCAAACCCAAGCAAACTGATCCAG 1 3 5 0  
R F D C Q Y L M A T F V N V Y I A S F I R G P N P S K L I Q
CAGTTT CT GACGTT GCGGCCAGAT CAGCAGCTT CACATCTT CAACACGCTT CAAGT CTCACCTAACTGACAAGGGGATTCGT GACATCTG 1 4 4 0  
Q F L T L R P D Q Q L H I F N T L Q V S P N
CCTTGGAAGATGAGTAGAGTCCACCTGGGGCCCAGAGAGCTGGAGCAGGATGGAGTGGGGGCCAGTCGCCAAGGCCGCCCAGCTGCTGTG 1 5 3 0  
ACTT AGAT AAT GAAAAGCTT CAACT C 1 5 5 6
Figure 3.18 Sequence generated from clone 1247-c2
The figures shows the nucleotide and derived amino acid sequence from clone 
1247-c2 which represents Cds2. The start and stop codons are highlighted and 
underlined in red and the primer sequences of the primers (table 3.6) which 
were used to sequence the clone are shown in purple.
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Figure 3.19 Restriction map of clone 1247
The figure shows a schematic restriction map of the Cds2 cDNA clone 
1247 and a gel photograph of a series of restriction digests. The clone 
was digested using BamHl, Hindlll, EcoRl and Pstl restriction 
enzymes. Some of the reactions have not gone to completion, but these 
bands are easily identified. The schematic map was compiled using the 
gel results then verified by sequencing data.
Key: H- Hindlll, B- BamHl, E- EcoRl, P- Pstl, x4 - Hindlll, BamHl, 
EcoRl and Pstl.
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3.2.3 Cds2 sequence homology between species
In order to examine the amino acid sequence identity between human and mouse Cds2 
an alignment of the sequences were performed (figure 3.20). The human and mouse 
Cds2 sequences show a 96% sequence identity at the amino acid level. In section 3.1 an 
alignment of amino acid sequences from Drosophila eye-cds (GenBank accession 
number: P56076) and mouse Cdsl shared an identity of 56%. The same alignment was 
performed with the Drosophila eye-cds amino acid sequence but this time with the 
amino acid sequence representing Cds2 (figure 3.21). The identity between Drosophila 
eye-cds and mouse Cds2 is 57% at the amino acid level.
In order to predict the number of transmembrane domains each protein has all three, 
human CDS2, mouse Cds2 and Drosophila eye-cds, amino acid sequences were entered 
into the transmembrane-spanning region predictive programme TMPred (see section 3.1 
for programme details). The resultant hydrophobicity plots for mouse Cds2 and 
Drosophila eye-cds are shown in figure 3.22 and the plots for human CDS2 and mouse 
Cds2 are shown in figure 3.23. The plots predict that the Drosophila, mouse and human 
have seven transmembrane domains.
3.2.4 Summary of section 3.2
In summary, the murine Cds2 gene is at least 1556bp in length (with only limited 5' and 
3' UTR having been identified to date), with a derived amino acid length of 432 and 
predicted protein structure containing seven transmembrane domains. The sequence was 
generated using two cDNA clones, 1500-b 19 and 1247-c2. The experiments performed 
in this section were done in order to gather information about the mouse Cds2 gene.
The information generated was then used in section 3.4 to generate the genomic 
structure, in section 3.6 to examine the expression patterns of the gene and in section
3.7 in the preparation of a Drosophila rescue construct.
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Figure 3.20 Amino acid alignment of human and mouse Cds2
An amino acid alignment of mouse Cds2 and human CDS2 
sequences. The boxed and shaded areas indicate identical 
residues whereas similar residues are only shaded. The sequences 
are 96% identical.
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Figure 3.21 Drosophila cds and mouse Cds2 amino acid alignment
Shown is the amino acid alignment of Drosophila cds and mouse Cds2. Residues which are identical are 
boxed and shaded whereas residues which are similar are just shaded. The sequences are 57% identical. 
Two regions of high sequence homology are highlighted in red. These regions correspond to predicted 
transmembrane domains shown in figure 3.26.
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Figure 3.22 Drosophila and mouse Cds2 hydrophobicity plots
Shown above are the hydrophobicity plots that the online software program TMPRED plotted from the amino acid 
sequences of mouse Cds2 and Drosophila cds. The mouse (A) and the Drosophila (B) plots show seven predicted
transmembrane domains numbered I-VII in red.
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Figure 3.23 Human and mouse Cds2 hydrophobicity plots
Indicated above are the hydrophobicity plots that the online software program TMPRED plotted from the amino acid 
sequences of mouse Cds2 and human CDS2. The mouse (A) and the human (B) plots show seven predicted 
transmembrane domains (I-VII), the pattern shown is very similar between the two species.
3.3 Genomic structure o f  murine Cdsl
3.3.1 Identification of a PAC clone representing Cdsl
A genomic clone of mouse Cdsl was required for gene mapping studies (see section 
3.5) and to determine the genomic structure of the gene. In order to identify a genomic 
clone a mouse PI artificial chromosome (PAC) library (HGMP-RC) was screened (see 
section 2.3.1.19.2). The library was screened by hybridising the gridded filters with a 
probe made from the entire 1.3kb insert from the cDNA clone 801-h9, which represents 
Cdsl that had been randomly 32P-radiolabelled (see section 2.3.1.20). The filters were 
hybridised overnight (see sections 2.3.1.21) then washed at a stringency of 0.1X SSC, 
0.1% SDS. The filters were exposed to autoradiography film (Kodak) at -80°C for 72 
hours. Three positive clones were identified, 379-p6, 572-a24 and 620-k8 and obtained 
from HGMP-RC. DNA was prepared from each clone (see section 2.3.1.3-4) and the 
concentration estimated by spectrophotometry. The clones were verified on a Southern 
blot, lOpg of DNA from each PAC clone was digested with EcoRl, electrophoresed 
through an agarose gel (see section 2.3.1.10) and blotted onto Hybond-N (as 2.3.1.11). 
The blot was hybridised with the 1.3kb probe originally used to screen the PAC library 
filters. The autoradiography results (figure 3.24) show that the probe did not hybridise 
to clone 620-k8 and hence 620-k8 was deemed to be a false positive or alternatively the 
wrong clone had been sent from HGMP-RC. As there were two verified positive 
clones, 620-k8 was not pursued further. Clone 572-a24 was used for all further 
analysis.
3.3.2 Identification of Cdsl intron/exon boundaries
Previously a human PAC clone which contained human CDS1 (GenBank accession 
number: AC022739) had been identified by screening the high throughput genome 
sequence (htgs) database at NCBI (http://www.ncbi.nlm.nih.gov/BLAST) (S. Halford, 
personal communication) with the human CDS1 nucleotide sequence. The sequence 
information available from the human PAC clone indicated the positions of the intron 
splice sites of human CDSL However there was no mouse PAC clone containing 
sequence information about murine Cdsl available in the htgs database so the 
information available from the human PAC clone was used. As described in section 3.1 
the amino acid sequences of human and mouse Cdsl are 96% identical. Using an
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Figure 3.24 Southern blot of potential PAC clones
The PAC clones which were identified from the HGMP-RC 
PAC library were digested with enzymes BamWl, EcoRl and 
Hindlll. A Southern blot filter was made from the products. 
The filter was probed with the 801 probe. Shown is the 
autoradiograph eliminating PAC clone 620-k8 as a false 
positive. The two other clones appear to be very similar.
167
alignment of the two amino acid sequences derived from the cDNA sequence of both 
genes, the human intron splice sites were identified and hence used to represent the 
provisional placement of the mouse intron splice sites. In order to verify the position of 
the mouse intron splice sites and deduce the intron sizes, Cdsl specific oligonucleotide 
primers were designed approximately 50bp up- and downstream of the provisional 
splice sites (table 3.7) using mouse Cdsl nucleotide sequence.
3.3.3 Cdsl genomic structure
To deduce the size of the mouse introns and then verify the position of the splice 
boundaries, lOng of PAC clone 572-a24 DNA was used as template in PCR reactions 
(see section 2.3.1.16). The resultant fragments indicated the size of the introns (figure 
3.25). The PCR fragments were cloned into pGEM T-Easy vector (see section 2.3.1.13- 
14). The ends of the cloned intronic fragments were sequenced with M13F and M13R 
vector specific primers (see section 2.3.1.18). Some of the fragments proved difficult to 
clone and were sequenced directly. Some of the fragments proved difficult to clone and 
to sequence, but the intron sizes and the available sequence data confirming the position 
of the intron splice sites derived from the PAC clone are shown table 3.8. The Cdsl 
structural information gathered from PAC clone 572-a24 is shown schematically in 
figure 3.26.
3.3.4 Summary of section 3.3
In summary the murine Cdsl gene has twelve exons and genomically spans 
approximately 3 lkb. The experiments performed in this section generated a PAC clone 
representing murine Cdsl that was used to map the chromosomal location of the gene 
by fluorescent in situ hybridisation (FISH) in section 3.5. The information and 
resources reported in this section were essential, with the view to making a construct for 
the production of a knockout mouse.
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CDSlintronlF GACCACGAAACCGAGAGCAC 36
CDSlintronlR TGGCATCGAGATCTCTCCATAC 106
CDSlintron2F GTATGGAGATCTCGATGCCA 86
CDSlintron2R TCAGGAAGAAGAGGGAGATC 256
CDSlintron3F GATCTCCCTCTTCTTCCTGA 236
CDSlintron3R TAAACCATGGGAGGTCGTAG 376
CDSlintron4F ATATCCTTCGCCCTCTACCTGG 505
CDSlintron4R TGCTTCTTCACCAGGCTCAG 566
CDSlintron5F CTGAGCCTGGTGAAGAAGCA 547
CDSlintron5R GGATGACAAGATGTGACTGA 646
CDSlintron6F T CAGT CACAT C TTGT CAT C C 627
CDSlintron6R GATGTCATTGCAGATGACGC 711
CDSlintron7F GCGTCATCTGCAATGACATC 692
CDSlintron7R CACCAATGAATCCTTCCCAA 796
CDSlintron8F TTGGGAAGGATTCATTGGTG 777
CDSlintron8R TC CAC CGGGCACACAAAGTA 875
CDSlintron9F TACTTTGTGTGCCCGTGGA 856
CDSlintron9R CGCGAACGTTGAAAGGGCAA 1038
CDSlintronlOF TTGCCCTTTCAACGTTCGCG 1019
CDSlintronlOR AACCTGTCCATTATCCCGCC 1148
CDSlintronllF GGCGGGATAATGGACAGGTT 1128
CDSlintronllR AAGCACTAACAGCTGCTGG 1218
Table 3.7 Primers used to amplify Cdsl introns
The table lists the name, sequence and position of the primer in relation to the sequence 
generated from clone 2279-dl9 homologous to human CDSl. The primer pairs were 
used to amplify the introns of Cdsl using PAC clone 572-a24.
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Figure 3.25 Photograph of Cdsl introns
Shown are the PCR fragments representing the Cdsl intron sizes. 
The fragment for 6 (1.6kb) is missing from this photograph.
Lane 1-10 represent introns, 1 (4kb), 2 (2kb), 3 (5kb), 4 (3.9kb),
5 (1.8kb), 7 (2.5kb), 8 (2kb), 9 (1.3kb), 10 (2kb), 11 (3.8kb) 
respectively.
16S
B a a l
1 AG ACAGCAAAccggcgatggtagcggaaga.. i ... xxxxxxxxxxxAAACAGATAT 4
2 126 TATCTTCAAGxxxxxxxxxxxxxx.... 2 . . .  .xxxxxxxxxxxxxATGGAAGAAC 2
3 97 GATGCTTCTGaaacgccaagctatttaggt.... 3 ... .xxxxxxxxxxxxxGTTCTGGGCA 5
4 238 TACCTGGCAGxxxxxxxxxxxxxx... 4 .. .xxxxxxxxxxGTTTCTGCAT 3.9
5 59 GTTCTATATGxxxxxxxxxxxxxxx... 5 .. .tgttgttgggctattaacagTTCGCATGGA 1.8
6 83 GCATGATATGgtaagggactatgctgtgtt... 6 ... tccctgctaat gttttaaa gGTT CCTT GTT 1.6
7 88 TCTAATTAAacactacaggctgcagcattg... 7 .. .caagaactcctctaattaagCTGTCTCCTA 2.5
8 70 GGATTCATTGtgagttttagtaggatttta... 8 .. .agtcatatttggattcattgCTGCCTATGT 2
9 164 ACTGTG AGCT aagacaaaggacccgacaa... 9 .. .ccactgcctccctgtcacacTGTACCCCT 1.3
10 108 CAAAATCAAGgtgtgttgtgacattcttct... 10 .. .cactttgtctgtttctgcagGATTTTGCAA 2
11 104 GCTTCATCAGgggcccgaatcccagcaaag... 11 .. .xxxxxxxxxxxxxxxxGGGTCCGAAT 3.88
12 128 TTGAAGGTGTAG 3 ’UTR... 12
Table 3.8 Cdsl Splice junction information
The table lists the sizes of the exons and the introns of mouse Cdsl to date. The table also list some of the sequence generated around 
the exon splice sites. The information was gathered using PCR and sequencing. The primers used to generate this data are listed in 
table 3.7.
Pstl Pstl H indlll 
H indlll
2 3 5 6 7 8 I 9 I 1 0 !  11 12
4kb 2kb . 5kb 3.9kb 1.8kb 1.6 2.5kb 2kb 1.3 2kb 3.88kb
BamHl Pstl Bam H l Pstl
Figure 3.26 Schematic representation of the known Cdsl genomic restriction map
Shown is a schematic illustration of mouse Cdsl restriction map to date. This was generated by a combination of 
restriction digests and sequencing. The intron sizes are shown in red.
3.4 Genomic structure o f  murine Cds2
3.4.1 Identification of a genomic phage clone
To determine the genomic structure and chromosomal location (see section 3.5) of Cds2 
a genomic clone containing the gene was required. A phage library (Stratagene) 
constructed in the XFIX®II vector using 8  week male spleens from mouse strain 129/SvJ 
was screened (see section 2.3.1.19.1). The library filters were hybridised (see section 
2.3.1.21) with the entire insert from the cDNA clone 1500-M9, which had been 
randomly P-radiolabelled (see section 2.3.1.20). This resulted in the identification of 
four primary positives. A further round of screening resulted in only two positives. The 
two positive clones were given the laboratory numbers 1A and 2 0 A and were digested 
with the restriction enzyme Notl (see section 2.3.1.9) and the inserts cloned into 
pBluescriptSK+ plasmid vectors for easier manipulation (see section 2.3.1.13-14). 
Restriction digest analysis indicated that 20A was lkb longer than 1A and was used for 
further analysis.
3.4.2 Phage clone 20A
The insert from clone 20A is 18kb in length. A restriction map of 20A was generated 
with the restriction enzymes BamHl, EcoRl and Hindlll in a combination of single, 
double and triple digests (figure 3.27). The clone appears to cut most efficiently with 
enzyme Hindlll, so a double digest with Hindlll and Notl was performed to determine 
which fragment contained the vector. As seen in figure 3.27 (lane 6 ), when 20A in 
pBluescript SK+ is digested with only Hindlll six fragments are produced, 9kb, 6 kb, 
4.5kb, 300bp, 250bp and 200bp but when the clone 20A is digested with Hindlll and 
Notl, seven fragments are produced, 9kb, 6 kb, 3kb (vector), 1.5kb and the same three 
small fragments. This data positioned the 1.5kb Notl/Hindlll fragment at the 5’ end of 
the clone by using the vetor Notl site as an anchor point. Since the Notl/Hindlll 
fragments were digesting most efficiently the six insert fragments were subcloned into 
pBluescriptSK+ vectors for further analyis. The cloned fragments generated from 20A 
were sequenced initially using vector primers M13F and M13R, the small fragments did 
not sequence well and no sequence information was obtained. Using the sequencing 
data derived from the larger fragments, two of the fragments contained sequence 
identical to that derived from cDNA clone 1247-c2 and one fragment (9kb) did not 
produce any sequence recognisable as Cds2.
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Figure 3.27 Photograph of restriction fragments generated from 20A
The clone 20A was restriction digested with various enzymes. The reactions 
are contained within the following lanes. Lane 1, EcoRl gives three bands of 
~20kb, 2kb and 800bp. Lane 2, EcoRVBamHl double digest gives eight 
bands ranging from 5kb to 200bp. Lane 3, BamHl gives seven bands ranging 
from 5kb to 200bp. Lane 4, £coRI digest. Lane5, EcoRUHindlW digest gives 
seven bands ranging from 6 kb to 200bp. Lane 6 , Hindlll digest giving six 
bands from 9kb to 200bp (small bands are barely visible in photo but were 
clearly visible on the gel) these fragments were subcloned for further 
analysis. Lane 7, Hindlll digest. Lane 8 , Hindlll!BamHl digest giving seven 
bands ranging from 3.2kb to 200bp. Lane 9, BamHl digest. Lane 10, triple 
digest of all enzymes. This gel was used in forming the restriction map of 
20A which can be seen in figure 3.28.
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Sequence data derived from the 5’end of the 1.5kb Notl/Hindlll fragment had ~150bp 
of unknown sequence before sequence from 510bp into clone 1247-c2 sequence was 
recognised, thus 20A was deemed not to contain all of Cds2. The first 90bp of the 
sequence derived from the 3’end of the 1.5kb fragment was not recognised then the 
sequence aligned with sequence from ~800bp into the cDNA clone 1247-c2. The 
sequence data from the 5’end of the 6 kb HindUL subcloned fragment was not recognised 
as aligning with the Cds2 cDNA sequence, but the sequence data from the 3’ end of the 
fragment aligned with the 3’ end of cDNA clone 1247-c2. With no information 
available from the small fragments, provisional data suggested that all the Cds2 
genomic information was contained within the 1.5kb and 6 kb fragments which were 
provisionally positioned adjacently at the 5 ’ end of the restriction map of 20A. The 
positions of the 1.5kb and 6 kb fragments were subsequently verified by fully 
sequencing intron 6 . No Hindlll sites were found within the intron that would indicate 
the presence of any of the small Hindlll fragments between the 1.5kb and 6 kb 
fragments. Initially the 9kb fragment was positioned at the 3’ end of clone 20A with the 
three small fragments positioned centrally after the 6 kb fragment. The EcoRl fragments 
were positioned onto the map of 20A in a similar way. Since there are only three EcoRl 
fragment sized, 18kb, 2kb and 800bp (figure 3.27 lanel), the large 18kb fragment is the 
only fragment that could contain the 3kb vector fragment. The first iscoRI site was 
positioned on the map 15kb from the 5’ end of the clone using the vector EcoRl as an 
anchor point. The positions of the other two EcoRl fragments were determined later.
To determine the position of the small Hindlll fragments in the map of 20 A, Southern 
blot panels (see section 2.3.1.11) were prepared from 20A DNA restriction digested 
with enzymes BamHl, EcoRl and Hindlll. These panels were hybridised with probes
‘j'j
made from the cloned inserts of the small HindlU fragments randomly P- 
radiolabelled. The results (figure 3.28) show that the 300bp and 250bp Hindlll 
fragments both hybridise to the 15kb EcoRl fragment which are positioned adjacent to 
the 6 kb fragment. The 200bp fragment probe appears to hybridise to the 2kb EcoRl 
fragment although it does not appear to hybridise to itself. This may indicate that the 
probe does not truly represent the 200bp Hindlll fragment as first thought, and the 
position of the fragment, which has been positioned at the very 3' end of clone 20A, 
remains tentative. The result using the 200bp probe positions the two remaining
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1 Kb H H/EE E/B B H/B H 1 Kb
Figure 3.28 Autoradiographs determining the position of the small Hindlll fragments in 20A
Shown is the 20A digest gel (A), which was Southern blotted to provide the filter for hybridisation. The filter was probed with 
each of the small Hindlll fragments from 20A in order to position then onto a restriction map of the 20A clone. (B) 300bp 
fragment that hybridises to the 18kb EcoRl fragment, 5kb BamHl fragment and a 300bp Hindlll fragment. (C) 250bp fragment 
that hybridises as the 300bp fragment except to the 250bp Hindlll fragment. (D) A new blot had to be prepared for the final 
fragment, 200bp fragment which hybridises to the 2kb EcoRl fragment and the 2.8 and 3.2kb BamHl fragments although there 
is no self hybridisation (hence the results are still tentative). It is apparent that the 200bp fragment is hybridising to a
completely different set of fragments than the previous probes. The deduced map is shown in figure 3.29.
EcoRl fragments. The order is 800bp fragment followed by the 2kb fragment at the 31 
end. The results from this section conclude that Cds2 genomic information is contained 
within the 1.5kb and 6 kb Hindlll fragments at the 5' end of clone 20A.
3.4.3 Identification of a PAC clone representing Cds2
In a similar way as was described in section 3.3, a human PAC clone had been
identified (GenBank accession number: ACO16073) and the intron/exon boundaries 
determined for human CDS2 (S. Halford, personal communication). Using the 
information about the human boundary sites the provisional mouse intron boundary 
sites were positioned on the cDNA sequence. Sequence specific primers were designed 
approximately 50bp up- and downstream (table 3.9) using the provisional intron 
boundary sites. The primers listed in table 3.9 were used in PCR reactions (see section 
2.3.1.16) to amplify the available introns using clone 20A derived DNA as template. 
This provisional intron splice site information was used to deduce that the 1.5kb 
Notl/Hindlll cloned fragment contained 150bp of the 3’ end of intron 3 to the first 90bp 
of intron 7. The information gathered from these PCR reactions found that the 6 kb 
HindYR fragment contains the remainder of intron 7 to the start of the 3’ UTR of Cds2 
(figure 3.29). Sequencing of 20A using primers in table 3.9 verified the position of the 
intron splice sites, and the information obtained was used to compile part of table 3.10. 
Table 3.10 shows a large number of non-canonical splice sites. This may be due to the 
fragments which were analysed being generated via PCR. PCR errors leading to 
changes in the sequence of the boundaries may have produced this feature. These sites 
should therefore be verified using cloned DNA or various PCR products amplified on 
different occasions and both strands sequenced. Using the restriction information the 
remaining sites were positioned on the 5’ end of 20A containing the genomic structural 
information of Cds2. This information confirmed that a more 5’ genomic clone was 
required to deduce the remainder of the Cds2 genomic structure.
To obtain a genomic clone containing the 5’ end of Cds2 a gridded PAC library 
(HGMP-RC) was screened (see section 2.3.1.19.2). The filters were hybridised 
overnight with a probe generated from the entire insert from the 1.5kb Notl/Hindlll 
fragment, which was subcloned from 20A. This identified two positive clones, 439-n24 
and 542-j8, which were obtained from HGMP-RC. DNA was prepared from both 
clones (see section 2.3.1.3-4) and the concentration determined by spectrophotometry.
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lOpg of each DNA was digested using the restriction enzyme EcoRl and a Southern 
blot was prepared. The Southern blot filter was probed overnight with the same 1.5kb 
fragment as used to screen the PAC library. The results showed that both clones were 
true positives and 439-n24 was used in further studies.
CDS2 INTRONIF CAGCATGAC CGAAC TACG 122
CDS2 INTRON1R TGTTTCCGCTCGGCTCTC 246
MEX2F GAATCAGAGTCCGAAGCAAA 180
MEX2R T CAT CAAAAC CAT TGGT C C C 409
CDS2 INTRON2F CTTTGGCCATGATCGCGTT 349
CDS2 INTRON2R CAGGTCGTAGGAGTGGTAT 489
CDS2 INTRON3F CAGATTAAGTGTTTCCATG 426
CDS2 INTRON3R GACCAGAGTGAAGAAGTAG 582
CDS2 INTRON5F GTCCAGAGACAGGAGCCT 579
CDS2 INTRON5R CATGTAGAACTGCAGCC 711
CDS2 INTRON6F GATTCTGCATGTTTGTAC 653
CDS2 INTRON6R GATTCTGCATGTTTGTAC 787
1500F3 GTAACGCAGTCACACCTTGT 744
MEX4R CGTCTAGTCGCTGCTCTACC 825
CDS2 INTRON7F CAAAGAAGACCTGGGAAGGC 889
1500R3 CCACAGTGAAGCTGTTGGTG 1030
MEX8F ACCAACAGCTTCACTGTGGAC 1013
MEX9R ATGAGCGACCGCAAGGTGGA 1168
MEX9F TCCACCTTCGCCTCGCTCAT 1149
MEX10R CTGGCGATGTACACATTGAC 1319
1500F2 GGCCACCTTTGTCAATGTGT 1289
1500R1 ATCTAAGTCACAGCAGCTGG 1544
Table 3.9 Primers used to amplify Cds2 introns
Listed are the primer name, sequences and the start site for the primers used to amplify 
the Cds2 introns. The primers were designed to the nucleotide sequence of 1247-c2.
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Figure 3.29 Restriction map of 20A
Shown is the basic restriction map of clone 20A. The blots shown in figure 3.32 positioned the 250bp and 300bp 
Hindlll fragments adjacent to the 6 kb HindiII fragment. The blots were inconclusive for the third small Hindlll 
fragment. Shown on the map in red are two possible positions of the 200bp HindiII fragment. The position of the 
EcoRl fragments were identified using the vector sites (shown in blue) as anchor points. The blot in figure 3.32 probed 
with the 200bp Hindlll fragment implies the position of the 2kb and 800bp EcoRl sites and the positions are shown 
above. The size of the fragments are indicated on the map.
1 1 7 6 GGAGGACAAGxxxxxxxxxxxxxxxx... i .. .xxxxxxxxxxxxxxGAATCAGAGT X
2 a 1 3 9 CAAGGTGGAAaacctggcttagacacccca... 2 a . gccctttccaacctgtcctcGAACTGGTGG
/v
1 1 0 0
2 b 9 5 GATGATGATTtttcttcattatcatttaccc... 2 b .. .gatgcctctgtttttttcagGTTATGTGTG 1 2 0 0
3 9 8 CCCTCAGCTGxxxxxxxxxxxxxxxxx... 3 .. .atggtcttcactgtttccagGTACTTCCTG 1 8 0 0
4 1 4 0 TATCTGACAGgcaggtatcacgtgtctctc... 4 .. .tttattctctctccaactagGATTCTGCAT 2 2 5
5 5 9 GTTCTACATGgtaagaggagcgtgcacgtg... 5 .. .tcatttccgtctacatgcagTTTGGCTGGA 7 5 0
6 83 GAATGATATGgtaagtgtgacagaagtttt... 6 .. .actccttttggggtctccagGTTTATTGTT 1400
7 88 ACTCATTAAGgtaagtggatcaccctggcg... 7 .. .attgtgttctccatctgcagCTCTCTCCAA 620
8 69 TGGCCTTTTGgtaggtggtagctcccatct... 8 . . .tctgctcttcgtccttagCTCTCCTATG 820
9 153 CATTGGCTGGgtgcgtaccctttacatgag.. . 9 .. .xxxxxxxxxxxxxxxAAAACGGTGA 1470
10 120 TAAAATCAAAgtatgggaactctgccccac.. . 10 . . .tctttcttttcctctaacagGATTTTGCCA 400
11 104 GCTTTATCAGattatgtgccgaactatctc... 11 .. .gtgccttatgttctgttgtagGGTCCAAAC 200
12 137 CACCTAACTGA 3’ UTR
Table 3.10 Known Cds2 splice junction information
The table lists the sizes of the exons and the introns of mouse Cds2 to date. The table also list some of the sequence generated 
around the exon splice sites. The information was obtained using PCR and sequencing. The primers used to generate this data 
are listed in table 3.9.
The remaining introns that could not be amplified from 20A were amplified using the 
primers listed in table 3.9 and 439-n24 as template. During the course of amplifying the 
remaining introns it was found that exon 2  had a lkb insert in the centre, so the 
nomenclature of exon 2a and 2b was adopted. The size of the PCR fragments generated 
in these reactions determined the size of the introns in Cds2 (figure3.30). However the 
primer pair designed to amplify intronl failed to amplify even after repeated attempts 
using varying condition within the PCR reaction. To identify if PAC clone 439-n24 
contained exonl, a Southern blot was prepared from 439-n24 PAC DNA restriction 
digested with a combination of single and double enzymes including BamYil, EcoBl and 
HindiII (figure 3.31c). Two probes were generated from clone 1247-c2 (see section 
3.2), these probes were generated in order to determine if exon 1 is contained in 439- 
n24 and to possibly deduce the size of intron 1. The first probe generated from 1247-c2 
was prepared by restriction digest, using the enzymes EcoBl (artifical vector site) and 
BspEl (position 170bp, just 5’ of exon 1/exon 2a boundary). This probe represented 
exon 1 (figure 3.31a). The second probe was generated by PCR, in this reaction exon 
2a and 2b cDNA was amplified using primers Mex2F and Mex2R (table 3.9) (figure 
3.3 le). The results when the Southern blot was probed with exon 1 (figure 3.31b) 
showed that the probe hybridised to a 5kb EcoRl, EcoRUBamHl, EcdRUHindRl and 
triple digest fragments as well as an 8 kb HindllI and HindYWBamHl fragment. The 
filter was stripped before probing with the exon 2a/2b probe (figure 3.3Id). This probe 
hybridises to a 17kb EcoRl, a 12kb Hindlll, HindllVEcoRI and a 7kb EcoJU/BamHl, 
BamHl and triple digest bands. These results indicated that clone 439-n24 contains 
both exon 1 and exon 2 a/2 b but they are not sufficiently close to be amplified using 
standard PCR and the results do not allow the intron size to be determined.
In an attempt to determine the size of intron 1 and thereby complete the structural 
information, the human PAC clone (GenBank accession number: AC01673), which was 
used to identify the intron splice sites was re-examined. The sizes of the human CDS2 
introns are comparable to those identified for the mouse. Human CDS2 intron 1 is 43kb 
in length which is beyond the range of standard PCR amplification. The size of the 
mouse Cds2 intron 1 is yet to be determined.
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Figure 3.30 Schematic representation of the genomic structure of mouse Cds2
Shown is a schematic representation of the mouse Cds2 genomic structure. The exons are shown in red and the exon and 
intron sizes are shown in blue. The sizes of the introns were determined by PCR using either clone 20 A or PAC clone 439- 
n24 as template. The area of the gene contained within the 1.5 and 6 kb HindlW fragments generated from clone 20A is 
indicated The primers used to amplify the introns are listed in table 3.9. Full listings of the the sizes of the introns and
exons are given in table 3.10. __________________________________________________________________________
(A) (B) i 2 3 4 5  6 7  (C) 1 2 3 4 5 6  7 (D)l 23  4 5 6  7 (E)
Figure 3.31 Southern blot confirming the presence of exon 1 in PAC clone 439-n24
The five panels represent (A) the 170bp exonl probe generated by restriction digest using enzymes EcoRl and BspVl 
on clone 1247. (B) The autoradiograph of the bands to which the exonl probe hybridised, 5kb EcoRl, EcoRV BamWl, 
EcoRVHind III and the triple digest as well as the 8 kb Hind III and Hind Ul/BamWl band. (C) The 439-n24 PAC 
ethidium stained digest gel. The enzymes used were, EcoRl (1), EcoRV BamWl (2), BamWl (3), Hind III/BamWl (4), 
Hind III (5), Hind UVEcoRX (6 ) and Hind 11V BamWVEcoRl (7). The lanes were smeary due to possible bacterial 
contamination. (D) The autoradiograph of the bands to which the exon 2a/2b probe hybridised, a 17kb EcoRl, 12kb 
Hind III, Hind WV EcoRl and 7kb EcoRVBamHl, BamWl and Hind III! BamWV EcoRl fragments. (E) The gel photo of 
the 224bp probe representing Cds2 exon 2a/2b which was generated by PCR using primers Mex2F and Mex2R and 
clone 1247-c2 as template. This showed that although both exons are contained within 439-n24 PAC clone they are too 
distant to be amplified by PCR.
3.4.4 Summary of section 3.4.1-3.4.3
In summary the murine Cds2 gene has thirteen exons and genomically spans 
approximately 1 lkb excluding intron 1. The experiments performed in this section 
generated a phage clone and a PAC clone representing murine Cds2. The PAC clone 
was subsequently used to map the chromosomal location of the gene by fluorescent in 
situ hybridisation (FISH) in section 3.5. The information gathered about clone 20A was 
used in section 3.8 for the generation of a construct for the production of a knockout 
mouse.
3.4.5 A comparison of the gene structures of Cdsl and Cds2
In sections 3.1 through to section 3.4 the isolation and characterisation of the murine
CDP-diacylglycerol synthase genes were reported. The isolation of the murine genes 
came about through database screening using CDS nucleotide sequences from other 
species. The first cds gene sequence to be used in this manner was the Drosophila cds 
sequences for the identification of the human CDS genes (Halford et al., 1998). The 
human sequences were then used to isolate the murine sequences. Since this project has 
commenced, several other types of CDS genes have become available through the EST 
database. The sequences include; rat Cdsl (NP_112521) and Cds2 (NP446095), human 
Cdsl (XP003308) and Cds2 (CAB89852), Drosophila cds (AAF50483), C.elegans cds 
(NP_501297), S. cerevisae cds (NP009585) and S. pombe cds (CAB99396). Figure 
3.32 shows a ClustralX alignment of the derived amino acid sequences of these genes 
and it can be seen clearly that certain regions of these different genes share very high 
levels of homology. Using the amino acids sequences shown in the alignments, a 
phylogenetic tree was generated by the neighbour joining method (Saitou., et al., 1986) 
(figure 3.33). The figure shows an evolutionary pattern that is expected with the tree 
rooted using the E.coli sequence.
An interesting point is that the Cds2 amino acid sequence shows marginally more 
identity to Drosophila cds (57%) than does mouse Cdsl (56%). This has previously 
also been reported to be the case for human CDS2 (Volta, et al., 1999). Although the 
expression patterns reported in section 3.6.3 and also by Volta et al. (1999) (discussed 
in section 4.3), suggests that Cdsl is more likely to function in a role similar to 
Drosophila eye-cds than Cds2.
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Figure 3.32 Cds alignment
Shown is the alignment o f mouse Cdsl amino acid sequence with cds sequences from S. pombe, S. Cerevisae, C. elegans, Drosophila, rat 
Cdsl, rat Cds2, mouse Cds2, human CDS1 and human CDS2. The red dots indicate residues identical to the mouse Cdsl sequence, blue 
dashes represent gaps made in the sequences to ensure the best alignment, and residues which are not identical to mouse Cdsl are 
represented by the appropriate letter. The alignment was produced using software ClustalW. As can be seen the sequences are highly 
homologous not only between the different species but also between the two genes.
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Figure 3.33 Phylogenetic tree
Shown above is the phylogenetic tree derived from the amino acid sequences of, rat cdsl and Cds2, mouse Cdsl and Cds2, human 
CDS1 and CDS2, and Drosophila, C. elegans, S. cerevisae, S.pombe and E. coli cds. The tree is rooted using E. coli. The bootstrap 
values are shown and the distance of the lines corresponds to the number of substitutes in the sequences of each species relative to 
each other. The tree produces the expected pattern of evolution
When the genomic structure of both mouse Cds genes are compared (figure 3.34) it is 
apparent that the exonic sizes of the genes are comparable whereas the intronic sizes 
vary greatly. It will be interesting to compare the gene structure again when intron 1 of 
Cds2 has been identified and to analyse the sequences derived from the introns of both 
genes in an attempt to isolate regions which may represent promoters or enhancers of 
the genes. Even when all this data has been collected the true function role of the 
murine genes will only be elucidated by the generation of knockout mouse models for 
each gene. The preparation of a knockout construct for Cds2 is described in section 3.8.
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Cdsl Introns (kb) 
Cdsl Exons (bp) ? 126 97 238
3.9 1.8 1.6
59 83 8
2.5 2 1.3 2 3.88
70 164 108 104 128
Cds2 Introns (kb) ? 1.1 1.2 1.8 0.25 0.75 1.4 0.6 0.8 1.47 0.4 0.2
Cds2 Exons (bp) 176 139 95 98 140 59 83 88 69 153 120 104 137
Figure 3.34 Comparison of genomic structure of Cdsl and Cds2
Shown above are schematic representations o f the Cdsl and Cds2 genes. They are drawn to the same scale, and it can be seen that 
Cds2 is just slightly more than half the genomic size o f Cdsl (excluding intron 1). A proper comparison can only be made when intron 
1 has been sized and the full lengths o f the 5’ and 3’ UTRs of each gene determined.
3.5 Chromosomal Localisation o f  Cdsl and Cds2
3.5.1 Bioinformatic mapping of Cdsl and Cds2
The provisional mapping of mouse genes which have previously mapped human 
homologues, can be performed bioinformatically at the NCBI web site (see chapter 3.1 
for web address). NCBI has a web page called the Human-mouse homology map, 
which compiles syntenic regions between human and mouse chromosomes. The maps 
are constructed by integrating homologues collected by the mouse genome database 
(Jackson Laboratory) with putative homologues identified by sequence homology. The 
sequence-based pairs are identified by a megaBLAST using non-EST mRNAs. Two 
megaBLAST analyses are performed, one in which human mRNA is the query and one 
in which the mouse mRNA is the query. Only pairs exhibiting reciprocal best 
megaBLAST scores are included in the analysis. Pairs for which identifying a 
reciprocal best hit is not ambiguous, or pairs identified in the megaBLAST that are not 
conflicting with the collected mouse homology information are reviewed. Human- 
mouse homologue pairs that meet the following criteria are used to calculate conserved 
synteny bins, (i) unambiguous location of the human mRNA on the human genome 
assembly, (ii) mouse homologues that are on the mouse genome database genetic map.
Conserved synteny bins are established using human sequence as the master, and 
looking for breaks in the mouse map. A conserved segment must include at least two 
loci from the same region of the mouse genome. Once the conserved synteny bins are 
established, cytogenetically mapped loci are integrated where possible. Pairs for which 
a human position can be determined, but for which there is no known mapping data are 
virtually mapped based on the homology bins. All these mapping assignments should 
be considered highly speculative in the absence of experimental data.
3.5.2 Previously mapped CDS genes
Both human CDS genes have been mapped using GeneBridge4 radiation hybrid 
mapping panel and fluorescence in situ hybridisation (FISH) to chromosomes 4q21 
(CDS1) and to 20pl3 {CDS2) (Halford et al., 1998; Volta et al., 1999). Volta et al. 
(1999) also described the mapping of mouse Cds2 to mouse chromosome 2. On 
examination of the syntenic maps, human chromosome 2 0  shares exclusive homology 
to mouse chromosome 2 (figure 3.35a). Human chromosome 4q21 shares homology
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Cytogen Position Human symbol Mouse Chr Mouse symbol cM Position
4q21 PRDM8 5 4930565F05Rik
4q21 FGF5 5 Fgf5 55
4q 13.1 -q21.1 PRKG2 5 Prkg2 53
4ql3-q21 HNRPDL 5 Hnrpdl
4 KIAA0905 5 1810024J 13 Rik
4q21.21 -q21.23MRPS18-1 5 1110037D14Rik
4 KIAA0993 5 2610509D04Rik
4q22.1-q23 MAPK10 5 MapklO
4q21.3 PTPN13 5 Ptpnl3 56
4q21 MLLT2 5 Mllt2h 56
4q21.3 DSPP 5 Dspp 56
4q21 DMP1 5 Dmpl 56
4q21-q25 IBSP 5 Ibsp 56
4q21-q25 SPP1 5 Sppl 56
4q21-q23 PKD2 5 Pkd2 55
4q22 ABCG2 Abcg2 28.5
4q21 HERC3 5730409F18Rik
4q21 SNCA Snca 29
4q21.3 HPSE * Hpa
4q21 IGJ * igj
4q21 AM BN*
5 1 Ambn 464q21 SCYB10 * 5
4q21-q25 ADH5 3 1I Adh54 KIAA0094 3 11 1700029C17Rik
4q21-q25 EIF4E 25
4q21-q24 PPP3CA 3 ■ Ppp3ca
Figure 3.35a Schematic representation of human and mouse chromosome 
synteny
Shown is a portion of the human chromosome 4q21 map displayed on the NCBI 
web site synteny with regions from mouse chromosomes. As can be seen human 
chromosome 4q21 has syntenic regions on mouse chromosomes 5, 6 , 3, and 12. 
Some of the known gene positions are shown on this map with their distance in 
centimorgans (cM).
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Cytogenic pos Human symbol Mouse Chr Mouse symbol cM position
20pl3 SOX22 
20p 12.2-20pl 3XAP4 
20pl3 CSNK2A1 
20pl3 TCF15 2
Sox 12
Ubce7ip3-pending
Csnk2al
Tcfl5 83.9
2 0 MGC4675 2 1700008JlORik
20pl3 FKBP1A 2 Fkbpla
2 0 pter-pl2 PDYN 2 Pdyn 73.3
2 0 q 1 1 . 2 TGM3 2 Tgm3
20pl3 SNRPB 2 Snrpb 73
2 0 NOP56 2 2310044F10Rik
20pl2.3-pl3 CPX-1 2 CPX-1
20pl3 OXT 2 Oxt 73.5
20pl3 AVP 2 Avp 73.2
2 0 MGC2592 2 2600009E05Rik
2 Op ITPA 2 Itpa 73.6
20pl3 ATRN 2 Atm 73.9
20pl3 SN 2 Sn 73.9
20pl3 CENPB 2 Cenpb 73.9
20pl3 CDC25B 2 Cdc25b 73.9
2 0 FLJ11729 2 4933409119Rik
20pl3 ADRA1D 2 Adrald 74.9
2 0 pter-pl2 PCNA 2 Pena 75
20pl3 PTPNS1 * 2 Ptpnsl 73.1
20pl3 PTPRA * 2 Ptpra 73.5
20pl3 ANGPT4 * 2 Agpt4 84
2 0 KIAA1434 2 2310032D16Rik
20ql3 VAPB * Vapb
Figure 3.35b Schematic representation of human and mouse chromosome 
synteny
Shown is a portion of the human chromosome 20pl3 map displayed on the 
NCBI web site synteny with regions from mouse chromosomes. As can be seen 
human chromosome 20pl3 has syntenic regions only on mouse chromosomes 2 . 
Some of the known gene positions are shown on this map with their distance in 
centimorgans (cM).
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with a variety of mouse chromosomes, predominately regions of mouse chromosome 5 
but also regions from chromosomes 3, 6  and 12 (figure 3.35b).
3.5.3 Fluorescence in situ Hybridisation (FISH) mapping of Cdsl and Cds2
The identification of the chromosomal locations of both mouse Cds genes were carried
out using FISH mapping. The FISH mapping was performed in the MRC Cytogentic 
unit at Harwell by Ruby Baneijee (see section 2.3.3.2).
The mouse PAC clones (see chapters 3.3 and 3.4 for PAC information) were used as 
probes to identify the genes. PAC clone 572-a24, representing Cdsl, was labelled by 
Nick translation with biotin-16dUTP and used to probe a metaphase spread of mouse 
chromosomes, hybridisation was detected with Avidin Texas Red fluorescence (figure 
3.36). The mouse Cdsl gene was localised to the mouse chromosome 5 band E3. 
Figure 3.37 illustrates the position of the gene on four individual metaphase spreads, all 
pairs show hybridisation to 5 E3, this is then represented on a schematic diagram of 
mouse chromosome 5.
Mouse Cds2 was mapped in the same way using PAC clone 439-n24 labelled by nick 
translation with biotin 16dUTP and detected with avidin FITC fluorescence. This 
experiment was performed to verify the results reported in Volta et al. (1999). Cds2 
was assigned to mouse chromosome 2 band Gl. Figure 3.38 illustrates the metaphase 
spread with the gene location highlighted by green fluorescence. Figure 3.39 shows the 
position of the gene on a schematic diagram of mouse chromosome 2 Gl.
3.5.4 Summary of section 3.5
The results from this section show the mapping of mouse Cdsl to chromosome 5 E3 
and mouse Cds2 to chromosome 2 Gl. These chromosomal results were predicted 
bioinformatically and Cds2 mapping confirms results by Volta et al. (1999). The FISH 
mapping in this section confirms a previous result and positioned the genes to a more 
precise location on the mouse chromosomes.
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Figure 3.36 Metaphase spread probed with Cdsl PAC clone
This fluorescent in situ hybridisation panel shows the chromosomal 
location of mouse Cdsl on a metaphase spread. The metaphases 
were probed with Pac clone 572-n24 labelled with Flurophore 
Avidin Texas Red. Mouse Cdsl mapping to chromosome 5E1 is 
indicated by the white arrows.
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Figure 3.37 Schematic representation of the position of Cdsl on mouse chromosome 5
Shown is a schematic diagram of mouse chromosome 5. Also shown are four individual metaphase spreads each show 
hybridisation to chromosome 5 band E3.
Figure 3.38 Metaphase spread probed with Cds2 PAC clone 
This fluorescent in situ hybridisation panel shows the chromosomal 
location of mouse Cds2. The chromosomes were probed with PAC 
clone 439-n24 labelled with the fluorophore FITC. Mouse Cds2 
maps to mouse chromosome 2G1 as indicated by the white arrows.
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Figure 3.39 Schematic representation of the position of Cds2 on the mouse chromosome 2
Shown is a schematic diagram o f mouse chromosome 2. Also shown are four individual metaphase spreads each show 
hybridisation to chromosome 2 band G l.
3.6 Expression studies o f  Cdsl and Cds2
3.6.1 Mouse RNA MasterBlot™
A mouse multiple tissue Masterblot™ (Clontech) was used to determine general sites of 
Cdsl and Cds2 gene expression. This commercially available blot contains polyA+ 
RNA samples from various mouse tissues. Figure 3.40b shows the key to the gridded 
filter, which indicates the positions of the various tissues and control samples. In 
addition to the various adult tissues, the blot has four embryonic tissue samples from 7 
days post coitus (d.p.c) to 17 d.p.c. cDNA probes were generated (see section 2.3.1.20) 
using the entire inserts from the Cdsl clone 801-b9, (see section 3.1 for clone 801 
information), and the Cds2 clone 1247-c2 (see section 3.2 for clone 1247 information). 
The probes were randomly radio-labelled with 32P a-dCTP. The radio-labelled probes 
were used in separate hybridisation reactions with the blot as per the manufacturer’s 
instructions, the blots were washed to O.lxSSC, 0.1% SDS before exposing the probed 
filters to autoradiographic film for 48 hours at -80°C. After the first probe was used the 
blot was stripped (as per the manufacturer’s instructions), then hybridised with the 
second probe under the same conditions.
The expression patterns of the genes can be seen in figures 3.40a and 3.40c. The 
expression of Cdsl is limited to the adult brain, eye, smooth muscle and testis samples, 
with very weak expression in the kidney and no expression observed in any of the 
embryonic tissue samples (figure 3.40a). The expression pattern observed when the blot 
was hybridised with the Cds2 probe was very different to the pattern observed with the 
Cdsl probe. When the blot was hybridised with the Cds2 probe (figure 3.40c) every 
adult tissue on the blot showed expression (refer to the key in figure 3.40b for the list of 
tissues present on the blot). Expression of the gene in the brain sample showed the 
highest intensity. In addition to expression observed in all adult tissues, Cds2 
expression was observed in all embryonic stages.
3.6.1.1 Discussion points of section 3.6.1
There are several negative controls on the blot for the purpose of reducing the level of 
non-specific background, which is crucial for achieving high sensitivity. The negative 
controls include, yeast total RNA, yeast tRNA, E.coli rRNA, E.coli DNA (for the 
detection of non-specific hybridisation), poly r(A) (detection of oligo (dT) sequences),
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Figure 3.40 RNA Masterblots probed with Cdsl and Cds2
The blots shown above are RNA Masterblots (Clontech) hybridised as with the whole inserts from the cDNA clones 
801 (Cdsl) and 1247 (Cds2). As can be seen in blot (a), probed with 801, the areas of expression are limited to the 
eye, brain, smooth muscle and testis, with weak expression in the kidney sample (barely visible in photograph but was 
apparent on autoradiograph film). No expression was observed in the embryonic tissues. Blot (c) was probed with 
1247, the probe hybridised to every sample on the filter, with the highest level of expression observed in the brain 
sample. Expression could be seen from the earliest embryonic sample, implying that the gene may be developmentally 
important.
C0t-1 DNA (detection of repetitive sequences) and two mouse genomic DNA controls 
(detection of repetitive sequences, if the gene is highly abundant or if the gene belongs 
to a multi-gene family).
Neither gene probe hybridised with the yeast, E.coli rRNA, poly r(A) or C0t-1 DNA 
controls. Both probes hybridised to the E.coli DNA control sample. The 
manufacturer’s notes on this control state; ‘ In some cases, you may observe a signal for 
E.coli DNA, but not the other three controls. This may be explained by the presence of 
E.coli sequences that are homologous to mammalian mRNA. If your probe hybridises 
to the dot containing E.coli DNA, but not yeast total RNA, yeast tRNA, E.coli rRNA, 
you should verify that your gene has homology to bacterial sequences.’ In section
1.2.4.5 the cds gene was described, the first cds gene identified was the E.coli cds gene 
(Langley and Kennedy, 1978). This finding will be discussed further in chapter 4.
The probes also hybridised to a second control on the panel, the mouse genomic DNA 
control. This control is used to detect repetitive sequences, highly abundant genes or 
genes which belong to multi-gene families. The detection of repetitive sequences could 
be eliminated as a reason for hybridisation since neither probe hybridised with the C0t-1 
DNA sample which is also present on the blot for the detection of repetitive sequences. 
The hybridisation with the genomic DNA control could be for either one of the other 
two reasons given above. The Cds2 gene was shown on the blot to be present in every 
tissue and therefore occurs abundantly, and Cdsl and Cds2 form a family of genes of 
which other members have yet to be identified. The final reason may again be genomic 
DNA contamination in the probes from the laboratory environment. However, even 
with the hybridisation to two of the control samples, the pattern of expression of the 
genes on the blot is still significant.
The different patterns of expression suggest that Cdsl and Cds2 may have different 
functional roles. When the blot was hybridised with the Cds2 probe, all adult tissues 
and embryonic tissues showed expression. This result suggests that the Cds2 gene is 
involved in mouse development, and may be a ubiquitously expressed gene encoding a 
protein used in general signalling pathways requiring the regeneration of PIP2 to occur. 
The expression pattern observed when the blot was hybridised with the Cdsl probe, is 
limited to adult eye, brain, smooth muscle, kidney and testis tissues, which suggests that
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this gene may have a specific function in certain tissues of the adult. The results will be 
discussed further in chapter 4.
3.6.2 Northern blot analysis
3.6.2.1 Preparation of Northern blot filter
None of the cDNA clones identified for the two Cds genes are full-length since neither 
contains a poly-aaenylation signal and the start codon was also absent in the cDNA 
clones identified for Cdsl. In order to determine the full transcript length of Cdsl and 
Cds2, a Northern blot was prepared (see section 2.3.2.4). Total RNA was prepared (see 
section 2.3.2.1) from the following adult mouse tissues; eye, brain, liver, spleen and 
kidney. A260/A280 ratio calculations were performed on the samples to assess the 
concentration and quality of the RNA where a ratio of 1.8 is the ideal. The rather lower 
ratios shown in table 3.11 indicate that some protein was present in the samples. The 
liver sample shows the least purity of the samples and the effects of this can be seen in 
the blot figures where there is the identifiable presence of high molecular weight 
proteins in the samples. lOpg of RNA from each tissue was used in the preparation of 
the blot. The agarose gel photo of the RNA samples is shown in figure 3.41. The blot 
was hybridised at 42°C (see section 2.3.1.21) with 32P a-dCTP radiolabelled probes 
generated using the whole insert from cDNA clones 801-b9 (Cdsl) and 1247-c2 (Cds2) 
(see section 2.3.1.20).
Brain 0. 714 0.488 2 . 86 1. 5
Eye 0.082 0 . 55 0 .328 1. 5
Spleen 1.46 0 . 977 5 . 84 1. 5
Kidney 0.676 0 .460 2 . 7 1.4
Liver 0 .447 0.312 8 . 94 1. 5
Table 3.11 Shown are the A260/A280 ratios of the RNA samples generated from various 
mouse tissues.
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3.9kb
Figure 3.41 Total RNA gel
Shown is the ethidium bromide stained gel photograph of the mouse 
RNA samples prior to Northern blotting. ~10pg each of eye, brain, 
liver, spleen and kidney tissues were used. The liver sample appears 
to be slightly degraded and showed least purity in the A260/A28o ratios 
(table 3.11). The ribosomal RNA bands at 3.9kb and 1.9kb are 
indicated.
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3.6.2.2 Northern blot probed with Cdsl
The results of the Northern blot hybridised with the Cdsl probe are shown in figure 
3.42. The blot shows that the Cdsl probe hybridises to two fragments, one ~4.1kb and 
one ~2kb. These fragment sizes are very close to the sizes of the ribosomal bands, but 
on close inspection, the position of the bands in this blot are not identical to those which 
would be present if cross-hybridisation to ribosomal RNA had occurred and these bands 
are not present in all lanes. As far as can be determined therefore, the probe is not 
hybridising to ribosomal RNA. This result confirms what was previously known, that 
the cDNA clone 801-b9 (1.3kb in length) which represents the 3’ end of Cdsl does not 
contain the full-length transcript of the gene. In section 3.1, the coding sequence of the 
Cdsl gene along with sequence from the EST database representing the 3’UTR of 
mouse Cdsl was compiled to form a 3.7kb transcript (figure 3.12) minus sequence 
information for the 5’UTR. This sequence information suggests that the larger 4.1 kb 
fragment on the Northern blot represents the transcript size hence implying that the 5' 
UTR, which to date is not known, is likely to be approximately 400bp in length. The 
Cdsl Northern blot also confirms results from the Masterblot, that Cdsl is expressed in 
the eye, brain and kidney.
3.6.2.3 Northern blot probed with Cds2
The results of the Northern blot hybridised with the Cds2 probe is shown in figure 3.43. 
In all lanes two fragments of ~2.1kb and ~4kb were observed. Ribosomal RNA cross- 
hybridisation was eliminated since, as before, on close inspection of the blots the 
ribosomal and Cdsl bands differ in size. In the lanes containing spleen and kidney 
RNA a third band of approximately 2.9kb was observed. In the brain and eye RNA 
sample lanes a band of ~6 kb was also identified; this band seems too large to be the 
transcript size and showed weaker intensity levels of hybridisation than the other two 
smaller bands on the blot, indicating it may represent cross-hybridisation to another 
transcript. These results confirm that the cDNA clone representing Cds2 (1.6kb in 
length) does not contain the full gene transcript. It is most likely that the 4kb band 
represents the full transcript length and that the 2.9kb band in the spleen and kidney 
samples is a splice variant isoform of the gene that has a specific role in certain tissues. 
The possible role of the splice variants will be discussed in chapter 4.
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-2.1 kb
Figure 3.42 Cdsl probed Northern blot
Shown is the autoradiograph result of the Northern blot filter 
probed with the 801-b9 (Cdsl) probe. The probe hybridises to 
two bands, one approximately 4.1 kb and one approximately 
2.1kb. The sequence reported in chapter 3.3 implies that the 
size of the transcript must be represented by the upper 4.1 kb 
band.
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2.9kb
Figure 3.43 Cds2 probed Northern blot
Shown is the Northern blot filter (from figure 3.6.3.1) probed with 
the 1247-c2 (Cds2) probe. The probe hybridises to three bands, 
one approximately 6kb, one approximately 4.1 kb and one 
approximately 2kb in the eye and the brain but hybridises to a third 
band in the spleen and kidney of approximately 2.9kb. It is 
possible that the lower band is the transcript size and that a splice
variant occurs in other tissues to give the 2.9kb band.
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3.6.2.4 Discussion points of section 3.6.2
Although the two genes produce bands of relatively similar sizes, cross-hybridisation 
between the genes can be eliminated because the Cdsl probe does not hybridise to all 
samples on the blot. In addition, the same probes were used on the Northern blots as 
were used on the RNA MasterBlots™ (figure 3.40) where no cross-hybridisation 
occurred.
The Northern blots were washed at a much higher stringency than the Masterblots 
(0.01XSSC, 0.1% SDS compared to 0.1 XSSC, 0.1 %SDS) since there was much higher 
background on the Northern blots, this higher stringency has also reduced the likelihood 
of cross-hybridisation of genes occurring. Absence of cross-hybridisation was also 
noted in the in situ hybridisation studies (see section 3.6.3) where the genes displayed 
very different expression patterns. A full discussion on the results generated in this 
section can be found in chapter 4.
3.6.3 In situ hybridisation studies
3.6.3.1 Production of riboprobes
To identify specific sites of Cdsl and Cds2 expression in the adult eye, the specific 
pattern of transcription was established by in situ hybridisation (see section 2.3.3.1) of 
gene specific digixygenin-labelled riboprobes to 5 pm thick sections of whole mouse 
eyes. Sense and anti-sense riboprobes were generated (see section 2.3.2.5). The sense 
probe shares the same sequence as the transcript and should not bind to the gene 
transcripts in the sections. The sense probes are used as the negative control in the 
experiments. The anti-sense probe is the complementary sequence to the gene transcript 
and should therefore hybridise to the gene transcript. Six riboprobes were generated in 
total. A sense and an anti-sense probe were generated for each of the following genes, 
Cdsl (cDNA clone 801-M9 was used as template), Cds2 (cDNA clone 1247-c2 was 
used as template) and human rod opsin. None of the sections were counter-stained after 
probing as this increases the chance of masking faint positive signals.
3.6.3.2 Location of gene transcripts
All sections used were whole adult eyes, the entire structure was examined for areas of 
positivity. Only regions displaying hybridisation to specific gene transcripts are shown 
from each section. All figures in this section show a Haematoxylin and Eosin stained 
section presenting the region of the eye being examined to define the various layers.
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To test the methodology the rod opsin probes were used as positive controls. The rod 
opsin gene transcript is known to be expressed in the outer nuclear layer of the retina. 
Figure 3.44 shows the results from the control experiments. The anti-sense probe 
detects expression in the outer nuclear layer of the retina with all other layers of the 
retina being negative.
The results from using the Cdsl riboprobes can be seen in figure 3.45. Expression was 
only observed in the retina. On probing with the anti-sense probe, expression of the 
Cdsl gene transcript is observed only in the inner segments of the photoreceptor cells.
In contrast to the previous probes used, Cds2 gene transcript expression is not restricted 
to the retina. The Cds2 anti-sense probe detected expression in the cornea (figure 3.46) 
and cilary body (figure 3.47) as well as in the retina (figure 3.48). When the sections 
were probed with the Cds2 anti-sense probe, expression was observed in the epithelial 
and endothelial layers only with no expression detected in the stroma of the cornea 
(figure 3.46). Expression was observed in the cilary body (figure 3.47) and in the 
ganglion cell layer and the inner nuclear layer of the retina (figure 3.48).
The masterblot (figure 3.40) showed that Cds2 is expressed in all tissues present on the 
blot and that Cdsl is expressed only in the brain, eye and smooth muscle. To further 
examine these results an in situ hybridisation study was performed using a panel of 
mouse tissues. The tissues that were used in the panel are listed in table 3.12.
Using in situ hybridisation on paraformaldehyde fixed, paraffin embedded sections, a 
high level of Cds2 expression was found in various areas of the brain. This confirms the 
masterblot results for the brain since this tissue showed the highest level of expression 
on the blot. A very distinctive pattern was observed in the brain tissue with expression 
in the Purkinje cells of the cerebellum, Ammon’s horn of the hippocampus, the 
temporal cortex except for layer 1 , the anterior hypothalamus, and the lateral and 
medulary reticular nuclei of the spinal cord (figures 3.49 A-E).
In addition to expression in the brain, Cds2 expression was seen in the sebaceous glands 
and epithelium of ear skin, the pancreas (3.50 A and B), the spleen, the chronic 
inflammatory cells of the core villi of the small intestine (3.51 A and B), the semi-
202
iU
C
(c) Rod opsin sense probed section(a) Haematoxylin stained section (b) Rod opsin anti-sense probed section
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Figure 3.44 Rod opsin transcript expression in the adult mouse retina
All sections used for in situ hybridisation are adult mouse whole eye sections which have been formaldehyde fixed and 
paraffin embedded. Section (a) shows a Haematoxylin and Eosin stained section, section (b) was probed with the 
anti-sense positive control which was human rod opsin and section (c) shows a opsin sense probed section. The red 
arrow highlights the outer nuclear layer of the retina where immunoreactivity can be seen. All other layers of the retina 
are negative.___________________________________________________________________________________________
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(c) Cdsl sense probed section(a) Haematoxylin stained section
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(b) Cdsl anti-sense probed section
Figure 3.45 Cdsl expression in mouse retinal sections
Mouse adult retina sections stained with Haematoxylin and Eosin (a), a Cdsl anti-sense probed section (the lower 
region of the section has folded over) (b) and a Cdsl sense probed section (c). As demonstrated by the red arrow, 
immunoreactivity can be seen only in the inner segments of the photoreceptors.
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(a) Haematoxylin stained section (b) Cds2 anti-sense probed section (c) Cds2 sense probed section
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Figure 3.46 Cds2 expression in adult mouse cornea
This figure shows the cornea stained with Haematoxylin and Eosin (a), probed with the anti-sense probe (b) and probed 
with the sense probe for Cds2 (c). As the red arrows indicate, areas of immunoreactivity can be seen in endothelium and 
the epithelium, but the stroma is completely negative.
(a) Haematoxylin and Eosin stain (b) Cds2 anti-sense probed section (c) Cds2 sense probed section
Figure 3.47 Cds2 expression in the cilary body
Section (a) shows an Haematoxylin and Eosin stained section of the ciliary body of a adult mouse eye. Section (b) 
shows immunoreactivity in the ciliary body (indicated with red arrows) when probed with the Cds2 anti-sense riboprobe. 
Section (c) was probed with the sense riboprobe and shows no positivity.
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(a) Haematoxylin stained section (b) Cds2 anti-sense probed section (c) Cds2 sense probed section
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Figure 3.48 Cds2 expression in mouse retinal sections
Mouse adult retinal sections. Stained with Haematoxylin and Eosin (a), a Cds2 anti-sense probed section (b) and a 
Cds2 sense section (c). The anti-sense probed section shows expression in the ganglion cell layer and the inner nuclear 
layer of the retina. These positive regions are highlighted with red arrows.
Figure 3.49 Cds2 expression in neural tissues
A panel of tissues were examined using sense and anti-sense Cds2 probes. Various 
regions of positivity were found in the brain. Shown above are these positive regions 
along with H & E stained equivalent sections. Positivity was found in the cortex (A), 
cerebellum (B), hippocampus (C), the hypothalamus (D) and the spinal cord (E).
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Figure 3.50 Cds2 expression in ear skin and pancreas.
Cds2 probed tissues showed positive expression in the skin (A) and the pancreas (B). This figure show the antisense
probed tissue, a H & E stained equivalent section and the sense probed tissues. Positivity can be found in the epithelium (red arrow) and
sebaceous glands (green arrow) of the skin will a general expression is seen in the pancreas.______________________________________
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Figure 3.51 Cds2 expression in the spleen and small intestine.
Cds2 positivity was detected in the spleen (A) and small intestine (B). This figure shows the antisense probed sections, an H & E 
equivalent and the negative sense probed section.
nipherous tubular epithelium of the testis, and the lymph nodes (figure 3.52 A and B). 
However the in situ hybridisation studies did not show expression in the lung, liver, 
heart, kidney, thymus or muscle as they did on the blot. This may be due to lower levels 
of Cds2 mRNA on the tissue sections compared with the concentrated dot on the blot 
membrane. This interpretation is consistent with the observation that some of the 
samples that do not give expression in the tissue panel are expressed at a much lower 
level on the blot.
The role of Cds2 is still elusive, but the pattern of expression in the non-neural tissues 
may suggest a role in secretory cells. However the best way to define the function of the 
Cds2 gene is to generate a knockout model (see discussion).
The same panel of tissues was probed with Cdsl. Like the masterblot, the results were 
more specific than the pattern seen in Cds2. Positivity was only seen in the cortex 
(except layer 1), the spinal cord, the lymph nodes and the testis (figure 3.53 A-D). The 
role of Cdsl is still unknown, but a knockout model would again be informative. 
However from the masterblot and from the in situ experiments, it appears that the role 
of Cdsl is more restricted than that of Cds2. A list of all tissues tested appears in table 
3.12
The most likely explanation for the discrepancies between the results of the in situ 
hybridisation experiments and that of the masterblot is that there is a greater 
concentration of RNA on the blot than found in any given section of a tissue, hence 
weak signals may not have been detected using in situ hybridisation. Another 
explanation may be that Cds2 is not constantly expressed in all tissues and was not 
expressed in some of the tissues at the time of death of the animal used for the in situ 
hybridisation experiments. The conclusion that can be drawn from these experiments is 
that Cds2 is more widely expressed than Cdsl, confirming the results of the masterblot.
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Figure 3.52 Cds2 expression in testis and lymph nodes
The final areas of Cds2 positivity were the testis (A) and the lymph nodes (B). Shown in this figure are the antisense probed 
tissues, the equivalent H & E stained section and the negative sense probed tissues.
Figure 3.53 Cdsl expression in the brain, lymph nodes and testis
A panel of tissues were probed with Cdsl sense and anti-sense probes, only 
the cortex (A), the spinal cord (B), the lymph nodes (C) and the testis (D) 
produced positive results, these are accompanied above by H & E views of 
the positive tissues.
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Brain
Cds2
+
Cdsl
+
Spinal cord + +
Sciatic Nerve - -
Eyes + +
Small Intestine + 1
Lung - -
Liver - -
Heart - -
Kidney - -
Thymus - -
Spleen + -
Lymph node + -
Muscle - -
Ear Skin + -
Pancreas + -
Testis + +
Table 3.12 Presence (+) and absence (-) of Cdsl and Cds2 expression in a range of 
tissues.
3.6.3.3 Discussion points of section 3.6.3
The results from this section show that the transcripts from Cdsl and Cds2 are 
expressed in very different discrete locations within the eye. Cdsl is confined to the 
retina whereas Cds2 is found in various ocular structures. Further discussion of the 
location of these transcripts can be found in chapter 4.
3.6.4 Rodless, coneless and rodless coneless mice
rd or retinal degeneration mice were first identified in the wild in Switzerland, England 
and France and subsequently in several laboratory strains (Pittler and Baehr., 1991). 
Mice homozygous for the rd mutation display hereditary retinal degeneration and the 
classic rd lines have subsequently served as models for human retinitis pigmentosa. In 
the affected retinas the rod photoreceptor cells begin to degenerate at postnatal day 8 
and by four weeks there are no rod cells present. The degeneration is preceded by 
accumulation of cyclic GMP (Carter-Dawson et al., 1978, Bowes., et al 1990) in the 
retina and is correlated with the deficient activity of the rod photoreceptor cGMP- 
phosphodiesterase. The degeneration of the rod cells is followed at a slower rate by the 
loss of cone cells. However, there are still 1.5-5% of the original population of cone 
cells present in 18 month old rd mice (Carter-Dawson et al., 1978). For the analysis of
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the function of the retina after the removal of cone cell function, Wang et al. (1992) 
generated a transgenic mouse (cl) by introducing of a construct consisting of a portion 
of the human red cone opsin promoter attached to an attenuated diphtheria toxin gene. 
These mice have the normal number of rod cells but lose all green cone cells and greater 
than 95% of UV cone cells. A study by Lucas et al. (1999) generated a strain of rodless, 
coneless mice by mating cl mice with homozygous rd mice. This generated a strain of 
mice lacking all photoreceptor cells.
With the evidence that the Cdsl transcripts were present in the photoreceptor layer of 
the retina, further investigations were carried out to establish if the transcripts were 
present in rod cells or cone cells or both. Initially this was investigated by RT-PCR 
using the primers Cdsl intron8 F and Cdsl intron9R and Mex8 F and MexlOR (as 
controls) with retinal cDNA templates from rd/rd, cl and rd/rd cl mice (kindly gifted by 
Professor Russell Foster, Imperial College London). Since the photoreceptor layer of 
the mouse retina is composed predominately of rod cells, the rd/rd retina is very 
degenerate due to the loss of these cells (figure 3.55). However it is possible that there 
are residual cone cells present in the rd/rd retina. The cl mouse retina is not as 
degenerated, since the predominately rod scaffolding structure of the photoreceptor 
layer is in place to maintain the retina. The rd/rd cl mouse retina does not contain any 
photoreceptor cells and is as degenerate as the rd/rd mouse. The results show that the 
Cdsl transcripts were only present in the cl cDNA, indicating that Cdsl is only 
expressed in rod cells (figure 3.54).
Unfortunately tissue was not available from cl or rd/rd cl mice since the mutant mouse 
lines have not been maintained by Professor Foster and sourcing the tissue from other 
laboratories was not possible. The in situ study was restricted therefore to rd/rd retinal 
sections (figure 3.55). Since the mutant mice are pigmented, age and sex matched 
pigmented wild-type mice were used as controls for this experiment (figure 3.55). The 
in situ experiments show that no expression can be detected in the cone cells of the 
rd/rd retina. This result confirms the RT-PCR result shown in figure 3.54.
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Cdsl Cds2
1 2 3 4 5 6 7 8 9 10 11 12
Figure 3.54 The RT-PCR results shown confirm that Cdsl is only expressed in the rod 
photoreceptors. Lanes 1-6 Cdsl, 1 -  marker, 2- water, 3- WT, 4- rodless, 5 -  coneless, 
6- rodless/coneless. Yellow arrow indicates the Cdsl band of 300bp. Lanes 7-12 Cds2 
following the same order. Green arrow indicates the Cds2 band of 250bp.
In conclusion therefore, the expression of Cdsl only in rod photoreceptors may imply 
that Cdsl has a role in phototransduction in dim light conditions, but this finding would 
have to be confirmed by the generation of a knockout mouse model for Cdsl. 
Nevertheless, the results from this section has strengthened the case that a mutation in 
Cdsl may be responsible for some forms of RP and this should be investigated further 
using panels of RP patients where the causative gene is still unknown (see discussion).
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A. Cdsl anti-sense probed WT section B. Cdsl sense probed WT section C. H aematoxylin stained WT section
GCL
D. Cdsl anti-sense probed Rd section
. ’ .oVC*/.
F. H aematoxylin stained Rd sectionE. Enlargement of boxed area
Figure 3.55 Comparison of Cdsl transcript expression in wild type and Rodless retinas
Section A. was a wildtype mouse adult retina probed with the anti-sense Cdsl probe, section B. shows the sense probed 
wildtype retina C. shows a haematoxylin and eosin stained section. D. was a Rodless adult retina probed with the anti­
sense Cdsl probe, section E. shows and enlargement (40x) of the area of interest and section F. shows a haematoxylin 
And eosin stained Rodless section.
3.6.5 Sub-cellular localisation of Cds2
To identify the sub-cellular localisation of a protein in mammalian cells in the absence 
of a specific antibody, epitope tags can be used. This technique allows a small 
(approximately 10 amino acids) tag to be cloned in frame with the gene of interest. The 
tagged gene is then expressed and can be detected using an antibody to the tag. At the 
time this study was performed the whole coding sequence of Cdsl had not been 
deduced so only Cds2 was tagged. Cds2 protein was tagged with the epitope c-myc. C- 
myc tag is a ten amino acid (EQKLISEEDL) synthetic peptide designed against 
residues 408-439 of the human c-myc gene product. The Cds2-myc tagged construct 
was cloned into a mammalian expression vector and transfected into mammalian human 
embryonic kidney (HEK) 293T cells in culture. Gene expression was evaluated by 
immunohistochemistry and Western blotting.
3.6.5.1 Production of the Cds2-myc tagged construct
The Cdls2-myc-tagged construct was amplified by PCR (see section 2.3.1.16). In order 
to amplify the construct, four primers were designed (see table 3.13) to the coding 
sequence of Cds2 deduced from the cDNA clone 1247-c2 (see section 3.2). Two of the 
primers were designed to the exact sequence of the gene. The primer MCds2For was 
designed at the start codon and the primer MCds2Rev was designed to the stop codon. 
The second set of primers, were designed to the same sequence but had the myc-tag 
nucleotide sequence added to the end of the Cds2 gene sequence. The primers were 
designed in this way to allow two constructs to be generated, one with the myc-tag at 
the N-terminus of the gene and the other with the tag at the C-terminus. The reason for 
generating two constructs with tags at either terminus is that some epitope tags can 
interfere with the folding and transportation of the protein. With tags at either terminus 
the results of the experiments can be compared to ensure that the presence of the tag has 
no effect on the localisation of the proteins.
lOng of clone 1247-c2 cDNA was used as template in the PCR reactions (see section 
2.3.1.16), with the non-tagged primers MCds2For and Mcds2Rev to amplify the coding 
region of Cds2. This product was diluted and used as template for the next round of 
amplification. Two reactions were performed with primers MCds2F and MCds2C-myc 
in one reaction and MCds2Rev and MCds2N-myc in the other.
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The products with a tag at either the C-terminal or N-terminal were subcloned into 
pGEMT-easy vector (Promega) (see section 2.3.1.13-14) and maxi prep stocks were 
generated (see section 2.3.1.2).
MCds2For ggcgcaagcttATGACCGAACTACGGCAG 128
MCds2N-myc ggcgcaagcttATGGAACAGAAGCTTATT
TCCGAAGAGGATCTGAAGATGACCGAACT
ACGGCAG
128
MCds2Rev gcgccggaattcTCAGTTAGGTGAGACTT
GAAG
1426
MCds2C-myc gcgccggaattcCTACTTCAGATCCTCTT
CGGAAATAAGCTTCTGTTCCATTTCAGTT
AGGTAGACTTGAAG
1426
Table 3.13 The primer names and sequences used to amplify Cds2 incorporating myc- 
tags (regions underlined) from 1247-c2.
The products were excised from the pGEM vector with restriction enzymes EcoKl and 
HindiII (see section 2.3.1.9). The fragments were subcloned into the EcoRI and Hindlll 
sites of expression vector pcDNA3 (Invitrogen). The clones were sequenced (see 
section 2.3.1.18) to ensure that they were in frame and did not contain any PCR 
amplification errors.
3.6.4.2 Transfection of cells for immunolocalisation
HEK-293T cells were plated onto coverslips and transfected with 5pg of the myc- 
tagged constructs described above (see section 2.3.4.5). The transfected cells were 
incubated at 37°C overnight. The cells were incubated in a 1:500 dilution (in PBS) of 
anti-myc-primary antibody (Santa Cruz Biotechnology, Inc.) followed by an anti-mouse 
FITC conjugated secondary antibody (Pierce, UK) which detects the primary antibody 
used and can be used for visualisation using fluorescence microscopy. However, on 
examination under a fluorescent microscope, no signal was seen and the cells appeared 
to be apoptotic. To ensure that transfection had occurred successfully, fresh cells had
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the construct microinjected into them (courtesy of Dr Peter Adamson). Again no signal 
was seen and the cells appeared apoptotic.
3.6.5.3 Western blots
Since the immunostaining experiments did not yield any positive results, Western blots 
were prepared (see section 2.3A.2-4) to assess if any protein was being produced by the 
transfected cells.
HEK-293T cells were grown on petri dishes until they reached 40-50% confluency.
5pg of construct (see section 3.6.4.1) was then transfected into the cells. The cells were 
incubated for 48 hours at 37°C before being scraped from the plates and pelleted. The 
pellets were stored at -80°C until required (see section 2.3.1.15). The cell pellets were 
used to make cell membrane preparations (see section 2.3.4.2). The cell membrane 
preps were electrophoresed through an SDS-PAGE gel (see section 2.3.4.3) and electro­
blotted onto nitrocellulose membranes (see section 2.3.4.4). The Western blots were 
incubated with commercial anti-C-myc mouse monoclonal antibody (Santa Cruz 
Biotechnology, Inc). Control cell preparations, from non-transfected cells were used as 
a negative control. The results of the Western blots show a series of non-specific bands 
in both sample lanes (figure 3.56) with no clear differences between the transfected and 
non-transfected cells. This suggests that either the commercial antibody was not 
specific enough to detect the c-myc tag or that no tagged protein was being produced.
3.6.5.4 Discussion point of section 3.6.5
No tagged protein appears to be produced by the cells and the cells which were 
transfected and immunostained appeared to be apoptotic, this could be due to the cells 
relaying a stress response which triggers apoptosis. At this stage it can only be 
postulated that the gene product may be toxic to the cells. These results will be 
discussed further in chapter 4.
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(a) secondary antibody (b) no antibody (c) primary & secondary
Figure 3.56 Western blotting to detect myc-tagged protein expression
Filter (a) is a control with only the secondary antibody applied, filter (b) 
has had no antibodies applied and filter (c) has had both primary and 
secondary antibodies applied. As can be seen there is little difference 
between filters (a) and (c), this was probably due to lack of specificity of 
the anti-C-myc antibody or the absence of any tagged protein.
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3.7 Drosophila Transgenics
This experiment was performed to elucidate which, if either, mouse Cds gene would 
successfully rescue the Drosophila eye-cds mutant phenotype. Drosophila with 
mutations in the eye-cds gene experience light dependent retinal degeneration (the cds 
gene is described in section 1.2.4.5). In a previous study another Drosophila mutant 
which experiences light dependent retinal degeneration, rdgC, has been successfully 
rescued using the murine homologue (Chang et al., 1997). The rescue experiment had 
two main sections, firstly, the production of the rescue construct and then the mapping 
and expression study of the transgenes in the flies.
3.7.1 Cds rescue construct preparations
The rescue constructs have two components, the Cds coding sequence and green 
fluorescent protein (GFP) tag which have to be fused together and inserted into a 
Drosophila expression vector. The vector has P-element ends, P5' and P3' which when 
coinjected with an intact P-element allows the transgene to insert into the fly genome 
(for a full description of P-elements see section 1.3.1). The vector also contains the 
white+ gene which acts as a marker for detection of the transgene. The fly strain into 
which the construct is injected is a laboratory strain which have white eyes compared to 
wild type flies which have red eyes, when the transgene is successfully incorporated the 
transgenic flies display a yellow eye phenotype due to the incorporation of the white+ 
gene. The GFP tag is used to identify the sites of Cds-tagged protein expression in the 
transgenic flies using fluorescence microscopy.
The primers shown in table 3.14 were used to amplify (see section 2.3.1.16) the Cds 
gene fragments using lOng of the cDNA clones 2279-dl9 {Cdsl) and 1247-c2 (Cds2) as 
template. The GFP fragment was amplified from the fly vector expression vector, 
pUAST-GFP (Brand and Perrimon, 1993)(supplied by Dr Raghu Padinjat, Cambridge 
University fly laboratory) using primers GFPC and GFPD (table 3.14). The vector 
pUAST is an inducible expression system that utilises the yeast transcription factor 
GAL4 as a promoter (figure 3.57).
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Figure 3.57 Schematic representation of vector pP[UAST]
pUAST consists of five tandemly arrayed optimized GAL4 binding sites (red) 
followed by the hsp70 TATA box and transcrptional start (blue), a polylinker 
(green) containing unique restriction sites for £<%>RI, Bg/ll, Notl, Xhol, Kpnl and 
Xbal and the SV40 small t intron and polyadenylation site. These features are 
included in a P-element vector (pCaSpeR3) containing the P element ends (P3' and 
P5') and the white gene which acts as a marker for successful incorporation into the
Drosophila genome (Brand and Perimon ,1993).
7,73
CdslintronlF GACCACGAAACCGAGAGCAC
CdslB CTTTACTCCTATGAGCCATCACCTTCAAGGTGGGGC
Cds2intronlF CAGCATGACCGAACTACG
Cds2B CTTTACTCCTATGAGCCATGTTAGGTGAGACTTG
GFPC ATGGC T CATAGGAGTAAAGGAGAAGAA
GFPD CATATGTTTGTATAGTTCATC
Table 3.14 Lists the primers used to amplify the components for the Drosophila 
rescue constructs. The primers are written in the 5’-3’orientation.
Three gene fragments were amplified. The fragment bands were excised from the 
agarose gel (see section 2.3.1.10) and spun through Wizard™ (Promega) purification 
columns in a microcentrifuge at 5000rpm for 2 minutes. The concentration of the 
purified DNAs were measured by spectrophotometry, then used in fusion reactions to 
join the fragments (figure 3.58 schematically summarises the fusion reaction). The 3’ 
end of the primers Cds IB and Cds2B were designed to contain complementary 
sequence to the 5’ end of the GFPC primer. This overhanging sequence was used in 
fusion reactions to join the two fragments. A total of 250ng of purified DNA was used 
in each fusion reaction, the ratios of Cds gene fragments to GFP fragment were 
calculated based on the relative sizes of each and their purified band concentrations. To 
perform the fusion reaction, the correct ratios of DNA fragments were set up then 
heated at 65°C for 10 minutes. The reactions were then cooled slowly in a water bath to 
37°C over 20 minutes. At 37°C lOx Reaction buffer 1 (Promega), Klenow (GibcoBRL) 
and dNTPs (Promega) were added. The reaction was then incubated at 37°C for two 
hours to allow the fragments to fuse completely.
The product from each fusion reaction was used as a PCR template to amplify the 
construct using primers CdslintronlF or Cds2intronlF and GFPD (table 3.14). The 
fragments that were generated are shown in figure 3.59. The amplified fragments were 
excised from the agarose gel (see section 2.3.1.11) and spin-column purified as before.
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Figure 3.58 Cds and GFP fusion reaction
Shown is a schematic representation of the fusion reaction performed to generate Cds2 tagged with GFP. (A) Shows the initial PCR 
amplification reaction using primers Cds2intronlF with Cds2B and GFPC with GFPD. This results in two fragments being generated, which 
are shown in (B). (B) A Cds2 fragment with an overhanging complementary sequence to GFP and a GFP fragment. (C) shows the fusion 
reaction where the products from (B) are heated then cooled slowly. The product from this reaction is shown in (D). (D) shows the 
amplification of the fusion product using primers Cds2intronlF and GFPD. This PCR reaction results in a Cds2/GFP fusion fragment, which 
is shown in (E).___________________________________________________________________________________________________________
Figure 3.59 GFP fusion PCR fragments
Shown are the fusion fragments generated in the fusion 
reaction performed using the fragments shown in figure 
3.54. The fusion fragment is approximately 2kb and will be 
cloned into the Drosophila expression vector pUAST.
The purified fusion product was cloned into the vector pGEM T-Easy (see section 
2.3.1.13-14) and DNA prepared (see section 2.3.1.1). Using the restriction enzyme 
EcoRl (see section 2.3.1.9) the fusion fragments were excised from the vector. The 
EcoKl Cds-GFT* fusion fragments were then subcloned into the EcoBl site o f the 
Drosophila expression vector pUAST (supplied by Dr Raghu Padinjat, Cambridge 
University fly laboratory). As described above the pUAST vector contains the white+ 
gene, confering eye colour which will be used to detect flies containing the transgene. 
The vector has a GAL4 promoter, which can be induced by mating the transgenic Cds 
flies with GAL4 expressing flies to initiate transgene expression. The vector pUAST 
does not contain the LacZ gene and hence the colonies are not colour selectable. As the 
pUAST vector is not colour selectable, colony PCR (see section 2.3.1.17) was 
performed on all colonies using the primers CdslintronlF or Cds2intronlF and GFPD. 
Clones identified as containing inserts were sequenced to check the orientation o f the 
insert. The primers used in the sequencing reactions are listed in table 3.15.
After verifying the orientation o f the inserted fragments, the correct clones were then 
sequenced with primers 1500F2 and CDS1INTRON1 IF, which verified the fusion 
region o f the fragment and ensured that reading frame was continuous. The entire 
sequence o f each o f the constructs was verified using automated sequencing to ensure 
amplification errors had not occurred. Maxi preps o f the positive clones were prepared 
(see section 2.3.1.2).
3.7.2 Mapping and expression studies of the transgenic Drosophila
I performed all fly mapping and expression experiments in the Fly Laboratory at the
University o f Cambridge under the guidance o f Dr Raghu Padinjat. The Maxi preps of  
construct circular DNA (see section 3.7.1) were microinjected into the Drosophila 
embryos. The circular construct DNAs were co-injected into the posterior pole o f 300 
w 1118 (white eyed) Drosophila embryos with a second plasmid carrying the transposase
1 1 1 o
enzyme (Rubin and Spradling, 1983) (figure 1.21). The w (white eyed) flies are a 
transgenic laboratory fly line which have white eye colour instead o f the wild type red 
eye colour. The construct was injected into the posterior pole o f the embryos, as this is 
where the developing germ cells are situated, thereby increasing the chance o f the
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construct being incorporated into the fly germline. The transgenic DNA will randomly 
incorporate into developing germ cell DNA (described in section 1.3.1).
Cds2intronlR TGTTTCCGCTCGGCTCTC
Cds2intron2R CAGGTCGTAGGAGTGGTAT
Cds2intronlF CAGCATGACCGAACTACG
Cds2intron6F GATTCTGCATGTTTGTAC
Cds2B CTTTACTCCTATGAGCCATGTTAGGTGAGACTTG
GFPD CATATGTTTGTATAGTTCATC
1500F2 GGCCACCTTTGTCAATGTGT
CdslintronlR TGGCATCGAGATCTCCATAC
CdslintronlF GACCACGAAACCGAGAGCAC
Cdslintron8F TTGGGAAGGATTCATTGGTG
CdslB CTTTACTCCTATGAGCCATCACCTTCAAGGTGGGC
CdslintronllF GGCGGGATAATGGACAGGTT
Table 3.15 Lists the primers used to verify the orientation of the fusion fragment with 
the fly pUAST vector. The first three primers were used to verify Cds 2 and the others 
were used to verify Cdsl.
The emerging adults had white eye colour and were separated by sex while still virgins.
• • / *  • * 1 1 1 8 * *The potentially transgenic (Cds) flies were back-crossed with w virgin Drosophila.
The resulting progeny were selected as carrying the Cds transgene by eye colour. The
transgenic progeny from the first cross, had eye colour ranging from pale yellow to dark
orange due to the introduction of the mini-white+ gene that was inserted as part of the
pUAST vector.
Subsequent fly standard crosses were performed to map the location of the inserted 
transgenes. The mapping crosses were performed with fly lines that have been 
developed with dominant gene marker phenotype (balancer chromosomes) (chart of 
crosses shown in figure 3.60). This resulted in stable transgenic Drosophila lines where
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Figure 3.60 Chart of mapping crosses- see next page for legend.
Figure 3.60 Chart of mapping crosses
Shown are the various mapping crosses performed in order to identify the chromosomal 
location o f the integrated transgene. Each of the horizontal lines represents a Drosophila 
chromosome, sex chromosome (X/Y), 2 and 3. Chromosome 4 is not analysed, because 
it is so small homologous recombination is infrequent and hence the transgene is unlikely 
to have integrated. The symbols represent the various dominant and recessive mutations, 
which produce various phenotypes in the crosses and allow the site o f integration to be 
determined. Curly o f  Oster (CyO) a dominant marker representing an inversion on 
chromosome 2, which gives the curly wing phenotype. Enhancer o f  forked (If) is the 
recessive chromosome 2 marker and give a phenotype o f abnormal bristles. MKRS 
represents a transposition on chromosome 3; the dominant marker is stubble (Sb) which 
produces flies with shortened thickened bristles, small wings and twisted legs. Third 
multiple six (TM6) is an inversion o f chromosome 3, the dominant marker for this is 
tubby (Tb) where the flies display shorter thicker bodies. Male and female balancers are 
slightly different; they only have dominant markers.
the transgene is inserted onto only one chromosome. Sufficient lines were set up to 
have a transgene insert on each chromosome. Balancer chromosomes have multiple 
inversions which, prevent the transmission o f recombinant chromosomes to the 
progeny, interfere with homologous pairing and reduce the frequency o f crossing over 
along most o f that chromosome. These characteristics allow the determination o f the 
site o f integration o f the transgene.
The transgenic fly lines were then crossed with Rhl-GAL4 flies that induce GAL4 
expression and hence result in the expression o f the transgene and GFP. The rhodopsin 
1 (Rhl) gene drives expression in rhabdomeres. The successful progeny should express 
the transgene and fluoresce in regions o f the deep pseudopupil in live flies (figure 3.61). 
When the desired cross was performed to induce the Cds transgene expression the 
progeny were examined using fluorescence microscopy. No fluorescence was detected 
in any o f the transgenic Drosophila lines (figure 3.61). One possibility for the absence 
of fluorescence is that the level o f expression o f the transgene may have been too low to 
be detected by light microscopy.
To analyse if  there was low level expression that could not be detected using the deep 
pseudopupil fluorescence a Western blot was prepared (see section 2.3.3.4) using 
protein samples generated from transgenic fly heads (see section 2.3.4.1). The Western 
blots were incubated with GFP-antiserum (figure 3.62). No specific bands were 
detected and the Cds protein samples were indistinguishable from the control sample.
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Figure 3.61 Fluorescence microscopy of live Drosophila eyes
Shown in figure (A) is a positive control fly (courtesy of Raghu
Padinjat) showing fluorescence in rhabdomeres 1-6 (deep pseudopupil)
the fluorescent region is indicated by a red arrow. Shown in figure, (B)
is an example of the observations made on examination of the Cds
transgenic flies where no fluorescence was present. The eye region is
indicted with a red arrow.
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Figure 3.62 Western blots of transgenic fly head extracts
Protein extracts were generated from Cds transgenic fly heads and 
were blotted with a Potassium channel protein extract (KRIII) 
which was used as a control (~160kDa) (courtesy of Dr R 
Padinjat). The blots were incubated with anti-GFP primary 
antibody and then with anti-rabbit horseradish peroxidase (HRP) 
conjugated seconday antibody. As can be seen from the blot only 
non-specific bands were produced in the Cds samples. The 
conclusions were that no protein was being expressed or that the 
level of expression was too low to be detected by immunoblotting.
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Since there was lack o f protein expression, evidence for RNA expression was 
determined. RNA was extracted (see section 2.3.2.1-2) from the progeny o f rhodopsin 
driven GAL4 expressing flies crossed with the Cds transgenic flies (Rhl-GAL4*UAS- 
cds) and RT-PCR experiments were performed (see section 2.3.2.3) (figure 3.63). 
Primers that were used were CdslintronlF with Cdslintron8R and Cds2intronlF with 
Mex7R (see tables 3.7 and 3.9 for sequence information) as well as primers to amplify 
the GFP tag (primers GFPC and GFPD, see table 3.14). Expression o f both genes and 
GFP was observed. These experiments show that the gene and the GFP tag are present 
and being transcribed in the transgenic flies but the protein is not being expressed.
Since low-level expression in adult flies can be difficult to observe, expression of the 
proteins were examined in the transgenic embryos since this is where the proteins are 
usually most highly expressed. The engrailed-GAL4 (en-GAL4) promoter was used for 
this experiment instead o f the Rhl-GAL4 promoter. The en-GAL4 is one o f the 
strongest drivers available for this type o f experiment. The driver uses the engrailed 
gene, which defines segmentation in the developing embryo so if  the transgenic proteins 
are being expressed they will follow the segmentation pattern o f expression shown by 
characteristic stripes. The results o f this experiment are shown in figure 3.64. The 
positive control (courtesy o f Dr Raghu Padinjat) shows expression, but no expression is 
observed in either o f the Cds transgene embryos.
3.7.3 Discussion points of section 3.7
Experiments to rescue the cds mutant fly phenotype were not pursued since there was 
no evidence, from the results reported in this section, to suggest expression o f the Cds 
proteins. The conclusions that can be drawn from these experiments are that the 
transgenic fly lines do not express protein in the tissues checked or that the level o f  
expression was too low to be able to detect by the procedures employed above.
However the RNA transcribed from the transgenes seems to be present in the transgenic 
flies. There are various reasons as to why no protein was detected in these experiments 
and these will be discussed in detail in chapter 4.
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Figure 3.63 RT-PCR experiments using transgenic fly RNA extracts
RT-PCR was performed using RNA extracted from Cds transgenic flies as template. These experiments were 
performed to check that transgenic RNA was being produced. From the photographs shown above, it can be seen 
that RNA from Cdl and Cds2 is present and gives a band of around 800bp. The third photograph shows that the 
GFP tag is also present in the transgenic DNA (using primers GAL41/GAL42 (provided by Dr R Padinjat) and is 
also approximately 800bp. The relevant controls were also performed and shown in the photographs
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Figure 3.64 Detection of transgene in embryos using the en- 
GAL4 promoter
(A) positive control transgenic fly embryo where expression can be 
observed in the position where the protein encoded by the engrailed 
gene is expressed (indicated by the arrows). (B) shows the Cdsl 
transgenic fly embryo resulting from a cross with the flies 
expressing en-GAL4 promoter, no expression of the transgenic 
protein is observed. (C) shows the Cds2 transgenic fly, crossed in 
the same way as (B), again no protein expression is observed.
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3.8 Cds2 Targeting Construct
3.8.1 Construct vector pPNT
The expression vector, designed for construct production (Tybulewicz et al., 1991), 
pPNT was used in this experiment (see figure 3.65). The vector pPNT contains several 
unique restriction sites, which are utilised for inserting specific genomic gene fragments 
into the vector. These gene fragments are inserted around a neomycin cassette using the 
unique vector sites. The role o f the neomycin cassette in the construct vector is two 
fold; it disrupts the regions o f specific gene fragments and it conveys resistance to the 
antibiotic neomycin. Resistance to neomycin is one o f the two selectable markers used 
for positively identifying targeted embryonic stem (ES) cell colonies. The second 
selectable marker is the thymidine kinase gene, also present in the pPNT vector, and 
causes susceptibility to the antibiotic gancyclovir. When successful homologous 
recombination (described in section 1.3.2) occurs between the ES cell DNA and the 
transfected construct DNA the position o f the vector’s selectable marker genes is such 
that the neomycin cassette is carried into the targeted ES cell DNA with the gene 
specific fragments surrounding it and the thymidine kinase gene excluded. This allows 
positively targeted cells to grow in media containing both neomycin and gancyclovir.
3.8.2 Cds2 knockout construct production
The data that was gathered in sections 3.2 and 3.4, was used to form the knockout 
mouse construct. The clone 20 A (see section 3.4) was used in the production o f the 
construct. As described in section 3 .4 ,20A was digested using Notl and Hindlll 
restriction enzymes (see section 2.3.1.9) and the resulting fragments were subcloned 
into pBluescript SK+ vectors (see section 2.3.1.13-14). The adjacently positioned 1.5kb 
and 6kb Hindlll fragments contained all the Cds2 genomic information from clone 20A. 
The restriction map deduced from data gathered in sections 3.2 and 3.4 is shown in 
figure 3.66. It was decided that exon 6 o f Cds2 would be targeted, with the neomycin 
cassette replacing half o f exon 6 and approximately 90bp o f intron 6. Using the map o f  
pPNT (figure 3.65) the unique Xhol and BamRl situated either side o f the neomycin 
cassette sites were selected for insertion o f Cds2 genomic fragments.
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Figure 3.65 pPNT vector
The figure shows a schematic representation of the pPNT vector used to 
form the Cds2 knockout construct. The restriction sites that were known 
to be unique are highlighted with stars. The unique BamWl and Xhol sites 
were used to insert the gene specific fragments.
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Figure 3.66 Wild type and targeted Cds2 structures
This figure shows a schematic representation of the genomic structure wild type Cds2 compared to the structure which would 
be seen in targeted ES cells, where a neomycin cassette is inserted into exon 6. The 750bp Pstl/BamHl probe, which was used 
in the detection of correctly targeted ES cells, is shown as a pale blue box. The important restriction sites are indicated, B- 
BamHl, H-Hindill, P-PstI and E-EcoR\. The BamUl and EcoRl sites after the neomycin cassette in the recombinant structure 
are sites acquired from the insertion of the 3kb Bamlil fragment and are derived from pBluescript vector.
3.8.2.1 3kb BamYll construct fragment
The 6kb Hindlll fragment containing most of intron 6 to 12 was used to produce the 
3kb construct fragment (figure 3.67). The 6kb Hindlll fragment derived from 20A was 
digested using BamYll. The pBluescript vector (in which the 6kb fragment was 
contained), BamYll site was used and formed the 3kb fragment with the central BamYll 
site situated in intron 8. The 3kb BamYll fragment which was produced, was excised 
from the agarose gel (see section 2.3.1.10) and purified using a Wizard™ spin column 
(Promega). The fragment was then cloned into the BamYll site in the pPNT vector. To 
ensure the fragment was inserted into the vector in the correct orientation, it was 
sequenced (see section 2.3.1.18) using the primers listed in table 3.16.
Cds2int7F CCAGGTAACACTAATATTGG
CDS2INTRON3R CAGATTAAGTGTTTCCATG
1500F3 GTAACGCAGTCACACCTTGT
Table 3.16 The primer name and sequence used to verify the orientation of the gene 
fragments within the pPNT expression vector.
3.8.2.2 1.4kb X hol construct fragment
The second fragment to be inserted into the pPNT construct vector was a 1.4kb Xhol 
fragment generated from the 1.5kb NotVHindlll fragment derived from 20A. The 1.5kb 
NotUHindlll fragment contains 150bp of intron 3 - 5 ’ end of intron 6 (figure 3.68). 
Since the restriction map generated for the 1.5kb NotUHindlll fragment did not provide 
any suitable restriction sites for cloning into the pPNT vector, primers with Xhol tags 
(listed in table 3.17) were designed against sequence derived from intron 3 and exon 6. 
The primers were used to amplify a 1.4kb Xhol fragment using the 1.5kb NotUHindlll 
fragment as template (see section 2.3.1.16). The PCR product was cloned into a pGEM 
T-Easy vector and the insert excised using the restriction Xhol to ensure the tags were in 
place. The fragment was excised from an agarose gel and purified as before. The 
purified Xhol fragment was then subcloned into the unique Xhol site in the pPNT vector 
which already contained the 3kb BamYll fragment.
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Figure 3.67 The generation of the 3’ Cds2 construct fragment
Shown is a schematic illustration of the 3kb BamHl fragment that was used as the 3' construct gene fragment. 
The fragment was derived from the 6k Hindlll clone and utilises one of the vector restriction sites to create 
the fragment of interest. This fragment was then cloned into the pPNT expression vector.
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Figure 3.68 The generation of the 5’ Cds2 construct fragment
Shown is a schematic illustration of the 1.4kb fragment that was used as the 5' construct gene fragment. The 
fragment was amplified from the 1.5k Hindlll clone using the primers Con IF and Con6R. This fragment was 
then cloned into the pPNT expression vector.
To ensure that the Xhol fragment had been inserted in the correct orientation and the 
subsequent sequence was not in frame preventing normal protein production, the 
construct was sequenced using the primers listed in table 3.18. A summary of the 
production is schematically illustrated in figure 3.69. A Maxi prep was prepared (see 
section 2.3.1.2) for the construct and was linearised using the unique Notl site in the 
pPNT vector.
Primer Name_______________ Primer Sequence 5 ,I l3 r
CDS2ConF 1 GGCCTCGAGG AGCTC AATT AACC
CDS2Con6Rl CGCCCTCGAGCAAGTTAGGATAACAAGGT
Table 3.17 Xhol tagged primers used to generate the 5’ gene fragment for the Cds 2 
knockout mouse construct.
I nt 5 F G C A T G C A T T G T C C A I G T C T G
SIF3 GTAACGCAGTCACACCTTGT
ConFor CAGGACGTGACAAAT
Con2R ATTTGTCACGTCCTGCACGA
Table 3.18 Primers used to verify orientation and to verify that there is a stop codon 
present to prematurely terminate the translation of the gene.
3.8.3 Embryonic stem (ES) cell electroporation
The linearised construct DNA was given to Dr Kim Wells of the Transgenic unit, 
Imperial School of Medicine, Charing Cross hospital, for electroporation into ES cells 
(see section 2.3.1.12.3). All ES cell work was performed by Dr K Wells.
lxlO7 cells in a volume of 0.6ml cold PBS were electroporated with either 25 pg or 6pg 
of linearised CDS2 plasmid at 250volts 500pF in a Biorad Gene Pulser (0.4mm 
cuvette).
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table 3.14. The construct was then linearised 
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Figure 3.69 The steps taken to form the Cds2 construct
Shown is a schematic illustration of the steps carried out to prepare the Cds2
knockout construct.
743
After incubating on ice, the cells were suspended in 22ml o f fresh media and plated out 
onto three plates, two plates with 10ml of the cell suspension and a third plate with 2mls 
diluted out to 10ml final. This third plate was subjected to G418 selection only as a 
control for transfection and plating efficiency. A mock transfection was also carried 
out. After two days in culture the plates were changed to media containing 2pM 
gancyclovir and 200pg/ml G418. Selection was maintained for 8 days by which time 
there were no surviving colonies in the mock transfected control plates.
A total o f 26 ‘healthy’ colonies were picked from plates subjected to positive selection 
with G418 only. These plates contained a tenth o f the cell number plated on the double 
selection plates. This colony number is therefore equivalent to 260 clones, which is a 
lower number than expected. Three clones were obtained from double selection, this 
equated to 1.15% of the total number o f transfectants. The number o f targeted clones 
seems acceptable for the percentage o f homologous integration events in transfected 
clones. However, the total number of transfectants initially obtained was a lower than 
expected. DNA was prepared (see section 2.3.1.7) from the selected colonies.
3.8.4 Screening of potentially targeted ES cells
lOpg o f each o f the potentially targeted DNA samples were restriction digested using 
enzyme EcoBl and Southern blotted (see section 2.3.1.11). A probe was generated from 
the 6kb Hindlll fragment (derived from clone 20A) that was outside the area used in the 
construct production. The 750bp PstI/BamHI fragment (figure 3.68) was 32P- 
radiolabelled (see section 2.3.1.20) and used in a hybridisation reaction (see section 
2.3.1.21) with the Southern blot. In wild type DNA the probe fragment should 
hybridise to a 15kb EcoKL fragment. Figure 3.70 shows the wildtype band produced 
when wildtype mouse genomic DNA is probed with the 750bp fragment. Use was 
made o f the EcoRl site, which had been incorporated into the construct with the 3kb 
BamHI fragment when it was inserted into the pPNT vector (figure 3.67). Thus 
targeted DNA should show two bands on an autoradiograph, one from the wild type 
gene and another smaller band from the targeted gene. Unfortunately none o f the 
samples showed this double-band profile and it was considered that no homologous 
recombination had taken place.
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Figure 3.10 Control Southern blot for assessment of future targeted ES cells
Shown is a Southern blot autoradiograph of mouse genomic DNA digested with 
the restriction enzyme £coRI. The blot was probed with the 750bp fragment 
derived from intron 9 (figure 3.66). A band of ~17kb was observed. This control 
shows that future targeted ES cells should produce a band smaller than 17kb 
when probed with the same fragment due to the iscoRI site that was inserted 
when the construct was made.
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Several further electroporation runs were performed altering some o f the variables such 
as, the quantity o f DNA used for electroporation, the number o f cell in the cuvette and 
the concentrations o f the antibiotics used. The results from these experiments suggested 
that the level o f G418 selection may be too stringent as the single selection plates 
should have had dozens o f colonies whereas there were only a few.
A dose response curve was prepared comparing another expresion vector (PGKneo) to 
the pPNT vector (empty vectors used). 40fig of linearised plasmid was used and 0.8ml 
o f cells at 1 x l0 7/ml. The DNA was dissolved in sterile lOmM Tris O.lmM EDTA 
pH7.5. The rest o f the experimental conditions were as described above. Selection was 
applied on day two after electroporation. The electroporated cells were split onto 5 
plates and the following concentrations of active G418 were used: 200,190,180  
170mg/ml or no selection. The media were changed every day and the colonies 
assessed after 10 days o f selection (figure 3.71). The results from this experiment are 
shown graphically in figure 3.72.
Based on the data derived from the control experiments described above, the final 
targeting electroporation was carried out using 50pg o f linearised plasmid, either the 
CDS2 construct or empty pPNT vector, transfected into cells at a concentration o f 0.8 
ml at 1 x 10 cells/ml, with electroporation conditions as previously described.
Selection was performed two days after electroporation with either G418 alone at 
170pg/ml or dual selection G418 170pg/ml and 2pM Gancyclovir. Photographs o f  
single and dual selection plates, stained in the same way as in figure 3.74, were taken 
after 10 days o f selection (figure 3.73). These show that cells containing the empty 
vector grow reasonably well, but when Cds2 gene fragments are inserted very few 
colonies grow. Hence the targeting experiments using the Cds2 construct described 
above were not pursued.
3.8.S Discussion point of section 3.8
From the results o f all o f the above experiments, it appears that the colonies, which 
were tested from the first round, did not contain the targeted gene. It may be that the 
clones from the first round o f cells were dying and not actively growing at the time o f  
picking from the plate and that the cultures were overgrown with non-G418 resistant 
cells once the selection was removed. Another interesting result, and will be discussed
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Figure 3.71 ES cells transfected with control PGKneo vector
ES cells transfected with PGKneo vector which have been fixed and 
stained with haematoxylin. The colonies were grown on plates, 
clockwise from top left, containing 180jig/ml, 170pg/ml, 190pg/ml 
and 200pg/ml of G418. A fixed size central square from each plate 
was imaged and the number of objects and their pixel size was 
assessed using SigmaScan (picture courtesy of Dr K. Wells)
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Figure 3.72 PGKneo vs. pPNT colony count/drug dose graph
The number of colonies containing PGKneo vector compared to 
pPNT vector present on plates containing 170-200pg of G418 
antibiotics (courtesy of Dr K. Wells).
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Dual selection Single selection
Figure 3.73 Dual and single drug selection of Cds2 targeted ES cells
Shown are the fixed, stained plates of dual and single selection of Cds2 
construct. Dual selection with gancyclovir and G418 (top left), and single 
selections with G418 alone of pPNT vector (top right) and Cds2 construct 
(bottom right) (picture courtesy of Dr K. Wells).
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further in chapter 4, was that although the number o f colonies on the ‘pPNT vector 
only’ plate were lower than that o f the other PGKneo vector, they were still present in a 
reasonable amount. However, when the construct containing Cds2 DNA was 
introduced into the ES cells, the number o f colonies on the plates were substantially 
reduced.
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3.9 Patient Screening
Human CDS1 was mapped to chromosome 4q 12-22 and CDS2 to 20pl3 (Halford et al., 1998, 
Volta et al., 1999). The region 4q21-22 does not contain any ocular disease loci but two disease 
loci with ocular phenotypes are localised to the 20pl3 region. These are neuron degeneration 
with brain iron accumulation 1 (NBIA1) which was previously called Hallervorden-Spatz 
disease, which often shows retinal degeneration and optic atrophy as secondary features, and 
congenital hereditary endothelial dystrophy of the cornea (CHED2). Recently, mutations in 
pantothenate kinase were shown to be responsible for NBIA1 (Zhou et al, 2001).
CHED can be inherited as both an autosomal dominant, CHED1, and an autosomal recessive 
disease, CHED2 (Maumenee, 1960). Both disorders are characterised by diffuse oedema that 
varies in severity from a mild haze to an opaque cornea and is generally present at birth or 
shortly after, with little progression. Both CHED1 and CHED2 map to chromosome 20. The 
gene responsible for CHED1 has been mapped to chromosome 20pl 1.2 (Toma et al., 1995) and 
that for CHED2 to 20pl3 (Callaghan et al., 1999, Hand et al., 1999). The CHED2 disease locus 
spans 3.4 Mb of DNA in a relatively gene dense interval (Mohamed et al., 2001Deloukas et al., 
2001).
Using in situ hybridisation, Cds2 was found to be expressed in the cornea (figure 3.46); 
this data combined with the map location o f the gene, suggested that CDS2 is a good 
candidate gene for CHED2. In order to assess this possibility the genomic organisation 
o f human CDS2 was determined, using methods described in sections 3.1-3.4, and this 
information was used for mutation screening in a CHED2 family. Table 3.19 provides 
information about the exon-intron boundaries of human CDS2 generated from PAC 
clones known to contain the gene (Halford, personal communication). Using the exon- 
intron boundary information generated from the PAC clones, PCR primers (table 3.20) 
were designed to amplify the thirteen exons o f the CDS2 gene in two affected and one 
normal member o f the CHED2 Pakistani family described by Mohamed et al. (2001). 
The exons were amplified (section 2.3.1.6), directly sequenced (2.3.1.18), and compared 
to the known exon sequence. The exon-intron boundaries were also sequenced and 
analysed. No changes were detected in the exon-intron boundaries or in the coding 
region o f the gene, making it highly unlikely that that CDS2 is responsible for the
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Exon Exon size 
(bp)
5’ intron Exon sequence 3’ intron Intron size 
(bp)
1 57* 5’UTR ATGACAGAGC ---------CGAGGACAAG gtagcggcagcgtcggggtg 46373
2 137 tctgtatttctgccacttag GAGTCAGAGT -------- TGTCTTCAAG gtaacctggcttaatgatgc 1523
3 97 tcccctgctctctgacctag ATGGAAGAAC------- ---------GATGATAATC gtaagtgccatttcacacta 1368
4 98 gaatgttttgtgtcccgcag GTGATGTGCG---------------- CGCTCAGCTG gtaagctctccggccccaca 2071
5 140 tgacctgtcttcatttacag GTACTTTCTC-------- --------TATCTAATAG gtatgcattaagcagttcac 3430
6 59 ctcctcccacctcaaactag GATTCTGCAT-------- -------- GTTCTACATG gtaaaggaaatgcatgcgtg 615
7 83 tatttttcttttttttgcag TTTGGCTGGA----------------GAATGATCTG gtgagaattgggagttggat 1714
8 88 tactttggttcatttctag GTTCATTGTC ACTCATCAAG gtaaatggattaccctaag 812
9 69 aacttgctctctgtccacag CTGTCCCCGA TGGCCTTCTG gtaggtggtggctttcagct 860
10 153 tctctgttattcctcctcag CTGTCCTATG-------- -------- CATTGGCTGG gtatgtgccactcacagggg 2227
11 120 acttcatttactcttctcag AAAACGGTCC-------- -------- TAAAATCAAA gtaggaaaaccgtcttacgt 548
12 104 ccttcccctgcctctaacag GACTTTGCCA-------- --------GTTTTATCAG gtatagtacctttccatctg 263
13 133A ttcttcacattctgttccag AGGCCCTAAC-------- -------- GGACGAGTAG 3’UTR
Table 3.19 The exon-intron boundaries o f human CDS2. (* Length from translational start site, A Length to stop codon)
comeal dystrophy seen in this family. This work has subsequently been published 
Halford et al., 2002 (appendix 1).
Exon Primer sequence Amplimer
(bp)
1 F 5’- GGCTGCTAAGGGAACTGTCAG-3’
R 5 ’-AAGGGTCAGAGAACAAGACGAC-3 ’
305
2 F 5 ’-ATGACAGGCATAGACTTCTC-3 ’ 
R 5 ’-CCACTGCTAAGCACTAGATT-3 ’
383
3 F 5 ’-GTGAATCTGGAAAGGACTGA-3 ’ 
R 5 ’-AGTCACAGATGTTCTATGGC-3 ’
369
4 F 5 ’-TCATGACCTGTTGGTTTCCA-3 ’ 
R 5 ’-CCTCTCCAGCATTTATCTCT-3 ’
286
5 F 5’- ATTTCTCACCTACGGTGTCA-3’ 
R 5’- ATTTCTCACCTACGGTGTCA-3’
446
6 F 5 ’-CTGCTGGGAATAAATTAGCC-3 ’ 
R 5 ’-CCTTCATGCTCTAGATGCAT-3 ’
305
7 F 5’- CCTGATCTTACCTGTTCACT-3 ’ 
R 5 ’-CTGTGCTATAATGAACCCTG-3 ’
366
8 F 5 ’-ACTCCTTAATGGGTTACCAG-3 ’ 
R 5 ’-CTAGATTTCTTCTGTCTGCC-3 ’
309
9 F 5 ’-GACATGGTTAAGAGAATGGG-3 ’ 
R 5 ’-AGAAGGCTACCTGCTGATG-3 ’
433
10 F 5 ’-CATGAACCTCTGAGCACATA-3 ’ 
R 5 ’-GAGCAATTCTCCTTCATCCT-3 ’
429
11 F 5 ’-GGCCACAATGAGGATGAAAT-3 ’ 
R 5 ’-CTAAATTCAGTGCATGGGTC-3 ’
359
12 F 5 ’-TGTCCTAATATAGCCTCACC-3 ’ 
R 5 ’-ATTAACAGATGACAGGAGGC-3 ’
420
13 F 5 ’-GCCTCCTGTCATCTGTTAAT-3 ’ 
R 5 ’-GTCATTGTCTAAGTCACACC-3 ’
343
Table 3.20 Primer pairs for CDS2 mutation analysis.
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CHAPTER FOUR 
DISCUSSION
4.1 RNA MasterBlots™
The results o f the MasterBlots™ (see section 3.6.1) showed that Cdsl and Cds2 had 
very different expression patterns. It was apparent that Cds2 was a ubiquitously 
expressed gene and was involved in the development o f the embryo from as early as 
7.5d.p.c whereas Cdsl had a more restricted pattern of expression and was not 
expressed in the embryonic samples. However previous reports indicate that Cdsl is 
expressed in the embryo although only at 12d.p.c and only in the thymic rudiment 
(Volta, et al., 1999). Volta et al. (1999) also reported the embryonic expression of 
Cds2. They report that expression appears from 12.5d.p.c onwards, yet the blot shown 
in figure 3.43c clearly shows expression from a much earlier time point. Only by 
studying timed embryo sections more closely will these finding be confirmed.
The E.coli DNA negative control was briefly discussed in section 3.6.1.2, further to the 
discussion in the previous section, an alignment o f the E.coli cds and mouse Cdsl and 
Cds2 amino acid sequences were performed (figure 4.1a and 4.1b). The figures show 
that there is a region o f high homology between residues 216 and 222 (using the E.coli 
sequence as reference) equating to an identity o f potentially 20 nucleotides. Since 
oligonucleotide sequences as short as 20 base pairs can be used as primers or probes, 
this is possibly a large enough region o f homology to allow hybridisation to occur. 
Since the E.coli genome does not have introns, this region o f homology is continuous 
and the cDNA probes generated from the mouse Cds clones may provide sufficient 
homology to result in hybridisation. This is reinforced by the alignments shown in 
figure 3.32, where the yeast samples have a greater degree o f homology to Cds than 
E.coli, but due to the presence o f introns in the yeast genome, hybridisation to the 
control yeast sample does not occur. In addition to the evidence provided by the 
negative controls, the data gathered from the MasterBlots™ for Cdsl and Cds2 are 
validated since the genes display very different patterns o f expression, hence implying 
that cross-hybridisation did not occur. The same clones, 801-h9 and 1247-c2, which 
were used to make the cDNA probes used on the MasterBlot™, were used to make the 
riboprobes which were used for the in situ hybridisation studies shown in figures 3.44
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Cdsl mouse aa 
E .c o l i  CDS
LRHF GGCPGPGGAGAPPLREGEAAGGDHETESTSDKETDIDDRYGDLDARGDSDVPE 60
AWEVG-----------------------------------------------------------------------------------------  8
Cdsl mouse aa 
E .c o l i  CDS
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LSG-Tl R5QR\
R/VKNV WIRGIL1 LTMISLFFL
AVLCGLL
tTIYMGSF ML 
— ALML
aL^LGIQV
LL3-EYHR
120
42
Cdsl mouse aa KCFHEII1
E .c o l i  cds NIHQPLVE 1 5
Gyrvyhsyc
LWA 5
W'RTLE 
W
:VNYFFY
-LLVL
5ET\
FY^GS/
ApYFATFVC REEQLQF 
 IV R'JSKT-
L1 
L-
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83
Cdsl mouse aa RYFRFI
E .c o l i  cds — RLI
ALYLAGFCMF1VL 
VL
V<KHYRL(F 
 F
VMF/ WFHVTLLITVTQ5
W5 MLALRAVHi'-DE
LVIC LF
HYS
EG 240
116
Cdsl mouse aa 
E .c o l i  cds iv'PISE YVMILvrOWG/ DIDSdAYMFGKUFGKFGFRFGRTFHE K . S PS P l KTW:KTW' GFIGGGFIGG -FS1LATA/ — FGSWG'i F I  AGMA\I 295176
Cdsl mouse aa 
E .c o l i  cds
YVLSKYQYFVjC
LDVAPVTLLiC
PVEYRSDVNSF
5 1 ----------
VFECEPSELFQLQNYSLPPF 
A A------------------------
L3/ V4SRETVSLYPFQIH 355
V .----------------------  197
Cdsl mouse aa 
E .c o l i  cds
SIALSTFASLIGPF iFF/S(JFKR  ^
)LTE S
F AFKIKD- 
MFKREACIKD5
:AN'
;ghi
1  ^ DRlF
L I P G H G C  . DRl
DCQ'i
DS - L1
TF
A A -
VFVYIT
VFVFAC
415
240
Cdsl mouse aa 
E .c o l i  cds
SFIRGPNPSKVLQC LL 
------------------------LL
L^PEQQLNDRTL
-VFRTL
KIHLTEKGILQPTLKV 461
249
Figure 4.1a E.coli cds and mouse C dsl amino acid alignment
Shown is the alignment between the two cds amino acid sequences, the overall homology is ~20% with the E.coli sequence spanning a 
much shorter distance. The shaded area shows regions of similarity and the boxed and shaded area shows regions of identity. The 
area highlighted in red is a stretch of seven amino acids, which are identical. This region of the sequence may be the reason why the 
E.coli DNA control on the MasterBlot™ many have been positive.
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Figure 4.1b E.coli cds and mouse Cds2 amino acid alignment
Shown is the alignment between the two cds amino acid sequences, the overall homology is 20% with the E.coli sequence 
spanning a much shorter distance. The shaded area shows regions of similarity and the boxed and shaded area shows 
regions of identity. The area highlighted in red is a stretch of seven amino acids, which are identical. This region of the 
sequence may be the reason why the E.coli DNA control on the MasterBlot™ many have been positive.
to 3.55 (discussed in section 4.3). In situ hybridisation on tissue sections using 
riboprobes is generally regarded as being more sensitive than techniques such as the 
Masterblot™ since RNA probes detect gene transcripts when using in situ hybridisation 
compared to cDNA probing RNA samples on the MasterBlot™. No cross-hybridisation 
was
observed in the in situ hybridisation studies. Therefore, the pattern o f expression 
derived from the MasterBlot™ should be regarded as an accurate interpretation o f the 
expression pattern o f murine Cdsl and Cds2.
4.3 Northern Blots
The Northern blots shown in figures 3.42 and 3.43 provide evidence for more than one 
transcript for each gene. This is most likely due to the presence o f different size splice 
variants that exist for each gene. There is evidence that the human CDS gene has splice 
variants (Volta et al.t 1999; S. Halford, personal communication). Hence the true 
transcript size is most likely to be ~4kb in length, with the smaller bands representing 
the splice variant sizes where certain exons have been excluded. The data presented in 
sections 3.6.1 and 3.6.2 differs from data reported by Lykidis et al. (1997), who report 
low levels o f expression o f human CDS1 in the brain, lung, placenta, small intestine, 
ovary and testis using Northern blotting. In these tissues they identified two transcripts 
o f 5.6kb and 3.9kb. Lykidis et al. (1997) used human tissue however mouse and human 
Cdsl transcripts are o f a similar length as regards to the coding and 3' UTR sequences 
(described in 3.1). Therefore, unless the 5' UTR is much greater in human than in 
mouse, these findings confer differences between the two sets o f results. Another 
finding reported by Lykidis et al. (1997) that differs from results reported in this thesis 
is that when foetal tissue was used to form the Northern blot, transcripts were identified 
in lung, kidney and brain samples. These results are surprising since clearly there was 
no expression in foetal samples in figure 3.41a when probed with Cdsl and the only 
report to suggest that Cdsl is expressed in the embryo identifies a specific time point 
and with expression only present in the thymus. Volta et al. (1999) reported findings 
from Northern blots probed with human CDS2, in which three transcript lengths, 9.5,
4.4 and ~3kb, were identified and found to be expressed at different levels. Again, 
these results differ from the finding reported in this thesis. In order to verify these 
previously reported findings, various improvements to the Northern blot filters prepared
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in this study should be performed, this will be discussed in chapter five which will 
detail all future work.
4.4 In situ hybridisation studies
The results reported in section 3.6.3, were interesting since both Cds genes evolved 
from a single ancestral Drosophila gene (figure 3.33), they display very different 
expression patterns, including very different locations within the ocular tissues. Cds2, 
shares more sequence homology (57%) than Cdsl (56%) to Drosophila eye-cds but 
does not have an expression pattern to suggest that it plays a direct role in 
phototransduction. This variant, may have a more general signalling role. The data 
gathered from the comeal sections shows that Cds2 is expressed in this tissue. As 
described in the introductory chapter the chromosomal map location o f human CDS2, 
20pl3, includes various ocular diseases including autosomal recessive congenital 
hereditary endothelial dystrophy (CHED2). CHED2 patients experience diffuse 
bilateral clouding o f the cornea caused by an abnormality in the endothelium with many 
patients requiring comeal transplantation to restore vision (Hand et al., 1999). Since the 
expression data indicated a role for Cds2 in the cornea, screening o f CHED2 patients 
could eliminate Cds2 as the causative gene. Results previously reported by Volta et al. 
(1999) claimed that Cds2 was not expressed in the adult retina. This finding is very 
much the converse o f data reported in this thesis (figure 3.48).
Another finding by Volta et al. (1999), which disagrees with results reported here, is 
that Cdsl is expressed in the inner segments o f the photoreceptor layer o f the retina, 
whereas as reported here, there is also expression in the ganglion cell layer (figure 
3.45). The location o f the Cdsl molecule in the inner segments o f the photoreceptors 
suggests that this gene may play a direct role in phototransduction. The inner segments 
contain the cytoplasmic machinery for the synthesis o f proteins, the production o f  
energy-rich nucleoside triphosphate and the assembly o f disc membranes. Other 
molecules known to play an important role in phototransduction, such as rhodopsin, 
show a similar spatial and temporal expression pattern in the inner segments (Ishiguro et 
al., 1987; Bowes et al., 1988). The RT-PCR and in situ studies using the rd mice 
proved interesting as it was shown that Cdsl is expressed only in the rod
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photoreceptors. However, the function of Cdsl is likely only to be defined by the 
production o f a knockout mouse model.
Chapter five will describe some o f the future work that is required to elucidate the type 
o f photoreceptor cells expressing Cdsl, what the function o f both the Cdsl and Cds2 
genes are and whether they can be excluded from causing specific ocular diseases.
4.5 Epitope tagging and subcellular localisation o f  Cdsl and Cds2
The set o f experiments performed in section 3.6.5 were done in order to elucidate the 
molecular weight o f the Cds proteins after translation and to localise them subcellularly. 
As described in section 3.6.5 the Western blots prepared to elucidate the size o f the 
protein produced a number o f non-specific bands, which were at first thought to be lack 
o f specificity on behalf o f the commercial antibody against c-myc. The cells were then 
transfected and immunostained prior to examination by fluorescence microscopy. The 
cells had an appearance that would suggest that an apoptotic event had occurred. This 
suggested that the antibody may have been working but the cells had not produced any 
myc-tagged protein hence the non-specific bands.
Apoptosis may have occurred in the transfected cell as a result o f an accumulation o f  
mis- or un-folded proteins in the endoplasmic reticulum (ER). The ER is a vast 
structure, which post-translationally modifies proteins and folds them into their tertiary 
structure before directing them to their final locations. The unfolded protein response 
(UPR) constitutes stress signalling from the ER lumen to the nucleus in response to 
accumulation o f mis-folded or unfolded polypeptides (reviewed in Kaufman, 1999; 
Pahl, 1999; Mori, 2000). By pathways not fully characterised in mammals, the UPR 
may induce transcription o f additional chaperone molecules (to assist folding), 
attenuation o f translation (to prevent generation of more mutant protein), and 
mechanisms for protein degradation. Additional death-inducing signals are generated 
by the ER overload response (EOR). It is therefore, conceivable that the tags on the 
Cds proteins are interfering with the correct folding and overloading the ER hence 
inducing a stress signal culminating in programmed cell death (Plemper and Wolf, 
1999).
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In chapter five various future experiments will be outlined in order to re-address some 
of the points discussed in this section, such as ways around using tagged proteins, or 
using different expression systems and also ways to verify if  the cells described are 
really apoptotic.
4.6 Mutant fly  rescue system
The object o f this set o f experiments was to identify which if  either of the mouse Cds 
genes conferred a function similar enough to that o f the Drosophila eye-cds gene so as 
to rescue the mutant phenotype in the fly. This experiment has been successfully 
performed using a murine homologue o f the Drosophila gene rdgB (Chang et al., 1997), 
which is a gene required for phototransduction in the fly. Sequence information from 
both mouse genes suggest that Cds2 is more similar to Drosophila eye-cds but Cdsl has 
a retinal expression pattern which suggests it is more likely to be directly involved in 
phototransduction. Constructs were prepared for both Cdsl and Cds2 (see section 3.7 
for details). The results show, using RNA extracted from transgenic flies, that both the 
Cds genes and the green fluorescent protein (GFP) tag fused to the gene are present and 
being transcribed. However, no protein was detected by fluorescence, embryo 
immunostaining or by Western blots prepared from transgenic fly heads. This could be 
because the proteins are being translated but being rapidly degraded but more likely the 
information required to form viable proteins is not complete. The experiment carried 
out in this thesis was performed in the standard way, but recently as more genes are 
being analysed in this manner it has been found that many fail to form viable proteins. 
These genes are found only to form viable proteins when intronic sequence is present in 
the original construct (R. Padinjat, personal communication). The likely explanations 
for these findings is that enhancers o f the genes are present within introns and are 
required for proper protein expression or that the genes require all genomic information 
to produce all splice variants o f the gene, without intronic information this is not 
possible. To date not enough is known about splicing mechanisms and the full role o f  
the introns to speculate further in these findings. The construct used in this thesis was 
produced using cDNA before these observations were made. Results from the Northern 
blots and information about the human genes implies that splice variants exist for 
murine Cdsl and Cds2. The experiment was not completed in section 3.7, since no
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GFP expression was detected in the transgenic flies there was no evidence to suggest 
completing the crosses would rescue the cds mutant fly phenotype.
In the light o f recent findings from analysis o f other genes being examined in a similar 
way, chapter five details some future work that could change the outcome o f this type o f  
experiment and elucidate whether the murine Cds genes convey a similar function to 
those o f Drosophila cds.
4.7 Cds2 knockout mouse
Data gathered in this thesis after the production o f the Cds2 knockout construct, shows 
that the method used may not be the most optimal for the production o f the Cds2 mouse, 
and Cdsl appears to be a much better option for the method used. The MasterBlot™ 
results clearly show that Cds2 is expressed in all tissues and is present in very early 
embryonic samples. This indicates that removal o f Cds2 may result in embryonic 
lethality. The embryonic tissues that would be affected are not known and future in situ 
hybridisation studies could be performed to determine the exact time points and tissues 
expressing Cds2. A better approach for the production o f the Cds2 mouse is described 
later in this section.
An interesting finding to arise from this study is that the vector which was used (pPNT) 
has a lower transfection efficiency than some others which are available, and in future 
studies involving the production of knockout mice, pPNT should not be used. Table 4.1 
lists some o f the other vectors available with the PGKneo being the one o f future 
choice. Although the vector is not as strong as some listed in table 4.1, as figure 3.73 
illustrates, colonies are produced when empty vector is transfected into ES cells. 
However, when the vector contained some Cds2 sequence hardly any colonies grew. 
This suggests that the truncated sequence may be producing a poison sequence, which 
kills the cells. If this gene is to be pursued as a candidate for a knockout study, different 
regions o f the gene will have to be examined to identify a more suitable site for the 
introduction o f the neomycin cassette. In future studies, detailed in chapter 5, use 
should made o f p-lox sites when making the knockout constructs.
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The Crdlox  system is highly efficient for inducing genomic changes at a specific time 
in specific tissues. The Cre (cyclization recombination) recombinase is a 38kDa 
bacteriophage PI protein that catalyses recombination between two 34bp loxP (locus of 
X-over of PI) recognition sites without the need for any cofactors. Depending on the 
relative orientation and location of the loxP sites, Cre-mediated recombination results in 
DNA inversion, excision/integration, and translocation, thereby conferring flexibility 
(figure 4.2).
PMClneopA 13 1
RV4 . 0 1632 125
MClneobpA 464 36
TKneobpA 124 10
Pol2sneobpA 324 25
Pol2neobpA 788 61
pPNT 260 3
PGKneobpA 940 72
Table 4.1 Various knockout construct vectors with the average number of resistant 
colonies and their relative efficiency (taken from Gene Targeting -  A Practical 
Approach.).
The Cre//ox-directed engineering uses a construct containing loxP sites which 
introduced the sites into a specific chromosomal location by homologous recombination 
in ES cells and then deliver Cre to recombine them as required. By using this method, 
any embryonic lethality can be avoided so the function of the gene in the adult can be 
examined (Araki et al., 1995; Rajewsky et al., 1996; Sauer et al., 1998; Metzger and 
Feil, 1999; Metzger and Chambon, 2001; Ryding et al., 2001). The system will be of 
most use for disruption of Cds2, where expression of the transgene will not be initiated 
until adulthood. It is possible to use specific Cre, whereby activity could be 
concentrated in a specific tissue (table 4.2), by introducing Cre driven by a tissue 
specific promoter, such as expression in the retina via a rhodopsin driven Cre. The 
specific Cre recombinases can be introduced at the transfected cell stage for immediate 
gene disruption effect, or can be introduced by breeding the inactive transgene 
containing mice with specific Cre-expressing mice, to produce progeny lacking the 
specific gene in a specific tissue. This procedure gives insight into the
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(b) (c) (d)
Excisionl
Inversions
 Integration
Translocation
(a)
I
5’ AT AACTT CGT AT AAT GT AT AT GCT AT ACG AAGTT AT 3’ 
3’ T ATT G AAGC AT ATT ACAT AT ACG AT AT GCTT CAAT A 5’
t
Figure 4.2 The Cre/lox site-specific recombination system.
Cre promotes site-specific recombination between two 34bp loxP recognition 
sequences (triangles), (a) The loxP sequence consists of two 13bp inverted 
repeats (horizontal arrows) flanking an 8bp asymmetric core region that 
confers an overall directionality. The two sites cleaved by Cre are indicated 
by vertical arrows, (b) Recombination between two loxP sites inserted into 
the same DNA molecule (intramolecular recombination) in opposite 
orientation leads to inversion of the intervening DNA segment, whereas
(c) recombination between directly repeated loxP sites results in excision of 
the flanked DNA region (circular product) leaving one loxP site behind. 
When the loxP sites are located on separate DNA molecules (intermolecular 
recombination), (c) DNA integration or (d) translocation can be achieved.
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functional role o f the gene under study without introducing the effect o f embryonic 
lethality.
4.7 Conclusions
In this thesis the isolation and characterisation o f both homologues o f the Drosophila 
eye-cds gene have been reported. The Drosophila eye-cds gene plays a key role in 
phototransduction and when mutated results in light induced retinal degeneration. In 
addition to the characterisation o f these genes, an expression study was performed and it 
was found that murine Cdsl is expressed only in a small number o f adult tissues in 
comparison to Cds2 which was expressed ubiquitously in both embryonic and adult 
tissues. More specifically in the eye, Cdsl is confined to the inner segments o f the 
retina whereas Cds2 is expressed in the cornea, cilary body and outer nuclear layer o f  
the retina. In an attempt to rescue the cds mutant fly phenotype, it was found that the 
cDNA construct approach was not always successful and evidence suggests that 
genomic DNA may be required to rescue the phenotype. In the production o f a 
knockout model o f Cds2 it was found that the region o f DNA used for the construct was 
effectively killing the ES cells. Hence, new strategies would have to be adopted if  the 
functional roles o f the murine Cds genes are to be elucidated.
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Tissue-Specific Cre mice
ma-Cre aA-crystal1in Eye Lens
CaMKIIa-Cre Calcium/calmodulin- Forebrain (CA1 pyramidal
dependent protein cells)
kinase Ila
PO-Cre PO gene Schwann cells
POMC-Cre Pro-opiomelanocortin Pituitary gland 
(intermediate lobe)
IRBP-Cre Interphotoreceptor Retina (photoreceptor
retinoid binding cells)
protein
Wntl-Cre Wnt-1 Nervous system
En2-Cre Engrailed-2 Nervous system
LcK-Cre Proximal lck T cells
CD19-Cre CD19 (knock in) B cells
aMHC-Cre a myosin heavy chain Heart (ventricular 
myocytes)
MLC2v-Cre Myosin light chain 2v Heart (ventricular
(knock in) myocytes)
MCK-Cre Muscle creatine 
kinase
Skeletal muscle, heart
RIP-Cre Insulin Pancreas (3 cells)
Alb-Cre Albumin 
enhancer/promoter
Liver
WAP-Cre Whey acidic protein Mammary gland, brain
BLG-Cre P-lactoglobin Mammary gland
AP2-Cre Adipose protein 2 Adipose tissue
K5-Cre Keratin 5 Skin (basal 
keratinocytes)
Inducible Cre mice
Mx-Cre Mxl (interferon- 
inducible)
Widespread
CMV-tTA/tetO-Cre Tet o / cytomegalovirus 
minimal 9tetracycline 
controlled)
Muscle, skin
Tamoxifen-activated Cre
Mice
CMV-CreERT Cytomegalovirus Widespread
Wnt1-CreERT Wnt-1 Nervous system
E(i/SV4 0 -CreERT Ig heavy chain B cells
enhancer/SV40 early 
minimal promoter
RU86-activated Cre mice
CaMKIIa-CrePRl Calcium/calmodulin­ Brain (cortex,
dependent protein hippocampus)
kinase Ila
Thyl-CrePRl thy-1 Brain
Table 4.2 Examples of tissue-specific and inducible Cre transgenic mice (Metzger and 
Feil, 1999).
265
CHAPTER FIVE 
FUTURE WORK
There are a number o f questions raised by the work in this thesis and future experiments 
on this project should be set out to answer them. Through the work carried out and 
presented here it is apparent that the genes are far more complex than first anticipated.
If the exciting goal o f producing animals lacking the Cdsl or Cds2 gene is to be met, 
then some further studies on these genes are required.
5,1 Gene structure studies
The potential presence o f splice variants in both genes has affected the outcome of  
several o f the experiments. If the Drosophila rescue experiments (more detail is given 
in section 5.5), are to proceed to identify the mouse Cds gene that is most similar in 
function to the Drosophila eye-cds, then any splice variants are required to be confirmed 
and the data considered when making a new rescue construct. The splice variants could 
be identified using a panel o f different tissue specific cDNAs as template in a PCR 
reaction with primers designed to the start and stop codons.
In order to form viable knockout constructs (more detail given in section 5.6), the 
intronic sequence from each gene is required to be examined for enhancers, promoters, 
or any other sequence motif which may affect the outcome o f the construct's viability. 
As reported earlier the gene fragments chosen previously to form the construct have 
been shown to kill the ES cells and the reason for this needs to be identified prior to the 
formation o f a new construct.
To date the sizes o f the full-length transcripts of mouse Cdsl and Cds2 remains 
unknown. In order to identify the transcript lengths, 5' and 3' RACE (rapid 
amplification o f cDNA ends) should be performed to identify the size o f the 3' and 5' 
UTRs. The 5' RACE experiment uses a primer which is designed to allow amplification 
from dC-tailed cDNA. Using this primer and two gene specific primers a nested PCR 
can be performed to amplify the 5' end. The same principles apply for 3f RACE only 
using an oligo dT primer which will bind to the poly A+ tail o f the gene. In both cases 
mouse brain cDNA should be used as template. The information gathered about the
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splice variants and the transcript lengths, should go some way to confirm the Northern 
blot findings in section 3.6.2.
5.2 Northern blot studies
The Northern blots produced in section 3.6.2 implied splice variants existed for each of 
the Cds genes. This information was valuable in deducing some reasons to explain the 
outcome o f the fly rescue experiments. To finalise the data a new blot should be 
prepared, using poly A+ RNA with greater purity than the previous attempt to verify the 
data reported. Ideally a commercial blot should be used to ensure a constant quantity 
and quality o f RNA used, unfortunately as yet there are no blots available that contain 
RNA from eye. The probes used on the blots should also be reconsidered in light o f  
splice variant information that might be found.
5.3 In situ Hybridisation studies
Possibly the most exciting data to be reported in this thesis was the expression patterns 
found in the adult tissue for Cdsl and Cds2. It would be interesting and useful to 
pursue the in situ hybridisation studies in timed embryos. The data that would be 
gathered from the embryos section would give a good idea o f the tempo-spatial 
expression o f Cds2 in the development o f the mouse. The developmental data would be 
useful when manipulating the expression o f a knockout construct in a future Cds2 
mouse model, to influence the point at which the disrupted gene is expressed to avoid 
certain critical time points or allow expression only in certain adult tissues. In addition 
to using the same probes to carry out the experiments listed above, any splice variants 
which were identified could be used to form riboprobes to screen both the embryos and 
the adults to isolate the location o f expression o f particular transcripts. Human sections 
could also be used to examine the expression o f the Cds genes to proceed further with 
the in situ hybridisation studies. The data gathered from these studies would show a 
much more in depth time course for Cds gene expression and may help deduce a 
possible functional role.
5.4 Protein studies
In this thesis attempts to find the subcellular location o f the Cds2 protein in mammalian 
cells resulted in cells which appeared to be apoptotic. This study would prove
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interesting if  the subcellular location was deduced as this may imply a functional role 
for the protein. The first experiment that is required to be performed is the 
establishment o f the cause o f cell death. The problem could be solved by TdT-mediated 
dUTP digoxygenin nick end labelling (TUNEL) staining o f the transfected cells which 
would identify truly apoptotic cells. If they proved to be apoptotic, the most likely 
cause is endoplasmic reticulum overload response due to mis-folded protein that results 
in a stress signal to the nucleus and culminates in apoptosis. This problem however, 
may be limited to mammalian cells, so yeast and bacterial expression systems should be 
transfected with the myc-tagged construct. If the outcome was as before then it would 
most likely be assumed that the myc-tag is interfering sufficiently with the protein 
folding to culminate in apoptosis. By the production o f native antibodies raised against 
Cdsl and Cds2, the problems with the tag could be eliminated and the subcellular 
location o f the protein determined and hence would identify the subcellular structures 
that had interactions with the Cds proteins.
5 .5 cds m utant D rosophila rescue studies
In chapter 3.7 an attempt to rescue the mutant cds fly phenotype was performed. It 
would still be very interesting to find out which o f the mouse Cds genes had a 
sufficiently similar function that they could rescue the mutant fly phenotype, and hence 
imply a functional role for the gene in the mouse. Taking into consideration all the data 
that has arisen since the first rescue construct was formed, future construct should be 
prepared not from cDNA, but instead from genomic DNA. In order to perform this, 
either the existing PAC clones (detailed in section 3.2 and 3.4) will have to be 
characterised and the relevant regions cloned, or new genomic phage clones will have to 
be identified. This again produces another question that needs to be addressed. How 
large is intron 1 o f Cds2? At the moment the answer is possibly up to 43kb. Probably 
only when the sequence o f the mouse PAC clone 439-n24 becomes available online will 
the size be deduced. With an intron of this size, the sequence data derived will be very 
interesting. As has been shown recently, the introns o f one gene may contain whole 
different genes which either run in a different direction or in a different frame from the 
original (Halford et al., 2001). It will be interesting to analyse Cds2 intron 1 for the 
presence o f other genes, enhancers or promoters that may have an effect on the 
expression o f the mouse gene in other species.
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5.6 Knockout mouse models.
Some very interesting data arose from this project which showed that many genes are 
far more complex then often originally anticipated. A very exciting aspect o f the 
project was the production o f the knockout mouse model o f Cds2. This study showed 
that the DNA used in these studies should be analysed closely as was seen in this 
project, the DNA used cause the ES cells to die. Data from this project showed that in 
order to form a viable construct various new considerations are required. The future 
work to more closely examine the intron structure will hopefully elucidate the reason 
why the first construct resulted in ES cell death. However, should the construct be 
remade with the MasterBlot™ data in mind, the knockout model should be made taking 
advantage o f the Crc/lox system (described in chapter 4). This system will allow the 
activation o f the transgene in a more controlled manner to hopefully avoid embryonic 
lethality due to the likelihood that Cds2 is a developmentally regulated gene. There 
may be more advantages to using Cdsl to form a knockout construct, the main 
advantage being the problems o f embryonic lethality expected from the Cds2 construct 
would be avoided since the MasterBlot™ showed no sign o f embryonic expression 
when probed with Cdsl. The data gathered from PAC clone 572-a24, should identify 
the most appropriate regions o f Cdsl for the formation o f the knockout construct. The 
pPNT vector should not be used in future studies, but instead pGKNEO (table 4.1) 
should be used as this vector appears to be more efficient.
The final issue to be addressed from work performed in this thesis, is the screening o f  
patients with diseases which have ocular phenotypes and a chromosomal map position 
close to that o f CDS1 or CDS2 (4q21 or 20pl3). Currently there are no diseases o f that 
nature described that map to a position close to 4q21, but this should be made an 
ongoing study. Even although CDS2 has been eliminated as the causative gene for 
CHED2, more possible candidate genes with ocular phenotypes should be screen when 
disease loci arise. Panels o f RP patients with no known causative gene should also be 
screened.
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